
<html lang="en"     class="pb-page"  data-request-id="a7de72ae-3a73-4927-ad82-fea8664835b9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-24;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c00894;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1" /></meta><meta name="dc.Creator" content="Paola  Munoz-Tello" /></meta><meta name="dc.Creator" content="Hua  Lin" /></meta><meta name="dc.Creator" content="Pasha  Khan" /></meta><meta name="dc.Creator" content="Ian Mitchelle S.  de Vera" /></meta><meta name="dc.Creator" content="Theodore M.  Kamenecka" /></meta><meta name="dc.Creator" content="Douglas J.  Kojetin" /></meta><meta name="dc.Description" content="Nurr1/NR4A2 is an orphan nuclear receptor transcription factor implicated as a drug target for neurological disorders including Alzheimer’s and Parkinson’s diseases. Previous studies identified sma..." /></meta><meta name="Description" content="Nurr1/NR4A2 is an orphan nuclear receptor transcription factor implicated as a drug target for neurological disorders including Alzheimer’s and Parkinson’s diseases. Previous studies identified sma..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 8, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00894" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00894" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00894" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00894" /></link>
        
    
    

<title>Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00894" /></meta><meta property="og:title" content="Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0011.jpeg" /></meta><meta property="og:description" content="Nurr1/NR4A2 is an orphan nuclear receptor transcription factor implicated as a drug target for neurological disorders including Alzheimer’s and Parkinson’s diseases. Previous studies identified small-molecule NR4A nuclear receptor modulators, but it remains unclear if these ligands affect transcription via direct binding to Nurr1. We assessed 12 ligands reported to affect NR4A activity for Nurr1-dependent and Nurr1-independent transcriptional effects and the ability to bind the Nurr1 ligand-binding domain (LBD). Protein NMR structural footprinting data show that amodiaquine, chloroquine, and cytosporone B bind the Nurr1 LBD; ligands that do not bind include C-DIM12, celastrol, camptothecin, IP7e, isoalantolactone, ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl]acetate (TMPA), and three high-throughput screening hit derivatives. Importantly, ligands that modulate Nurr1 transcription also show Nurr1-independent effects on transcription in a cell type-specific manner, indicating that care should be taken when interpreting the functional response of these ligands in transcriptional assays. These findings should help focus medicinal chemistry efforts that desire to optimize Nurr1-binding ligands." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00894"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00894">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00894&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00894&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00894&amp;href=/doi/10.1021/acs.jmedchem.0c00894" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 15639-15654</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00690" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01072" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.1c00526"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Paola Munoz-Tello</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paola Munoz-Tello</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Integrative Structural and Computational Biology, The Scripps Research Institute, Jupiter, Florida 33458, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paola++Munoz-Tello">Paola Munoz-Tello</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hua Lin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hua Lin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Medicine, The Scripps Research Institute, Jupiter, Florida 33458, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hua++Lin">Hua Lin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0840-6553" title="Orcid link">http://orcid.org/0000-0002-0840-6553</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pasha Khan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pasha Khan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Medicine, The Scripps Research Institute, Jupiter, Florida 33458, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pasha++Khan">Pasha Khan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ian Mitchelle S. de Vera</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ian Mitchelle S. de Vera</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Integrative Structural and Computational Biology, The Scripps Research Institute, Jupiter, Florida 33458, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ian+Mitchelle+S.++de+Vera">Ian Mitchelle S. de Vera</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4682-901X" title="Orcid link">http://orcid.org/0000-0003-4682-901X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Theodore M. Kamenecka</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Theodore M. Kamenecka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Medicine, The Scripps Research Institute, Jupiter, Florida 33458, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Theodore+M.++Kamenecka">Theodore M. Kamenecka</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3077-0167" title="Orcid link">http://orcid.org/0000-0002-3077-0167</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Douglas J. Kojetin</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Douglas J. Kojetin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Integrative Structural and Computational Biology, The Scripps Research Institute, Jupiter, Florida 33458, United States</div><div class="loa-info-affiliations-info">Department of Molecular Medicine, The Scripps Research Institute, Jupiter, Florida 33458, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#caaea1a5a0afbea3a48ab9a9b8a3babab9e4afaebf"><span class="__cf_email__" data-cfemail="82e6e9ede8e7f6ebecc2f1e1f0ebf2f2f1ace7e6f7">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+J.++Kojetin">Douglas J. Kojetin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8058-6168" title="Orcid link">http://orcid.org/0000-0001-8058-6168</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00894&amp;href=/doi/10.1021%2Facs.jmedchem.0c00894" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 15639–15654</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 8, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 May 2020</li><li><span class="item_label"><b>Published</b> online</span>8 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00894" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00894</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D15639%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPaola%2BMunoz-Tello%252C%2BHua%2BLin%252C%2BPasha%2BKhan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D24%26contentID%3Dacs.jmedchem.0c00894%26title%3DAssessment%2Bof%2BNR4A%2BLigands%2BThat%2BDirectly%2BBind%2Band%2BModulate%2Bthe%2BOrphan%2BNuclear%2BReceptor%2BNurr1%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D15654%26publicationDate%3DDecember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00894"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1034</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00894" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Paola&quot;,&quot;last_name&quot;:&quot;Munoz-Tello&quot;},{&quot;first_name&quot;:&quot;Hua&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Pasha&quot;,&quot;last_name&quot;:&quot;Khan&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;Mitchelle S. de Vera&quot;},{&quot;first_name&quot;:&quot;Theodore&quot;,&quot;last_name&quot;:&quot;M. Kamenecka&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;J. Kojetin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;15639-15654&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00894&quot;},&quot;abstract&quot;:&quot;Nurr1/NR4A2 is an orphan nuclear receptor transcription factor implicated as a drug target for neurological disorders including Alzheimer’s and Parkinson’s diseases. Previous studies identified small-molecule NR4A nuclear receptor modulators, but it remains unclear if these ligands affect transcription via direct binding to Nurr1. We assessed 12 ligands reported to affect NR4A activity for Nurr1-dependent and Nurr1-independent transcriptional effects and the ability to bind the Nurr1 ligand-binding domain (LBD). Protein NMR structural footprinting data show that amodiaquine, chloroquine, and cytosporone B bind the Nurr1 LBD; ligands that do not bind include C-DIM12, celastrol, camptothecin, IP7e, isoalantolactone, ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl]acetate (TMPA), and three high-throughput screening hit derivatives. Importantly, ligands that modulate Nurr1 transcription also show Nurr1-independent effects on transcription in a cell type-specific manner, indicating that care should be taken when in&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00894&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00894" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00894&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00894" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00894&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00894" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00894&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00894&amp;href=/doi/10.1021/acs.jmedchem.0c00894" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00894" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00894" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (11 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00894%26sid%3Dliteratum%253Aachs%26pmid%3D33289551%26genre%3Darticle%26aulast%3DMunoz-Tello%26date%3D2020%26atitle%3DAssessment%2Bof%2BNR4A%2BLigands%2BThat%2BDirectly%2BBind%2Band%2BModulate%2Bthe%2BOrphan%2BNuclear%2BReceptor%2BNurr1%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D24%26spage%3D15639%26epage%3D15654%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290694" title="Bioluminescent probes">Bioluminescent probes</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/jmcmar.2020.63.issue-24/20201224/jmcmar.2020.63.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Nurr1/NR4A2 is an orphan nuclear receptor transcription factor implicated as a drug target for neurological disorders including Alzheimer’s and Parkinson’s diseases. Previous studies identified small-molecule NR4A nuclear receptor modulators, but it remains unclear if these ligands affect transcription via direct binding to Nurr1. We assessed 12 ligands reported to affect NR4A activity for Nurr1-dependent and Nurr1-independent transcriptional effects and the ability to bind the Nurr1 ligand-binding domain (LBD). Protein NMR structural footprinting data show that amodiaquine, chloroquine, and cytosporone B bind the Nurr1 LBD; ligands that do not bind include C-DIM12, celastrol, camptothecin, IP7e, isoalantolactone, ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl]acetate (TMPA), and three high-throughput screening hit derivatives. Importantly, ligands that modulate Nurr1 transcription also show Nurr1-independent effects on transcription in a cell type-specific manner, indicating that care should be taken when interpreting the functional response of these ligands in transcriptional assays. These findings should help focus medicinal chemistry efforts that desire to optimize Nurr1-binding ligands.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17837" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17837" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The NR4A nuclear receptor transcription factors regulate important physiological processes including cellular homeostasis, metabolic regulation, apoptosis, and cell differentiation.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The three members of the NR4A family—NR4A1 (Nur77), NR4A2 (Nurr1), and NR4A3 (NOR1)—regulate the transcription of target genes through binding to specific genomic DNA response element sequences. Nuclear receptors are generally classified as ligand-dependent transcription factors. However, the NR4As have an unconventional putative orthosteric ligand-binding pocket compared to other nuclear receptors. Crystal structures of the Nur77 and Nurr1 ligand-binding domains (LBDs) show a collapsed orthosteric pocket that is filled with residues containing bulky hydrophobic side chains, suggesting that these receptors may function independent of the binding ligand within an orthosteric pocket.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> Furthermore, contributing to their status as orphan receptors, it remains unclear if the NR4As are regulated by binding physiological or endogenous ligands, although unsaturated fatty acids,<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a> prostaglandins,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and dopamine metabolites<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> have been shown to interact with the Nur77 and/or Nurr1 LBDs.</div><div class="NLM_p">Regulating Nurr1 activity with small-molecule ligands is implicated to provide a therapeutic benefit in several Nurr1-related diseases including neurological disorders, such as Alzheimer’s and Parkinson’s diseases, inflammation, autoimmunity, cancer, and multiple sclerosis.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a> To develop therapies to treat these diseases, several groups have initiated studies to discover small molecules that modulate Nurr1 transcription. Among these studies, ligands with a 4-amino-7-chloroquinoline scaffold—including amodiaquine, chloroquine, and glafenine—were identified in a high-throughput screen as ligands that increase Nurr1 transcription in human neuroblastoma SK-<i>N</i>-BE(2)-C cells.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Amodiaquine improves behavioral alterations in a Parkinson’s disease animal model<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and improves neuropathology and memory impairment in an Alzheimer’s disease animal model.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> NMR structural footprinting studies revealed that the Nurr1 LBD binding epitopes of these ligands are similar to the binding epitopes of unsaturated fatty acids.<a onclick="showRef(event, 'ref4 ref5 ref12'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref12">(4,5,12)</a></div><div class="NLM_p">Amodiaquine is the most potent and efficacious Nurr1 agonist of the 4-amino-7-chloroquinoline ligands, but these ligands are not Nurr1-specific; they also target other proteins including the apelin receptor<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and are capable of antiviral<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> and antimalarial<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> activity. However, knowledge that the 4-amino-7-chloroquinoline scaffold can directly bind to the Nurr1 LBD opens the path to future structure–activity relationship (SAR) studies to develop more potent and efficacious ligands with better specificity for Nurr1 over other molecular targets. Screening efforts have identified other classes of Nurr1-activating ligands with poorly defined mechanisms of action, and ligands reported to influence Nur77 activity represent another potential source to discover Nurr1 ligands because evolutionarily related nuclear receptors (e.g., ERα and ERβ) often display broad specificity for similar ligands.</div><div class="NLM_p last">It would be useful to know if the Nurr1- and Nur77-modulating ligands reported in the literature affect Nurr1 transcription through direct binding to Nurr1. We tested 12 ligands reported to affect the activity of Nurr1 or Nur77 for Nurr1-dependent transcription using cellular reporter assays and for direct binding to the Nurr1 LBD using a protein NMR structural footprinting assay that provides information on ligand-binding epitopes. We found that most of the ligands display cell type-specific transcriptional activities through Nurr1-dependent and Nurr1-independent mechanisms. Furthermore, using protein NMR, we found that only three of the ligands directly bind to the Nurr1 LBD: amodiaquine, chloroquine, and cytosporone B. These findings should be of interest to medicinal chemists who want to focus on the discovery and optimization of Nurr1-binding ligands as opposed to ligands that affect Nurr1 activity through other indirect mechanisms.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54728" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54728" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> NR4A Ligand Selection and Properties</h3><div class="NLM_p">The 12 ligands we selected represent most, if not all, of the chemical scaffolds reported to modulate Nurr1- or Nur77-dependent transcription or other activities (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Of these, nine were available from commercial sources and three others (SR10098, SR24237, and SR10658; compounds <b>1</b>, <b>2</b>, and <b>3</b>, respectively) were synthesized in-house.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of the 12 NR4A ligands characterized in this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Amodiaquine and chloroquine are antimalarial ligands that contain a 4-amino-7-chloroquinoline scaffold and were identified in a screen using SK-<i>N</i>-BE(2)-C cells transfected with full-length Nurr1 and a luciferase reporter plasmid containing four copies of the NGFI-B response element (NBRE) motif.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> These ligands are activators of Nurr1 transcription with micromolar potency that directly bind to the Nurr1 LBD at low nanomolar potency.</div><div class="NLM_p">Four ligands were hits or optimized from a hit identified in different high-throughput screening (HTS) campaigns as ligands that increase Nurr1-dependent transcription with low nanomolar potency using an NBRE-based luciferase reporter assay. The benzimidazole SR10098 (compound 12 in;<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> full-length Nurr1 EC<sub>50</sub> = 24 nM) and the isoxazolo-pyridinone SR10658 (compound 7a in;<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> full-length Nurr1 EC<sub>50</sub> = 4.1 nM) were discovered in a screen using the MN9D dopaminergic cellular model; IP7e (full-length Nurr1 EC<sub>50</sub> = 3.9 nM) is an analogue of SR10658 reported to have improved solubility for <i>in vivo</i> studies and displayed <i>in vivo</i> efficacy in the experimental autoimmune encephalomyelitis mice (EAE) model of multiple sclerosis (MS).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The imidazopyridine SR24237 (compound 3 in;<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> full-length Nurr1 EC<sub>50</sub> = ∼1–240 nM) is an optimized ligand from a hit discovered in two screens using a Chinese hamster ovary (CHO) and mouse neuronal N2A cell lines; an analogue of SR24237 displays neuroprotective and anti-inflammatory activity.</div><div class="NLM_p">Two additional ligands were previously reported as Nurr1 modulators. C-DIM12 or 1,1-bis(3′-indolyl)-1-(<i>p</i>-chlorophenyl)methane was reported as a synthetic Nurr1 activator with micromolar potency that increases transcription in a Gal4-Nurr1 fusion assay; affects the expression of dopaminergic genes in pancreatic cells, keratinocyte epidermal cells, and primary neurons; and displays <i>in vivo</i> efficacy in models of Parkinson’s disease.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25">(22−25)</a> Camptothecin, an antitumor chemotherapeutic agent and cyclooxygenase-2 inhibitor, is a natural product identified in a high-throughput screen using an NBRE-based luciferase reporter assay in HEK293T cells as an inhibitor of Nurr1 transcription at 200 nM that triggers an antitumor response by reducing Foxp3<sup>+</sup> T regulatory cells and inducing IFNγ<sup>+</sup> T helper 1 cells, indicating that Nurr1 may be a target for cancer immunotherapy.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p last">We also tested four ligands reported to modulate the activity of Nur77. Celastrol is a natural product discovered in surface plasmon resonance screens that binds the Nur77 LBD with high affinity (<i>K</i><sub>d</sub> = 290 nM), inhibits Nur77 transcription at 500 nM in a reporter assay in HEK293T cells, and influences Nur77 activity through multiple mechanisms.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Isoalantolactone is a natural product discovered in a screen using a Gal4-Nur77 fusion reporter assay in MiaPaCa-2 cells as an inhibitor of Nur77 transcription at 5 μg/mL and an activator of AMPKα in 3T3-L1 cells, leading to a cascade of events that highlights a role for targeting Nur77 in protection against metabolic disorders and obesity.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Cytosporone B (CsnB) is a natural product identified as a Nur77 agonist that binds to the Nur77 LBD (LBD <i>K</i><sub>d</sub> = 1.5 μM) and activates Nur77 transcription (EC<sub>50</sub> = ∼0.1–0.3 nM).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> CsnB was also shown to activate transcription in a Gal4-Nurr1 fusion assay in BGC-823 human gastric carcinoma cells. Later work using another chemical screen identified an analogue of CsnB, ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl]acetate (TMPA), which showed low micromolar affinity for the Nur77 LBD.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Unlike CsnB, TMPA does not function as a canonical agonist of Nur77 transcription; rather, it inhibits the interaction between Nur77 and liver kinase B1 (LKB1), and it also enhances phosphorylation of AMPKα. Another CsnB analogue that was not commercially available, pentyl 2-(3,5-dihydroxy-2-nonanoylphenyl)acetate (PDNPA), inhibits the interaction between Nur77 and the MAP kinase p38α,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> suggesting that inhibition of Nur77–kinase interactions may be a general mode of action for these ligands.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Cellular Assays to Characterize Ligand-Mediated Transcription of Nurr1</h3><div class="NLM_p">Nurr1 regulates gene expression as a monomer through binding to NGFI-B response element (NBRE) motifs,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> which are present in the majority of well-characterized Nurr1 genomic binding sites including the promoter region of tyrosine hydroxylase (TH)<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> and topoisomerase IIβ (topIIβ).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Most of the ligands in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> were discovered or validated using a monomeric NBRE luciferase (NBRE-luc) reporter plasmid. Another motif termed the Nur response element (NurRE) was identified in the promoter of the pro-opiomelanocortin (POMC) gene<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> that enables binding of Nur77 or Nurr1 dimers.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> Furthermore, Nurr1 can form a heterodimer with the retinoid X receptor (RXR) on a DR5 motif that contains two consensus nuclear receptor binding elements separated by a five-nucleotide linker.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> To the best of our knowledge, no Nurr1 target genes have been reported to contain DR5 motifs. However, RXR ligands can activate transcription of Nurr1 monomers on NBRE motifs.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">Given these observations, we assessed the effect of the ligands on Nurr1-mediated transcription by cotransfecting full-length Nurr1 with a luciferase reporter plasmid containing three repeats of the NBRE or NurRE response element (NBRE3-luc and NurRE3-luc, respectively). Because RXR influences transcription of Nurr1 monomers, we also tested the effect of cotransfection of full-length Nurr1 and full-length RXRα together. We performed the assays in three cell lines including HEK293T, a kidney embryonic cell line commonly used to assess general nuclear receptor activity, as well as two cell lines relevant to Nurr1 functions in neurons: PC12, a rat pheochromocytoma cell line exhibiting neuronal-like characteristics, and SK-<i>N</i>-BE(2)-C, a neuroblastoma cell line displaying moderate levels of tyrosine hydroxylase activity and dopamine-b-hydroxylase activity. We used four ligand concentrations in the assays, which differ among all the ligands, based on previously reported cellular potencies in the original reports of each ligand as well as initial studies that included higher concentrations that for some ligands gave bell-shaped response curves or a significant decrease in luciferase activity, indicative of colloidal aggregation and/or toxicity.</div><div class="NLM_p last">We also performed two control assays to determine the specificity of the ligands and assess Nurr1-dependent and Nurr1-independent effects on transcription using the same ligand concentrations tested in the NBRE and NurRE luciferase assays. First, we used a VP16-Gal4 control assay to test for toxicity and overall effects on general transcription; cells are transfected with a reporter plasmid containing five copies of the yeast Gal4 upstream activation sequence (UAS), followed by the firefly luciferase gene (UAS-luc) along with an expression plasmid containing the yeast Gal4 DNA-binding domain fused to the herpes simplex virus protein VP16 activation domain. The Gal4-VP16 fusion protein displays constitutively high luciferase activity; ligands that show decreased activity may either display cytotoxicity or inhibit general transcription in a Nurr1-independent manner, whereas ligands that show increased activity activate general transcription in a Nurr1-indepenent manner. Second, we also tested the ligands using the CellTiter–Glo luminescence cell viability assay as a more direct measure of cytotoxicity. For each assay type (reporter or control), we displayed the same y-axis range corresponding to the fold change in luciferase activity normalized to vehicle-treated cells in order to directly compare the magnitude of the activity changes between different ligands in the same assay.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Characterization of Ligands in the Cellular Assays</h3><div class="NLM_p">For the 4-amino-7-chloroquinoline scaffold ligands, amodiaquine (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A) and to a lesser extent chloroquine (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) increased activity of the NBRE-luc (Nurr1 and Nurr1-RXRα) and NurRE-luc (Nurr1) reporters in SK-<i>N</i>-BE(2)-C cells, consistent with previously published data.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, decreases in luciferase signal were observed in HEK293T and PC12 cells, respectively. Both ligands increased activity of the Gal4-VP16/UAS-luc control assay in SK-<i>N</i>-BE(2)-C cells at concentrations up to ∼15 μM and abruptly decreased activity at 125 μM without showing some cytotoxicity activity in the CellTiter–Glo assay. Taken together, these data indicate that amodiaquine and chloroquine affect general transcription through Nurr1-independent mechanisms.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of the 4-amino-7-chloroquinoline derivatives on transcription of (A) full-length Nurr1 or (B) Nurr1-RXRα using NBRE3-luc or NurRE3-luc reporters in HEK293T, PC12, and SK-<i>N</i>-BE(2)-C cells. (C) Control assays including a constitutively active Gal4-VP16/UAS-luc assay and a CellTiter–Glo toxicity assay. Data represent mean ± standard error of the mean (s.e.m.) (<i>n</i> = 4); *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, ****<i>P</i> ≤ 0.0001, one-way ANOVA with multiple comparisons to vehicle control in each condition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For the HTS hits, SR10098 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A) slightly increased luciferase activity of both reporters under certain conditions in HEK293T cells (Nurr1 and Nurr1-RXRα), SK-<i>N</i>-BE(2)-C cells (Nurr1, NBRE-luc and NurRE-luc; Nurr1-RXRα, NurRE-luc), and PC12 cells (Nurr1-RXRα, NurRE-luc). SR24237 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B) and SR10658 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C) showed slight to moderate dose-responsive increased activity under most conditions. IP7e (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D) only showed increased activity at the highest concentration tested (100 nM) under most conditions. However, all four of these HTS ligands increased the activity of the Gal4-VP16/UAS-luc control assay in the same cell lines and conditions that showed activation in the NBRE-luc and NurRE-luc assays without showing any significant cytotoxicity activity in the CellTiter–Glo assay, indicating that they affect general transcription via Nurr1-independent mechanisms.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of the Nurr1 HTS-derived ligands on transcription of (A) full-length Nurr1 or (B) Nurr1-RXRα using NBRE3-luc or NurRE3-luc reporters in HEK293T, PC12, and SK-<i>N</i>-BE(2)-C cells. (C) Control assays including a constitutively active Gal4-VP16/UAS-luc assay and a CellTiter–Glo toxicity assay. Data represent mean ± s.e.m. (<i>n</i> = 4); *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, ****<i>P</i> ≤ 0.0001, one-way ANOVA with multiple comparisons to vehicle control in each condition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For the Nurr1 modulators, C-DIM12 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A) showed decreased activity in HEK293T and SK-<i>N</i>-BE(2)-C cells under most conditions (Nurr1 and Nurr1-RXRα, NBRE-luc and NurRE-luc) except in the Nurr1-RXRα/NBRE3-luc assay where there was an increase and decrease in activity and relatively no effect in PC12 cells except for Nurr1-RXRα/NBRE3-luc. Camptothecin (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B) showed decreased activity under most conditions except in PC12 cells (Nurr1, NurRE-luc). For the most part, both ligands also showed decreased activity of the Gal4-VP16/UAS-luc control assay and/or CellTiter–Glo activity in the same cell lines and conditions that showed decreased activity in the NBRE-luc and NurRE-luc assays, indicating that Nurr1-independent and cytotoxic mechanisms contribute to activity of these ligands.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of the other Nurr1 modulators on transcription of (A) full-length Nurr1 or (B) Nurr1-RXRα using NBRE3-luc or NurRE3-luc reporters in HEK293T, PC12, and SK-<i>N</i>-BE(2)-C cells. (C) Control assays including a constitutively active Gal4-VP16/UAS-luc assay and a CellTiter–Glo toxicity assay. Data represent mean ± s.e.m. (<i>n</i> = 4); *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, ****<i>P</i> ≤ 0.0001, one-way ANOVA with multiple comparisons to vehicle control in each condition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Finally, for the Nur77 modulators, celastrol (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A) showed increased or decreased activity in a cell type-specific and reporter-specific manner, affecting the Nurr1 and Nurr1-RXRα assays similarly. Isoalantolactone (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B) showed decreased activity in HEK293T and SK-<i>N</i>-BE(2)-C cells (Nurr1 and Nurr1-RXRα, NBRE-luc and NurRE-luc) and a slight decrease in activity for Nurr1/NurRE-luc in PC12 cells under any condition. Cytosporone B (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C) showed decreased activity for some conditions at the highest 1–2 concentrations tested (25 μM and/or 100 μM), whereas TMPA (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D) showed relatively no activity under all conditions. Notably, all four ligands showed decreased activity of the Gal4-VP16/UAS-luc control assay and/or CellTiter–Glo activity in the same cell lines and conditions that showed decreased activity in the NBRE-luc and NurRE-luc assays, indicating that Nurr1-independent and cytotoxic mechanisms contribute to activity of these ligands.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of the Nur77 modulators on transcription of (A) full-length Nurr1 or (B) Nurr1-RXRα using NBRE3-luc or NurRE3-luc reporters in HEK293T, PC12, and SK-<i>N</i>-BE(2)-C cells. (C) Control assays including a constitutively active Gal4-VP16/UAS-luc assay and a CellTiter–Glo toxicity assay. Data represent mean ± s.e.m. (<i>n</i> = 4); *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, ****<i>P</i> ≤ 0.0001, one-way ANOVA with multiple comparisons to vehicle control in each condition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Binding Analysis by Protein NMR Structural Footprinting</h3><div class="NLM_p">The notion that all the ligands tested in the cellular assays show Nurr1-independent mechanisms on general transcription raises a question as to whether they physically interact with and bind to the Nurr1 LBD as opposed to binding upstream effector proteins such as kinases that in turn regulate Nurr1 transcription through downstream cellular functions. We therefore used a protein NMR spectroscopy structural footprinting assay to determine if the NR4A ligands directly bind to the Nurr1 LBD. We collected 2D [<sup>1</sup>H,<sup>15</sup>N]-TROSY-HSQC of <sup>15</sup>N-labeled Nurr1 LBD in the presence of vehicle control or 2 molar equivalents of the ligand (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Protein NMR spectroscopy ligand footprinting data. 2D [<sup>1</sup>H,<sup>15</sup>N]-TROSY-HSQC data (700 MHz, 298 K) of <sup>15</sup>N-labeled Nurr1 LBD in the presence of vehicle control (black spectra) or 2× ligand reveal ligands that do not bind to the Nurr1 LBD (blue spectra) and ligands that bind to the Nurr1 LBD (orange spectra).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To provide a direct comparison of the relative residue-specific binding effects caused by the 12 ligands, we calculated a mean and standard deviation (s.d.) of the chemical shift perturbation (CSP) changes (changes in the chemical environment caused by structural changes upon binding) and peak intensity changes (NMR line broadening indicative of changes in protein dynamics and/or exchange effects due to residues involved in ligand binding) for all residues and ligands grouped together (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Then, for each ligand, we plotted the per-residue NMR CSP changes (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A) and peak intensity changes (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Grouped quantitative analysis of the 2D NMR ligand footprinting data. (A) NMR CSPs and (B) peak intensities were used to determine the group mean and s.d. cutoffs to highlight significant changes in the per-ligand quantitative analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Per-ligand quantitative analysis of the 2D NMR ligand footprinting data, including (A) differential NMR CSP analysis and (B) NMR peak intensity analysis. Blue circles indicate residues with no significant effect; residues with a CSP or peak intensity change ≥ mean ± 4 s.d. or 8 s.d. are colored orange or black, respectively; residues with peak intensities that decrease or disappear into the noise are colored orange or black, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Consistent with previous data,<a onclick="showRef(event, 'ref4 ref12'); return false;" href="javascript:void(0);" class="ref ref4 ref12">(4,12)</a> addition of amodiaquine and to a lesser degree chloroquine, which is less potent than amodiaquine,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> showed select NMR CSP and peak intensity changes for Nurr1 LBD residues within helix 3, helix 6, helix 10/11, and helix 12, indicating that they directly bind to the Nurr1 LBD. Of the other 10 NR4A ligands, only cytosporone B showed NMR structural footprinting results, indicating direct binding to the Nurr1 LBD. In contrast, SR10098, SR24237, SR10658, IP7e, C-DIM12, camptothecin, celastrol, isoalantolactone, and TMPA showed no evidence of binding to the Nurr1 LBD. The profile of cytosporone B-induced CSP and peak intensity changes are similar to the changes caused by amodiaquine, indicating that they likely share a common binding site within the Nurr1 LBD.</div><div class="NLM_p">To visualize the NMR-detected binding effects, we mapped the NMR structural footprinting changes for amodiaquine, chloroquine, and cytosporone B onto the crystal structure of Nurr1 LBD<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A) and compared the binding epitopes to the crystal structure of TMPA-bound Nur77 LBD,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> PDNPA-bound Nur77 LBD,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and the Nur77 modeled binding sites of cytosporone B<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and celastrol<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> relative to the canonical ligand-binding pocket (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B). Amodiaquine, chloroquine, and cytosporone B show similar binding epitopes on the Nurr1 LBD, with most of the NMR-detected changes occurring for residues within or near the canonical orthosteric-ligand-binding pocket. For Nur77, the crystallized TMPA binding poses and modeled celastrol and cytosporone B binding poses are all surface-exposed.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Comparison of NMR structural footprinting data to ligand-bound NR4A LBD crystal structures. (A) NMR mapped onto the Nurr1 LBD crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OVL">1OVL</a>, chain B). The inset legend shows the coloring scheme for residues with significant NMR CSP or peak intensity values. (B) Crystal structures of TMPA-bound Nur77 LBD (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3V3Q">3V3Q</a>) with other modeled and crystallized Nur77 ligand binding sites reported in the literature highlighted as well as Nurr1 LBD crystal structures bound to 5,6-dihydroxyindole (DHI; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DDA">6DDA</a>, chain A) and prostaglandin A1 (PGA1; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5Y41">5Y41</a>, chain A).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Although there is some overlap between the surface-exposed Nur77 interaction sites and the Nurr1 NMR-detected binding epitopes, there are also differences. For example, cytosporone B and TMPA are derived from the same scaffold, and the modeled cytosporone B interaction site agrees with one of the two crystallized TMPA binding modes—a solvent-exposed surface in the Nur77 LBD. However, the NMR-detected cytosporone B binding epitope on Nurr1 is different, suggesting that the interaction occurs within the canonical ligand-binding pocket similar to amodiaquine, chloroquine, and unsaturated fatty acids.<a onclick="showRef(event, 'ref4 ref5 ref12'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref12">(4,5,12)</a> These data suggest that cytosporone B likely binds differently to Nurr1 and Nur77, but another explanation could be that the solution NMR structural footprinting analysis picks up on binding events or structural changes that are not apparent in solid-state crystallography studies.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Characterization of Binding Ligands for NR4A Specificity</h3><div class="NLM_p last">Finally, we performed cellular luciferase reporter assays using full dose responses for amodiaquine, chloroquine, and cytosporone B to obtain insight into the activity of these three Nurr1-binding compounds against all three NR4A receptors. We cotransfected HEK293T, PC12, and SK-<i>N</i>-BE(2)-C cells with full-length Nurr1, Nur77, NOR-1, or empty control plasmids along with the NBRE3-luc or NurRE3-luc reporter plasmids in the absence and presence of full-length RXRα (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00894/suppl_file/jm0c00894_si_001.pdf" class="ext-link">Figures S1–S3</a>). Notably, all the ligands show complicated dose response curves because of a combination of cellular toxicity issues (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>–<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, Cell-Titer Glo data) and NR4A-independent nonspecific transcriptional effects (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>–<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, VP16-Gal4 control data). Furthermore, the ligand dose response profiles appear nearly identical for cells transfected with Nurr1, Nur77, NOR-1, or an empty control plasmid, the latter of which, when considered with the Cell-Titer Glo and VP16-Gal4 control data, indicates that the luciferase reporter dose response profiles are not NR4A-dependent. We therefore did not attempt to fit these data to extract EC<sub>50</sub>/IC<sub>50</sub> values given that the potency and efficacy responses in the dose response experiments appear to be dominated by NR4A-independent contributions; examples could include binding to an off-target (non-NR4A) protein, cell death, fluorescent assay artifacts, and so forth.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42738" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42738" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Defining if and how ligands bind to Nurr1 is critical not only for understanding the Nurr1 function and regulation but also in prioritizing and directing medicinal chemistry efforts on Nurr1-binding ligands. Relative to other nuclear receptors, crystal structures have not revealed a well-defined ligand-binding pocket in the Nurr1 LBD. Solution-state structural studies indicate that the Nurr1 ligand-binding pocket is dynamic and solvent-accessible, indicating that the absence of a pocket captured in Nurr1 LBD crystal structures represents a collapsed conformation.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The lack of a well-defined Nurr1 ligand-binding pocket has arguably stunted efforts to discover and design Nurr1-binding ligands. Several ligands have been reported in the literature to interact with the Nurr1 LBD. Unsaturated fatty acids, amodiaquine, and chloroquine appear to bind to the Nurr1 orthosteric ligand-binding pocket,<a onclick="showRef(event, 'ref4 ref5 ref12'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref12">(4,5,12)</a> whereas the endogenous dopamine metabolite 5,6-dihydroxyindole (DHI) and prostaglandin A1 (PGA1) covalently bind to the noncanonical site via covalent attachment to a surface-exposed cysteine residue on helix 11 in the Nurr1 LBD.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">Our studies here show that most of the NR4A ligands we studied that influence the cellular functions of Nurr1 do not appear to function through direct binding to Nurr1. These findings indicate that these ligands may exert their effects on Nurr1 activity through binding to upstream effector proteins such as kinases, which could then affect Nurr1 cellular activity via downstream effects. Several other observations support this idea.</div><div class="NLM_p">First, most, if not all, of the NR4A ligands show cell type-specific functions. It is possible that this is due to the availability of different transcriptional coregulator proteins present within different cell types that could be recruited to Nurr1 in a ligand-dependent manner. However, given that most of the NR4A ligands do not directly bind Nurr1, it is possible that cell type-specific expression of effector proteins upstream of the NR4As or other non-NR4A proteins also contributes to the cell type-specific activities of the ligands. Cell type-specific Nurr1 activity has been highlighted previously in neuronal cell lines, suggesting that endogenous factors expressed in specific neuronal cell lines influence Nurr1 activation.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Cell type-specific dependence may apply to other types including bladder cancer cells and other human cancer cells where Nurr1 activity has been found to be critical for survival.<a onclick="showRef(event, 'ref25 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref25 ref42 ref43">(25,42,43)</a></div><div class="NLM_p">Second, some of these NR4A ligands are polypharmacology modulators. As one example, C-DIM12 and related analogues were reported as Nurr1 activators in pancreatic cancer cells,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> bladder cancer cells,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and neuronal cells<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> and a Nurr1 inhibitor in glioblastoma cells.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> However, C-DIM compounds also activate other nuclear receptors in various cell types including Nur77,<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> COUP-TF1<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and PPARγ.<a onclick="showRef(event, 'ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref48 ref49 ref50">(48−50)</a> Indeed, previous studies suggest that the mechanisms of action of these C-DIM ligands may occur independent of nuclear receptor binding or via nuclear receptor-independent mechanisms through affecting kinase activity.<a onclick="showRef(event, 'ref46 ref51 ref52 ref53 ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref46 ref51 ref52 ref53 ref54 ref55 ref56">(46,51−56)</a><i>In silico</i> ligand docking studies suggested that C-DIM12 may bind to the Nurr1 LBD coregulator binding surface.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> However, our protein NMR structural footprinting data clearly show that C-DIM12 does not directly bind to the Nurr1 LBD. Further selectivity profiling such as chemoproteomic methods is warranted to determine the molecular target of C-DIM12 and related analogues.</div><div class="NLM_p">Related to polypharmacology, some of the other NR4A ligands that we profiled that do not directly bind to the Nurr1 LBD but activate Nurr1 transcription have been shown to function through targets other than the NR4As, which in principle could affect Nurr1 activity through downstream functions of the targets. Celastrol, which contains a reactive quinone methide moiety enabling covalent attachment to cysteine residues,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> including direct binding and inhibition of c-Myc-Max heterodimers;<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> cancerous inhibition of protein phosphatase 2A (CIP2A),<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> STAT3,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> SHOC-2 to inhibit ERK signaling,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> IKKα, and IKKβ;<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and HSP90-chaperone interactions,<a onclick="showRef(event, 'ref63 ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref63 ref64 ref65">(63−65)</a> directly binds nearly 70 protein targets in a proteome microarray assay<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and affects other cellular signaling pathways including protein phosphatase 2A-Akt, AMPK, and WNT/β-catenin.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Isoalantolactone activates AMPKα<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and inhibits STAT3<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> and IKKβ.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Camptothecin inhibits topoisomerase I.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Given that the other Nurr1 activators identified in HTS screens or derived from HTS hits (SR10098, SR10658 and the related analogue IP7e, and SR24237) do not directly bind to the Nurr1 LBD, these ligands likely target other effector proteins that influence Nurr1 activity or other general transcriptional machinery because some showed activity in the VP16-Gal4 assay. This concept of ligands affecting Nurr1 activity via binding to upstream effectors of Nurr1 is supported by a study showing that kinase inhibitors can activate and inhibit Nurr1 transcription.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Thus, kinases could act as upstream effector proteins on downstream Nurr1 activities.</div><div class="NLM_p">Amodiaquine and chloroquine were two of the three ligands in our panel of 12 NR4A ligands that physically bind to the Nurr1 LBD and activated Nurr1 transcription in a screen using SK-<i>N</i>-BE(2)-C neuronal cells.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, we also found that amodiaquine and chloroquine activated transcription in the VP16-Gal4 assay in SK-<i>N</i>-BE(2)-C cells, indicating that they also have Nurr1-independent effects on transcription. Amodiaquine is well known as an antimalarial drug mostly used against strains of <i>Plasmodium falciparum</i>,<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> but it also inhibits human histamine <i>N</i>-methyltransferase<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> and several human cytochrome P450 enzymes.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Chloroquine, which is also an antimalarial drug, is a chemokine receptor CXCR4 antagonist<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> and used as an anticancer agent capable of inhibiting autophagy by disrupting the fusion of autophagosomes with lysosomes.<a onclick="showRef(event, 'ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref75 ref76">(75,76)</a> Future work on this 4-amino-7-chloroquinoline scaffold may result in the development of direct Nurr1-binding ligands with better specificity toward Nurr1 and reduced general effects on transcription. In fact, the observation that amodiaquine shows more efficacious activity over chloroquine suggests that there is the possibility to develop SAR on this scaffold.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><div class="NLM_p">Our NMR studies show that cytosporone B, which was the first identified Nur77 agonist and shown to activate a Gal4-Nurr1 LBD fusion construct in BGC-823 human gastric cancer cells,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> directly binds to the Nurr1 LBD; however, the related analogue TMPA, which binds to the Nur77 LBD<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> does not bind to the Nurr1 LBD. We found that cytosporone B did not activate Nurr1 transcription in HEK293T cells or the PC12 and SK-<i>N</i>-BE(2)-C neuronal cell lines, but it did decrease NBRE3/NurRE-luc activity as well as the activity in the Gal4-VP16/UAS-luc and CellTiter–Glo assays, indicating that it also displays Nurr1-independent and cytotoxic effects on transcription. Future studies are needed to detail whether cytosporone B can affect Nurr1 transcription through direct binding in other cell types to determine if it represents a potential starting point for future medicinal chemistry efforts on Nurr1-binding ligands.</div><div class="NLM_p last">In conclusion, our studies emphasize the need for determining whether ligands that affect Nurr1 activity or NR4A activity more broadly indeed bind directly to the LBD or function through other cellular mechanisms such as effector proteins that function upstream of the NR4As. The fact that amodiaquine and chloroquine show NR4A-independent effects in luciferase assays because they show activity in VP16-Gal4 constitutive control and CellTiter–Glo cell viability assays indicates that caution should be taken when interpreting the functional response of 4-amino-7-chloroquinoline ligands in Nurr1 reporter assays. The discovery of these ligands as Nurr1 agonists was performed using luciferase reporter assays normalized by an internal β-galactosidase internal control plasmid (reporter activity over control activity).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> A more recent study used a Renilla luciferase plasmid to normalize Nurr1 luciferase reporter data for amodiaquine and chloroquine, which produced a profile suggesting activation of Nurr1 with a very steep dose response transition (hill slope ≫ 1).<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Internal control plasmids, which can be used to account for well-to-well differences in transfection efficiency and/or cell number in multiwell assay plates, typically contain a general promoter (e.g., SV40) for constitutive expression. However, their use is implicit on the premise that ligand treatment does not influence cell viability, which is the case for amodiaquine and chloroquine. Ligand concentration-dependent cell death will cause a decrease in β-galactosidase or Renilla luciferase internal control activity.<a onclick="showRef(event, 'ref79 ref80 ref81 ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref79 ref80 ref81 ref82 ref83">(79−83)</a> Normalization of luciferase reporter activity by the internal control will artifactually influence the dose response curves, often causing a steep dose-responsive increase in normalized luciferase activity. For amodiaquine and chloroquine, normalization of luciferase reporter data to an internal control would mask the real impacts on Nurr1-mediated transcription. Thus, both the luciferase reporter activity and internal control activity should be carefully inspected to ensure that ligand concentration-dependent profiles modulate the reporter and not the internal control. Future studies employing biochemical, biophysical, or structure-based screening might lead to new direct binding Nurr1/NR4A ligand scaffolds that do not show notable NR4A-independent functional effects, which would open new possibilities for developing Nurr1-binding ligands. Furthermore, chemoproteomic studies could aid in the identification of the molecular target(s) of the ligands that impact Nurr1/NR4A activity but do not bind to their LBDs.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53112" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53112" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> General</h3><div class="NLM_p last">A total of 9 of the 12 ligands were purchased from commercial vendors: amodiaquine (Xenotech Llc), chloroquine (Chem Impex Intl. Inc.), IP7e (Tocris), C-DIM12 (Sigma-Aldrich), camptothecin (Cayman), celastrol (Cayman), isoalantolactone (Indofine), cytosporone B (Tocris), and TMPA (EMD Millipore). Three ligands were synthesized in-house using previously described methods including SR10098,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> SR10658,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and SR24237.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The purity of all synthesized and commercially purchased ligands is > 95%. For synthesized ligands, purity was confirmed using reverse-phase analytical HPLC (Shimadzu Prominence; 5 ≥ 95 CH<sub>3</sub>CN/H<sub>2</sub>O, 3 mL/min, YMC Pack-Pro C18 50 × 4.6 mm ID, S-5 μm) and identity was confirmed by <sup>1</sup>H NMR (Bruker 600 MHz NMR spectrometer) and mass analysis (Thermo Scientific Ultimate 3000/LCQ Fleet system ESI mass spectrometer). For commercially purchased ligands, purity was confirmed in vendor certificate of analysis (CoA) sheets. Ligands were suspended, according to vendor recommendations when applicable, in water (chloroquine), ethanol-<i>d</i><sub>6</sub> (amodiaquine), or DMSO-<i>d</i><sub>6</sub> (all other ligands).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Spectral Characterization of Synthesized Compounds</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> (SR10098)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz), δ(p.p.m.): 8.42–8.4 (m, 1H), 8.23–8.19 (m, 2H), 8.16 (dd, 1H), 7.79 (dd, 1H), 7.48–7.43 (m, 2H). MS (ESI): Expected mass for C<sub>14</sub>H<sub>9</sub>FN<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup>: 256.06 Da, observed mass: 256.79 Da.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> (SR24237)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz), δ(p.p.m.): 10.37 (s, 1H), 9.49 (s, 1H), 8.79–8.77 (m, 1H), 8.69 (d, 1H), 8.18 (dd, 1H), 8.09 (dt, 1H), 8.03 (dt, 1H), 7.98–7.96 (m, 2H), 7.83 (dt, 1H), 7.49 (ddd, 1H), 7.43–7.39 (m, 1H), 7.18–7.15 (m, 1H). MS (ESI): Expected mass for C<sub>19</sub>H<sub>14</sub>N<sub>4</sub>O (M + H)<sup>+</sup>: 314.12 Da, observed mass: 314.80 Da.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> (SR10658)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz), δ(p.p.m.): 8.17–8.15 (m, 2H), 7.53–7.44 (m, 5H), 7.06–7.03 (m, 2H), 6.74 (s, 1H). MS (ESI): Expected mass for C<sub>26</sub>H<sub>22</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup>: 334.13 Da, observed mass: 332.87 Da.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Cell Lines</h3><div class="NLM_p last">All cell lines were obtained from ATCC, including HEK293T (#CRL-11268), PC12 (#CRL-1721.1), and SK-<i>N</i>-BE(2)-C (#CRL-2268), and cultured according to ATCC guidelines. HEK293T cells were grown at 37 °C, 5% CO<sub>2</sub> in DMEM (Gibco) supplemented with 10% fetal bovine serum (Gibco) and 100 units/mL of penicillin, 100 μg/mL of streptomycin, and 0.292 mg/mL of glutamine (Gibco) until 90–95% confluence prior to subculture or use. SK-<i>N</i>-BE(2)-C were maintained at 37 °C and 5% CO<sub>2</sub> in a medium containing a 1:1 mixture of <i>Eagle’s minimal essential medium</i> (ATCC) and F12 medium (Gibco) supplemented with 10% fetal bovine serum (Gibco) until 90–95% confluence prior to subculture or use. PC12 cells were grown at 37 °C and 5% CO<sub>2</sub> in FK-12 medium (Gibco) supplemented with 15% horse serum (Sigma) and 2.5% fetal bovine serum (Gibco) until 90–95% confluence prior to subculture or use.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Plasmids</h3><div class="NLM_p last">DNA encoding the Nurr1 LBD (NR4A2; residues 353–598) was cloned into the pET-46 expression vector using the Ek/LIC system (EMD Chemicals/Novagen) as tobacco etch virus (TEV) protease-cleavable <i>N</i>-terminal 6x-polyhistidine tag fusion protein. Full-length human Nurr1 and Nur77 were cloned into the mammalian expression vector pcDNA3.1; full-length NOR-1, cloned into the mammalian expression vector pEGFP, was kindly provided by Dr. R. Brandes (Goethe-Universität). The 3xNBRE- and 3xNurRE-luciferase reporters were generated by cloning three copies of the NBRE DNA response element (5′-GAGTTTTAAAAGGTCATGCTCAATT TGTC-3′) and three copies of the NurRE POMC promoter DNA response element (5′-GATCGTGATATTTACCTCCAAATGCCA-3′), respectively, into the pGL3 promoter luciferase reporter vector (Promega). The pBIND Gal4-VP16 plasmid, pCMV-SPORT6 full-length RXRα, and the pGL4.35-5xUAS luciferase reporter plasmid were kindly provided by Dr. P. Griffin (Scripps Research). All plasmids were confirmed by Sanger sequencing (Genewiz) prior to use.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Cellular Transcription Assays</h3><div class="NLM_p last">HEK293T (#CRL-11268), PC12 (#CRL-1721.1), and SK-<i>N</i>-BE(2)-C (#CRL-2268) cells were seeded in a 10 cm Petri dish at 1.5 million cells. The following day, cells were transfected using Lipofectamine 2000 (Thermo Fisher Scientific) and Opti-MEM with full-length Nurr1, Nur77, NOR-1, or the empty vector control (pcDNA3.1 or pEGFP) expression plasmid without (2 μg) or with (1 μg) contransfection of the full-length RXRα plasmid (1 μg) along with 3xNBRE3 or the 3xNurRE-luciferase reporter plasmid (6 μg) to a total of 8 μg of total DNA and incubated for 18 h. For Gal4-VP16 transactivation, cells were transfected the same way but with a Gal4-VP16 expression plasmid (2 μg) and 5xUAS-luciferase reporter plasmid (Upstream Activation Sequence; 2 μg). Cells were transferred to white 384-well plates (Thermo Fisher Scientific) at 10,000 cells/well in 20 μL and incubated for 4 h. Ligands were prepared in dose response dilutions using the vehicle control: water (chloroquine), ethanol (amodiaquine), or DMSO (all others). Ligands in the dose response format or the respective vehicle controls were added to the cells (20 μL) in quadruplicate. Cells were then incubated for 18 h and harvested for luciferase activity quantified using Britelite Plus (Perkin Elmer; 20 μL) on a Synergy Neo plate reader (Biotek). Data were plotted as mean ± s.e.m in GraphPad Prism and are generally representative of ≥2 independent experiments. One-way ANOVA analysis was used for statistical analysis of the data using multiple comparisons (the vehicle control compared to each ligand-treated condition).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Cell Viability Assays</h3><div class="NLM_p last">HEK293T, PC12, or SK-N-BE(2)-C cells were seeded in a 10 cm Petri dish at 1.5 M cells. The following day, cells were transferred to white 384-well plates (Thermo Fisher Scientific) at 10,000 cells/well in 20 μL and incubated for 4 h. Ligands (or vehicle controls) were added (20 μL) in quadruplicate, and cells were incubated for 18 h and harvested for cell viability quantitation using CellTiter–Glo (Promega; 20 μL) on a Synergy Neo plate reader (Biotek). Data were plotted as mean ± s.e.m in GraphPad Prism and are generally representative of ≥2 independent experiments. One-way ANOVA analysis was used for statistical analysis of the data using multiple comparisons (the vehicle control compared to each ligand-treated condition).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Expression and Purification of <sup>15</sup>N-Labeled Nurr1 LBD</h3><div class="NLM_p last">Recombinant <sup>15</sup>N-labeled Nurr1 LBD (NR4A2; residues 353–598) was expressed and purified as previously described.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Briefly, the protein was expressed in <i>Escherichia coli</i> BL21(DE3) cells (Life Technologies) using a pET-46 tobacco etch virus (TEV) protease-cleavable <i>N</i>-terminal hexahistidine tag fusion protein in M9 media supplemented with <sup>15</sup>NH<sub>4</sub>Cl (Cambridge Isotope Labs, Inc.). Nurr1 LBD was eluted against a 500 mM imidazole gradient through a Ni-NTA column, followed by overnight dialysis against a buffer without imidazole for TEV protease His tag cleavage at 4 °C. The next morning, the sample was loaded onto the Ni-NTA column for contaminant and tag removal. The flow through containing the purified protein was collected, concentrated, and ran through an S75 size exclusion column (GE healthcare) in the NMR buffer (20 mM KPO<sub>4</sub> pH 7.4, 50 mM KCl, and 0.5 mM ethylenediaminetetraacetic acid). The corresponding protein peak was collected and stored at −80 °C. All the ligands were dissolved in water, DMSO-<i>d</i><sub>6</sub>, or ethanol-<i>d</i><sub>6</sub> for NMR experiments.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Protein NMR Spectroscopy Structural Footprinting</h3><div class="NLM_p last">Data were obtained on a Bruker 700 MHz NMR spectrometer equipped with a QCI cryoprobe at 298 K. For each ligand titration, 2D [<sup>1</sup>H,<sup>15</sup>N]-TROSY-HSQC were obtained at 298 K using 200 μM <sup>15</sup>N-labeled Nurr1 LBD in the NMR buffer containing 10% D<sub>2</sub>O in the presence of 400 μM ligand or vehicle control as follows: amodiaquine, 0.8% ethanol-<i>d</i><sub>6</sub>; chloroquine, water; SR10098, 0.8% DMSO-<i>d</i><sub>6</sub>; SR24237, 1.6% DMSO-<i>d</i><sub>6</sub>; SR10658, 0.8% DMSO-<i>d</i><sub>6</sub>; IP7e, 0.4% DMSO-<i>d</i><sub>6</sub>; C-DIM12, 1.6% DMSO-<i>d</i><sub>6</sub>; camptothecin, 2.4% DMSO-<i>d</i><sub>6</sub>; celastrol, 2% DMSO-<i>d</i><sub>6</sub>; isoalantolactone, 2% DMSO-<i>d</i><sub>6</sub>; cytosporone B, 1.6% DMSO-<i>d</i><sub>6</sub>; TMPA, 2% DMSO-<i>d</i><sub>6</sub>. Data were processed using NMRFx<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> and analyzed using NMRViewJ.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> CSP analysis was performed by transfer of Nurr1 LBD NMR chemical shift assignments<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> that we previously validated and reported<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> from the vehicle for each ligand (described above) to the 2× ligand spectra using the minimal NMR chemical shift method.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Peaks were identified to have broadened to zero if there was no confident peak in proximity to the vehicle peak. CSP values were calculated using the equation <span class="NLM_inline-formula"><img class="imgWithoutFigViewer inline-formula-styles" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_m001.gif" alt="" id="_i22" /></img></span>, where α is the ratio of the <sup>15</sup>N and <sup>1</sup>H gyromagnetic ratios (−27,130,000 and 267,520,000 rad s<sup>–1</sup> T<sup>–1</sup>, respectively). The average CSP and the s.d. in the CSPs and peak intensities were calculated for titrations after rejecting outliers more than 2 s.d. from the mean. Peaks that displayed changes in CSP or peak intensity greater than 4 s.d. above (CSP and peak intensity) or below (peak intensity) the average were noted as significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00894" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21867" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21867" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00894?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00894</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">HPLC data for in-house synthesized compounds and CoA data for purchased compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00894/suppl_file/jm0c00894_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00894/suppl_file/jm0c00894_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00894/suppl_file/jm0c00894_si_001.pdf">jm0c00894_si_001.pdf (3.98 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00894/suppl_file/jm0c00894_si_002.csv">jm0c00894_si_002.csv (0.87 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00894" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51617" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51617" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas J. Kojetin</span> - <span class="hlFld-Affiliation affiliation">Department
of Integrative Structural and Computational Biology, The Scripps Research Institute, Jupiter, Florida 33458, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, The Scripps Research
Institute, Jupiter, Florida 33458, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8058-6168" title="Orcid link">http://orcid.org/0000-0001-8058-6168</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5e3a3531343b2a37301e2d3d2c372e2e2d703b3a2b"><span class="__cf_email__" data-cfemail="a6c2cdc9ccc3d2cfc8e6d5c5d4cfd6d6d588c3c2d3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paola Munoz-Tello</span> - <span class="hlFld-Affiliation affiliation">Department
of Integrative Structural and Computational Biology, The Scripps Research Institute, Jupiter, Florida 33458, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hua Lin</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, The Scripps Research
Institute, Jupiter, Florida 33458, United
States</span>; 
    <span>Present Address:
                        Current address: Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou 350117, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0840-6553" title="Orcid link">http://orcid.org/0000-0002-0840-6553</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pasha Khan</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, The Scripps Research
Institute, Jupiter, Florida 33458, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian Mitchelle S. de Vera</span> - <span class="hlFld-Affiliation affiliation">Department
of Integrative Structural and Computational Biology, The Scripps Research Institute, Jupiter, Florida 33458, United States</span>; 
    <span>Present Address:
                        Current address: Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4682-901X" title="Orcid link">http://orcid.org/0000-0003-4682-901X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Theodore M. Kamenecka</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, The Scripps Research
Institute, Jupiter, Florida 33458, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3077-0167" title="Orcid link">http://orcid.org/0000-0002-3077-0167</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>P.M.-T. and D.J.K. conceived and designed the research. P.M.-T. performed cellular assays, expressed and purified proteins, and performed and analyzed NMR data. H.L., P.K., and T.M.K. synthetized compounds. I.M.S.d.V. contributed to preliminary studies on the project. D.J.K. analyzed data and supervised the research. P.M.T. and D.K. wrote the manuscript with input from all authors. The authors collectively declare no conflicts of interest in the completion of this study.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was supported in part by National Institutes of Health (NIH) grants R01GM114420 (D.J.K.) and S10OD021550.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">CSP</td><td class="NLM_def"><p class="first last">chemical shift perturbation</p></td></tr><tr><td class="NLM_term">DHI</td><td class="NLM_def"><p class="first last">5,6-dihydroxyindole</p></td></tr><tr><td class="NLM_term">EAE</td><td class="NLM_def"><p class="first last">experimental autoimmune encephalomyelitis</p></td></tr><tr><td class="NLM_term">LBD</td><td class="NLM_def"><p class="first last">ligand-binding domain</p></td></tr><tr><td class="NLM_term">NBRE</td><td class="NLM_def"><p class="first last">NGFI-B response element</p></td></tr><tr><td class="NLM_term">NurRE</td><td class="NLM_def"><p class="first last">Nur response element</p></td></tr><tr><td class="NLM_term">PGA1</td><td class="NLM_def"><p class="first last">prostaglandin A1</p></td></tr><tr><td class="NLM_term">RXR</td><td class="NLM_def"><p class="first last">retinoid X receptor</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 87 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herring, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elison, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tessem, J. S.</span></span> <span> </span><span class="NLM_article-title">Function of Nr4a Orphan Nuclear Receptors in Proliferation, Apoptosis and Fuel Utilization Across Tissues</span>. <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1373</span>, <span class="refDoi"> DOI: 10.3390/cells8111373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.3390%2Fcells8111373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BB3cXns1GgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=1373&author=J.+A.+Herringauthor=W.+S.+Elisonauthor=J.+S.+Tessem&title=Function+of+Nr4a+Orphan+Nuclear+Receptors+in+Proliferation%2C+Apoptosis+and+Fuel+Utilization+Across+Tissues&doi=10.3390%2Fcells8111373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Function of Nr4a orphan nuclear receptors in proliferation, apoptosis and fuel utilization across tissues</span></div><div class="casAuthors">Herring, Jacob A.; Elison, Weston S.; Tesse, Jeffery S.</div><div class="citationInfo"><span class="NLM_cas:title">Cells</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1373</span>CODEN:
                <span class="NLM_cas:coden">CELLC6</span>;
        ISSN:<span class="NLM_cas:issn">2073-4409</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The Nr4a family of nuclear hormone receptors is composed of three members-Nr4a1/Nur77, Nr4a2/Nurr1 and Nr4a3/Nor1.  While currently defined as ligandless, these transcription factors have been shown to regulate varied processes across a host of tissues.  Of particular interest, the Nr4a family impinge, in a tissue dependent fashion, on cellular proliferation, apoptosis and fuel utilization.  The regulation of these processes occurs through both nuclear and non-genomic pathways.  The purpose of this review is to provide a balanced perspective of the tissue specific and Nr4a family member specific, effects on cellular proliferation, apoptosis and fuel utilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq86S-YVAgdLVg90H21EOLACvtfcHk0liq_MXmri6r_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXns1GgsLg%253D&md5=c7e16caaa658578580053471374e2c94</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3390%2Fcells8111373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells8111373%26sid%3Dliteratum%253Aachs%26aulast%3DHerring%26aufirst%3DJ.%2BA.%26aulast%3DElison%26aufirst%3DW.%2BS.%26aulast%3DTessem%26aufirst%3DJ.%2BS.%26atitle%3DFunction%2520of%2520Nr4a%2520Orphan%2520Nuclear%2520Receptors%2520in%2520Proliferation%252C%2520Apoptosis%2520and%2520Fuel%2520Utilization%2520Across%2520Tissues%26jtitle%3DCells%26date%3D2019%26volume%3D8%26spage%3D1373%26doi%3D10.3390%2Fcells8111373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aarnisalo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlmann, T.</span></span> <span> </span><span class="NLM_article-title">Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>423</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1038/nature01645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fnature01645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=12774125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktVygtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=423&publication_year=2003&pages=555-560&author=Z.+Wangauthor=G.+Benoitauthor=J.+Liuauthor=S.+Prasadauthor=P.+Aarnisaloauthor=X.+Liuauthor=H.+Xuauthor=N.+P.+C.+Walkerauthor=T.+Perlmann&title=Structure+and+function+of+Nurr1+identifies+a+class+of+ligand-independent+nuclear+receptors&doi=10.1038%2Fnature01645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors</span></div><div class="casAuthors">Wang, Zhulun; Benoit, Gerard; Liu, Jinsong; Prasad, Srividya; Aarnisalo, Piia; Liu, Xiaohong; Xu, Haoda; Walker, Nigel P. C.; Perlmann, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">423</span>
        (<span class="NLM_cas:issue">6939</span>),
    <span class="NLM_cas:pages">555-560</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Members of the nuclear receptor (NR) superfamily of transcription factors modulate gene transcription in response to small lipophilic mols.  Transcriptional activity is regulated by ligands binding to the carboxy-terminal ligand-binding domains (LBDs) of cognate NRs.  A subgroup of NRs referred to as 'orphan receptors' lack identified ligands, however, raising issues about the function of their LBDs.  Here we report the crystal structure of the LBD of the orphan receptor Nurr1 at 2.2 Å resoln.  The Nurr1 LBD adopts a canonical protein fold resembling that of agonist-bound, transcriptionally active LBDs in NRs, but the structure has two distinctive features.  First, the Nurr1 LBD contains no cavity as a result of the tight packing of side chains from several bulky hydrophobic residues in the region normally occupied by ligands.  Second, Nurr1 lacks a 'classical' binding site for coactivators.  Despite these differences, the Nurr1 LBD can be regulated in mammalian cells.  Notably, transcriptional activity is correlated with the Nurr1 LBD adopting a more stable conformation.  Our findings highlight a unique structural class of NRs and define a model for ligand-independent NR function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf_Dsl30OicrVg90H21EOLACvtfcHk0lhekg7Y_0YI4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktVygtb4%253D&md5=d19448447ffb618404ae84e4aa37c505</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature01645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01645%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBenoit%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DAarnisalo%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DWalker%26aufirst%3DN.%2BP.%2BC.%26aulast%3DPerlmann%26aufirst%3DT.%26atitle%3DStructure%2520and%2520function%2520of%2520Nurr1%2520identifies%2520a%2520class%2520of%2520ligand-independent%2520nuclear%2520receptors%26jtitle%3DNature%26date%3D2003%26volume%3D423%26spage%3D555%26epage%3D560%26doi%3D10.1038%2Fnature01645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flaig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greschik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peluso-Iltis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moras, D.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the cell-specific activities of the NGFI-B and the Nurr1 ligand-binding domain</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">19250</span>– <span class="NLM_lpage">19258</span>, <span class="refDoi"> DOI: 10.1074/jbc.m413175200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1074%2Fjbc.M413175200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=15716272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFersLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=19250-19258&author=R.+Flaigauthor=H.+Greschikauthor=C.+Peluso-Iltisauthor=D.+Moras&title=Structural+basis+for+the+cell-specific+activities+of+the+NGFI-B+and+the+Nurr1+ligand-binding+domain&doi=10.1074%2Fjbc.m413175200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Cell-specific Activities of the NGFI-B and the Nurr1 Ligand-binding Domain</span></div><div class="casAuthors">Flaig, Ralf; Greschik, Holger; Peluso-Iltis, Carole; Moras, Dino</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">19250-19258</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">NGFI-B is a ligand-independent orphan nuclear receptor of the NR4A subfamily that displays important functional differences with its homolog Nurr1.  In particular, the NGFI-B ligand-binding domain (LBD) exhibits only modest activity in cell lines in which the Nurr1 LBD strongly activates transcription.  To gain insight into the structural basis for the distinct activation potentials, we detd. the crystal structure of the NGFI-B LBD at 2.4-Å resoln.  Superimposition with the Nurr1 LBD revealed a significant shift of the position of helix 12, potentially caused by conservative amino acids exchanges in helix 3 or helix 12.  Replacement of the helix 11-12 region of Nurr1 with that of NGFI-B dramatically reduces the transcriptional activity of the Nurr1 LBD.  Similarly, mutation of Met414 in helix 3 to leucine or of Leu591 in helix 12 to isoleucine (the corresponding residues found in NGFI-B) significantly affects Nurr1 transactivation.  In comparison, swapping the helix 11-12 region of Nurr1 into NGFI-B results in a modest increase of activity.  These observations reveal a high sensitivity of LBD activity to changes that influence helix 12 positioning.  Furthermore, mutation of hydrophobic surface residues in the helix 11-12 region (outside the canonical co-activator surface constituted by helixes 3, 4, and 12) severely affects Nurr1 transactivation.  Together, our data suggest that a novel co-regulator surface that includes helix 11 and a specifically positioned helix 12 det. the cell type-dependent activities of the NGFI-B and the Nurr1 LBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF1CyOIWd03LVg90H21EOLACvtfcHk0lhekg7Y_0YI4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFersLs%253D&md5=901b8ef3584d1e95bc78d6da1090adcb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413175200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413175200%26sid%3Dliteratum%253Aachs%26aulast%3DFlaig%26aufirst%3DR.%26aulast%3DGreschik%26aufirst%3DH.%26aulast%3DPeluso-Iltis%26aufirst%3DC.%26aulast%3DMoras%26aufirst%3DD.%26atitle%3DStructural%2520basis%2520for%2520the%2520cell-specific%2520activities%2520of%2520the%2520NGFI-B%2520and%2520the%2520Nurr1%2520ligand-binding%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D19250%26epage%3D19258%26doi%3D10.1074%2Fjbc.m413175200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Vera, I. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Tello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharmarajan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marciano, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matta-Camacho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giri, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rance, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojetin, D. J.</span></span> <span> </span><span class="NLM_article-title">Defining a Canonical Ligand-Binding Pocket in the Orphan Nuclear Receptor Nurr1</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.str.2018.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.str.2018.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30416039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFCgsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=66-77&author=I.+M.+S.+de%0AVeraauthor=P.+Munoz-Telloauthor=J.+Zhengauthor=V.+Dharmarajanauthor=D.+P.+Marcianoauthor=E.+Matta-Camachoauthor=P.+K.+Giriauthor=J.+Shangauthor=T.+S.+Hughesauthor=M.+Ranceauthor=P.+R.+Griffinauthor=D.+J.+Kojetin&title=Defining+a+Canonical+Ligand-Binding+Pocket+in+the+Orphan+Nuclear+Receptor+Nurr1&doi=10.1016%2Fj.str.2018.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Defining a Canonical Ligand-Binding Pocket in the Orphan Nuclear Receptor Nurr1</span></div><div class="casAuthors">de Vera, Ian Mitchelle S.; Munoz-Tello, Paola; Zheng, Jie; Dharmarajan, Venkatasubramanian; Marciano, David P.; Matta-Camacho, Edna; Giri, Pankaj Kumar; Shang, Jinsai; Hughes, Travis S.; Rance, Mark; Griffin, Patrick R.; Kojetin, Douglas J.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-77.e5</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Nuclear receptor-related 1 protein (Nurr1/NR4A2) is an orphan nuclear receptor (NR) that is considered to function without a canonical ligand-binding pocket (LBP).  A crystal structure of the Nurr1 ligand-binding domain (LBD) revealed no phys. space in the conserved region where other NRs with solvent accessible apo-protein LBPs bind synthetic and natural ligands.  Using soln. NMR spectroscopy, hydrogen/deuterium exchange mass spectrometry, and mol. dynamics simulations, we show that the putative canonical Nurr1 LBP is dynamic with high solvent accessibility, exchanges between two or more conformations on the microsecond-to-millisecond timescale, and can expand from the collapsed crystd. conformation to allow binding of unsatd. fatty acids.  These findings should stimulate future studies to probe the ligandability and druggability of Nurr1 for both endogenous and synthetic ligands, which could lead to new therapeutics for Nurr1-related diseases, including Parkinson's disease and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZuBncq_Z9MbVg90H21EOLACvtfcHk0lhekg7Y_0YI4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFCgsb3N&md5=f7b412a0b24e32cfae48ad55661f7707</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2018.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2018.10.002%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVera%26aufirst%3DI.%2BM.%2BS.%26aulast%3DMunoz-Tello%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DDharmarajan%26aufirst%3DV.%26aulast%3DMarciano%26aufirst%3DD.%2BP.%26aulast%3DMatta-Camacho%26aufirst%3DE.%26aulast%3DGiri%26aufirst%3DP.%2BK.%26aulast%3DShang%26aufirst%3DJ.%26aulast%3DHughes%26aufirst%3DT.%2BS.%26aulast%3DRance%26aufirst%3DM.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DKojetin%26aufirst%3DD.%2BJ.%26atitle%3DDefining%2520a%2520Canonical%2520Ligand-Binding%2520Pocket%2520in%2520the%2520Orphan%2520Nuclear%2520Receptor%2520Nurr1%26jtitle%3DStructure%26date%3D2019%26volume%3D27%26spage%3D66%26epage%3D77%26doi%3D10.1016%2Fj.str.2018.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Vera, I. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giri, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Tello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhrmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matta-Camacho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granados, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, W. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creamer, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojetin, D. J.</span></span> <span> </span><span class="NLM_article-title">Identification of a Binding Site for Unsaturated Fatty Acids in the Orphan Nuclear Receptor Nurr1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1795</span>– <span class="NLM_lpage">1799</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvVyhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1795-1799&author=I.+M.+S.+de%0AVeraauthor=P.+K.+Giriauthor=P.+Munoz-Telloauthor=R.+Brustauthor=J.+Fuhrmannauthor=E.+Matta-Camachoauthor=J.+Shangauthor=S.+Campbellauthor=H.+D.+Wilsonauthor=J.+Granadosauthor=W.+J.+Gardnerauthor=T.+P.+Creamerauthor=L.+A.+Soltauthor=D.+J.+Kojetin&title=Identification+of+a+Binding+Site+for+Unsaturated+Fatty+Acids+in+the+Orphan+Nuclear+Receptor+Nurr1&doi=10.1021%2Facschembio.6b00037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Binding Site for Unsaturated Fatty Acids in the Orphan Nuclear Receptor Nurr1</span></div><div class="casAuthors">de Vera, Ian Mitchelle S.; Giri, Pankaj K.; Munoz-Tello, Paola; Brust, Richard; Fuhrmann, Jakob; Matta-Camacho, Edna; Shang, Jinsai; Campbell, Sean; Wilson, Henry D.; Granados, Juan; Gardner, William J.; Creamer, Trevor P.; Solt, Laura. A.; Kojetin, Douglas J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1795-1799</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nurr1/NR4A2 is an orphan nuclear receptor, and currently there are no known natural ligands that bind Nurr1.  A recent metabolomics study identified unsatd. fatty acids, including arachidonic acid and docosahexaenoic acid (DHA), that interact with the ligand-binding domain (LBD) of a related orphan receptor, Nur77/NR4A1.  However, the binding location and whether these ligands bind other NR4A receptors were not defined.  Here, we show that unsatd. fatty acids also interact with the Nurr1 LBD, and soln. NMR spectroscopy reveals the binding epitope of DHA at its putative ligand-binding pocket.  Biochem. assays reveal that DHA-bound Nurr1 interacts with high affinity with a peptide derived from PIASγ, a protein that interacts with Nurr1 in cellular exts., and DHA also affects cellular Nurr1 transactivation.  This work is the first structural report of a natural ligand binding to a canonical NR4A ligand-binding pocket and indicates a natural ligand can bind and affect Nurr1 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnqenMorJ3jLVg90H21EOLACvtfcHk0liay8VlsxhktQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvVyhsLs%253D&md5=598f95ccc2051710ed6c2662c843d8f8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00037%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVera%26aufirst%3DI.%2BM.%2BS.%26aulast%3DGiri%26aufirst%3DP.%2BK.%26aulast%3DMunoz-Tello%26aufirst%3DP.%26aulast%3DBrust%26aufirst%3DR.%26aulast%3DFuhrmann%26aufirst%3DJ.%26aulast%3DMatta-Camacho%26aufirst%3DE.%26aulast%3DShang%26aufirst%3DJ.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DH.%2BD.%26aulast%3DGranados%26aufirst%3DJ.%26aulast%3DGardner%26aufirst%3DW.%2BJ.%26aulast%3DCreamer%26aufirst%3DT.%2BP.%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DKojetin%26aufirst%3DD.%2BJ.%26atitle%3DIdentification%2520of%2520a%2520Binding%2520Site%2520for%2520Unsaturated%2520Fatty%2520Acids%2520in%2520the%2520Orphan%2520Nuclear%2520Receptor%2520Nurr1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D1795%26epage%3D1799%26doi%3D10.1021%2Facschembio.6b00037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vinayavekhin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghatelian, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of a protein-metabolite interaction between unsaturated fatty acids and the nuclear receptor Nur77 using a metabolomics approach</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">17168</span>– <span class="NLM_lpage">17171</span>, <span class="refDoi"> DOI: 10.1021/ja208199h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja208199h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1OnsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=17168-17171&author=N.+Vinayavekhinauthor=A.+Saghatelian&title=Discovery+of+a+protein-metabolite+interaction+between+unsaturated+fatty+acids+and+the+nuclear+receptor+Nur77+using+a+metabolomics+approach&doi=10.1021%2Fja208199h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Protein-Metabolite Interaction between Unsaturated Fatty Acids and the Nuclear Receptor Nur77 Using a Metabolomics Approach</span></div><div class="casAuthors">Vinayavekhin, Nawaporn; Saghatelian, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">17168-17171</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neuron-derived clone 77 (Nur77) is an orphan nuclear receptor with currently no known natural ligands.  Here we applied a metabolomics platform for detecting protein-metabolite interactions (PMIs) to identify lipids that bind to Nur77.  Using this approach, we discovered that the Nur77 ligand-binding domain (Nur77LBD) enriches unsatd. fatty acids (UFAs) in tissue lipid mixts.  The interaction of Nur77 with arachidonic acid and docosahexaenoic acid was subsequently characterized using a no. of biophys. and biochem. assays.  Together these data indicate that UFAs bind to Nur77LBD to cause changes in the conformation and oligomerization of the receptor.  UFAs are the only endogenous lipids reported to bind to Nur77, which highlights the use of metabolomics in the discovery of novel PMIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqziCNKNrJSIrVg90H21EOLACvtfcHk0liay8VlsxhktQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1OnsbrJ&md5=4b50bc3a70cedccb6c188aa7959c0769</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fja208199h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja208199h%26sid%3Dliteratum%253Aachs%26aulast%3DVinayavekhin%26aufirst%3DN.%26aulast%3DSaghatelian%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520protein-metabolite%2520interaction%2520between%2520unsaturated%2520fatty%2520acids%2520and%2520the%2520nuclear%2520receptor%2520Nur77%2520using%2520a%2520metabolomics%2520approach%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D17168%26epage%3D17171%26doi%3D10.1021%2Fja208199h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toh, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beldar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feitosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petsko, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-S.</span></span> <span> </span><span class="NLM_article-title">PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">886</span>, <span class="refDoi"> DOI: 10.1038/s41589-020-0553-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fs41589-020-0553-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=32451509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVSgsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2020&pages=876-886&author=S.+Rajanauthor=Y.+Jangauthor=C.-H.+Kimauthor=W.+Kimauthor=H.+T.+Tohauthor=J.+Jeonauthor=B.+Songauthor=A.+Serraauthor=J.+Lescarauthor=J.+Y.+Yooauthor=S.+Beldarauthor=H.+Yeauthor=C.+Kangauthor=X.-W.+Liuauthor=M.+Feitosaauthor=Y.+Kimauthor=D.+Hwangauthor=G.+Gohauthor=K.-L.+Limauthor=H.+M.+Parkauthor=C.+H.+Leeauthor=S.+F.+Ohauthor=G.+A.+Petskoauthor=H.+S.+Yoonauthor=K.-S.+Kim&title=PGE1+and+PGA1+bind+to+Nurr1+and+activate+its+transcriptional+function&doi=10.1038%2Fs41589-020-0553-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function</span></div><div class="casAuthors">Rajan, Sreekanth; Jang, Yongwoo; Kim, Chun-Hyung; Kim, Woori; Toh, Hui Ting; Jeon, Jeha; Song, Bin; Serra, Aida; Lescar, Julien; Yoo, Jun Yeob; Beldar, Serap; Ye, Hong; Kang, Congbao; Liu, Xue-Wei; Feitosa, Melissa; Kim, Yeahan; Hwang, Dabin; Goh, Geraldine; Lim, Kah-Leong; Park, Hye Min; Lee, Choong Hwan; Oh, Sungwhan F.; Petsko, Gregory A.; Yoon, Ho Sup; Kim, Kwang-Soo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">876-886</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The orphan nuclear receptor Nurr1 is crit. for the development, maintenance and protection of midbrain dopaminergic (mDA) neurons.  Here we show that prostaglandin E1 (PGE1) and its dehydrated metabolite, PGA1, directly interact with the ligand-binding domain (LBD) of Nurr1 and stimulate its transcriptional function.  We also report the crystallog. structure of Nurr1-LBD bound to PGA1 at 2.05 Å resoln.  PGA1 couples covalently to Nurr1-LBD by forming a Michael adduct with Cys566, and induces notable conformational changes, including a 21° shift of the activation function-2 helix (H12) away from the protein core.  Furthermore, PGE1/PGA1 exhibit neuroprotective effects in a Nurr1-dependent manner, prominently enhance expression of Nurr1 target genes in mDA neurons and improve motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse models of Parkinson's disease.  Based on these results, we propose that PGE1/PGA1 represent native ligands of Nurr1 and can exert neuroprotective effects on mDA neurons, via activation of Nurr1's transcriptional function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMia6BJvwVdLVg90H21EOLACvtfcHk0liSTURZR4EMWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVSgsLzI&md5=5e726ca7eff0e5ed8216d4d4bc99b4e9</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fs41589-020-0553-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41589-020-0553-6%26sid%3Dliteratum%253Aachs%26aulast%3DRajan%26aufirst%3DS.%26aulast%3DJang%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DC.-H.%26aulast%3DKim%26aufirst%3DW.%26aulast%3DToh%26aufirst%3DH.%2BT.%26aulast%3DJeon%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DB.%26aulast%3DSerra%26aufirst%3DA.%26aulast%3DLescar%26aufirst%3DJ.%26aulast%3DYoo%26aufirst%3DJ.%2BY.%26aulast%3DBeldar%26aufirst%3DS.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DX.-W.%26aulast%3DFeitosa%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DHwang%26aufirst%3DD.%26aulast%3DGoh%26aufirst%3DG.%26aulast%3DLim%26aufirst%3DK.-L.%26aulast%3DPark%26aufirst%3DH.%2BM.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DOh%26aufirst%3DS.%2BF.%26aulast%3DPetsko%26aufirst%3DG.%2BA.%26aulast%3DYoon%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DK.-S.%26atitle%3DPGE1%2520and%2520PGA1%2520bind%2520to%2520Nurr1%2520and%2520activate%2520its%2520transcriptional%2520function%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2020%26volume%3D16%26spage%3D876%26epage%3D886%26doi%3D10.1038%2Fs41589-020-0553-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruning, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oltrabella, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kholodar, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletterick, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">England, P. M.</span></span> <span> </span><span class="NLM_article-title">Covalent Modification and Regulation of the Nuclear Receptor Nurr1 by a Dopamine Metabolite</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2019.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.chembiol.2019.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30853418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1MXks1SitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=674-685&author=J.+M.+Bruningauthor=Y.+Wangauthor=F.+Oltrabellaauthor=B.+Tianauthor=S.+A.+Kholodarauthor=H.+Liuauthor=P.+Bhattacharyaauthor=S.+Guoauthor=J.+M.+Holtonauthor=R.+J.+Fletterickauthor=M.+P.+Jacobsonauthor=P.+M.+England&title=Covalent+Modification+and+Regulation+of+the+Nuclear+Receptor+Nurr1+by+a+Dopamine+Metabolite&doi=10.1016%2Fj.chembiol.2019.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Modification and Regulation of the Nuclear Receptor Nurr1 by a Dopamine Metabolite</span></div><div class="casAuthors">Bruning, John M.; Wang, Yan; Oltrabella, Francesca; Tian, Boxue; Kholodar, Svetlana A.; Liu, Harrison; Bhattacharya, Paulomi; Guo, Su; Holton, James M.; Fletterick, Robert J.; Jacobson, Matthew P.; England, Pamela M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">674-685.e6</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nurr1, a nuclear receptor essential for the development, maintenance, and survival of midbrain dopaminergic neurons, is a potential therapeutic target for Parkinson's disease, a neurol. disorder characterized by the degeneration of these same neurons.  Efforts to identify Nurr1 agonists have been hampered by the recognition that it lacks several classic regulatory elements of nuclear receptor function, including the canonical ligand-binding pocket.  Here we report that the dopamine metabolite 5,6-dihydroxyindole (DHI) binds directly to and modulates the activity of Nurr1.  Using biophys. assays and X-ray crystallog., we show that DHI binds to the ligand-binding domain within a non-canonical pocket, forming a covalent adduct with Cys566.  In cultured cells and zebrafish, DHI stimulates Nurr1 activity, including the transcription of target genes underlying dopamine homeostasis.  These findings suggest avenues for developing synthetic Nurr1 ligands to ameliorate the symptoms and progression of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbfTNdzAqeRLVg90H21EOLACvtfcHk0liSTURZR4EMWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXks1SitLw%253D&md5=9d083c1ceca8cfb134b566ac191ef810</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2019.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2019.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DBruning%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DOltrabella%26aufirst%3DF.%26aulast%3DTian%26aufirst%3DB.%26aulast%3DKholodar%26aufirst%3DS.%2BA.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DBhattacharya%26aufirst%3DP.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DHolton%26aufirst%3DJ.%2BM.%26aulast%3DFletterick%26aufirst%3DR.%2BJ.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DEngland%26aufirst%3DP.%2BM.%26atitle%3DCovalent%2520Modification%2520and%2520Regulation%2520of%2520the%2520Nuclear%2520Receptor%2520Nurr1%2520by%2520a%2520Dopamine%2520Metabolite%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D674%26epage%3D685%26doi%3D10.1016%2Fj.chembiol.2019.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, U.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morpurgo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abudayyeh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjalkens, R. B.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptor 4A (NR4A) family - orphans no more</span>. <i>J. Steroid Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.jsbmb.2015.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.jsbmb.2015.04.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=25917081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnt1Wjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2016&pages=48-60&author=S.+Safeauthor=U.-H.+Jinauthor=B.+Morpurgoauthor=A.+Abudayyehauthor=M.+Singhauthor=R.+B.+Tjalkens&title=Nuclear+receptor+4A+%28NR4A%29+family+-+orphans+no+more&doi=10.1016%2Fj.jsbmb.2015.04.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptor 4A (NR4A) family - orphans no more</span></div><div class="casAuthors">Safe, Stephen; Jin, Un-Ho; Morpurgo, Benjamin; Abudayyeh, Ala; Singh, Mandip; Tjalkens, Ronald B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48-60</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The orphan nuclear receptors NR4A1, NR4A2 and NR4A3 are immediate early genes induced by multiple stressors, and the NR4A receptors play an important role in maintaining cellular homeostasis and disease.  There is increasing evidence for the role of these receptors in metabolic, cardiovascular and neurol. functions and also in inflammation and inflammatory diseases and in immune functions and cancer.  Despite the similarities of NR4A1, NR4A2 and NR4A3 and their interactions with common cis-genomic elements, they exhibit unique activities and cell-/tissue-specific functions.  Although endogenous ligands for NR4A receptors have not been identified, there is increasing evidence that structurally-diverse synthetic mols. can directly interact with the ligand binding domain of NR4A1 and act as agonists or antagonists, and ligands for NR4A2 and NR4A3 have also been identified.  Since NR4A receptors are key factors in multiple diseases, there are opportunities for the future development of NR4A ligands for clin. applications in treating multiple health problems including metabolic, neurol. and cardiovascular diseases, other inflammatory conditions, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWR4RU0ikZNrVg90H21EOLACvtfcHk0lgrXDVunaa-Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnt1Wjs7k%253D&md5=1dbc9721e70c9f19ea72032a60d351fe</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2015.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2015.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DSafe%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DU.-H.%26aulast%3DMorpurgo%26aufirst%3DB.%26aulast%3DAbudayyeh%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DTjalkens%26aufirst%3DR.%2BB.%26atitle%3DNuclear%2520receptor%25204A%2520%2528NR4A%2529%2520family%2520-%2520orphans%2520no%2520more%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2016%26volume%3D157%26spage%3D48%26epage%3D60%26doi%3D10.1016%2Fj.jsbmb.2015.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sekiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashiwagi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudensky, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichinose, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, A.</span></span> <span> </span><span class="NLM_article-title">The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">269</span>, <span class="refDoi"> DOI: 10.1038/ncomms1272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fncomms1272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=21468021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A280%3ADC%252BC3Mvht1Wqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=269&author=T.+Sekiyaauthor=I.+Kashiwagiauthor=N.+Inoueauthor=R.+Moritaauthor=S.+Horiauthor=H.+Waldmannauthor=A.+Y.+Rudenskyauthor=H.+Ichinoseauthor=D.+Metzgerauthor=P.+Chambonauthor=A.+Yoshimura&title=The+nuclear+orphan+receptor+Nr4a2+induces+Foxp3+and+regulates+differentiation+of+CD4%2B+T+cells&doi=10.1038%2Fncomms1272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells</span></div><div class="casAuthors">Sekiya Takashi; Kashiwagi Ikkou; Inoue Naoko; Morita Rimpei; Hori Shohei; Waldmann Herman; Rudensky Alexander Y; Ichinose Hiroshi; Metzger Daniel; Chambon Pierre; Yoshimura Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">269</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Regulatory T cells (Tregs) have a central role in maintaining immune homoeostasis through various mechanisms.  Although the Forkhead transcription factor Foxp3 defines the Treg cell lineage and functions, the molecular mechanisms of Foxp3 induction and maintenance remain elusive.  Here we show that Foxp3 is one of the direct targets of Nr4a2.  Nr4a2 binds to regulatory regions of Foxp3, where it mediates permissive histone modifications.  Ectopic expression of Nr4a2 imparts Treg-like suppressive activity to naive CD4(+) T cells by inducing Foxp3 and by repressing cytokine production, including interferon-γ and interleukin-2.  Deletion of Nr4a2 in T cells attenuates induction of Tregs and causes aberrant induction of Th1, leading to the exacerbation of colitis.  Nr4a2-deficeint Tregs are prone to lose Foxp3 expression and have attenuated suppressive ability both in vitro and in vivo.  Thus, Nr4a2 has the ability to maintain T-cell homoeostasis by regulating induction, maintenance and suppressor functions of Tregs, and by repression of aberrant Th1 induction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNsvtqioWPE1MGsG_HTXYFfW6udTcc2eYJkCILKKdJwbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mvht1Wqug%253D%253D&md5=52076bb0140c05bfbdce9a5f0f6e2f2e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fncomms1272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1272%26sid%3Dliteratum%253Aachs%26aulast%3DSekiya%26aufirst%3DT.%26aulast%3DKashiwagi%26aufirst%3DI.%26aulast%3DInoue%26aufirst%3DN.%26aulast%3DMorita%26aufirst%3DR.%26aulast%3DHori%26aufirst%3DS.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DRudensky%26aufirst%3DA.%2BY.%26aulast%3DIchinose%26aufirst%3DH.%26aulast%3DMetzger%26aufirst%3DD.%26aulast%3DChambon%26aufirst%3DP.%26aulast%3DYoshimura%26aufirst%3DA.%26atitle%3DThe%2520nuclear%2520orphan%2520receptor%2520Nr4a2%2520induces%2520Foxp3%2520and%2520regulates%2520differentiation%2520of%2520CD4%252B%2520T%2520cells%26jtitle%3DNat.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D269%26doi%3D10.1038%2Fncomms1272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sekiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashiwagi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichinose, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, A.</span></span> <span> </span><span class="NLM_article-title">Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1038/ni.2520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fni.2520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=23334790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=230-237&author=T.+Sekiyaauthor=I.+Kashiwagiauthor=R.+Yoshidaauthor=T.+Fukayaauthor=R.+Moritaauthor=A.+Kimuraauthor=H.+Ichinoseauthor=D.+Metzgerauthor=P.+Chambonauthor=A.+Yoshimura&title=Nr4a+receptors+are+essential+for+thymic+regulatory+T+cell+development+and+immune+homeostasis&doi=10.1038%2Fni.2520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis</span></div><div class="casAuthors">Sekiya, Takashi; Kashiwagi, Ikkou; Yoshida, Rei; Fukaya, Tomohiro; Morita, Rimpei; Kimura, Akihiro; Ichinose, Hiroshi; Metzger, Daniel; Chambon, Pierre; Yoshimura, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">230-237</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Regulatory T cells (Treg cells) develop from progenitor thymocytes after the engagement of T cell antigen receptors (TCRs) with high-affinity ligands, but the underlying mol. mechanisms are still unclear.  Here we show that the Nr4a nuclear receptors, which are encoded by immediate-early genes upregulated by TCR stimulation in thymocytes, have essential roles in Treg cell development.  Mice that lacked all Nr4a factors could not produce Treg cells and died early owing to systemic autoimmunity.  Nr4a receptors directly activated the promoter of the gene encoding the transcription factor Foxp3, and forced activation of Nr4a receptors bypassed low-strength TCR signaling to drive the Treg cell developmental program.  Our results suggest that Nr4a receptors have key roles in detg. CD4+ T cell fates in the thymus and thus contribute to immune homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVYG89540YGbVg90H21EOLACvtfcHk0lgrXDVunaa-Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSjtL0%253D&md5=dcd81ab80944a238b75ef81985d22d35</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fni.2520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2520%26sid%3Dliteratum%253Aachs%26aulast%3DSekiya%26aufirst%3DT.%26aulast%3DKashiwagi%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DR.%26aulast%3DFukaya%26aufirst%3DT.%26aulast%3DMorita%26aufirst%3DR.%26aulast%3DKimura%26aufirst%3DA.%26aulast%3DIchinose%26aufirst%3DH.%26aulast%3DMetzger%26aufirst%3DD.%26aulast%3DChambon%26aufirst%3DP.%26aulast%3DYoshimura%26aufirst%3DA.%26atitle%3DNr4a%2520receptors%2520are%2520essential%2520for%2520thymic%2520regulatory%2520T%2520cell%2520development%2520and%2520immune%2520homeostasis%26jtitle%3DNat.%2520Immunol.%26date%3D2013%26volume%3D14%26spage%3D230%26epage%3D237%26doi%3D10.1038%2Fni.2520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naffin-Olivos, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petsko, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-S.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson’s disease</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">8756</span>– <span class="NLM_lpage">8761</span>, <span class="refDoi"> DOI: 10.1073/pnas.1509742112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1073%2Fpnas.1509742112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=26124091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOrs7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=8756-8761&author=C.-H.+Kimauthor=B.-S.+Hanauthor=J.+Moonauthor=D.-J.+Kimauthor=J.+Shinauthor=S.+Rajanauthor=Q.+T.+Nguyenauthor=M.+Sohnauthor=W.-G.+Kimauthor=M.+Hanauthor=I.+Jeongauthor=K.-S.+Kimauthor=E.-H.+Leeauthor=Y.+Tuauthor=J.+L.+Naffin-Olivosauthor=C.-H.+Parkauthor=D.+Ringeauthor=H.+S.+Yoonauthor=G.+A.+Petskoauthor=K.-S.+Kim&title=Nuclear+receptor+Nurr1+agonists+enhance+its+dual+functions+and+improve+behavioral+deficits+in+an+animal+model+of+Parkinson%E2%80%99s+disease&doi=10.1073%2Fpnas.1509742112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson's disease</span></div><div class="casAuthors">Kim, Chun-Hyung; Han, Baek-Soo; Moon, Jisook; Kim, Deog-Joong; Shin, Joon; Rajan, Sreekanth; Nguyen, Quoc Toan; Sohn, Mijin; Kim, Won-Gon; Han, Minjoon; Jeong, Inhye; Kim, Kyoung-Shim; Lee, Eun-Hye; Tu, Yupeng; Naffin-Olivos, Jacqueline L.; Park, Chang-Hwan; Ringe, Dagmar; Yoon, Ho Sup; Petsko, Gregory A.; Kim, Kwang-Soo</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">8756-8761</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Parkinson's disease (PD), primarily caused by selective degeneration of midbrain dopamine (mDA) neurons, is the most prevalent movement disorder, affecting 1-2% of the global population over the age of 65.  Currently available pharmacol. treatments are largely symptomatic and lose their efficacy over time with accompanying severe side effects such as dyskinesia.  Thus, there is an unmet clin. need to develop mechanism-based and/or disease-modifying treatments.  Based on the unique dual role of the nuclear orphan receptor Nurr1 for development and maintenance of mDA neurons and their protection from inflammation-induced death, we hypothesize that Nurr1 can be a mol. target for neuroprotective therapeutic development for PD.  Here we show successful identification of Nurr1 agonists sharing an identical chem. scaffold, 4-amino-7-chloroquinoline, suggesting a crit. structure-activity relationship.  In particular, we found that two antimalarial drugs, amodiaquine and chloroquine stimulate the transcriptional function of Nurr1 through phys. interaction with its ligand binding domain (LBD).  Remarkably, these compds. were able to enhance the contrasting dual functions of Nurr1 by further increasing transcriptional activation of mDA-specific genes and further enhancing transrepression of neurotoxic proinflammatory gene expression in microglia.  Importantly, these compds. significantly improved behavioral deficits in 6-hydroxydopamine lesioned rat model of PD without any detectable signs of dyskinesia-like behavior.  These findings offer proof of principle that small mols. targeting the Nurr1 LBD can be used as a mechanism-based and neuroprotective strategy for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaWD4RLxZ8nbVg90H21EOLACvtfcHk0lhgAWXBPN3qOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOrs7%252FL&md5=715bbb21e39675989c84aa2ab51447dc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1509742112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1509742112%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DC.-H.%26aulast%3DHan%26aufirst%3DB.-S.%26aulast%3DMoon%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DD.-J.%26aulast%3DShin%26aufirst%3DJ.%26aulast%3DRajan%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DQ.%2BT.%26aulast%3DSohn%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DW.-G.%26aulast%3DHan%26aufirst%3DM.%26aulast%3DJeong%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DK.-S.%26aulast%3DLee%26aufirst%3DE.-H.%26aulast%3DTu%26aufirst%3DY.%26aulast%3DNaffin-Olivos%26aufirst%3DJ.%2BL.%26aulast%3DPark%26aufirst%3DC.-H.%26aulast%3DRinge%26aufirst%3DD.%26aulast%3DYoon%26aufirst%3DH.%2BS.%26aulast%3DPetsko%26aufirst%3DG.%2BA.%26aulast%3DKim%26aufirst%3DK.-S.%26atitle%3DNuclear%2520receptor%2520Nurr1%2520agonists%2520enhance%2520its%2520dual%2520functions%2520and%2520improve%2520behavioral%2520deficits%2520in%2520an%2520animal%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3D8756%26epage%3D8761%26doi%3D10.1073%2Fpnas.1509742112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-S.</span></span> <span> </span><span class="NLM_article-title">Nurr1 (NR4A2) regulates Alzheimer’s disease-related pathogenesis and cognitive function in the 5XFAD mouse model</span>. <i>Aging Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>, <span class="NLM_elocation-id">e12866</span> <span class="refDoi"> DOI: 10.1111/acel.12866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1111%2Facel.12866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30515963" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&author=M.+Moonauthor=E.+S.+Jungauthor=S.+G.+Jeonauthor=M.-Y.+Chaauthor=Y.+Jangauthor=W.+Kimauthor=C.+Lopesauthor=I.+Mook-Jungauthor=K.-S.+Kim&title=Nurr1+%28NR4A2%29+regulates+Alzheimer%E2%80%99s+disease-related+pathogenesis+and+cognitive+function+in+the+5XFAD+mouse+model&doi=10.1111%2Facel.12866"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Facel.12866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Facel.12866%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DM.%26aulast%3DJung%26aufirst%3DE.%2BS.%26aulast%3DJeon%26aufirst%3DS.%2BG.%26aulast%3DCha%26aufirst%3DM.-Y.%26aulast%3DJang%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DW.%26aulast%3DLopes%26aufirst%3DC.%26aulast%3DMook-Jung%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DK.-S.%26atitle%3DNurr1%2520%2528NR4A2%2529%2520regulates%2520Alzheimer%25E2%2580%2599s%2520disease-related%2520pathogenesis%2520and%2520cognitive%2520function%2520in%2520the%25205XFAD%2520mouse%2520model%26jtitle%3DAging%2520Cell%26date%3D2019%26volume%3D18%26doi%3D10.1111%2Facel.12866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McAnally, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiquee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomaa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divlianska, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peddibhotla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morfa, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hershberger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terry, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farjo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quigley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulton, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. H.</span></span> <span> </span><span class="NLM_article-title">Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">e0202436</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0202436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1371%2Fjournal.pone.0202436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30208056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlagsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&author=D.+McAnallyauthor=K.+Siddiqueeauthor=A.+Gomaaauthor=A.+Szaboauthor=S.+Vasileauthor=P.+R.+Maloneyauthor=D.+B.+Divlianskaauthor=S.+Peddibhotlaauthor=C.+J.+Morfaauthor=P.+Hershbergerauthor=R.+Falterauthor=R.+Williamsonauthor=D.+B.+Terryauthor=R.+Farjoauthor=A.+B.+Pinkertonauthor=X.+Qiauthor=J.+Quigleyauthor=M.+E.+Boultonauthor=M.+B.+Grantauthor=L.+H.+Smith&title=Repurposing+antimalarial+aminoquinolines+and+related+compounds+for+treatment+of+retinal+neovascularization&doi=10.1371%2Fjournal.pone.0202436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization</span></div><div class="casAuthors">McAnally, Danielle; Siddiquee, Khandaker; Gomaa, Ahmed; Szabo, Andras; Vasile, Stefan; Maloney, Patrick R.; Divlianska, Daniela B.; Peddibhotla, Satyamaheshwar; Morfa, Camilo J.; Hershberger, Paul; Falter, Rebecca; Williamson, Robert; Terry, David B.; Farjo, Rafal; Pinkerton, Anthony B.; Qi, Xiaping; Quigley, Judith; Boulton, Michael E.; Grant, Maria B.; Smith, Layton H.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e0202436/1-e0202436/23</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Neovascularization is the pathol. driver of blinding eye diseases such as retinopathy of prematurity, proliferative diabetic retinopathy, and wet age-related macular degeneration.  The loss of vision resulting from these diseases significantly impacts the productivity and quality of life of patients, and represents a substantial burden on the health care system.  Current std. of care includes biologics that target vascular endothelial growth factor (VEGF), a key mediator of neovascularization.  While anti-VGEF therapies have been successful, up to 30% of patients are non-responsive.  Therefore, there is a need for new therapeutic targets, and small mol. inhibitors of angiogenesis to complement existing treatments.  Apelin and its receptor have recently been shown to play a key role in both developmental and pathol. angiogenesis in the eye.  Through a cell-based highthroughput screen, we identified 4-aminoquinoline antimalarial drugs as potent selective antagonists of APJ.  The prototypical 4-aminoquinoline, amodiaquine was found to be a selective, non-competitive APJ antagonist that inhibited apelin signaling in a concentrationdependent manner.  Addnl., amodiaquine suppressed both apelin-and VEGF-induced endothelial tube formation.  Intravitreal amodaiquine significantly reduced choroidal neovascularization (CNV) lesion vol. in the laser-induced CNV mouse model, and showed no signs of ocular toxicity at the highest doses tested.  This work firmly establishes APJ as a novel, chem. tractable therapeutic target for the treatment of ocular neovascularization, and that amodiaquine is a potential candidate for repurposing and further toxicol., and pharmacokinetic evaluation in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIAOMW3MbqSrVg90H21EOLACvtfcHk0lhgAWXBPN3qOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlagsbrJ&md5=d3ed9a88af05b43d9c4ed842bf481de6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0202436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0202436%26sid%3Dliteratum%253Aachs%26aulast%3DMcAnally%26aufirst%3DD.%26aulast%3DSiddiquee%26aufirst%3DK.%26aulast%3DGomaa%26aufirst%3DA.%26aulast%3DSzabo%26aufirst%3DA.%26aulast%3DVasile%26aufirst%3DS.%26aulast%3DMaloney%26aufirst%3DP.%2BR.%26aulast%3DDivlianska%26aufirst%3DD.%2BB.%26aulast%3DPeddibhotla%26aufirst%3DS.%26aulast%3DMorfa%26aufirst%3DC.%2BJ.%26aulast%3DHershberger%26aufirst%3DP.%26aulast%3DFalter%26aufirst%3DR.%26aulast%3DWilliamson%26aufirst%3DR.%26aulast%3DTerry%26aufirst%3DD.%2BB.%26aulast%3DFarjo%26aufirst%3DR.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DQuigley%26aufirst%3DJ.%26aulast%3DBoulton%26aufirst%3DM.%2BE.%26aulast%3DGrant%26aufirst%3DM.%2BB.%26aulast%3DSmith%26aufirst%3DL.%2BH.%26atitle%3DRepurposing%2520antimalarial%2520aminoquinolines%2520and%2520related%2520compounds%2520for%2520treatment%2520of%2520retinal%2520neovascularization%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26doi%3D10.1371%2Fjournal.pone.0202436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesplède, T.</span></span> <span> </span><span class="NLM_article-title">Antimalarial drugs and their metabolites are potent Zika virus inhibitors</span>. <i>J. Med. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">1182</span>– <span class="NLM_lpage">1190</span>, <span class="refDoi"> DOI: 10.1002/jmv.25440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1002%2Fjmv.25440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30801742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvVOqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2019&pages=1182-1190&author=Y.+Hanauthor=H.+T.+Phamauthor=H.+Xuauthor=Y.+Quanauthor=T.+Mespl%C3%A8de&title=Antimalarial+drugs+and+their+metabolites+are+potent+Zika+virus+inhibitors&doi=10.1002%2Fjmv.25440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drugs and their metabolites are potent Zika virus inhibitors</span></div><div class="casAuthors">Han, Yingshan; Pham, Hanh T.; Xu, Hongtao; Quan, Yudong; Mesplede, Thibault</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Virology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1182-1190</span>CODEN:
                <span class="NLM_cas:coden">JMVIDB</span>;
        ISSN:<span class="NLM_cas:issn">0146-6615</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Studies aimed at repurposing existing drugs revealed that some antimalarial compds. possess anti-Zika virus (anti-ZIKV) activity.  Here, we further tested 14 addnl. antimalarial drugs and their metabolites or analogs for anti-ZIKV activity using a phenotypic screening approach.  We identified four compds. with varying anti-ZIKV activity, including a metabolite of amodiaquine termed desethylamodiaquine (DAQ) and N-desethylchloroquine (DECQ), a metabolite of chloroquine, which both exhibited low micromolar effective concns. against three different ZIKV strains.  Two other compds. termed dihydroartemisinin (DHA) and quinidine (QD) exhibited only partial inhibition of ZIKV replication.  Characterization of the inhibitory mechanisms of DAQ and DECQ showed that both drugs target the entry step as well as postentry events of the viral replication cycle.  These hits represent attractive starting points for future optimization of new anti-ZIKV drug candidates derived from antimalarial drugs and their analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolD7tHr00uD7Vg90H21EOLACvtfcHk0liOJZUUjCbDEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvVOqsLc%253D&md5=111c2c9601b956ac74b275827c3e9fa7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fjmv.25440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmv.25440%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DY.%26aulast%3DPham%26aufirst%3DH.%2BT.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DQuan%26aufirst%3DY.%26aulast%3DMespl%25C3%25A8de%26aufirst%3DT.%26atitle%3DAntimalarial%2520drugs%2520and%2520their%2520metabolites%2520are%2520potent%2520Zika%2520virus%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Virol.%26date%3D2019%26volume%3D91%26spage%3D1182%26epage%3D1190%26doi%3D10.1002%2Fjmv.25440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakakibara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, R. A.</span></span> <span> </span><span class="NLM_article-title">Novel amodiaquine derivatives potently inhibit Ebola virus infection</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2018.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.antiviral.2018.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30395872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyqsb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2018&pages=175-182&author=Y.+Sakuraiauthor=N.+Sakakibaraauthor=M.+Toyamaauthor=M.+Babaauthor=R.+A.+Davey&title=Novel+amodiaquine+derivatives+potently+inhibit+Ebola+virus+infection&doi=10.1016%2Fj.antiviral.2018.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Novel amodiaquine derivatives potently inhibit Ebola virus infection</span></div><div class="casAuthors">Sakurai, Yasuteru; Sakakibara, Norikazu; Toyama, Masaaki; Baba, Masanori; Davey, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">175-182</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ebola virus disease is a severe disease caused by highly pathogenic Ebolaviruses.  Although it shows a high mortality rate in humans, currently there is no licensed therapeutic.  During the recent epidemic in West Africa, it was demonstrated that administration of antimalarial medication contg. amodiaquine significantly lowered mortality rate of patients infected with the virus.  Here, in order to improve its antiviral activity, a series of amodiaquine derivs. were synthesized and tested for Ebola virus infection.  We found that multiple compds. were more potent than amodiaquine.  The structure-activity relationship anal. revealed that the two independent parts, which are the alkyl chains extending from the aminomethyl group and a halogen bonded to the quinoline ring, were keys for enhancing antiviral potency without increasing toxicity.  When these modifications were combined, the antiviral efficacy could be further improved with the selectivity indexes being over 10-times higher than amodiaquine.  Mechanistic evaluation demonstrated that the potent derivs. blocked host cell entry of Ebola virus, like the parental amodiaquine.  Taken together, our work identified novel potent amodiaquine derivs., which will aid in further development of effective antiviral therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg7fQHI66_hbVg90H21EOLACvtfcHk0liOJZUUjCbDEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyqsb7F&md5=eabfccce2ea4a88acdc00c1f6c2e745c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2018.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2018.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DSakurai%26aufirst%3DY.%26aulast%3DSakakibara%26aufirst%3DN.%26aulast%3DToyama%26aufirst%3DM.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DDavey%26aufirst%3DR.%2BA.%26atitle%3DNovel%2520amodiaquine%2520derivatives%2520potently%2520inhibit%2520Ebola%2520virus%2520infection%26jtitle%3DAntiviral%2520Res.%26date%3D2018%26volume%3D160%26spage%3D175%26epage%3D182%26doi%3D10.1016%2Fj.antiviral.2018.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, D. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluzman, I. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, D. E.</span></span> <span> </span><span class="NLM_article-title">On the molecular mechanism of chloroquine’s antimalarial action</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">11865</span>– <span class="NLM_lpage">11870</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.21.11865</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1073%2Fpnas.93.21.11865" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=8876229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADyaK28Xmtlamt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=11865-11870&author=D.+J.+Sullivanauthor=I.+Y.+Gluzmanauthor=D.+G.+Russellauthor=D.+E.+Goldberg&title=On+the+molecular+mechanism+of+chloroquine%E2%80%99s+antimalarial+action&doi=10.1073%2Fpnas.93.21.11865"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">On the molecular mechanism of chloroquine's antimalarial action</span></div><div class="casAuthors">Sullivan, David J., Jr.; Gluzman, Ilya Y.; Russell, David G.; Goldberg, Daniel E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">11865-11870</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Chloroquine is thought to exert its antimalarial effect by preventing the polymn. of toxic heme released during proteolysis of Hb in the Plasmodium digestive vacuole.  The mechanism of this blockade has not been established.  The authors incubated cultured parasites with subinhibitory doses of [3H]chloroquine and [3H]quinidine.  These [3H]quinoline compds. became assocd. with hemozoin as assessed by electron microscope autoradiog. and subcellular fractionation.  In vitro, binding of [3H]quinoline inhibitors to the hemozoin chain depended on the addn. of heme substrate.  These data counter previous conclusions regarding the lack of quinoline assocn. with hemozoin, explain the exaggerated accumulation of quinolines in the Plasmodium digestive vacuole, and suggest that a quinoline-heme complex incorporates into the growing polymer to terminate chain extension, blocking further sequestration of toxic heme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEX6AGc8Unx7Vg90H21EOLACvtfcHk0liOJZUUjCbDEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xmtlamt7k%253D&md5=075515c130f356354f42e5641693a356</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.21.11865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.21.11865%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DD.%2BJ.%26aulast%3DGluzman%26aufirst%3DI.%2BY.%26aulast%3DRussell%26aufirst%3DD.%2BG.%26aulast%3DGoldberg%26aufirst%3DD.%2BE.%26atitle%3DOn%2520the%2520molecular%2520mechanism%2520of%2520chloroquine%25E2%2580%2599s%2520antimalarial%2520action%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D11865%26epage%3D11870%26doi%3D10.1073%2Fpnas.93.21.11865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengerer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattes, H.</span></span> <span> </span><span class="NLM_article-title">Identification of a potent agonist of the orphan nuclear receptor Nurr1</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">955</span>– <span class="NLM_lpage">958</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200600078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1002%2Fcmdc.200600078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=16952138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVCmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=955-958&author=C.+Duboisauthor=B.+Hengererauthor=H.+Mattes&title=Identification+of+a+potent+agonist+of+the+orphan+nuclear+receptor+Nurr1&doi=10.1002%2Fcmdc.200600078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a potent agonist of the orphan nuclear receptor Nurr1</span></div><div class="casAuthors">Dubois, Celine; Hengerer, Bastian; Mattes, Henri</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">955-958</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Mimotope's SynPhase double lanterns were used for the development of a six-step synthesis of benzimidazoles.  A library of 3840 benzimidazoles was prepd. on Mimotope's double lanterns using the sort-and-combine strategy.  A no. of micromolar agonists of Nurr1, which increased the luciferase reporter-gene activity by a factor of 2, could be identified by screening the first generation library of 3256 compds.  To improve the potency of the first-generation hits, we designed and synthesized a second-generation library biased toward Nurr1.  Very potent Nurrl agonists (e.g. I ) were thus rapidly identified by designing, synthesizing, and screening a first-generation library oriented toward nuclear receptors, followed by a small, biased second-generation library.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqAkTyjtOyTbVg90H21EOLACvtfcHk0liOJZUUjCbDEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVCmu7o%253D&md5=cf81e4fdb1410b826f77479f61f0c30c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200600078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200600078%26sid%3Dliteratum%253Aachs%26aulast%3DDubois%26aufirst%3DC.%26aulast%3DHengerer%26aufirst%3DB.%26aulast%3DMattes%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520a%2520potent%2520agonist%2520of%2520the%2520orphan%2520nuclear%2520receptor%2520Nurr1%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D955%26epage%3D958%26doi%3D10.1002%2Fcmdc.200600078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Krosigk, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathé, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengerer, B.</span></span> <span> </span><span class="NLM_article-title">Identification of a series of highly potent activators of the Nurr1 signaling pathway</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.09.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.bmcl.2006.09.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=17035009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2sXislSg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=193-196&author=S.+Hintermannauthor=M.+Chiesiauthor=U.+von+Krosigkauthor=D.+Math%C3%A9author=R.+Felberauthor=B.+Hengerer&title=Identification+of+a+series+of+highly+potent+activators+of+the+Nurr1+signaling+pathway&doi=10.1016%2Fj.bmcl.2006.09.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a series of highly potent activators of the Nurr1 signaling pathway</span></div><div class="casAuthors">Hintermann, Samuel; Chiesi, Michele; von Krosigk, Ulrike; Mathe, Daniele; Felber, Richard; Hengerer, Bastian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-196</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The nuclear receptor Nurr1 (NR4A2) is critically involved in the development and maintenance of midbrain dopaminergic neurons and is believed to function independently of endogenous activation.  The hit identification and SAR studies leading to isoxazolo-pyridinone 7e (I), a highly potent, brain penetrable activator of the Nurr1 signaling pathway, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcDV-XImUf67Vg90H21EOLACvtfcHk0lgbMpUQIFe9aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXislSg&md5=8cb547a0ff17183aaef9a87dd1db29ef</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.09.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.09.062%26sid%3Dliteratum%253Aachs%26aulast%3DHintermann%26aufirst%3DS.%26aulast%3DChiesi%26aufirst%3DM.%26aulast%3Dvon%2BKrosigk%26aufirst%3DU.%26aulast%3DMath%25C3%25A9%26aufirst%3DD.%26aulast%3DFelber%26aufirst%3DR.%26aulast%3DHengerer%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520a%2520series%2520of%2520highly%2520potent%2520activators%2520of%2520the%2520Nurr1%2520signaling%2520pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D193%26epage%3D196%26doi%3D10.1016%2Fj.bmcl.2006.09.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montarolo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffaele, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furlan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertolotto, A.</span></span> <span> </span><span class="NLM_article-title">Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e108791</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0108791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1371%2Fjournal.pone.0108791" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=25265488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslegtbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=F.+Montaroloauthor=C.+Raffaeleauthor=S.+Pergaauthor=S.+Martireauthor=A.+Finardiauthor=R.+Furlanauthor=S.+Hintermannauthor=A.+Bertolotto&title=Effects+of+isoxazolo-pyridinone+7e%2C+a+potent+activator+of+the+Nurr1+signaling+pathway%2C+on+experimental+autoimmune+encephalomyelitis+in+mice&doi=10.1371%2Fjournal.pone.0108791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice</span></div><div class="casAuthors">Montarolo, Francesca; Raffaele, Chiara; Perga, Simona; Martire, Serena; Finardi, Annamaria; Furlan, Roberto; Hintermann, Samuel; Bertolotto, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e108791/1-e108791/9, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Multiple sclerosis (MS) is an autoimmune chronic disease of the central nervous system (CNS) characterized by immune-mediated inflammation, demyelination and subsequent axonal damage.  Gene expression profiling showed that Nurr1, an orphan nuclear receptor, is down-regulated in peripheral blood mononuclear cells of MS patients.  Nurr1 exerts an anti-inflammatory role repressing the activity of the pro-inflammatory transcription factor NF-kB.  Here, we report that the preventive treatment with isoxazolo-pyridinone 7e, an activator of Nurr1 signaling pathway, reduces the incidence and the severity of a MS murine model, i.e. exptl. autoimmune encephalomyelitis (EAE).  The compd. is able to attenuate inflammation and neurodegeneration in spinal cords of EAE mice by an NF-kB pathway-dependent process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqNGVvjCYeK7Vg90H21EOLACvtfcHk0lgbMpUQIFe9aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslegtbvP&md5=bdf7ca10afd4a66a10360bb2ef394c69</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0108791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0108791%26sid%3Dliteratum%253Aachs%26aulast%3DMontarolo%26aufirst%3DF.%26aulast%3DRaffaele%26aufirst%3DC.%26aulast%3DPerga%26aufirst%3DS.%26aulast%3DMartire%26aufirst%3DS.%26aulast%3DFinardi%26aufirst%3DA.%26aulast%3DFurlan%26aufirst%3DR.%26aulast%3DHintermann%26aufirst%3DS.%26aulast%3DBertolotto%26aufirst%3DA.%26atitle%3DEffects%2520of%2520isoxazolo-pyridinone%25207e%252C%2520a%2520potent%2520activator%2520of%2520the%2520Nurr1%2520signaling%2520pathway%252C%2520on%2520experimental%2520autoimmune%2520encephalomyelitis%2520in%2520mice%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0108791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lesuisse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malanda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyronel, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evanno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lardenois, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De-Peretti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abécassis, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnéoud, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgevin, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cegarra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dommergue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Even, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luc, T. P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almario, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castel, M.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taupin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigé, X.</span></span> <span> </span><span class="NLM_article-title">Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson’s disease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.bmcl.2019.01.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30773432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjt1Sqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=929-932&author=D.+Lesuisseauthor=A.+Malandaauthor=J.-F.+Peyronelauthor=Y.+Evannoauthor=P.+Lardenoisauthor=D.+De-Perettiauthor=P.-Y.+Ab%C3%A9cassisauthor=P.+Barn%C3%A9oudauthor=P.+Brunelauthor=M.-C.+Burgevinauthor=C.+Cegarraauthor=F.+Augerauthor=A.+Dommergueauthor=C.+Lafonauthor=L.+Evenauthor=J.+Tsiauthor=T.+P.+H.+Lucauthor=A.+Almarioauthor=A.+Olivierauthor=M.-N.+Castelauthor=V.+Taupinauthor=T.+Rooneyauthor=X.+Vig%C3%A9&title=Development+of+a+novel+NURR1%2FNOT+agonist+from+hit+to+lead+and+candidate+for+the+potential+treatment+of+Parkinson%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2019.01.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease</span></div><div class="casAuthors">Lesuisse, Dominique; Malanda, Andre; Peyronel, Jean-Francois; Evanno, Yannick; Lardenois, Patrick; De-Peretti, Danielle; Abecassis, Pierre-Yves; Barneoud, Pascal; Brunel, Pascale; Burgevin, Marie-Claude; Cegarra, Celine; Auger, Florian; Dommergue, Amelie; Lafon, Corinne; Even, Luc; Tsi, Joanna; Luc, Thy Phuong Hieu; Almario, Antonio; Olivier, Anne; Castel, Marie-Noelle; Taupin, Veronique; Rooney, Thomas; Vige, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">929-932</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the course of a program aimed at identifying Nurr1/NOT agonists for potential treatment of Parkinson's disease, a few hits from high throughput screening were identified and characterized.  A combined optimization pointed to a very narrow and stringent structure activity relationship.  A comprehensive program of optimization led to a potent and safe candidate drug displaying neuroprotective and anti-inflammatory activity in several in vitro and in vivo models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcufBh3Md1wbVg90H21EOLACvtfcHk0lgbMpUQIFe9aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjt1Sqtbg%253D&md5=20b882a19d4c0db9abf47f45dfbc8b61</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DLesuisse%26aufirst%3DD.%26aulast%3DMalanda%26aufirst%3DA.%26aulast%3DPeyronel%26aufirst%3DJ.-F.%26aulast%3DEvanno%26aufirst%3DY.%26aulast%3DLardenois%26aufirst%3DP.%26aulast%3DDe-Peretti%26aufirst%3DD.%26aulast%3DAb%25C3%25A9cassis%26aufirst%3DP.-Y.%26aulast%3DBarn%25C3%25A9oud%26aufirst%3DP.%26aulast%3DBrunel%26aufirst%3DP.%26aulast%3DBurgevin%26aufirst%3DM.-C.%26aulast%3DCegarra%26aufirst%3DC.%26aulast%3DAuger%26aufirst%3DF.%26aulast%3DDommergue%26aufirst%3DA.%26aulast%3DLafon%26aufirst%3DC.%26aulast%3DEven%26aufirst%3DL.%26aulast%3DTsi%26aufirst%3DJ.%26aulast%3DLuc%26aufirst%3DT.%2BP.%2BH.%26aulast%3DAlmario%26aufirst%3DA.%26aulast%3DOlivier%26aufirst%3DA.%26aulast%3DCastel%26aufirst%3DM.-N.%26aulast%3DTaupin%26aufirst%3DV.%26aulast%3DRooney%26aufirst%3DT.%26aulast%3DVig%25C3%25A9%26aufirst%3DX.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520NURR1%252FNOT%2520agonist%2520from%2520hit%2520to%2520lead%2520and%2520candidate%2520for%2520the%2520potential%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D929%26epage%3D932%26doi%3D10.1016%2Fj.bmcl.2019.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3’-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">1445</span>– <span class="NLM_lpage">1455</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2012.02.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.bcp.2012.02.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=22405837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFGitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=1445-1455&author=X.+Liauthor=S.-O.+Leeauthor=S.+Safe&title=Structure-dependent+activation+of+NR4A2+%28Nurr1%29+by+1%2C1-bis%283%E2%80%99-indolyl%29-1-%28aromatic%29methane+analogs+in+pancreatic+cancer+cells&doi=10.1016%2Fj.bcp.2012.02.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3'-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cells</span></div><div class="casAuthors">Li, Xi; Lee, Syng-Ook; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1445-1455</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NR4A2 (Nurr1) is an orphan nuclear receptor with no known endogenous ligands and is highly expressed in many cancer cell lines including Panc1 and Panc28 pancreatic cancer cells.  Structure-dependent activation of NR4A2 by a series of 1,1-bis(3'-indolyl)-1-(arom.)methane (C-DIM) analogs was detd. in pancreatic cancer cells transfected with yeast GAL4-Nurr1 chimeras and a UASx5-luc reporter gene or constructs contg. response elements that bind NR4A2.  Among 23 different structural analogs, Ph groups contg. p-substituted trifluoromethyl, t-Bu, cyano, bromo, iodo and trifluoromethoxy groups were the most active compds. in transactivation assay.  The p-bromophenyl analog (DIM-C-pPhBr) was used as a model for structure-activity studies among a series of ortho-, meta- and para-bromophenyl isomers and the corresponding indole 2- and N-Me analogs.  Results show that NR4A2 activation was maximal with the p-bromophenyl analog and methylation of the indole NH group abrogated activity.  Moreover, using GAL4-Nurr1 (full length) or GAL-Nurr1-A/B and GAL4-Nurr1-(C-F) chimeras expressing N- and C-terminal domains of Nurr1, resp., DIM-C-pPhBr activated all three constructs and these responses were differentially affected by kinase inhibitors.  DIM-C-pPhBr also modulated expression of several Nurr1-regulated genes in pancreatic cancer cells including vasoactive intestinal peptide (VIP), and the immunohistochem. and western blot analyses indicated that DIM-C-pPhBr activates nuclear NR4A2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS0O1bRvqj0LVg90H21EOLACvtfcHk0lhGnSUYEdS4uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFGitbY%253D&md5=c2a6e2dfb65f41fe9aa193af7335d25e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.02.021%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DS.-O.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DStructure-dependent%2520activation%2520of%2520NR4A2%2520%2528Nurr1%2529%2520by%25201%252C1-bis%25283%25E2%2580%2599-indolyl%2529-1-%2528aromatic%2529methane%2520analogs%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D1445%26epage%3D1455%26doi%3D10.1016%2Fj.bcp.2012.02.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjalkens, R. B.</span></span> <span> </span><span class="NLM_article-title">A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>607</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2015.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.neulet.2015.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=26383113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1SlurnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=607&publication_year=2015&pages=83-89&author=S.+L.+Hammondauthor=S.+Safeauthor=R.+B.+Tjalkens&title=A+novel+synthetic+activator+of+Nurr1+induces+dopaminergic+gene+expression+and+protects+against+6-hydroxydopamine+neurotoxicity+in+vitro&doi=10.1016%2Fj.neulet.2015.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro</span></div><div class="casAuthors">Hammond, Sean L.; Safe, Stephen; Tjalkens, Ronald B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">607</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83-89</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Degeneration of dopaminergic neurons in Parkinson's disease (PD) is assocd. with decreased expression of the orphan nuclear receptor Nurr1 (NR4A2), which is crit. for both homeostasis and development of dopamine (DA) neurons.  The synthetic, phytochem.-based compd., 1,1-bis (3'-indolyl)-1-(p-chlorophenyl) methane (C-DIM12) activates Nurr1 in cancer cells and prevents loss of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD in mice.  In the present study, we examd. the capacity of C-DIM12 to induce expression of Nurr1-regulated genes in two dopaminergic neuronal cell lines (N2A, N27) and to protect against 6-hydroxydopamine (6-OHDA) neurotoxicity.  C-DIM12 induced expression of Nurr1-regulated genes that was abolished by Nurr1 knockdown.  C-DIM12 increased expression of transfected human Nurr1, induced Nurr1 protein expression in primary dopaminergic neurons and enhanced neuronal survival from exposure to 6-OHDA.  These data indicate that C-DIM12 stimulates neuroprotective expression Nurr1-regulated genes in DA neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlLJOnSUsgArVg90H21EOLACvtfcHk0lhGnSUYEdS4uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1SlurnJ&md5=0d9a83edeeec515918023b330ab72f50</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2015.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2015.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DHammond%26aufirst%3DS.%2BL.%26aulast%3DSafe%26aufirst%3DS.%26aulast%3DTjalkens%26aufirst%3DR.%2BB.%26atitle%3DA%2520novel%2520synthetic%2520activator%2520of%2520Nurr1%2520induces%2520dopaminergic%2520gene%2520expression%2520and%2520protects%2520against%25206-hydroxydopamine%2520neurotoxicity%2520in%2520vitro%26jtitle%3DNeurosci.%2520Lett.%26date%3D2015%26volume%3D607%26spage%3D83%26epage%3D89%26doi%3D10.1016%2Fj.neulet.2015.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popichak, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richman, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damale, P. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, E. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backos, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjalkens, R. B.</span></span> <span> </span><span class="NLM_article-title">The Nurr1 Ligand,1,1-bis(3’-Indolyl)-1-(p-Chlorophenyl)Methane, Modulates Glial Reactivity and Is Neuroprotective in MPTP-Induced Parkinsonism</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">636</span>– <span class="NLM_lpage">651</span>, <span class="refDoi"> DOI: 10.1124/jpet.117.246389</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1124%2Fjpet.117.246389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=29626009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVCntb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2018&pages=636-651&author=S.+L.+Hammondauthor=K.+A.+Popichakauthor=X.+Liauthor=L.+G.+Huntauthor=E.+H.+Richmanauthor=P.+U.+Damaleauthor=E.+K.+P.+Chongauthor=D.+S.+Backosauthor=S.+Safeauthor=R.+B.+Tjalkens&title=The+Nurr1+Ligand%2C1%2C1-bis%283%E2%80%99-Indolyl%29-1-%28p-Chlorophenyl%29Methane%2C+Modulates+Glial+Reactivity+and+Is+Neuroprotective+in+MPTP-Induced+Parkinsonism&doi=10.1124%2Fjpet.117.246389"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The Nurr1 ligand,1,1-bis(3'-indolyl)-1-(p-chlorophenyl)methane, modulates glial reactivity and is neuroprotective in MPTP-induced parkinsonisms</span></div><div class="casAuthors">Hammond, Sean L.; Popichak, Katriana A.; Li, Xi; Hunt, Lindsay G.; Richman, Evan H.; Damale, Pranav U.; Chong, Edwin K. P.; Backos, Donald S.; Safe, Stephen; Tjalkens, Ronald B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">636-651</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We postulated that the activation of Nurr1 would suppress the activation of glia and thereby protect against loss of DA neurons after subacute lesioning with MPTP.  Our previous studies have shown that a synthetic Nurr1 ligand, C-DIM12, suppresses inflammatory gene expression in primary astrocytes and induces a dopaminergic phenotype in neurons.  Pharmacokinetic anal. of C-DIM12 in mice by liq. chromatog.-mass spectrometry demonstrated that approx. three times more compd. concd. in the brain than in plasma.  Mice treated with four doses of MPTP + probenecid over 14 days were monitored for neurobehavioral function, loss of dopaminergic neurons, and glial activation.  C-DIM12 protected against the loss of DA neurons in the substantia nigra pars compacta and DA terminals in the striatum, maintained a ramified phenotype in microglia, and suppressed activation of astrocytes.  In vitro reporter assays demonstrated that C-DIM12 was an effective activator of Nurr1 transcription in neuronal cell lines.  Computational modeling of C-DIM12 binding to the three-dimensional structure of human Nurr1 identified a high-affinity binding interaction with Nurr1 at the coactivator domain.  Taken together, these data suggest that C-DIM12 is an activator of Nurr1 that suppresses glial activation and neuronal loss in vivo after treatment with MPTP, and that this receptor could be an efficacious target for disease modification in individuals with Parkinson's disease and related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopgugLhnM2J7Vg90H21EOLACvtfcHk0lhVeCxsGljW7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVCntb3O&md5=77dd95db62e674cd310b56a041be2b89</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.117.246389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.117.246389%26sid%3Dliteratum%253Aachs%26aulast%3DHammond%26aufirst%3DS.%2BL.%26aulast%3DPopichak%26aufirst%3DK.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHunt%26aufirst%3DL.%2BG.%26aulast%3DRichman%26aufirst%3DE.%2BH.%26aulast%3DDamale%26aufirst%3DP.%2BU.%26aulast%3DChong%26aufirst%3DE.%2BK.%2BP.%26aulast%3DBackos%26aufirst%3DD.%2BS.%26aulast%3DSafe%26aufirst%3DS.%26aulast%3DTjalkens%26aufirst%3DR.%2BB.%26atitle%3DThe%2520Nurr1%2520Ligand%252C1%252C1-bis%25283%25E2%2580%2599-Indolyl%2529-1-%2528p-Chlorophenyl%2529Methane%252C%2520Modulates%2520Glial%2520Reactivity%2520and%2520Is%2520Neuroprotective%2520in%2520MPTP-Induced%2520Parkinsonism%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2018%26volume%3D365%26spage%3D636%26epage%3D651%26doi%3D10.1124%2Fjpet.117.246389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papineni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chintharlapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamat, A. M.</span></span> <span> </span><span class="NLM_article-title">1,1-Bis(3’-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3825</span>– <span class="NLM_lpage">3833</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-08-0730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1158%2F1535-7163.MCT-08-0730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=19074857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2iurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=3825-3833&author=T.+Inamotoauthor=S.+Papineniauthor=S.+Chintharlapalliauthor=S.-D.+Choauthor=S.+Safeauthor=A.+M.+Kamat&title=1%2C1-Bis%283%E2%80%99-indolyl%29-1-%28p-chlorophenyl%29methane+activates+the+orphan+nuclear+receptor+Nurr1+and+inhibits+bladder+cancer+growth&doi=10.1158%2F1535-7163.mct-08-0730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">1,1-Bis(3'-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth</span></div><div class="casAuthors">Inamoto, Teruo; Papineni, Sabitha; Chintharlapalli, Sudhakar; Cho, Sung-Dae; Safe, Stephen; Kamat, Ashish M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3825-3833</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Nurr1 is an orphan nuclear receptor and a member of the nerve growth factor I-B subfamily of transcription factors with no known endogenous ligand or stimulator.  We show, for the first time, evidence that Nurr1 is expressed in a panel of 11 human bladder cancer cell lines.  A new class of methylene-substituted diindolylmethanes (C-DIM) were screened and 1,1-bis(3'-indolyl)-1-(p-chlorophenyl)methane (DIM-C-pPhCl) activated the ligand-binding domain of Nurr1.  Treatment of bladder cancer cells with Nurr1-active C-DIM resulted in decreased cell survival (MTT assay) and induction of cell death pathways, resulting in poly(ADP-ribose) polymerase cleavage and DNA fragmentation.  The specificity of the Nurr1-active compd. was shown using RNA interference in 253J B-V cells, whereby small interfering RNA against Nurr1 attenuated ligand-dependent activation of Nurr1 and poly(ADP-ribose) polymerase cleavage.  Furthermore, activation of Nurr1 resulted in stimulation of tumor necrosis factor-related apoptosis-inducing ligand and small interfering RNA expts. attenuated tumor necrosis factor-related apoptosis-inducing ligand prodn.  In an orthotopic model of human bladder tumors established in nude mice, administration of a Nurr1-active C-DIM suppressed bladder cancer growth.  These results identify Nurr1 as a potential target for bladder cancer therapy and also identify a novel agent for activating Nurr1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouz8JILbKS57Vg90H21EOLACvtfcHk0lhVeCxsGljW7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2iurbK&md5=1cfbb9b8327fcd644d5eb996b79e2e69</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0730%26sid%3Dliteratum%253Aachs%26aulast%3DInamoto%26aufirst%3DT.%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DS.-D.%26aulast%3DSafe%26aufirst%3DS.%26aulast%3DKamat%26aufirst%3DA.%2BM.%26atitle%3D1%252C1-Bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-chlorophenyl%2529methane%2520activates%2520the%2520orphan%2520nuclear%2520receptor%2520Nurr1%2520and%2520inhibits%2520bladder%2520cancer%2520growth%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D3825%26epage%3D3833%26doi%3D10.1158%2F1535-7163.mct-08-0730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hibino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikuma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsukasa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omata-Mise, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Nr4a Receptors Enhances Antitumor Immunity by Breaking Treg-Mediated Immune Tolerance</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">3027</span>– <span class="NLM_lpage">3040</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-17-3102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1158%2F0008-5472.CAN-17-3102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=29559474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKjsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=3027-3040&author=S.+Hibinoauthor=S.+Chikumaauthor=T.+Kondoauthor=M.+Itoauthor=H.+Nakatsukasaauthor=S.+Omata-Miseauthor=A.+Yoshimura&title=Inhibition+of+Nr4a+Receptors+Enhances+Antitumor+Immunity+by+Breaking+Treg-Mediated+Immune+Tolerance&doi=10.1158%2F0008-5472.can-17-3102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Nr4a receptors enhances antitumor immunity by breaking Treg-mediated immune tolerance</span></div><div class="casAuthors">Hibino, Sana; Chikuma, Shunsuke; Kondo, Taisuke; Ito, Minako; Nakatsukasa, Hiroko; Omata-Mise, Setsuko; Yoshimura, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3027-3040</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Enhanced infiltration of regulatory T cells (Treg) into tumor tissue is detrimental to patients with cancer and is closely assocd. with poor prognosis as they create an immunosuppressive state that suppresses antitumor immune responses.  Therefore, breaking Treg-mediated immune tolerance is important when considering cancer immunotherapy.  Here, we show that the Nr4a nuclear receptors, key transcription factors maintaining Treg genetic programs, contribute to Treg-mediated suppression of antitumor immunity in the tumor microenvironment.  Mice lacking Nr4a1 and Nr4a2 genes specifically in Tregs showed resistance to tumor growth in transplantation models without exhibiting any severe systemic autoimmunity.  The chemotherapeutic agent camptothecin and a common cyclooxygenase-2 inhibitor were found to inhibit transcriptional activity and induction of Nr4a factors, and they synergistically exerted antitumor effects.  Genetic inactivation or pharmacol. inhibition of Nr4a factors unleashed effector activities of CD8+ cytotoxic T cells and evoked potent antitumor immune responses.  These findings demonstrate that inactivation of Nr4a in Tregs breaks immune tolerance toward cancer, and pharmacol. modulation of Nr4a activity may be a novel cancer treatment strategy targeting the immunosuppressive tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSj-KLLzLI-7Vg90H21EOLACvtfcHk0lhVeCxsGljW7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKjsb%252FK&md5=8121148b58f88e18a3eead1fe7c50522</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-17-3102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-17-3102%26sid%3Dliteratum%253Aachs%26aulast%3DHibino%26aufirst%3DS.%26aulast%3DChikuma%26aufirst%3DS.%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DNakatsukasa%26aufirst%3DH.%26aulast%3DOmata-Mise%26aufirst%3DS.%26aulast%3DYoshimura%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520Nr4a%2520Receptors%2520Enhances%2520Antitumor%2520Immunity%2520by%2520Breaking%2520Treg-Mediated%2520Immune%2520Tolerance%26jtitle%3DCancer%2520Res.%26date%3D2018%26volume%3D78%26spage%3D3027%26epage%3D3040%26doi%3D10.1158%2F0008-5472.can-17-3102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alitongbieke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-k.</span></span> <span> </span><span class="NLM_article-title">Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2017.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.molcel.2017.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=28388439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvFWgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2017&pages=141-153&author=M.+Huauthor=Q.+Luoauthor=G.+Alitongbiekeauthor=S.+Chongauthor=C.+Xuauthor=L.+Xieauthor=X.+Chenauthor=D.+Zhangauthor=Y.+Zhouauthor=Z.+Wangauthor=X.+Yeauthor=L.+Caiauthor=F.+Zhangauthor=H.+Chenauthor=F.+Jiangauthor=H.+Fangauthor=S.+Yangauthor=J.+Liuauthor=M.+T.+Diaz-Mecoauthor=Y.+Suauthor=H.+Zhouauthor=J.+Moscatauthor=X.+Linauthor=X.-k.+Zhang&title=Celastrol-Induced+Nur77+Interaction+with+TRAF2+Alleviates+Inflammation+by+Promoting+Mitochondrial+Ubiquitination+and+Autophagy&doi=10.1016%2Fj.molcel.2017.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy</span></div><div class="casAuthors">Hu, Mengjie; Luo, Qiang; Alitongbieke, Gulimiran; Chong, Shuyi; Xu, Chenting; Xie, Lei; Chen, Xiaohui; Zhang, Duo; Zhou, Yuqi; Wang, Zhaokai; Ye, Xiaohong; Cai, Lijun; Zhang, Fang; Chen, Huibin; Jiang, Fuquan; Fang, Hui; Yang, Shanjun; Liu, Jie; Diaz-Meco, Maria T.; Su, Ying; Zhou, Hu; Moscat, Jorge; Lin, Xiangzhi; Zhang, Xiao-kun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-153.e6</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mitochondria play an integral role in cell death, autophagy, immunity, and inflammation.  We previously showed that Nur77, an orphan nuclear receptor, induces apoptosis by targeting mitochondria.  Here, we report that celastrol, a potent anti-inflammatory pentacyclic triterpene, binds Nur77 to inhibit inflammation and induce autophagy in a Nur77-dependent manner.  Celastrol promotes Nur77 translocation from the nucleus to mitochondria, where it interacts with tumor necrosis factor receptor-assocd. factor 2 (TRAF2), a scaffold protein and E3 ubiquitin ligase important for inflammatory signaling.  The interaction is mediated by an LxxLL motif in TRAF2 and results not only in the inhibition of TRAF2 ubiquitination but also in Lys63-linked Nur77 ubiquitination.  Under inflammatory conditions, ubiquitinated Nur77 resides at mitochondria, rendering them sensitive to autophagy, an event involving Nur77 interaction with p62/SQSTM1.  Together, our results identify Nur77 as a crit. intracellular target for celastrol and unravel a mechanism of Nur77-dependent clearance of inflamed mitochondria to alleviate inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrONhphh-QPwrVg90H21EOLACvtfcHk0lgsjTLdXQCR-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvFWgs7s%253D&md5=a8efd7d1312b3252511ad4d8cd8db045</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2017.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2017.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DAlitongbieke%26aufirst%3DG.%26aulast%3DChong%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.-k.%26atitle%3DCelastrol-Induced%2520Nur77%2520Interaction%2520with%2520TRAF2%2520Alleviates%2520Inflammation%2520by%2520Promoting%2520Mitochondrial%2520Ubiquitination%2520and%2520Autophagy%26jtitle%3DMol.%2520Cell%26date%3D2017%26volume%3D66%26spage%3D141%26epage%3D153%26doi%3D10.1016%2Fj.molcel.2017.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-O.</span></span> <span> </span><span class="NLM_article-title">Dual targeting of Nur77 and AMPKalpha by isoalantolactone inhibits adipogenesis in vitro and decreases body fat mass in vivo</span>. <i>Int. J. Obes.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">952</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1038/s41366-018-0276-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fs41366-018-0276-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFSms7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2019&pages=952-962&author=Y.-S.+Jungauthor=H.-S.+Leeauthor=H.-R.+Choauthor=K.-J.+Kimauthor=J.-H.+Kimauthor=S.+Safeauthor=S.-O.+Lee&title=Dual+targeting+of+Nur77+and+AMPKalpha+by+isoalantolactone+inhibits+adipogenesis+in+vitro+and+decreases+body+fat+mass+in+vivo&doi=10.1038%2Fs41366-018-0276-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Dual targeting of Nur77 and AMPKα by isoalantolactone inhibits adipogenesis in vitro and decreases body fat mass in vivo</span></div><div class="casAuthors">Jung, Yeon-Seop; Lee, Hyo-Seon; Cho, Hye-Rin; Kim, Keuk-Jun; Kim, Joung-Hee; Safe, Stephen; Lee, Syng-Ook</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Obesity</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">952-962</span>CODEN:
                <span class="NLM_cas:coden">IJOBDP</span>;
        ISSN:<span class="NLM_cas:issn">0307-0565</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Background: Suppression of adipogenesis has been considered as a potential target for the prevention and treatment of obesity and assocd. metabolic disorders, and the nuclear receptor 4A1 (NR4A1/Nur77) and AMPKα are known to play important roles during early and intermediate stages of adipogenesis.  Therefore, we hypothesized that dual targeting Nur77 and AMPKα would show strong inhibitory effect on adipogenesis.  Methods: We screened a herbal medicine-based small mol. library to identify novel natural compds. dual targeting Nur77 and AMPKα, and the antiadipogenic effects and mechanisms of action of a "hit" compd. were studied in 3T3-L1 cells.  In vivo antiobesity effects of the compd. were also investigated in high-fat diet (HFD)-induced obese mice.  Results: We identified isoalantolactone (ISO) as a new NR4A1 inactivator that also activates AMPKα in 3T3-L1 cells.  ISO, as expected, inhibited adipogenic differentiation of 3T3-L1 preadipocytes, accompanied by reduced mitotic clonal expansion (MCE) which occurs in the early stage of adipogenesis and decreased expression of genes required for MCE and cell cycle markers including cyclin A, cyclin D1.  Furthermore, ISO reduced body wt. gain and fat mass (epididymal, s.c., perirenal, and inguinal white adipose tissues) in the high-fat diet-fed C57BL/6 N mice.  Serum levels of triglycerides, aspartate transaminase, and alanine transaminase and hepatic steatosis were also significantly improved in the ISO-treated group compared to the high-fat diet control group.  Conclusions: These results suggest that ISO dual targeting Nur77 and AMPKα during adipogenesis represents a novel class of mechanism-based antiadipogenic agents for treatment of obesity and assocd. metabolic disorders, including hyperlipidemia and fatty liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0v5SFb4ElYbVg90H21EOLACvtfcHk0lgsjTLdXQCR-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFSms7fP&md5=7e9eab7cc05227ff49cf98e8cf957bc7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fs41366-018-0276-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41366-018-0276-x%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DY.-S.%26aulast%3DLee%26aufirst%3DH.-S.%26aulast%3DCho%26aufirst%3DH.-R.%26aulast%3DKim%26aufirst%3DK.-J.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DSafe%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.-O.%26atitle%3DDual%2520targeting%2520of%2520Nur77%2520and%2520AMPKalpha%2520by%2520isoalantolactone%2520inhibits%2520adipogenesis%2520in%2520vitro%2520and%2520decreases%2520body%2520fat%2520mass%2520in%2520vivo%26jtitle%3DInt.%2520J.%2520Obes.%26date%3D2019%26volume%3D43%26spage%3D952%26epage%3D962%26doi%3D10.1038%2Fs41366-018-0276-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weimer, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span> <span> </span><span class="NLM_article-title">Cytosporone B is an agonist for nuclear orphan receptor Nur77</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1038/nchembio.106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fnchembio.106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=18690216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvFGrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=548-556&author=Y.+Zhanauthor=X.+Duauthor=H.+Chenauthor=J.+Liuauthor=B.+Zhaoauthor=D.+Huangauthor=G.+Liauthor=Q.+Xuauthor=M.+Zhangauthor=B.+C.+Weimerauthor=D.+Chenauthor=Z.+Chengauthor=L.+Zhangauthor=Q.+Liauthor=S.+Liauthor=Z.+Zhengauthor=S.+Songauthor=Y.+Huangauthor=Z.+Yeauthor=W.+Suauthor=S.-C.+Linauthor=Y.+Shenauthor=Q.+Wu&title=Cytosporone+B+is+an+agonist+for+nuclear+orphan+receptor+Nur77&doi=10.1038%2Fnchembio.106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Cytosporone B is an agonist for nuclear orphan receptor Nur77</span></div><div class="casAuthors">Zhan, Yanyan; Du, Xiping; Chen, Hangzi; Liu, Jingjing; Zhao, Bixing; Huang, Danhong; Li, Guideng; Xu, Qingyan; Zhang, Mingqing; Weimer, Bart C.; Chen, Dong; Cheng, Zhe; Zhang, Lianru; Li, Qinxi; Li, Shaowei; Zheng, Zhonghui; Song, Siyang; Huang, Yaojian; Ye, Zhiyun; Su, Wenjin; Lin, Sheng-Cai; Shen, Yuemao; Wu, Qiao</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">548-556</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nuclear orphan receptor Nur77 has important roles in many biol. processes.  However, a physiol. ligand for Nur77 has not been identified.  Here, we report that the octaketide cytosporone B (Csn-B) is a naturally occurring agonist for Nur77.  Csn-B specifically binds to the ligand-binding domain of Nur77 and stimulates Nur77-dependent transactivational activity towards target genes including Nr4a1 (Nur77) itself, which contains multiple consensus response elements allowing pos. autoregulation in a Csn-B-dependent manner.  Csn-B also elevates blood glucose levels in fasting C57 mice, an effect that is accompanied by induction of multiple genes involved in gluconeogenesis.  These biol. effects were not obsd. in Nur77-null (Nr4a1-/-) mice, which indicates that Csn-B regulates gluconeogenesis through Nur77.  Moreover, Csn-B induced apoptosis and retarded xenograft tumor growth by inducing Nur77 expression, translocating Nur77 to mitochondria to cause cytochrome c release.  Thus, Csn-B may represent a promising therapeutic drug for cancers and hypoglycemia, and it may also be useful as a reagent to increase understanding of Nur77 biol. function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAkSrX4z4xs7Vg90H21EOLACvtfcHk0lhZzGPOTS7QnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvFGrt7g%253D&md5=0514b5b3d32810b2de3b0218479e23f7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.106%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWeimer%26aufirst%3DB.%2BC.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DS.-C.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DQ.%26atitle%3DCytosporone%2520B%2520is%2520an%2520agonist%2520for%2520nuclear%2520orphan%2520receptor%2520Nur77%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D548%26epage%3D556%26doi%3D10.1038%2Fnchembio.106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Y.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, J.-j.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-r.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-k.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.-p.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.-j.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Y.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.-d.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.-q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span> <span> </span><span class="NLM_article-title">The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">904</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fnchembio.1069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=22983157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCqu7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=897-904&author=Y.-y.+Zhanauthor=Y.+Chenauthor=Q.+Zhangauthor=J.-j.+Zhuangauthor=M.+Tianauthor=H.-z.+Chenauthor=L.-r.+Zhangauthor=H.-k.+Zhangauthor=J.-p.+Heauthor=W.-j.+Wangauthor=R.+Wuauthor=Y.+Wangauthor=C.+Shiauthor=K.+Yangauthor=A.-z.+Liauthor=Y.-z.+Xinauthor=T.+Y.+Liauthor=J.+Y.+Yangauthor=Z.-h.+Zhengauthor=C.-d.+Yuauthor=S.-C.+Linauthor=C.+Changauthor=P.-q.+Huangauthor=T.+Linauthor=Q.+Wu&title=The+orphan+nuclear+receptor+Nur77+regulates+LKB1+localization+and+activates+AMPK&doi=10.1038%2Fnchembio.1069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK</span></div><div class="casAuthors">Zhan, Yan-yan; Chen, Yan; Zhang, Qian; Zhuang, Jia-jia; Tian, Min; Chen, Hang-zi; Zhang, Lian-ru; Zhang, Hong-kui; He, Jian-ping; Wang, Wei-jia; Wu, Rong; Wang, Yuan; Shi, Chunfang; Yang, Kai; Li, An-zhong; Xin, Yong-zhen; Li, Terytty Yang; Yang, James Y.; Zheng, Zhong-hui; Yu, Chun-dong; Lin, Sheng-Cai; Chang, Chawn-shang; Huang, Pei-qiang; Lin, Tianwei; Wu, Qiao</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">897-904</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Liver kinase B1 (LKB1) has important roles in governing energy homeostasis by regulating the activity of the energy sensor kinase AMP-activated protein kinase (AMPK).  The regulation of LKB1 function, however, is still poorly understood.  Here we demonstrate that the orphan nuclear receptor Nur77 binds and sequesters LKB1 in the nucleus, thereby attenuating AMPK activation.  This Nur77 function is antagonized by the chem. compd. Et 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl]acetate (TMPA), which interacts with Nur77 with high affinity and at specific sites.  TMPA binding of Nur77 results in the release and shuttling of LKB1 to the cytoplasm to phosphorylate AMPKα.  Moreover, TMPA effectively reduces blood glucose and alleviates insulin resistance in type II db/db and high-fat diet- and streptozotocin-induced diabetic mice but not in diabetic littermates with the Nur77 gene knocked out.  This study attains a mechanistic understanding of the regulation of LKB1-AMPK axis and implicates Nur77 as a new and amenable target for the design and development of therapeutics to treat metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodWFZn_EPN37Vg90H21EOLACvtfcHk0lhZzGPOTS7QnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCqu7jF&md5=f00c49daf55792014107d6857e8b729b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1069%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DY.-y.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhuang%26aufirst%3DJ.-j.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.-z.%26aulast%3DZhang%26aufirst%3DL.-r.%26aulast%3DZhang%26aufirst%3DH.-k.%26aulast%3DHe%26aufirst%3DJ.-p.%26aulast%3DWang%26aufirst%3DW.-j.%26aulast%3DWu%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DA.-z.%26aulast%3DXin%26aufirst%3DY.-z.%26aulast%3DLi%26aufirst%3DT.%2BY.%26aulast%3DYang%26aufirst%3DJ.%2BY.%26aulast%3DZheng%26aufirst%3DZ.-h.%26aulast%3DYu%26aufirst%3DC.-d.%26aulast%3DLin%26aufirst%3DS.-C.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DP.-q.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DQ.%26atitle%3DThe%2520orphan%2520nuclear%2520receptor%2520Nur77%2520regulates%2520LKB1%2520localization%2520and%2520activates%2520AMPK%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D897%26epage%3D904%26doi%3D10.1038%2Fnchembio.1069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.-w.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.-f.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-k.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.-p.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, Y.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.-j.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.-q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span> <span> </span><span class="NLM_article-title">Impeding the interaction between Nur77 and p38 reduces LPS-induced inflammation</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fnchembio.1788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=25822914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVOns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=339-346&author=L.+Liauthor=Y.+Liuauthor=H.-z.+Chenauthor=F.-w.+Liauthor=J.-f.+Wuauthor=H.-k.+Zhangauthor=J.-p.+Heauthor=Y.-z.+Xingauthor=Y.+Chenauthor=W.-j.+Wangauthor=X.-y.+Tianauthor=A.-z.+Liauthor=Q.+Zhangauthor=P.-q.+Huangauthor=J.+Hanauthor=T.+Linauthor=Q.+Wu&title=Impeding+the+interaction+between+Nur77+and+p38+reduces+LPS-induced+inflammation&doi=10.1038%2Fnchembio.1788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Impeding the interaction between Nur77 and p38 reduces LPS-induced inflammation</span></div><div class="casAuthors">Li, Li; Liu, Yuan; Chen, Hang-zi; Li, Feng-wei; Wu, Jian-feng; Zhang, Hong-kui; He, Jian-ping; Xing, Yong-zhen; Chen, Yan; Wang, Wei-jia; Tian, Xu-yang; Li, An-zhong; Zhang, Qian; Huang, Pei-qiang; Han, Jiahuai; Lin, Tianwei; Wu, Qiao</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">339-346</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sepsis, a hyperinflammatory response that can result in multiple organ dysfunctions, is a leading cause of mortality from infection.  Here, we show that orphan nuclear receptor Nur77 (also known as TR3) can enhance resistance to lipopolysaccharide (LPS)-induced sepsis in mice by inhibiting NF-κB activity and suppressing aberrant cytokine prodn.  Nur77 directly assocs. with p65 to block its binding to the κB element.  However, this function of Nur77 is countered by the LPS-activated p38α phosphorylation of Nur77.  Dampening the interaction between Nur77 and p38α would favor Nur77 suppression of the hyperinflammatory response.  A compd., n-pentyl 2-[3,5-dihydroxy-2-(1-nonanoyl) phenyl]acetate (PDNPA), screened from a Nur77-biased library, blocked the Nur77-p38α interaction by targeting the ligand-binding domain of Nur77 and restored the suppression of the hyperinflammatory response through Nur77 inhibition of NF-κB.  This study assocs. the nuclear receptor with immune homeostasis and implicates a new therapeutic strategy to treat hyperinflammatory responses by targeting a p38α substrate to modulate p38α-regulated functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlFjaOVE8eLrVg90H21EOLACvtfcHk0lj0z6ZZGEYNaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVOns74%253D&md5=648de4a3c58bba85279ae13a37a6c0a2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1788%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.-z.%26aulast%3DLi%26aufirst%3DF.-w.%26aulast%3DWu%26aufirst%3DJ.-f.%26aulast%3DZhang%26aufirst%3DH.-k.%26aulast%3DHe%26aufirst%3DJ.-p.%26aulast%3DXing%26aufirst%3DY.-z.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DW.-j.%26aulast%3DTian%26aufirst%3DX.-y.%26aulast%3DLi%26aufirst%3DA.-z.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DP.-q.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DQ.%26atitle%3DImpeding%2520the%2520interaction%2520between%2520Nur77%2520and%2520p38%2520reduces%2520LPS-induced%2520inflammation%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D339%26epage%3D346%26doi%3D10.1038%2Fnchembio.1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Law, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conneely, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMayo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, B. W.</span></span> <span> </span><span class="NLM_article-title">Identification of a new brain-specific transcription factor, NURR1</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2129</span>– <span class="NLM_lpage">2135</span>, <span class="refDoi"> DOI: 10.1210/mend.6.12.1491694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1210%2Fmend.6.12.1491694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1491694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADyaK3sXltFSnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1992&pages=2129-2135&author=S.+W.+Lawauthor=O.+M.+Conneelyauthor=F.+J.+DeMayoauthor=B.+W.+O%E2%80%99Malley&title=Identification+of+a+new+brain-specific+transcription+factor%2C+NURR1&doi=10.1210%2Fmend.6.12.1491694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a new brain-specific transcription factor, NURR1</span></div><div class="casAuthors">Law, Simon W.; Conneely, Orla M.; DeMayo, Franco J.; O'Malley, Bert W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2129-35</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    </div><div class="casAbstract">A novel member of the nuclear receptor superfamily was identified and cloned.  The cDNA was isolated from a mouse brain cDNA library and encodes a protein 598 amino acids in length with a predicted mol wt of 66 kDa.  The amino acid sequence of the protein is closely related to an addnl. family member and immediate early gene product, Nur77, and the novel factor is referred to as Nurr1 (Nur-related factor 1).  The relationship between Nurr1 and Nurr77 suggests that these proteins constitute an addnl. subfamily within the nuclear receptor superfamily.  Like Nur77, the expression of Nurr1 is induced by membrane depolarization of PC12 cells.  However, while Nur77 shows an early transcriptional response to nerve growth factor stimulation, the failure of Nurr1 to respond to this agent suggests a differential selectivity of the two proteins in terms of their transcriptional responses to specific stimuli.  Finally, both proteins are differentially expressed during development and in tissues of the adult mouse.  Unlike Nur77, Nurr1 is predominantly located in brain tissue, suggesting a primary role for this putative transcription factor in regulation of gene expression in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoRxB8SfdoCrVg90H21EOLACvtfcHk0lj0z6ZZGEYNaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltFSnsLY%253D&md5=9f919c247e1dca3d27f5ae7ad76edafc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1210%2Fmend.6.12.1491694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend.6.12.1491694%26sid%3Dliteratum%253Aachs%26aulast%3DLaw%26aufirst%3DS.%2BW.%26aulast%3DConneely%26aufirst%3DO.%2BM.%26aulast%3DDeMayo%26aufirst%3DF.%2BJ.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DB.%2BW.%26atitle%3DIdentification%2520of%2520a%2520new%2520brain-specific%2520transcription%2520factor%252C%2520NURR1%26jtitle%3DMol.%2520Endocrinol.%26date%3D1992%26volume%3D6%26spage%3D2129%26epage%3D2135%26doi%3D10.1210%2Fmend.6.12.1491694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakurada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohshima-Sakurada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gage, F. H.</span></span> <span> </span><span class="NLM_article-title">Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain</span>. <i>Development</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">4017</span>– <span class="NLM_lpage">4026</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10457011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADyaK1MXmsleqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=1999&pages=4017-4026&author=K.+Sakuradaauthor=M.+Ohshima-Sakuradaauthor=T.+D.+Palmerauthor=F.+H.+Gage&title=Nurr1%2C+an+orphan+nuclear+receptor%2C+is+a+transcriptional+activator+of+endogenous+tyrosine+hydroxylase+in+neural+progenitor+cells+derived+from+the+adult+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain</span></div><div class="casAuthors">Sakurada, Kazuhiro; Ohshima-Sakurada, Mikiko; Palmer, Theo D.; Gage, Fred H.</div><div class="citationInfo"><span class="NLM_cas:title">Development (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4017-4026</span>CODEN:
                <span class="NLM_cas:coden">DEVPED</span>;
        ISSN:<span class="NLM_cas:issn">0950-1991</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Adult rat-derived hippocampal progenitor cells express many of the mols. implicated in midbrain dopaminergic detn., including FGF receptors 1, 2 and 3, the sonic hedgehog receptor components Smo and Ptc, and the region-specific transcription factors Ptx3 and Nurr1.  Here we use undifferentiated progenitors to probe the events leading to the dopaminergic phenotype and find that the influences of Nurr1 can be temporally and mechanistically uncoupled from the patterning influences of sonic hedgehog and FGF-8 or the more generic process of neuronal differentiation itself.  In gain-of-function expts., Nurr1 is able to activate transcription of the tyrosine hydroxylase gene by binding a response element within a region of the tyrosine hydroxylase promoter necessary for midbrain-specific expression.  This activation is mediated through a retinoid X receptor independent mechanism and occurs in all precursors, regardless of differentiation status.  Overexpression of Nurr1 does not affect proliferation or stimulate neuronal differentiation and has no influence on the expression of other dopaminergic markers.  This uncoupling of tyrosine hydroxylase expression from other dopaminergic markers suggests that the midbrain dopaminergic identity is dictated by a combination of pan-dopaminergic (e.g., Shh/FGF-8) and region-specific (Nurr1) mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6NAMlC-Lq8rVg90H21EOLACvtfcHk0lj0z6ZZGEYNaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsleqsLc%253D&md5=3b9a7d90aab591a525fea0ef83ddc15f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakurada%26aufirst%3DK.%26aulast%3DOhshima-Sakurada%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DT.%2BD.%26aulast%3DGage%26aufirst%3DF.%2BH.%26atitle%3DNurr1%252C%2520an%2520orphan%2520nuclear%2520receptor%252C%2520is%2520a%2520transcriptional%2520activator%2520of%2520endogenous%2520tyrosine%2520hydroxylase%2520in%2520neural%2520progenitor%2520cells%2520derived%2520from%2520the%2520adult%2520brain%26jtitle%3DDevelopment%26date%3D1999%26volume%3D126%26spage%3D4017%26epage%3D4026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacson, O.</span></span> <span> </span><span class="NLM_article-title">Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">622</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2003.01671.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1046%2Fj.1471-4159.2003.01671.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=12694388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslyrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2003&pages=622-634&author=K.-S.+Kimauthor=C.-H.+Kimauthor=D.-Y.+Hwangauthor=H.+Seoauthor=S.+Chungauthor=S.+J.+Hongauthor=J.-K.+Limauthor=T.+Andersonauthor=O.+Isacson&title=Orphan+nuclear+receptor+Nurr1+directly+transactivates+the+promoter+activity+of+the+tyrosine+hydroxylase+gene+in+a+cell-specific+manner&doi=10.1046%2Fj.1471-4159.2003.01671.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner</span></div><div class="casAuthors">Kim, Kwang-Soo; Kim, Chun-Hyung; Hwang, Dong-Youn; Seo, Hyemyung; Chung, Sangmi; Hong, Seok Jong; Lim, Jin-Kyu; Anderson, Therese; Isacson, Ole</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">622-634</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Tyrosine hydroxylase (TH) catalyzes the first and rate-limiting step of catecholamine synthesis and its expression is necessary for neurotransmitter specification of all catecholaminergic neurons, while dopamine β-hydroxylase (DBH) is essential for the noradrenergic phenotype.  In the present study, we show that Nurr1, an orphan nuclear receptor crit. for dopaminergic (DA) neuron development, directly transactivates the promoter activity of the TH gene in a cell type-dependent manner, while it does not regulate the DBH promoter.  Consistent with these results, only the TH promoter contains multiple sequence motifs homologous to the known Nurr1-binding motif, NBRE.  TH promoter deletional anal. indicates that < 1.0 kb upstream sequences, encompassing three NBRE-like motifs (i.e. NL1, NL2 and NL3) are mostly responsible for the effects of Nurr1.  Among these potential motifs, site-directed mutational anal. showed that NL1, residing from -35 to -28 bp, was most crit. for mediating the transactivation by Nurr1.  Strikingly, however, both DNase I footprinting and electrophoretic mobility shift assays showed that NL3, but not NL1 or NL2, has high binding affinity to Nurr1.  To det. whether the proximity of these motifs may be important for transactivation by Nurr1 in the transient transfection assay, we generated reporter gene constructs in which NL3 is immediately proximal to the TATA box.  Indeed, NL3 was more efficient in this position than NL1 or NL2 for mediating the transactivation by Nurr1.  Our results suggest that Nurr1 may play a direct role for specification of DA neurotransmitter identity by activating TH gene transcription in a cell context-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4cyf0ggk2erVg90H21EOLACvtfcHk0liwclsU4bak6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslyrsL0%253D&md5=b2cfce68df99f27a0f0fa4404d4f98c2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2003.01671.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2003.01671.x%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.-S.%26aulast%3DKim%26aufirst%3DC.-H.%26aulast%3DHwang%26aufirst%3DD.-Y.%26aulast%3DSeo%26aufirst%3DH.%26aulast%3DChung%26aufirst%3DS.%26aulast%3DHong%26aufirst%3DS.%2BJ.%26aulast%3DLim%26aufirst%3DJ.-K.%26aulast%3DAnderson%26aufirst%3DT.%26aulast%3DIsacson%26aufirst%3DO.%26atitle%3DOrphan%2520nuclear%2520receptor%2520Nurr1%2520directly%2520transactivates%2520the%2520promoter%2520activity%2520of%2520the%2520tyrosine%2520hydroxylase%2520gene%2520in%2520a%2520cell-specific%2520manner%26jtitle%3DJ.%2520Neurochem.%26date%3D2003%26volume%3D85%26spage%3D622%26epage%3D634%26doi%3D10.1046%2Fj.1471-4159.2003.01671.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, W.</span></span> <span> </span><span class="NLM_article-title">Nurr1 regulates Top IIbeta and functions in axon genesis of mesencephalic dopaminergic neurons</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">4</span>, <span class="refDoi"> DOI: 10.1186/1750-1326-7-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1186%2F1750-1326-7-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=22296971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC38XotFKqtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=4&author=X.+Hengauthor=G.+Jinauthor=X.+Zhangauthor=D.+Yangauthor=M.+Zhuauthor=S.+Fuauthor=X.+Liauthor=W.+Le&title=Nurr1+regulates+Top+IIbeta+and+functions+in+axon+genesis+of+mesencephalic+dopaminergic+neurons&doi=10.1186%2F1750-1326-7-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Nurr1 regulates Top IIβ and functions in axon genesis of mesencephalic dopaminergic neurons</span></div><div class="casAuthors">Heng, Xin; Jin, Gang; Zhang, Xin; Yang, Dehuang; Zhu, Mingzhe; Fu, Shijun; Li, Xuping; Le, Weidong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: NURR1 (also named as NR4A2) is a member of the steroid/thyroid hormone receptor family, which can bind to DNA and modulate expression of target genes.  Previous studies have shown that NURR1 is essential for the nigral dopaminergic neuron phenotype and function maintenance and the defects of the gene are possibly assocd. with Parkinson's disease (PD).  Results: In this study, we used new born Nurr1 knock-out mice combined with Affymetrix genechip technol. and real time polymerase chain reaction (PCR) to identify Nurr1 regulated genes, which led to the discovery of several transcripts differentially expressed in the nigro-striatal pathway of Nurr1 knock-out mice.  We found that an axon genesis gene called Topoisomerase IIβ (Top IIβ) was down-regulated in Nurr1 knock-out mice and we identified two functional NURR1 binding sites in the proximal Top IIβ promoter.  While in Top IIβ null mice, we saw a significant loss of dopaminergic neurons in the substantial nigra and lack of neurites along the nigro-striatal pathway.  Using specific TOP II antagonist ICRF-193 or Top IIβ siRNA in the primary cultures of ventral mesencephalic (VM) neurons, we documented that suppression of TOP IIβ expression resulted in VM neurites shortening and growth cones collapsing.  Furthermore, microinjection of ICRF-193 into the mouse medial forebrain bundle (MFB) led to the loss of nigro-striatal projection.  Conclusion: Taken together, our findings suggest that Top IIβ might be a down-stream target of Nurr1, which might influence the processes of axon genesis in dopaminergic neurons via the regulation of TOP IIβ expression.  The Nurr1-Top IIβ interaction may shed light on the pathol. role of Nurr1 defect in the nigro-striatal pathway deficiency assocd. with PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb-6IDM-rUnLVg90H21EOLACvtfcHk0liwclsU4bak6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotFKqtLc%253D&md5=04ed715adc18a156f0b28a887f8ab862</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-7-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-7-4%26sid%3Dliteratum%253Aachs%26aulast%3DHeng%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLe%26aufirst%3DW.%26atitle%3DNurr1%2520regulates%2520Top%2520IIbeta%2520and%2520functions%2520in%2520axon%2520genesis%2520of%2520mesencephalic%2520dopaminergic%2520neurons%26jtitle%3DMol.%2520Neurodegener.%26date%3D2012%26volume%3D7%26spage%3D4%26doi%3D10.1186%2F1750-1326-7-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Philips, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesage, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingras, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maira, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hugo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drouin, J.</span></span> <span> </span><span class="NLM_article-title">Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">5946</span>– <span class="NLM_lpage">5951</span>, <span class="refDoi"> DOI: 10.1128/mcb.17.10.5946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1128%2FMCB.17.10.5946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=9315652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADyaK2sXmtlOisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=5946-5951&author=A.+Philipsauthor=S.+Lesageauthor=R.+Gingrasauthor=M.+H.+Mairaauthor=Y.+Gauthierauthor=P.+Hugoauthor=J.+Drouin&title=Novel+dimeric+Nur77+signaling+mechanism+in+endocrine+and+lymphoid+cells&doi=10.1128%2Fmcb.17.10.5946"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells</span></div><div class="casAuthors">Philips, Alexandre; Lesage, Sylvie; Gingras, Rock; Maira, Mario-Hernan; Gauthier, Yves; Hugo, Patrice; Drouin, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5946-5951</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Within the nuclear receptor family, Nur77 (also known as NGFI-B) distinguishes itself by its ability to bind a target sequence (the NBRE) as a monomer and by its role in T-cell receptor (TCR)-induced apoptosis in T cells.  We now report on a novel mechanism of Nur77 action that is mediated by homodimers.  These dimers bind a Nur77 response element (NurRE), which has been identified as a target of CRH-induced Nur77 in the pro-opiomelanocortin (POMC) gene promoter.  Both halves of the palindromic NurRE are required for responsiveness to physiol. signals, like CRH in pituitary-derived AtT-20 cells.  Similarly, in T-cell hybridomas, TCR activation induced NurRE but not NBRE reporters.  The in vivo signaling function of Nur77 thus appears to be mediated by dimers acting on a palindromic response element of unusual spacing between its half-sites.  This mechanism may represent the biol. relevant paradigm of action for this subfamily of orphan nuclear receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4vdXJoZYrCrVg90H21EOLACvtfcHk0liwclsU4bak6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtlOisr0%253D&md5=23aa8c40283a821e743b3ebafaaebb32</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1128%2FMCB.17.10.5946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.17.10.5946%26sid%3Dliteratum%253Aachs%26aulast%3DPhilips%26aufirst%3DA.%26aulast%3DLesage%26aufirst%3DS.%26aulast%3DGingras%26aufirst%3DR.%26aulast%3DMaira%26aufirst%3DM.%2BH.%26aulast%3DGauthier%26aufirst%3DY.%26aulast%3DHugo%26aufirst%3DP.%26aulast%3DDrouin%26aufirst%3DJ.%26atitle%3DNovel%2520dimeric%2520Nur77%2520signaling%2520mechanism%2520in%2520endocrine%2520and%2520lymphoid%2520cells%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1997%26volume%3D17%26spage%3D5946%26epage%3D5951%26doi%3D10.1128%2Fmcb.17.10.5946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philips, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drouin, J.</span></span> <span> </span><span class="NLM_article-title">Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">7549</span>– <span class="NLM_lpage">7557</span>, <span class="refDoi"> DOI: 10.1128/mcb.19.11.7549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1128%2FMCB.19.11.7549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10523643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFekt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=7549-7557&author=M.+Mairaauthor=C.+Martensauthor=A.+Philipsauthor=J.+Drouin&title=Heterodimerization+between+members+of+the+Nur+subfamily+of+orphan+nuclear+receptors+as+a+novel+mechanism+for+gene+activation&doi=10.1128%2Fmcb.19.11.7549"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation</span></div><div class="casAuthors">Maira, Mario; Martens, Christine; Philips, Alexandre; Drouin, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7549-7557</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The authors have recently shown that the orphan nuclear receptor Nur77 (NGFI-B) is most active in transcription when it is interacting with a cognate DNA sequence as a homodimer.  Further, the authors have shown that the target for Nur77 dimers, the Nur response element (NurRE), is responsive to physiol. stimuli in both endocrine and lymphoid cells, whereas other DNA targets of Nur77 action are not.  The Nur77 subfamily also includes two related receptors, Nur-related factor 1 (Nurr1) and neuron-derived orphan receptor 1 (NOR-1).  Often, more than one member of this subfamily is induced in response to extracellular signals.  The authors now show that Nur77 and Nurr1 form heterodimers in vitro in the presence or absence of NurRE, and the authors have documented interactions between these proteins in vivo by using a two-hybrid system in mammalian cells.  These heterodimers synergistically enhance transcription from NurRE reporters in comparison to that seen with homodimers.  The naturally occurring NurRE from the pro-opiomelanocortin gene preferentially binds and activates transcription in the presence of Nur77 homo- or heterodimers, while a consensus NurRE sequence does not show this preference.  Taken together, the data indicate that members of the Nur77 subfamily are most potent as heterodimers and that different dimers exhibit target sequence preference.  Thus, the authors propose that a combinatorial code relying on specific NurRE sequences might be responsible for the activation of subsets of target genes by one of the members of the Nur77 subfamily of transcription factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN_PcLpX1MWbVg90H21EOLACvtfcHk0liwclsU4bak6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFekt7k%253D&md5=6216924bd742d76309b033c091d273fd</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1128%2FMCB.19.11.7549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.19.11.7549%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DM.%26aulast%3DMartens%26aufirst%3DC.%26aulast%3DPhilips%26aufirst%3DA.%26aulast%3DDrouin%26aufirst%3DJ.%26atitle%3DHeterodimerization%2520between%2520members%2520of%2520the%2520Nur%2520subfamily%2520of%2520orphan%2520nuclear%2520receptors%2520as%2520a%2520novel%2520mechanism%2520for%2520gene%2520activation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1999%26volume%3D19%26spage%3D7549%26epage%3D7557%26doi%3D10.1128%2Fmcb.19.11.7549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis of binding of homodimers of the nuclear receptor NR4A2 to selective Nur-responsive DNA elements</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">19795</span>– <span class="NLM_lpage">19803</span>, <span class="refDoi"> DOI: 10.1074/jbc.ra119.010730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1074%2Fjbc.RA119.010730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=31723028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjt1agu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=19795-19803&author=L.+Jiangauthor=S.+Daiauthor=J.+Liauthor=X.+Liangauthor=L.+Quauthor=X.+Chenauthor=M.+Guoauthor=Z.+Chenauthor=L.+Chenauthor=H.+Weiauthor=Y.+Chen&title=Structural+basis+of+binding+of+homodimers+of+the+nuclear+receptor+NR4A2+to+selective+Nur-responsive+DNA+elements&doi=10.1074%2Fjbc.ra119.010730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of binding of homodimers of the nuclear receptor NR4A2 to selective Nur-responsive DNA elements</span></div><div class="casAuthors">Jiang, Longying; Dai, Shuyan; Li, Jun; Liang, Xujun; Qu, Lingzhi; Chen, Xiaojuan; Guo, Ming; Chen, Zhuchu; Chen, Lin; Wei, Hudie; Chen, Yongheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">19795-19803</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Proteins of nuclear receptor subfamily 4 group A (NR4A), including NR4A1/NGFI-B, NR4A2/Nurr1, and NR4A3/NOR-1, are nuclear transcription factors that play important roles in metab., apoptosis, and proliferation.  NR4A proteins recognize DNA response elements as monomers or dimers to regulate the transcription of a variety of genes involved in multiple biol. processes.  In this study, we detd. two crystal structures of the NR4A2 DNA-binding domain (NR4A2-DBD) bound to two Nur-responsive elements: an inverted repeat and an everted repeat at 2.6-2.8 Å resoln.  The structures revealed that two NR4A2-DBD mols. bind independently to the everted repeat, whereas two other NR4A2-DBD mols. form a novel dimer interface on the inverted repeat.  Moreover, substitution of the interfacial residue valine 298 to lysine as well as mutation of DNA bases involved in the interactions abolished the dimerization.  Overall, our structural, biochem., and bioinformatics analyses provide a mol. basis for the binding of the NR4A2 protein dimers to NurREs and advance our understanding of the dimerization specificity of nuclear receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgx9U7c_pOxrVg90H21EOLACvtfcHk0ljcTfjytiuBvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjt1agu7Y%253D&md5=3e3b4cb518d4011cd43b21feca17ebd6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA119.010730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA119.010730%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DDai%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520binding%2520of%2520homodimers%2520of%2520the%2520nuclear%2520receptor%2520NR4A2%2520to%2520selective%2520Nur-responsive%2520DNA%2520elements%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D19795%26epage%3D19803%26doi%3D10.1074%2Fjbc.ra119.010730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perlmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, L.</span></span> <span> </span><span class="NLM_article-title">A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">769</span>– <span class="NLM_lpage">782</span>, <span class="refDoi"> DOI: 10.1101/gad.9.7.769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1101%2Fgad.9.7.769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=7705655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADyaK2MXltVaht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=769-782&author=T.+Perlmannauthor=L.+Jansson&title=A+novel+pathway+for+vitamin+A+signaling+mediated+by+RXR+heterodimerization+with+NGFI-B+and+NURR1&doi=10.1101%2Fgad.9.7.769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1</span></div><div class="casAuthors">Perlmann, Thomas; Jansson, Lottie</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">769-82</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">In addn. to its role as a 9-cis retinoic acid receptor, RXR has an important role in the regulation of multiple hormonal pathways through heterodimerization with nuclear receptors.  Here, we show that two orphan receptors, NGFI-B and NURR1, which have been shown previously to interact with DNA as monomers, also can heterodimerize with RXR.  These heterodimers bind selectively to a class of retinoic acid response elements composed of direct repeats spaced by 5 nucleotides.  In this respect they are similar to heterodimers formed between RXR and the receptor for all-trans retinoic acid, RAR.  However, whereas RXR is inhibited in the RXR-RAR heterodimer, NGFI-B/NURR1 promote efficient activation in response to RXR ligands and therefore shift RXR from a silent to an active heterodimerization partner.  These data show that NGFI-B and NURR1 can increase the potential of RXR to modulate gene expression in a ligand-dependent manner by allowing a distinct class of direct repeats to serve as specific RXR response elements.  Because expression of both NGFI-B and NURR1 is rapidly induced by various growth factors, these findings also suggest a novel mechanism for convergence between vitamin A or retinoid and growth factor signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj7IW_x7cjxbVg90H21EOLACvtfcHk0ljcTfjytiuBvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXltVaht7c%253D&md5=c9ea7577edf4a5b92721144a5ef1382f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1101%2Fgad.9.7.769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.9.7.769%26sid%3Dliteratum%253Aachs%26aulast%3DPerlmann%26aufirst%3DT.%26aulast%3DJansson%26aufirst%3DL.%26atitle%3DA%2520novel%2520pathway%2520for%2520vitamin%2520A%2520signaling%2520mediated%2520by%2520RXR%2520heterodimerization%2520with%2520NGFI-B%2520and%2520NURR1%26jtitle%3DGenes%2520Dev.%26date%3D1995%26volume%3D9%26spage%3D769%26epage%3D782%26doi%3D10.1101%2Fgad.9.7.769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forman, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umesono, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">Unique response pathways are established by allosteric interactions among nuclear hormone receptors</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(95)90075-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2F0092-8674%2895%2990075-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=7758108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADyaK2MXlvVGgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1995&pages=541-550&author=B.+M.+Formanauthor=K.+Umesonoauthor=J.+Chenauthor=R.+M.+Evans&title=Unique+response+pathways+are+established+by+allosteric+interactions+among+nuclear+hormone+receptors&doi=10.1016%2F0092-8674%2895%2990075-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Unique response pathways are established by allosteric interactions among nuclear hormone receptors</span></div><div class="casAuthors">Forman, Barry Marc; Umesono, Kazuhiko; Chen, Jasmine; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-50</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Heterodimerization is a common paradigm among eukaryotic transcription factors.  The 9-cis retinoic acid receptor (RXR) serves as a common heterodimerization partner for several nuclear receptors, including the thyroid hormone receptor (T3R) and retinoic acid receptor (RAR).  This raises the question as to whether these complexes possess dual hormonal responsiveness.  The authors devised a strategy to examine the transcriptional properties of each receptor individually or when tethered to a heterodimeric partner.  The authors find that the intrinsic binding properties of RXR are masked in T3R-RXR and RAR-RXR heterodimers.  In contrast, RXR is active as a non-DNA-binding cofactor with the NGFI-B/Nurr1 orphan receptors.  Heterodimerization of RXR with constitutively active NGFI-B/Nurr1 creates a novel hormone-dependent complex.  These findings suggest that allosteric interactions among heterodimers create complexes with unique properties.  The authors suggest that allostery is a crit. feature underlying the generation of diversity in hormone response networks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXnSAjdD71E7Vg90H21EOLACvtfcHk0ljcTfjytiuBvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlvVGgurw%253D&md5=7a07058aae8f6557c939c1febcaacc92</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2895%2990075-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252895%252990075-6%26sid%3Dliteratum%253Aachs%26aulast%3DForman%26aufirst%3DB.%2BM.%26aulast%3DUmesono%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DUnique%2520response%2520pathways%2520are%2520established%2520by%2520allosteric%2520interactions%2520among%2520nuclear%2520hormone%2520receptors%26jtitle%3DCell%26date%3D1995%26volume%3D81%26spage%3D541%26epage%3D550%26doi%3D10.1016%2F0092-8674%2895%2990075-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvidsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolin, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlmann, T.</span></span> <span> </span><span class="NLM_article-title">Activity of the Nurr1 carboxyl-terminal domain depends on cell type and integrity of the activation function 2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">37483</span>– <span class="NLM_lpage">37490</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.52.37483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1074%2Fjbc.274.52.37483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10601324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD3cXpsFGn" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=37483-37490&author=D.+S.+Castroauthor=M.+Arvidssonauthor=M.+B.+Bolinauthor=T.+Perlmann&title=Activity+of+the+Nurr1+carboxyl-terminal+domain+depends+on+cell+type+and+integrity+of+the+activation+function+2&doi=10.1074%2Fjbc.274.52.37483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of the Nurr1 carboxyl-terminal domain depends on cell type and integrity of the activation function 2</span></div><div class="casAuthors">Castro, Diogo S.; Arvidsson, Mariette; Bolin, Maria Bondesson; Perlmann, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">37483-37490</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nurr1, a member of the nuclear hormone receptor superfamily, was recently demonstrated to be of crit. importance in the developing central nervous system, where it is required for the generation of midbrain dopamine cells.  Nuclear receptors encompass a transcriptional activation function (activation function 2; AF2) within their carboxyl-terminal domains important for ligand-induced transcriptional activation.  Since a Nurr1 ligand remains to be identified, the role of the Nurr1 AF2 region in transcriptional activation is unclear.  However, here we show that the Nurr1 AF2 contributes to constitutive activation independent of exogenously added ligands in human embryo kidney 293 cells and in neural cell lines.  Extensive mutagenesis indicated a crucial role of the AF2 core region for transactivation but also identified unique features differing from previously characterized receptors.  In addn., Nurr1 did not appear to interact with, and was not stimulated by, several previously identified coactivators such as the steroid receptor coactivator 1.  In contrast, adenovirus protein E1A, stably expressed in 293 cells, was shown to contribute to AF2-dependent activation.  Finally, while the AF2 core of RXR is required for ligand-induced transcriptional activation by Nurr1-RXR heterodimers, the functional integrity of Nurr1 AF2 core is not crit.  These results establish that the ligand binding domain of Nurr1 has intrinsic capacity for transcriptional activation depending on cell type and mode of DNA binding.  Furthermore, these results are consistent with the possibility that gene expression in the central nervous system can be modulated by an as yet unidentified ligand interacting with the ligand binding domain of Nurr1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMSA-jr5BbzrVg90H21EOLACvtfcHk0liI8w8a7-YzBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXpsFGn&md5=1edf1eaaffedb1ba2e1de924939b5308</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.52.37483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.52.37483%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DD.%2BS.%26aulast%3DArvidsson%26aufirst%3DM.%26aulast%3DBolin%26aufirst%3DM.%2BB.%26aulast%3DPerlmann%26aufirst%3DT.%26atitle%3DActivity%2520of%2520the%2520Nurr1%2520carboxyl-terminal%2520domain%2520depends%2520on%2520cell%2520type%2520and%2520integrity%2520of%2520the%2520activation%2520function%25202%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D37483%26epage%3D37490%26doi%3D10.1074%2Fjbc.274.52.37483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer</span>. <i>Clin. Transl. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">788</span>– <span class="NLM_lpage">794</span>, <span class="refDoi"> DOI: 10.1007/s12094-015-1305-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1007%2Fs12094-015-1305-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=26022133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2MXps1ejsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=788-794&author=J.+Guoauthor=G.+Zuauthor=T.+Zhouauthor=J.+Xingauthor=Z.+Wang&title=Clinicopathological+significance+of+orphan+nuclear+receptor+Nurr1+expression+in+gastric+cancer&doi=10.1007%2Fs12094-015-1305-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer</span></div><div class="casAuthors">Guo, J.; Zu, G.; Zhou, T.; Xing, J.; Wang, Z.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Translational Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">788-794</span>CODEN:
                <span class="NLM_cas:coden">CTOLAM</span>;
        ISSN:<span class="NLM_cas:issn">1699-048X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag Italia S.r.l.</span>)
        </div><div class="casAbstract">Background: Gastric cancer is the fourth most common cancer and the second leading cause of cancer-related deaths worldwide.  Gastric cancer is characterized by high levels of invasion and metastasis.  Increasing attention is being focused on discovering mol. markers for the diagnosis of gastric cancer and for predicting its prognosis.  The objective of the present study was to evaluate Nurr1 expression in gastric cancer and to assess its correlation with clinicopathol. parameters and prognosis in gastric cancer patients.  Methods: Tissue samples were obtained from 120 gastric cancer patients.  We investigated Nurr1 expression in human normal and gastric cancer tissues using real-time reverse transcription polymerase chain reaction (qRT-PCR), western blotting, and immunohistochem.  We detd. the assocn. between Nurr1 and recurrence, prognosis and patient clinicopathol. parameters.  Univariate and multivariate survival analyses with a Cox's proportional hazards regression model were used to identify independent factors related to recurrence and prognosis.  Results: The immunohistochem., qRT-PCR and western blot analyses revealed that Nurr1 expression was increased in gastric cancer tissues compared with normal gastric tissue (P < 0.05).  Nurr1 expression was significantly correlated with the tumor size, depth of tumor invasion, lymph node metastasis, recurrence, and distant metastasis of gastric cancer (P < 0.05).  Moreover, Nurr1-high patients also exhibited poorer overall survival (OS) and disease-free survival compared with Nurr1-low patients (P < 0.01).  The univariate and multivariate survival analyses suggested that Nurr1 expression (P = 0.011), histol. (P = 0.018), depth of tumor invasion (P = 0.037), and presence of lymph node metastasis (P = 0.031) were independent prognostic factors for recurrence.  In addn., Nurr1 expression (P = 0.007), depth of tumor invasion (P = 0.014), lymph node metastasis (P = 0.044), distant metastasis (P = 0.023), and recurrence (P = 0.011) were independent prognostic factors of OS in gastric cancer patients.  Conclusions: The Nurr1 protein may be useful as a marker of recurrence, metastasis, and poor prognosis following curative resection in patients with gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyB_9kJBZ_QLVg90H21EOLACvtfcHk0liI8w8a7-YzBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXps1ejsbs%253D&md5=8281bfca5d977599a8bf6211fec874bd</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs12094-015-1305-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12094-015-1305-z%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DZu%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DXing%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DClinicopathological%2520significance%2520of%2520orphan%2520nuclear%2520receptor%2520Nurr1%2520expression%2520in%2520gastric%2520cancer%26jtitle%3DClin.%2520Transl.%2520Oncol.%26date%3D2015%26volume%3D17%26spage%3D788%26epage%3D794%26doi%3D10.1007%2Fs12094-015-1305-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.-W.</span></span> <span> </span><span class="NLM_article-title">High cytoplasmic expression of the orphan nuclear receptor NR4A2 predicts poor survival in nasopharyngeal carcinoma</span>. <i>Asian Pac. J. Cancer Prev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2805</span>– <span class="NLM_lpage">2809</span>, <span class="refDoi"> DOI: 10.7314/apjcp.2013.14.5.2805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.7314%2FAPJCP.2013.14.5.2805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=23803035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A280%3ADC%252BC3sjmtVSjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=2805-2809&author=J.+Wangauthor=J.+Yangauthor=B.-B.+Liauthor=Z.-W.+He&title=High+cytoplasmic+expression+of+the+orphan+nuclear+receptor+NR4A2+predicts+poor+survival+in+nasopharyngeal+carcinoma&doi=10.7314%2Fapjcp.2013.14.5.2805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">High cytoplasmic expression of the orphan nuclear receptor NR4A2 predicts poor survival in nasopharyngeal carcinoma</span></div><div class="casAuthors">Wang Jian; Yang Jing; Li Bin-Bin; He Zhi-Wei</div><div class="citationInfo"><span class="NLM_cas:title">Asian Pacific journal of cancer prevention : APJCP</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2805-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  This study aimed at investigating whether the orphan nuclear receptor NR4A2 is significantly associated with clinicopathologic features and overall survival of patients with nasopharyngeal carcinoma (NPC).  METHODS:  Immunohistochemistry was performed to determine NR4A2 protein expression in 84 NPC tissues and 20 non-cancerous nasopharyngeal (NP) tissues.  The prognostic significance of NR4A2 protein expression was evaluated using Cox proportional hazards regression models and Kaplan-Meier survival analysis.  RESULTS:  We did not find a significant association between total NR4A2 expression and clinicopathological variables in 84 patients with NPC.  However, we observed that high cytoplasmic expression of NR4A2 was significantly associated with tumor size (T classification) (P = 0.006), lymph node metastasis (N classification) (P = 0.002) and clinical stage (P = 0.017).  Patients with higher cytoplasmic NR4A2 expression had a significantly lower survival rate than those with lower cytoplasmic NR4A2 expression (P = 0.004).  Multivariate Cox regression analysis analysis suggested that the level of cytoplasmic NR4A2 expression was an independent prognostic indicator for overall survival of patients with NPC (P = 0.033).  CONCLUSIONS:  High cytoplasmic expression of NR4A2 is a potential unfavorable prognostic factor for patients with NPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZwlxTnrwJ8_IW7hznt0zpfW6udTcc2ebIEnYk8wOUwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjmtVSjtQ%253D%253D&md5=b1e88320effe8f2e9d1c97b25974a9fd</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.7314%2FAPJCP.2013.14.5.2805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7314%252FAPJCP.2013.14.5.2805%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DB.-B.%26aulast%3DHe%26aufirst%3DZ.-W.%26atitle%3DHigh%2520cytoplasmic%2520expression%2520of%2520the%2520orphan%2520nuclear%2520receptor%2520NR4A2%2520predicts%2520poor%2520survival%2520in%2520nasopharyngeal%2520carcinoma%26jtitle%3DAsian%2520Pac.%2520J.%2520Cancer%2520Prev.%26date%3D2013%26volume%3D14%26spage%3D2805%26epage%3D2809%26doi%3D10.7314%2Fapjcp.2013.14.5.2805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, U.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohankumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelhaugh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjalkens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas</span>. <i>J. Neuro Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1007/s11060-019-03349-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1007%2Fs11060-019-03349-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=31754919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCitb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2020&pages=25-39&author=K.+Karkiauthor=X.+Liauthor=U.-H.+Jinauthor=K.+Mohankumarauthor=M.+Zareiauthor=S.+K.+Michelhaughauthor=S.+Mittalauthor=R.+Tjalkensauthor=S.+Safe&title=Nuclear+receptor+4A2+%28NR4A2%29+is+a+druggable+target+for+glioblastomas&doi=10.1007%2Fs11060-019-03349-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas</span></div><div class="casAuthors">Karki, Keshav; Li, Xi; Jin, Un-Ho; Mohankumar, Kumaravel; Zarei, Mahsa; Michelhaugh, Sharon K.; Mittal, Sandeep; Tjalkens, Ronald; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-39</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Introduction: The orphan nuclear receptor 4A2 (NR4A2) has been extensively characterized in subcellular regions of the brain and is necessary for the function of dopaminergic neurons.  The NR4A2 ligand, 1,1-bis (31-indoly1)-1-(p-chlorophenyl)methane (DIM-C-pPhCl) inhibits markers of neuroinflammation and degeneration in mouse models and in this study we investigated expression and function of NR4A2 in glioblastoma (GBM).  Methods: Established and patient-derived cell lines were used as models and the expression and functions of NR4A2 were detd. by western blots and NR4A2 gene silencing by antisense oligonucleotides resp.  Effects of NR4A2 knockdown and DIM-C-pPhCl on cell growth, induction of apoptosis (Annexin V Staining) and migration/invasion (Boyden chamber and spheroid invasion assay) and transactivation of NR4A2-regulated reporter genes were detd.  Tumor growth was investigated in athymic nude mice bearing U87-MG cells as xenografts.  Results: NR4A2 knockdown and DIM-C-pPhCl inhibited GBM cell and tumor growth, induced apoptosis and inhibited migration and invasion of GBM cells.  DIM-C-pPhCl and related analogs also inhibited NR4A2-regulated transactivation (luciferase activity) confirming that DIM-C-pPhCl acts as an NR4A2 antagonist and blocks NR4A2-dependent pro-oncogenic responses in GBM.  Conclusion: We demonstrate for the first time that NR4A2 is pro-oncogenic in GBM and thus a potential druggable target for patients with tumors expressing this receptor.  Moreover, our bis-indole-derived NR4A2 antagonists represent a novel class of anti-cancer agents with potential future clin. applications for treating GBM.  Graphic abstr.: [Figure not available: see fulltext.].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEdcmrnjM9ULVg90H21EOLACvtfcHk0liz0STD_pwY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCitb7P&md5=c59faaf59f390c4f657c058a44ff8791</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1007%2Fs11060-019-03349-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-019-03349-y%26sid%3Dliteratum%253Aachs%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DU.-H.%26aulast%3DMohankumar%26aufirst%3DK.%26aulast%3DZarei%26aufirst%3DM.%26aulast%3DMichelhaugh%26aufirst%3DS.%2BK.%26aulast%3DMittal%26aufirst%3DS.%26aulast%3DTjalkens%26aufirst%3DR.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DNuclear%2520receptor%25204A2%2520%2528NR4A2%2529%2520is%2520a%2520druggable%2520target%2520for%2520glioblastomas%26jtitle%3DJ.%2520Neuro%2520Oncol.%26date%3D2020%26volume%3D146%26spage%3D25%26epage%3D39%26doi%3D10.1007%2Fs11060-019-03349-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chintharlapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burghardt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papineni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">Activation of Nur77 by selected 1,1-Bis(3’-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">24903</span>– <span class="NLM_lpage">24914</span>, <span class="refDoi"> DOI: 10.1074/jbc.m500107200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1074%2Fjbc.M500107200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=15871945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFyqsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=24903-24914&author=S.+Chintharlapalliauthor=R.+Burghardtauthor=S.+Papineniauthor=S.+Ramaiahauthor=K.+Yoonauthor=S.+Safe&title=Activation+of+Nur77+by+selected+1%2C1-Bis%283%E2%80%99-indolyl%29-1-%28p-substituted+phenyl%29methanes+induces+apoptosis+through+nuclear+pathways&doi=10.1074%2Fjbc.m500107200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Nur77 by Selected 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes Induces Apoptosis through Nuclear Pathways</span></div><div class="casAuthors">Chintharlapalli, Sudhakar; Burghardt, Robert; Papineni, Sabitha; Ramaiah, Shashi; Yoon, Kyungsil; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">24903-24914</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nur77 is an orphan receptor and a member of the nerve growth factor-I-B subfamily of the nuclear receptor family of transcription factors.  Based on the results of transactivation assays in pancreatic and other cancer cell lines, we have now identified for the first time Nur77 agonists typified by 1,1-bis(3-indolyl)-1-(p-anisyl)methane that activate GAL4-Nur77 chimeras expressing wild-type and the ligand binding domain (E/F) of Nur77.  In Panc-28 pancreatic cancer cells, Nur77 agonists activate the nuclear receptor, and downstream responses include decreased cell survival and induction of cell death pathways, including tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and poly(ADP-ribose) polymerase (PARP) cleavage.  Moreover, the transactivation and apoptotic responses are also induced in other pancreatic, prostate, and breast cancer cells that express Nur77.  In Panc-28 cells, small inhibitory RNA for Nur77 reverses ligand-dependent transactivation and induction of TRAIL and PARP cleavage.  Nur77 agonists also inhibit tumor growth in vivo in athymic mice bearing Panc-28 cell xenografts.  These results identify compds. that activate Nur77 through the ligand binding domain and show that ligand-dependent activation of Nur77 through nuclear pathways in cancer cells induces cell death and these compds. are a novel class of anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_VexMGI2027Vg90H21EOLACvtfcHk0liz0STD_pwY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFyqsb8%253D&md5=d82803ea6f94a2fb25317d2cd9f7a57d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M500107200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M500107200%26sid%3Dliteratum%253Aachs%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DBurghardt%26aufirst%3DR.%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DRamaiah%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DK.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DActivation%2520of%2520Nur77%2520by%2520selected%25201%252C1-Bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-substituted%2520phenyl%2529methanes%2520induces%2520apoptosis%2520through%2520nuclear%2520pathways%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D24903%26epage%3D24914%26doi%3D10.1074%2Fjbc.m500107200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chintharlapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">683</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-06-2907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1158%2F0008-5472.CAN-06-2907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=17234778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVKrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=674-683&author=S.+D.+Choauthor=K.+Yoonauthor=S.+Chintharlapalliauthor=M.+Abdelrahimauthor=P.+Leiauthor=S.+Hamiltonauthor=S.+Khanauthor=S.+K.+Ramaiahauthor=S.+Safe&title=Nur77+agonists+induce+proapoptotic+genes+and+responses+in+colon+cancer+cells+through+nuclear+receptor-dependent+and+nuclear+receptor-independent+pathways&doi=10.1158%2F0008-5472.can-06-2907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Nur77 Agonists Induce Proapoptotic Genes and Responses in Colon Cancer Cells through Nuclear Receptor-Dependent and Nuclear Receptor-Independent Pathways</span></div><div class="casAuthors">Cho, Sung Dae; Yoon, Kyungsil; Chintharlapalli, Sudhakar; Abdelrahim, Maen; Lei, Ping; Hamilton, Stanley; Khan, Shaheen; Ramaiah, Shashi K.; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">674-683</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Nerve growth factor-induced Bα (NGFI-Bα, Nur77) is an orphan nuclear receptor with no known endogenous ligands; however, recent studies on a series of methylene-substituted diindolylmethanes (C-DIM) have identified 1,1-bis(3'-indolyl)-1-(phenyl)methane (DIM-C-Ph) and 1,1-bis(3'-indolyl)-1-(p-anisyl)methane (DIM-C-pPhOCH3) as Nur77 agonists.  Nur77 is expressed in several colon cancer cell lines (RKO, SW480, HCT-116, HT-29, and HCT-15), and we also obsd. by immunostaining that Nur77 was overexpressed in colon tumors compared with normal colon tissue.  DIM-C-Ph and DIM-C-pPhOCH3 decreased survival and induced apoptosis in RKO colon cancer cells, and this was accompanied by induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein.  The induction of apoptosis and TRAIL by DIM-C-pPhOCH3 was significantly inhibited by a small inhibitory RNA for Nur77 (iNur77); however, it was evident from RNA interference studies that DIM-C-pPhOCH3 also induced Nur77-independent apoptosis.  Anal. of DIM-C-pPhOCH3-induced gene expression using microarrays identified several proapoptotic genes, and anal. by reverse transcription-PCR in the presence or absence of iNur77 showed that induction of programmed cell death gene 1 was Nur77 dependent, whereas induction of cystathionase and activating transcription factor 3 was Nur77 independent.  DIM-C-pPhOCH3 (25 mg/kg/d) also inhibited tumor growth in athymic nude mice bearing RKO cell xenografts.  These results show that Nur77-active C-DIM compds. represent a new class of anti-colon cancer drugs that act through receptor-dependent and receptor-independent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUKcKfJxo5RLVg90H21EOLACvtfcHk0liz0STD_pwY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVKrtg%253D%253D&md5=a2f00bc08b0ee78096e8e27f6ea25c77</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-2907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-2907%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BD.%26aulast%3DYoon%26aufirst%3DK.%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DAbdelrahim%26aufirst%3DM.%26aulast%3DLei%26aufirst%3DP.%26aulast%3DHamilton%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DRamaiah%26aufirst%3DS.%2BK.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DNur77%2520agonists%2520induce%2520proapoptotic%2520genes%2520and%2520responses%2520in%2520colon%2520cancer%2520cells%2520through%2520nuclear%2520receptor-dependent%2520and%2520nuclear%2520receptor-independent%2520pathways%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D674%26epage%3D683%26doi%3D10.1158%2F0008-5472.can-06-2907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K.</span>; <span class="NLM_string-name">Chen, C. C.</span>; <span class="NLM_string-name">Orr, A. A.</span>; <span class="NLM_string-name">Barreto, P. N.</span>; <span class="NLM_string-name">Tamamis, P.</span>; <span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">Activation of COUP-TFI by a Novel Diindolylmethane Derivative</span>.  <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2019</span><b>,</b>  <span class="NLM_volume">8</span>.<span class="refDoi"> DOI: 10.3390/cells8030220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.3390%2Fcells8030220" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&author=K.+Yoon&author=C.+C.+Chen&author=A.+A.+Orr&author=P.+N.+Barreto&author=P.+Tamamis&author=S.+Safe&title=Activation+of+COUP-TFI+by+a+Novel+Diindolylmethane+Derivative&doi=10.3390%2Fcells8030220"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3390%2Fcells8030220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells8030220%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DK.%26atitle%3DActivation%2520of%2520COUP-TFI%2520by%2520a%2520Novel%2520Diindolylmethane%2520Derivative%26jtitle%3DCells%26date%3D2019%26volume%3D8%26doi%3D10.3390%2Fcells8030220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chintharlapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samudio, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">1,1-Bis(3’-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">5994</span>– <span class="NLM_lpage">6001</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-04-0399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1158%2F0008-5472.CAN-04-0399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=15342379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFCls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=5994-6001&author=S.+Chintharlapalliauthor=R.+Smithauthor=I.+Samudioauthor=W.+Zhangauthor=S.+Safe&title=1%2C1-Bis%283%E2%80%99-indolyl%29-1-%28p-substitutedphenyl%29methanes+induce+peroxisome+proliferator-activated+receptor+gamma-mediated+growth+inhibition%2C+transactivation%2C+and+differentiation+markers+in+colon+cancer+cells&doi=10.1158%2F0008-5472.can-04-0399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induce proxisome proliferator-activated receptor γ-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells</span></div><div class="casAuthors">Chintharlapalli, Sudhakar; Smith, Roger, III; Samudio, Ismael; Zhang, Wei; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5994-6001</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">1,1-bis(3'indolyl)-1-(p-substituted Ph methanes contg. p-trifluoromethyl (DIM-C-pPhCF3), p-t-Bu (DIM-C-pPhtBu), and p-Ph (DIM-C-pPhC6H5) groups induce peroxisome proliferator-activated receptor γ (PPARγ)-mediated transactivation in HT-29, HCT-15, RKO, and SW480 colon cancer cell lines.  Rosiglitazone also induces transactivation in these cell lines and inhibited growth of HT-29 cells, which express wild-type PPARγ but not HCT-15 cells, which express mutant (K422Q) PPARγ.  In contrast, DIM-C-pPhCF3, DIM-C-pPhtBu, and DIM-C-pPhC6H5 inhibited growth of both HT-29 and HCT-15 cells with IC50 values ranging from 1 to 10 μmol/L.  Rosiglitazone and diindolylmethane (DIM) analogs did not affect expression of cyclin D1, p21, or p27 protein levels or apoptosis in HCT-15 or HT-29 cells but induced keratin 18 in both cell lines.  However, rosiglitazone induced caveolins 1 and 2 in HT-29 but not HCT-15 cells, whereas these differentiation markers were induced by DIM-C-pPhCF3 and DIM-C-pPhC6H5 in both cell lines.  Because overexpression of caveolin 1 is known to suppress colon cancer cell and tumor growth, the growth inhibitory effects of rosiglitazone and the DIM compds. are assocd. with PPARγ-dependent induction of caveolins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpinNdV8qZTUrVg90H21EOLACvtfcHk0lguCkBf7FWvtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFCls70%253D&md5=1c770d15a7242e04d55353153676a97b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-0399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-0399%26sid%3Dliteratum%253Aachs%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DSamudio%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3D1%252C1-Bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-substitutedphenyl%2529methanes%2520induce%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma-mediated%2520growth%2520inhibition%252C%2520transactivation%252C%2520and%2520differentiation%2520markers%2520in%2520colon%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D5994%26epage%3D6001%26doi%3D10.1158%2F0008-5472.can-04-0399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrow, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samudio, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3’-indolyl)-1-(p-substituted phenyl)methanes</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=15026545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFCnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=247-260&author=C.+Qinauthor=D.+Morrowauthor=J.+Stewartauthor=K.+Spencerauthor=W.+Porterauthor=R.+Smithauthor=T.+Phillipsauthor=M.+Abdelrahimauthor=I.+Samudioauthor=S.+Safe&title=A+new+class+of+peroxisome+proliferator-activated+receptor+gamma+%28PPARgamma%29+agonists+that+inhibit+growth+of+breast+cancer+cells%3A+1%2C1-Bis%283%E2%80%99-indolyl%29-1-%28p-substituted+phenyl%29methanes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A new class of peroxisome proliferator-activated receptor γ (PPARγ) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes</span></div><div class="casAuthors">Qin, Chunhua; Morrow, Derek; Stewart, Jessica; Spencer, Kyle; Porter, Weston; Smith, Roger, III; Phillips, Timothy; Abdelrahim, Maen; Samudio, Ismael; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-260</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">1,1-Bis(3'-indolyl)-1-(p-trifluoromethylphenyl)methane (DIM-C-pPhCF3) and several p-substituted Ph analogs have been investigated as a new class of peroxisome proliferator-activated receptor γ (PPARγ) agonists.  Structure-activity studies in PPARγ-dependent transactivation assays in MCF-7 breast cancer cells show that 5-20 μM concns. of compds. contg. p-trifluoromethyl, t-Bu, cyano, dimethylamino, and Ph groups were active, whereas p-Me, hydrogen, methoxy, hydroxyl, or halogen groups were inactive as PPARγ agonists.  Induction of PPARγ-dependent transactivation by 15-deoxy-Δ12,14-prostaglandin J2 (PGJ2) and DIM-C-pPhCF3 was inhibited in MCF-7 cells cotreated with the PPARγ-specific antagonist N-(4'-aminopyridyl)-2-chloro-5-nitrobenzamide.  In mammalian two-hybrid assays, DIM-C-pPhCF3 and PGJ2 (5-20 μM) induced interactions of PPARγ with steroid receptor coactivator (SRC) 1, SRC2 (TIFII), and thyroid hormone receptor-assocd. protein 220 but not with SRC3 (AIB1).  In contrast, DIM-C-pPhCF3, but not PGJ2, induced interactions of PPARγ with PPARγ coactivator-1.  C-substituted diindolylmethanes inhibit carcinogen-induced rat mammary tumor growth, induce differentiation in 3T3-L1 preadipocytes, inhibit MCF-7 cell growth and G0/G1-S phase progression, induce apoptosis, and down-regulate cyclin D1 protein and estrogen receptor α in breast cancer cells.  These compds. are a novel class of synthetic PPARγ agonists that induce responses in MCF-7 cells similar to those obsd. for PGJ2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMkCAR_DeYarVg90H21EOLACvtfcHk0lguCkBf7FWvtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFCnsrc%253D&md5=e1c5b7fd6be48bb4a3f4956138344681</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DC.%26aulast%3DMorrow%26aufirst%3DD.%26aulast%3DStewart%26aufirst%3DJ.%26aulast%3DSpencer%26aufirst%3DK.%26aulast%3DPorter%26aufirst%3DW.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DPhillips%26aufirst%3DT.%26aulast%3DAbdelrahim%26aufirst%3DM.%26aulast%3DSamudio%26aufirst%3DI.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DA%2520new%2520class%2520of%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma%2520%2528PPARgamma%2529%2520agonists%2520that%2520inhibit%2520growth%2520of%2520breast%2520cancer%2520cells%253A%25201%252C1-Bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-substituted%2520phenyl%2529methanes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D247%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tjalkens, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbone, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">The peroxisome proliferator-activated receptor-gamma agonist 1,1-bis(3’-indolyl)-1-(p-trifluoromethylphenyl)methane suppresses manganese-induced production of nitric oxide in astrocytes and inhibits apoptosis in cocultured PC12 cells</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">618</span>– <span class="NLM_lpage">629</span>, <span class="refDoi"> DOI: 10.1002/jnr.21524</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1002%2Fjnr.21524" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=18041089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvF2qt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2008&pages=618-629&author=R.+B.+Tjalkensauthor=X.+Liuauthor=B.+Mohlauthor=T.+Wrightauthor=J.+A.+Morenoauthor=D.+L.+Carboneauthor=S.+Safe&title=The+peroxisome+proliferator-activated+receptor-gamma+agonist+1%2C1-bis%283%E2%80%99-indolyl%29-1-%28p-trifluoromethylphenyl%29methane+suppresses+manganese-induced+production+of+nitric+oxide+in+astrocytes+and+inhibits+apoptosis+in+cocultured+PC12+cells&doi=10.1002%2Fjnr.21524"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The peroxisome proliferator-activated receptor-γ agonist 1,1-bis(3'-indolyl)-1-(P-trifluoromethylphenyl)methane suppresses manganese-induced production of nitric oxide in astrocytes and inhibits apoptosis in cocultured PC12 cells</span></div><div class="casAuthors">Tjalkens, Ronald B.; Liu, Xuhong; Mohl, Brianne; Wright, Tyler; Moreno, Julie A.; Carbone, David L.; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">618-629</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Reactive astrogliosis is a prominent neuropathol. feature of manganism, a neurodegenerative disorder caused by excessive accumulation of manganese (Mn) in the basal ganglia.  Activation of astrocytes has been linked to neuronal injury in manganism resulting from overprodn. of inflammatory mediators, including tumor necrosis factor-α (TNFα), interferon-γ (IFNγ), interleukin-1β (IL-1β), and nitric oxide (NO), but the signaling mechanisms by which Mn regulates these factors remain poorly understood.  We previously reported that Mn enhances prodn. of NO in activated astrocytes that promotes apoptosis in cocultured neuronal cells by a mechanism involving the transcription factor nuclear factor-κB (NF-κB).  Because NF-κB-dependent expression of inducible nitric oxide synthase (NOS2) can be antagonized by the nuclear orphan receptor peroxisome proliferator-activated receptor-γ (PPARγ), we postulated that a novel agonist of this receptor, 1,1-bis(3'-indolyl)-1-(p-trifluoromethylphenyl)methane (cDIM1), would suppress expression of NOS2 in astrocytes and protect cocultured neuronal cells from apoptosis.  Submicromolar concns. of cDIM1 potently suppressed prodn. of NO and expression of NOS2 in cultured astrocytes exposed to Mn and IFNγ/TNFα and prevented apoptosis in cocultures of differentiated PC12 cells, but this neuroprotective effect was lost in the absence of astrocytes.  By using fluorescence reporter and chromatin immunopptn. (ChIP) assays, we found that cDIM1 prevented activation of NF-κB in astrocytes by a mechanism involving stabilization of the nuclear corepressor 2 (NCoR2) on the proximal NF-κB binding site of the NOS2 promoter.  These data suggest that PPARγ may be an effective target for limiting inflammatory activation of astrocytes during neurol. injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqiAX_z5uhR7Vg90H21EOLACvtfcHk0liAgg_-nPU9FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvF2qt7o%253D&md5=e548a174ef0e5d8c3de6c0aefb001c42</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fjnr.21524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.21524%26sid%3Dliteratum%253Aachs%26aulast%3DTjalkens%26aufirst%3DR.%2BB.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMohl%26aufirst%3DB.%26aulast%3DWright%26aufirst%3DT.%26aulast%3DMoreno%26aufirst%3DJ.%2BA.%26aulast%3DCarbone%26aufirst%3DD.%2BL.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DThe%2520peroxisome%2520proliferator-activated%2520receptor-gamma%2520agonist%25201%252C1-bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-trifluoromethylphenyl%2529methane%2520suppresses%2520manganese-induced%2520production%2520of%2520nitric%2520oxide%2520in%2520astrocytes%2520and%2520inhibits%2520apoptosis%2520in%2520cocultured%2520PC12%2520cells%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2008%26volume%3D86%26spage%3D618%26epage%3D629%26doi%3D10.1002%2Fjnr.21524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3’-indoly)-1-(p-substituted phenyl)methanes</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3363</span>– <span class="NLM_lpage">3372</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-08-0439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1158%2F1535-7163.MCT-08-0439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=18852139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ensbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=3363-3372&author=P.+Leiauthor=M.+Abdelrahimauthor=S.+D.+Choauthor=X.+Liuauthor=S.+Safe&title=Structure-dependent+activation+of+endoplasmic+reticulum+stress-mediated+apoptosis+in+pancreatic+cancer+by+1%2C1-bis%283%E2%80%99-indoly%29-1-%28p-substituted+phenyl%29methanes&doi=10.1158%2F1535-7163.mct-08-0439"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3'-indoly)-1-(p-substituted phenyl)methanes</span></div><div class="casAuthors">Lei, Ping; Abdelrahim, Maen; Cho, Sung Dae; Liu, Xingi; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3363-3372</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">1,1-Bis(3'-indoly)-1-(p-substituted phenyl)methanes (C-DIM) exhibit structure-dependent activation of peroxisome proliferator-activated receptor γ and nerve growth factor-induced Bα (Nur77) and induce receptor-dependent and receptor-independent apoptosis in cancer cells and tumors.  In this study, we investigated the activation of apoptosis in pancreatic cancer cells by p-bromo (DIM-C-pPhBr) and p-fluoro (DIM-C-pPhF) and structurally related analogs that do not activate either peroxisome proliferator-activated receptor γ or Nur77.  The ortho, meta, and para-bromo and -fluoro isomers all activated endoplasmic reticulum (ER) stress-dependent apoptosis in pancreatic cancer cells; however, methylation of the indole N group significantly decreased activity, suggesting that a free N was important for activation of ER stress.  Both DIM-C-pPhBr and DIM-C-pPhF resembled the classic ER stress inducer thapsigargin in pancreatic cancer cells and activated ER stress markers, such as glucose-related protein 78 and the c-Jun NH2 kinase pathway, resulting in the induction of CCAAT/enhancer-binding protein homologous protein, death receptor 5, and the extrinsic apoptotic pathway.  Moreover, DIM-C-pPhBr also inhibited tumor growth in an orthotopic model for pancreatic cancer, demonstrating the clin. potential for this C-DIM compd. in pancreatic cancer chemotherapy. [Mol Cancer Ther 2008;7(10):3363-72].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw6lLOXOR9trVg90H21EOLACvtfcHk0liAgg_-nPU9FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ensbzN&md5=72c77dbedcc137b04ca11b4efab1e734</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0439%26sid%3Dliteratum%253Aachs%26aulast%3DLei%26aufirst%3DP.%26aulast%3DAbdelrahim%26aufirst%3DM.%26aulast%3DCho%26aufirst%3DS.%2BD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DStructure-dependent%2520activation%2520of%2520endoplasmic%2520reticulum%2520stress-mediated%2520apoptosis%2520in%2520pancreatic%2520cancer%2520by%25201%252C1-bis%25283%25E2%2580%2599-indoly%2529-1-%2528p-substituted%2520phenyl%2529methanes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D3363%26epage%3D3372%26doi%3D10.1158%2F1535-7163.mct-08-0439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chintharlapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">1,1-Bis(3’-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1139</span>– <span class="NLM_lpage">1147</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgn103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1093%2Fcarcin%2Fbgn103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=18460448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1Wjtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=1139-1147&author=P.+Leiauthor=M.+Abdelrahimauthor=S.+D.+Choauthor=S.+Liuauthor=S.+Chintharlapalliauthor=S.+Safe&title=1%2C1-Bis%283%E2%80%99-indolyl%29-1-%28p-substituted+phenyl%29methanes+inhibit+colon+cancer+cell+and+tumor+growth+through+activation+of+c-jun+N-terminal+kinase&doi=10.1093%2Fcarcin%2Fbgn103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase</span></div><div class="casAuthors">Lei, Ping; Abdelrahim, Maen; Cho, Sung Dae; Liu, Shengxi; Chintharlapalli, Sudhakar; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1139-1147</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes (C-DIMs) activate the orphan receptors peroxisome proliferator-activated receptor γ (PPARγ) and Nur77 and induce receptor-dependent and -independent apoptotic pathways in colon and other cancer cells.  Structure-activity studies show that the p-bromo (DIM-C-pPhBr) and p-fluoro (DIM-C-pPhF) analogs, which exhibit minimal activation of Nur77 and PPARγ, induce expression of CCAAT/enhancer-binding protein homologous protein (CHOP/GADD153) in colon cancer cells.  Moreover, among a series of bromo and fluoro C-DIM analogs, their induction of CHOP was dependent on the position of the Ph substituents (para ≥ meta ≥ ortho) and required a free indole group.  DIM-C-pPhBr and DIM-C-pPhF not only induced CHOP but also activated death receptor 5 (CHOP dependent), cleavage of caspase 8 and poly (ADP ribose) polymerase (PARP) that is consistent with activation of the extrinsic pathway of apoptosis.  These responses were assocd. with the activation of c-jun N-terminal kinase (JNK) pathway since inhibition of JNK inhibited induction of the extrinsic apoptotic pathway by these C-DIMs.  However, in contrast to classical inducers of endoplasmic reticulum (ER) stress such as tunicamycin and thapsigargin, the C-DIM compds. did not induce glucose-related protein 78 that is a marker of ER stress.  Proapoptotic and anticarcinogenic effects were also obsd. in athymic nude mice bearing RKO cell xenografts and treated with 30 mg/kg/day DIM-C-pPhBr and this was accompanied by increased JNK phosphorylation in the tumors.  Thus, the anticarcinogenic activity of DIM-C-pPhBr in colon cancer cells and tumors is related to a novel ER stress-independent activation of JNK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAQ0-WoIHm_LVg90H21EOLACvtfcHk0liAgg_-nPU9FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1Wjtrg%253D&md5=21550476c08f698ed832bb5c241bc5f9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgn103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgn103%26sid%3Dliteratum%253Aachs%26aulast%3DLei%26aufirst%3DP.%26aulast%3DAbdelrahim%26aufirst%3DM.%26aulast%3DCho%26aufirst%3DS.%2BD.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3D1%252C1-Bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-substituted%2520phenyl%2529methanes%2520inhibit%2520colon%2520cancer%2520cell%2520and%2520tumor%2520growth%2520through%2520activation%2520of%2520c-jun%2520N-terminal%2520kinase%26jtitle%3DCarcinogenesis%26date%3D2008%26volume%3D29%26spage%3D1139%26epage%3D1147%26doi%3D10.1093%2Fcarcin%2Fbgn103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montes-Grajales, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivero-Verbél, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, J. T.</span></span> <span> </span><span class="NLM_article-title">3,3’-Diindolylmethane (DIM) and its ring-substituted halogenated analogs (ring-DIMs) induce differential mechanisms of survival and death in androgen-dependent and -independent prostate cancer cells</span>. <i>Genes Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.18632/genesandcancer.60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.18632%2Fgenesandcancer.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=26124925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCmtbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=265-280&author=A.+A.+Goldbergauthor=H.+Drazauthor=D.+Montes-Grajalesauthor=J.+Olivero-Verb%C3%A9lauthor=S.+H.+Safeauthor=J.+T.+Sanderson&title=3%2C3%E2%80%99-Diindolylmethane+%28DIM%29+and+its+ring-substituted+halogenated+analogs+%28ring-DIMs%29+induce+differential+mechanisms+of+survival+and+death+in+androgen-dependent+and+-independent+prostate+cancer+cells&doi=10.18632%2Fgenesandcancer.60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">3,3'-Diindolylmethane (DIM) and its ring-substituted halogenated analogs (ring-DIMs) induce differential mechanisms of survival and death in androgen-dependent and -independent prostate cancer cells</span></div><div class="casAuthors">Goldberg, Alexander A.; Draz, Hossam; Montes-Grajales, Diana; Olivero-Verbel, Jesus; Safe, Stephen H.; Sanderson, J. Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">265-280</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Impact Journals LLC</span>)
        </div><div class="casAbstract">We recently reported that novel ring-substituted analogs of 3,3'-diindolylmethane (ring-DIMs) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cells.  In this paper, we have focused on the mechanism(s) assocd. with ring-DIM-mediated cell death, and on identifying the specific intracellular target(s) of these compds.  The 4,4'- and 7,7'-dichloroDIMs and 4,4'- and 7,7'-dibromoDIMs induced the death of LNCaP, C42B and DU145 prostate cancer cells, but not that of immortalized normal human prostate epithelial (RWPE-1) cells.  Ring-DIMs caused the early loss of mitochondrial membrane potential (MMP) and decreased mitochondrial ATP generation in prostate cancer cells.  Cyclosporin A, an inhibitor of the mitochondrial permeability transition pore, inhibited ring-DIM-mediated cell death, and salubrinal, an inhibitor of ER stress, inhibited cell death mediated only by 4,4'-dihaloDIMs.  We found that although salubrinal did not inhibit the onset of ER stress, it prevented 4,4'-dibromoDIM mediated loss of MMP.  Salubrinal potentiated cell death in response to 7,7'-dihaloDIMs and DIM, and this effect concurred with increased loss of MMP.  Using in silico 3-D docking affinity anal., we identified Ca2+/calmodulin-dependent kinase II (CaMKII) as a potential direct target for the most toxic ring-DIM, 4,4'-dibromoDIM.  An inhibitor of CaMKII, KN93, but not its inactive analog KN92, abrogated cell death mediated by 4,4'-dibromoDIM.  The ring-DIMs induced ER stress and autophagy, but these processes were not necessary for ring-DIM-mediated cell death.  Inhibition of autophagy with bafilomycin A1, 3-methyladenine or by LC3B gene silencing sensitized LNCaP and C42B, but not ATG5-deficient DU145 cells to ring-DIM- and DIM-mediated cell death.  We propose that autophagy induced by the ring-DIMs and DIM has a cytoprotective function in prostate cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB4daZF7T7PbVg90H21EOLACvtfcHk0liAgg_-nPU9FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCmtbnP&md5=477fbec4d80e44c678d3b3f74fc73e11</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.18632%2Fgenesandcancer.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Fgenesandcancer.60%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DA.%2BA.%26aulast%3DDraz%26aufirst%3DH.%26aulast%3DMontes-Grajales%26aufirst%3DD.%26aulast%3DOlivero-Verb%25C3%25A9l%26aufirst%3DJ.%26aulast%3DSafe%26aufirst%3DS.%2BH.%26aulast%3DSanderson%26aufirst%3DJ.%2BT.%26atitle%3D3%252C3%25E2%2580%2599-Diindolylmethane%2520%2528DIM%2529%2520and%2520its%2520ring-substituted%2520halogenated%2520analogs%2520%2528ring-DIMs%2529%2520induce%2520differential%2520mechanisms%2520of%2520survival%2520and%2520death%2520in%2520androgen-dependent%2520and%2520-independent%2520prostate%2520cancer%2520cells%26jtitle%3DGenes%2520Cancer%26date%3D2015%26volume%3D6%26spage%3D265%26epage%3D280%26doi%3D10.18632%2Fgenesandcancer.60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papineni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chintharlapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">1,1-bis(3’-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1002/mc.20378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1002%2Fmc.20378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=17957723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1egt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=252-263&author=S.+D.+Choauthor=P.+Leiauthor=M.+Abdelrahimauthor=K.+Yoonauthor=S.+Liuauthor=J.+Guoauthor=S.+Papineniauthor=S.+Chintharlapalliauthor=S.+Safe&title=1%2C1-bis%283%E2%80%99-indolyl%29-1-%28p-methoxyphenyl%29methane+activates+Nur77-independent+proapoptotic+responses+in+colon+cancer+cells&doi=10.1002%2Fmc.20378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells</span></div><div class="casAuthors">Cho, Sung Dae; Lei, Ping; Abdelrahim, Maen; Yoon, Kyungsil; Liu, Shengxi; Guo, Jingjing; Papineni, Sabitha; Chintharlapalli, Sudhakar; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">252-263</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">1,1-Bis(3'-indolyl)-1-(p-methoxyphenyl)methane (DIM-C-pPhOCH3) is a methylene-substituted diindolylmethane (C-DIM) analog that activates the orphan receptor nerve growth factor-induced-Bα (NGFI-Bα, Nur77).  RNA interference studies with small inhibitory RNA for Nur77 demonstrate that DIM-C-pPhOCH3 induces Nur77-dependent and -independent apoptosis, and this study has focused on delineating the Nur77-independent proapoptotic pathways induced by the C-DIM analog.  DIM-C-pPhOCH3 induced caspase-dependent apoptosis in RKO colon cancer cells through decreased mitochondrial membrane potential which is accompanied by increased mitochondrial bax/bcl-2 ratios and release of cytochrome c into the cytosol.  DIM-C-pPhOCH3 also induced phosphatidylinositol-3-kinase-dependent activation of early growth response gene-1 which, in turn, induced expression of the proapoptotic nonsteroidal anti-inflammatory drug-activated gene-1 (NAG1) in RKO and SW480 colon cancer cells.  Moreover, DIM-C-pPhOCH3 also induced NAG-1 expression in colon tumors in athymic nude mice bearing RKO cells as xenografts.  DIM-C-pPhOCH3 also activated the extrinsic apoptosis pathway through increased phosphorylation of c-jun N-terminal kinase which, in turn, activated C/EBP homologous transcription factor (CHOP) and death receptor 5 (DR5).  Thus, the effectiveness of DIM-C-pPhOCH3 as a tumor growth inhibitor is through activation of Nur77-dependent and -independent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqqncrgkKkjLVg90H21EOLACvtfcHk0ljes5pzQU1PCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1egt74%253D&md5=d6696f104bc24c55291c2afe90992e89</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fmc.20378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.20378%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BD.%26aulast%3DLei%26aufirst%3DP.%26aulast%3DAbdelrahim%26aufirst%3DM.%26aulast%3DYoon%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3D1%252C1-bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-methoxyphenyl%2529methane%2520activates%2520Nur77-independent%2520proapoptotic%2520responses%2520in%2520colon%2520cancer%2520cells%26jtitle%3DMol.%2520Carcinog.%26date%3D2008%26volume%3D47%26spage%3D252%26epage%3D263%26doi%3D10.1002%2Fmc.20378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chintharlapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papineni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">1,1-bis(3’-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">558</span>– <span class="NLM_lpage">569</span>, <span class="refDoi"> DOI: 10.1124/mol.106.028696</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1124%2Fmol.106.028696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=17093136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=558-569&author=S.+Chintharlapalliauthor=S.+Papineniauthor=S.+Safe&title=1%2C1-bis%283%E2%80%99-indolyl%29-1-%28p-substitutedphenyl%29methanes+inhibit+growth%2C+induce+apoptosis%2C+and+decrease+the+androgen+receptor+in+LNCaP+prostate+cancer+cells+through+peroxisome+proliferator-activated+receptor+gamma-independent+pathways&doi=10.1124%2Fmol.106.028696"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">1,1-Bis(3'-indolyl)-1-(p-substituted-phenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor γ-independent pathways</span></div><div class="casAuthors">Chintharlapalli, Sudhakar; Papineni, Sabitha; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">558-569</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">1,1-Bis(3'-indolyl)-1-(p-substituted-phenyl)methanes (C-DIMs) contg. para-trifluoromethyl, t-Bu, and Ph groups are a novel class of peroxisome proliferator-activated receptor (PPAR)γ agonists.  In LNCaP prostate cancer cells, these compds. induce PPARγ-dependent transactivation, inhibit cell proliferation, and induce apoptosis.  In addn., these PPARγ agonists modulate a no. of antiproliferative and proapoptotic responses, including induction of p27, activating transcription factor 3, and nonsteroidal anti-inflammatory drug-activated gene-1 and down-regulation of cyclin D1 and caveolin-1.  Moreover, the PPARγ antagonist 2-chloro-5-nitrobenzanilide (GW9662) does not inhibit these effects.  The C-DIM compds. also abrogate androgen receptor (AR)-mediated signaling and decrease prostate-specific antigen (PSA) and AR protein expression, and these responses were PPARγ-independent.  The effects of C-DIMs on AR and PSA were due to decreased AR and PSA mRNA expression in LNCaP cells.  Thus, this series of methylene-substituted diindolylmethane derivs. simultaneously activate multiple pathways in LNCaP cells, including ablation of androgen-responsiveness and down-regulation of caveolin-1.  Both of these responses are assocd. with activation of proapoptotic pathways in this cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMOfRk7P3197Vg90H21EOLACvtfcHk0ljes5pzQU1PCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWrsL0%253D&md5=e866e2d7ef19b3d67a945fda976c4edf</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.028696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.028696%26sid%3Dliteratum%253Aachs%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3D1%252C1-bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-substitutedphenyl%2529methanes%2520inhibit%2520growth%252C%2520induce%2520apoptosis%252C%2520and%2520decrease%2520the%2520androgen%2520receptor%2520in%2520LNCaP%2520prostate%2520cancer%2520cells%2520through%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma-independent%2520pathways%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D71%26spage%3D558%26epage%3D569%26doi%3D10.1124%2Fmol.106.028696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">1,1-Bis(3’-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2324</span>– <span class="NLM_lpage">2336</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-06-0184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1158%2F1535-7163.MCT-06-0184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=16985067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1ynsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2324-2336&author=P.+Leiauthor=M.+Abdelrahimauthor=S.+Safe&title=1%2C1-Bis%283%E2%80%99-indolyl%29-1-%28p-substituted+phenyl%29methanes+inhibit+ovarian+cancer+cell+growth+through+peroxisome+proliferator-activated+receptor-dependent+and+independent+pathways&doi=10.1158%2F1535-7163.mct-06-0184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways</span></div><div class="casAuthors">Lei, Ping; Abdelrahim, Maen; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2324-2336</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">1,1-Bis(3'-indolyl)-1-(p-t-butylphenyl)methane (DIM-C-pPhtBu) is a peroxisome proliferator-activated receptor γ (PPARγ) agonist, and treatment of SKOV3 ovarian cancer cells with this compd. (5 μmol/L) inhibits cell proliferation, whereas up to 15 μmol/L rosiglitazone had no effect on cell growth.  DIM-C-pPhtBu also inhibits G0-G1 to S phase cell cycle progression and this is linked, in part, to PPARγ-dependent induction of the cyclin-dependent kinase inhibitor p21.  DIM-C-pPhtBu induces PPARγ-independent down-regulation of cyclin D1 and we therefore further investigated activation of receptor-independent pathways.  DIM-C-pPhtBu also induced apoptosis in SKOV3 cells and this was related to induction of glucose-related protein 78, which is typically up-regulated as part of the unfolded protein response during endoplasmic reticulum (ER) stress.  Activation of ER stress was also obsd. in other ovarian cancer cell lines treated with DIM-C-pPhtBu.  In addn., DIM-C-pPhtBu induced CCAAT/enhancer binding protein homologous protein through both ER stress and c-jun NH2-terminal kinase-dependent pathways, and CCAAT/enhancer binding protein homologous protein activated death receptor 5 and the extrinsic pathway of apoptosis.  These results show that DIM-C-pPhtBu inhibits growth and induces apoptosis in ovarian cancer cells through both PPARγ-dependent and PPARγ-independent pathways, and this complex mechanism of action will be advantageous for future clin. development of these compds. for treatment of ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMKBTSTWgdm7Vg90H21EOLACvtfcHk0ljW13mK02iKmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1ynsLc%253D&md5=4d1d58ed4b13a2a0b2e30870b33a6bd2</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0184%26sid%3Dliteratum%253Aachs%26aulast%3DLei%26aufirst%3DP.%26aulast%3DAbdelrahim%26aufirst%3DM.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3D1%252C1-Bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-substituted%2520phenyl%2529methanes%2520inhibit%2520ovarian%2520cancer%2520cell%2520growth%2520through%2520peroxisome%2520proliferator-activated%2520receptor-dependent%2520and%2520independent%2520pathways%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D2324%26epage%3D2336%26doi%3D10.1158%2F1535-7163.mct-06-0184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salminen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtonen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paimela, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaarniranta, K.</span></span> <span> </span><span class="NLM_article-title">Celastrol: Molecular targets of Thunder God Vine</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>394</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">442</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2010.03.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.bbrc.2010.03.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=20226165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC3cXks1Kjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=2010&pages=439-442&author=A.+Salminenauthor=M.+Lehtonenauthor=T.+Paimelaauthor=K.+Kaarniranta&title=Celastrol%3A+Molecular+targets+of+Thunder+God+Vine&doi=10.1016%2Fj.bbrc.2010.03.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Celastrol: Molecular targets of Thunder God Vine</span></div><div class="casAuthors">Salminen, Antero; Lehtonen, Marko; Paimela, Tuomas; Kaarniranta, Kai</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">439-442</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Celastrol, a quinone methide triterpene, is a pharmacol. active compd. present in Thunder God Vine root exts. used as a remedy of inflammatory and autoimmune diseases, e.g. rheumatoid arthritis.  Celastrol is one of the most promising medicinal mols. isolated from the plant exts. of traditional medicines.  Mol. studies have identified several mol. targets which are mostly centered on the inhibition of IKK-NF-κB signaling.  Celastrol (i) inhibits directly the IKKα and β kinases, (ii) inactivates the Cdc37 and p23 proteins which are co-chaperones of HSP90, (iii) inhibits the function of proteasomes, and (iv) activates the HSF1 and subsequently triggers the heat shock response.  It seems that the quinone methide structure present in celastrol can react with the thiol groups of cysteine residues, forming covalent protein adducts.  In lab. expts., celastrol has proved to be a potent inhibitor of inflammatory responses and cancer formation as well as alleviating diseases of proteostasis deficiency.  Celastrol needs still to pass several hurdles, e.g. ADMET assays, before it can enter the armory of western drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAqujhaYI_2bVg90H21EOLACvtfcHk0ljW13mK02iKmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXks1Kjurs%253D&md5=4fff51afc9fc9b391ed0195ab70618bd</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2010.03.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2010.03.050%26sid%3Dliteratum%253Aachs%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DLehtonen%26aufirst%3DM.%26aulast%3DPaimela%26aufirst%3DT.%26aulast%3DKaarniranta%26aufirst%3DK.%26atitle%3DCelastrol%253A%2520Molecular%2520targets%2520of%2520Thunder%2520God%2520Vine%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2010%26volume%3D394%26spage%3D439%26epage%3D442%26doi%3D10.1016%2Fj.bbrc.2010.03.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teriete, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raveendra-Panickar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendelton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazo, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiseman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holien, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misund, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliynyk, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsenian-Henriksson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosford, N. D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prochownik, E. V.</span></span> <span> </span><span class="NLM_article-title">Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">32380</span>– <span class="NLM_lpage">32395</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.6116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.18632%2Foncotarget.6116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=26474287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A280%3ADC%252BC28zitlGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=32380-32395&author=H.+Wangauthor=P.+Terieteauthor=A.+Huauthor=D.+Raveendra-Panickarauthor=K.+Pendeltonauthor=J.+S.+Lazoauthor=J.+Eisemanauthor=T.+Holienauthor=K.+Misundauthor=G.+Oliynykauthor=M.+Arsenian-Henrikssonauthor=N.+D.+P.+Cosfordauthor=A.+Sundanauthor=E.+V.+Prochownik&title=Direct+inhibition+of+c-Myc-Max+heterodimers+by+celastrol+and+celastrol-inspired+triterpenoids&doi=10.18632%2Foncotarget.6116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids</span></div><div class="casAuthors">Wang Huabo; Hu Angela; Pendelton Kelsey; Prochownik Edward V; Teriete Peter; Raveendra-Panickar Dhanya; Cosford Nicholas D P; Lazo John S; Eiseman Julie; Eiseman Julie; Prochownik Edward V; Holien Toril; Misund Kristine; Sundan Anders; Oliynyk Ganna; Arsenian-Henriksson Marie; Prochownik Edward V</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">32380-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Many oncogenic signals originate from abnormal protein-protein interactions that are potential targets for small molecule inhibitors.  However, the therapeutic disruption of these interactions has proved elusive.  We report here that the naturally-occurring triterpenoid celastrol is an inhibitor of the c-Myc (Myc) oncoprotein, which is over-expressed in many human cancers.  Most Myc inhibitors prevent the association between Myc and its obligate heterodimerization partner Max via their respective bHLH-ZIP domains.  In contrast, we show that celastrol binds to and alters the quaternary structure of the pre-formed dimer and abrogates its DNA binding.  Celastrol contains a reactive quinone methide group that promiscuously forms Michael adducts with numerous target proteins and other free sulfhydryl-containing molecules.  Interestingly, triterpenoid derivatives lacking the quinone methide showed enhanced specificity and potency against Myc.  As with other Myc inhibitors, these analogs rapidly reduced the abundance of Myc protein and provoked a global energy crisis marked by ATP depletion, neutral lipid accumulation, AMP-activated protein kinase activation, cell cycle arrest and apoptosis.  They also inhibited the proliferation of numerous established human cancer cell lines as well as primary myeloma explants that were otherwise resistant to JQ1, a potent indirect Myc inhibitor.  N-Myc amplified neuroblastoma cells showed similar responses and, in additional, underwent neuronal differentiation.  These studies indicate that certain pharmacologically undesirable properties of celastrol such as Michael adduct formation can be eliminated while increasing selectivity and potency toward Myc and N-Myc.  This, together with their low in vivo toxicity, provides a strong rationale for pursuing the development of additional Myc-specific triterpenoid derivatives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLYuH_K-VTYFMGsG_HTXYFfW6udTcc2ebEuqWvdRh8mrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zitlGmug%253D%253D&md5=c11fcf599276f90b82c813af934f12b1</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.6116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.6116%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DTeriete%26aufirst%3DP.%26aulast%3DHu%26aufirst%3DA.%26aulast%3DRaveendra-Panickar%26aufirst%3DD.%26aulast%3DPendelton%26aufirst%3DK.%26aulast%3DLazo%26aufirst%3DJ.%2BS.%26aulast%3DEiseman%26aufirst%3DJ.%26aulast%3DHolien%26aufirst%3DT.%26aulast%3DMisund%26aufirst%3DK.%26aulast%3DOliynyk%26aufirst%3DG.%26aulast%3DArsenian-Henriksson%26aufirst%3DM.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26aulast%3DSundan%26aufirst%3DA.%26aulast%3DProchownik%26aufirst%3DE.%2BV.%26atitle%3DDirect%2520inhibition%2520of%2520c-Myc-Max%2520heterodimers%2520by%2520celastrol%2520and%2520celastrol-inspired%2520triterpenoids%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D32380%26epage%3D32395%26doi%3D10.18632%2Foncotarget.6116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Z.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.-B.</span></span> <span> </span><span class="NLM_article-title">Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">914</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgt395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1093%2Fcarcin%2Fbgt395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=24293411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtVOhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=905-914&author=Z.+Liuauthor=L.+Maauthor=Z.-S.+Wenauthor=Z.+Huauthor=F.-Q.+Wuauthor=W.+Liauthor=J.+Liuauthor=G.-B.+Zhou&title=Cancerous+inhibitor+of+PP2A+is+targeted+by+natural+compound+celastrol+for+degradation+in+non-small-cell+lung+cancer&doi=10.1093%2Fcarcin%2Fbgt395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer</span></div><div class="casAuthors">Liu, Zi; Ma, Liang; Wen, Zhe-Sheng; Hu, Zheng; Wu, Fu-Qun; Li, Wei; Liu, Jinsong; Zhou, Guang-Biao</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">905-914</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Summary Celastrol binds CIP2A and enhances CIP2A-CHIP interaction, leading to ubiquitination/degrdn. of CIP2A and inhibition of lung cancer cells in vitro and in vivo.  Celastrol potentiates cisplatin's efficacy by suppressing the CIP2A-Akt pathway, and therefore CIP2A inhibitors may represent novel therapeutics for cancer.  Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an oncoprotein overexpressed and inversely assocd. with prognosis in lung and many other human cancers.  It modulates phospho-Akt and stabilizes c-Myc, and is required for cell proliferation and malignant transformation, indicating that CIP2A may play an important role in carcinogenesis.  We reported here that a small compd. celastrol could induce a rapid degrdn. of CIP2A, through the ubiquitin-proteasome pathway with the carboxyl terminus of Hsp70-interacting protein (CHIP) as the E3 ligase.  Celastrol directly bound CIP2A protein and promoted CIP2A-CHIP interaction, leading to subsequent degrdn. of CIP2A in non-small-cell lung cancer cells.  Furthermore, celastrol effectively inhibited cell proliferation and induced apoptosis in non-small-cell lung cancer cells, whereas CIP2A silencing enhanced these effects.  Celastrol also suppressed tumor growth in xenograft murine models.  In addn., celastrol potentiated the inhibitory effect of cytotoxic agent cisplatin on lung cancer cells in vitro and in vivo via inhibition of CIP2A-Akt pathway.  These data indicate that celastrol is a CIP2A-targeting agent that may have therapeutic potentials in lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXNNdcS85iUrVg90H21EOLACvtfcHk0lguUSe9cadSNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtVOhsro%253D&md5=4bbe0e98b42f03543ce12a6a3d835434</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgt395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgt395%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWen%26aufirst%3DZ.-S.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DF.-Q.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.-B.%26atitle%3DCancerous%2520inhibitor%2520of%2520PP2A%2520is%2520targeted%2520by%2520natural%2520compound%2520celastrol%2520for%2520degradation%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DCarcinogenesis%26date%3D2014%26volume%3D35%26spage%3D905%26epage%3D914%26doi%3D10.1093%2Fcarcin%2Fbgt395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span> <span> </span><span class="NLM_article-title">Celastrol Attenuates Angiotensin II-Induced Cardiac Remodeling by Targeting STAT3</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1007</span>– <span class="NLM_lpage">1023</span>, <span class="refDoi"> DOI: 10.1161/circresaha.119.315861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1161%2FCIRCRESAHA.119.315861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=32098592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmvFShu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2020&pages=1007-1023&author=S.+Yeauthor=W.+Luoauthor=Z.+A.+Khanauthor=G.+Wuauthor=L.+Xuanauthor=P.+Shanauthor=K.+Linauthor=T.+Chenauthor=J.+Wangauthor=X.+Huauthor=S.+Wangauthor=W.+Huangauthor=G.+Liang&title=Celastrol+Attenuates+Angiotensin+II-Induced+Cardiac+Remodeling+by+Targeting+STAT3&doi=10.1161%2Fcircresaha.119.315861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Celastrol Attenuates Angiotensin II-Induced Cardiac Remodeling by Targeting STAT3</span></div><div class="casAuthors">Ye, Shiju; Luo, Wu; Khan, Zia A.; Wu, Gaojun; Xuan, Lina; Shan, Peiren; Lin, Ke; Chen, Taiwei; Wang, Jingying; Hu, Xiang; Wang, Shengjie; Huang, Weijian; Liang, Guang</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1007-1023</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Rationale: Excessive Ang II (angiotensin II) levels lead to a profibrotic and hypertrophic milieu that produces deleterious remodeling and dysfunction in hypertension-assocd. heart failure.  Agents that disrupt Ang II-induced cardiac dysfunction may have clin. utility in the treatment of hypertension-assocd. heart failure.  Objective: We have examd. the potential effect of celastrol-a bioactive compd. derived from the Celastraceae family-on Ang II-induced cardiac dysfunction.  Methods and results: In rat primary cardiomyocytes and H9C2 (rat cardiomyocyte-like H9C2) cells, celastrol attenuates Ang II-induced cellular hypertrophy and fibrotic responses.  Proteome microarrays, surface plasmon resonance, competitive binding assays, and mol. simulation were used to identify the mol. target of celastrol.  Our data showed that celastrol directly binds to and inhibits STAT (signal transducer and activator of transcription)-3 phosphorylation and nuclear translocation.  Functional tests demonstrated that the protection of celastrol is afforded through targeting STAT3.  Overexpression of STAT3 dampens the effect of celastrol by partially rescuing STAT3 activity.  Finally, we investigated the in vivo effect of celastrol treatment in mice challenged with Ang II and in the transverse aortic constriction model.  We show that celastrol administration protected heart function in Ang II-challenged and transverse aortic constriction-challenged mice by inhibiting cardiac fibrosis and hypertrophy.  Conclusions: Our studies show that celastrol inhibits Ang II-induced cardiac dysfunction by inhibiting STAT3 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrbLcHejN-jrVg90H21EOLACvtfcHk0lguUSe9cadSNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmvFShu7o%253D&md5=77fc07db5196b5c92f7d925cbe104a19</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.119.315861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.119.315861%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DKhan%26aufirst%3DZ.%2BA.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DXuan%26aufirst%3DL.%26aulast%3DShan%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DG.%26atitle%3DCelastrol%2520Attenuates%2520Angiotensin%2520II-Induced%2520Cardiac%2520Remodeling%2520by%2520Targeting%2520STAT3%26jtitle%3DCirc.%2520Res.%26date%3D2020%26volume%3D126%26spage%3D1007%26epage%3D1023%26doi%3D10.1161%2Fcircresaha.119.315861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao-Pei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji-Kuai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao-Fang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ya-Min, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen-Jun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang-Bo, Z.</span></span> <span> </span><span class="NLM_article-title">Systematic identification of Celastrol-binding proteins reveals that Shoc2 is inhibited by Celastrol</span>. <i>Biosci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">BSR20181233</span>, <span class="refDoi"> DOI: 10.1042/bsr20181233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1042%2FBSR20181233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30333251" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=BSR20181233&author=H.+Xiao-Peiauthor=C.+Ji-Kuaiauthor=W.+Xueauthor=Y.+F.+Dongauthor=L.+Yanauthor=Z.+Xiao-Fangauthor=P.+Ya-Minauthor=C.+Wen-Junauthor=Z.+Jiang-Bo&title=Systematic+identification+of+Celastrol-binding+proteins+reveals+that+Shoc2+is+inhibited+by+Celastrol&doi=10.1042%2Fbsr20181233"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1042%2FBSR20181233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBSR20181233%26sid%3Dliteratum%253Aachs%26aulast%3DXiao-Pei%26aufirst%3DH.%26aulast%3DJi-Kuai%26aufirst%3DC.%26aulast%3DXue%26aufirst%3DW.%26aulast%3DDong%26aufirst%3DY.%2BF.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DXiao-Fang%26aufirst%3DZ.%26aulast%3DYa-Min%26aufirst%3DP.%26aulast%3DWen-Jun%26aufirst%3DC.%26aulast%3DJiang-Bo%26aufirst%3DZ.%26atitle%3DSystematic%2520identification%2520of%2520Celastrol-binding%2520proteins%2520reveals%2520that%2520Shoc2%2520is%2520inhibited%2520by%2520Celastrol%26jtitle%3DBiosci.%2520Rep.%26date%3D2018%26volume%3D38%26spage%3DBSR20181233%26doi%3D10.1042%2Fbsr20181233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1321</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2006.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.bcp.2006.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=16984800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSrtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=1311-1321&author=J.-H.+Leeauthor=T.+H.+Kooauthor=H.+Yoonauthor=H.+S.+Jungauthor=H.+Z.+Jinauthor=K.+Leeauthor=Y.-S.+Hongauthor=J.+J.+Lee&title=Inhibition+of+NF-kappa+B+activation+through+targeting+I+kappa+B+kinase+by+celastrol%2C+a+quinone+methide+triterpenoid&doi=10.1016%2Fj.bcp.2006.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of NF-κB activation through targeting IκB kinase by celastrol, a quinone methide triterpenoid</span></div><div class="casAuthors">Lee, Jeong-Hyung; Koo, Tae Hyeon; Yoon, Hyunkyung; Jung, Haeng Sun; Jin, Hui Zi; Lee, Kyeong; Hong, Young-Soo; Lee, Jung Joon</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1311-1321</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Celastrol, a quinone methide triterpenoid, was isolated as an inhibitor of NF-κB from Celastrus orbiculatus.  This compd. dose-dependently inhibited a variety of stimuli-induced NF-κB-regulated gene expression and the DNA-binding of NF-κB in different cell lines without affecting DNA-binding activity of AP-1.  Preincubation of celastrol completely blocked the LPS-, TNF-α-, or PMA-induced degrdn. and phosphorylation of IκBα.  Importantly, celastrol inhibited IKK activity and the constitutively active IKKβ activity in a dose-dependent manner without either affecting the NF-κB activation induced by RelA over-expression or directly suppressing the DNA-binding of activated NF-κB.  However, mutation of cysteine 179 in the activation loop of IKKβ abolished sensitivity towards to celastrol, suggesting that celastrol suppressed the NF-κB activation by targeting cysteine 179 in the IKK.  To verify that celastrol is a NF-κB inhibitor, we investigated its effect on some NF-κB target genes expressions.  Celastrol prevented not only LPS-induced mRNA expression of iNOS and TNF-α, but also TNF-α-induced Bfl-1/A1 expression, a prosurvival Bcl-2 homolog.  Consistent with these results, celastrol significantly suppressed the prodn. of NO and TNF-α in LPS-stimulated RAW264.7 cells, and increased the cytotoxicity of TNF-α in HT-1080 cells.  We also demonstrated that celastrol showed anti-inflammatory and anti-tumor activities in animal models.  Taken together, this study extends our understanding on the mol. mechanisms underlying the anti-inflammatory and anti-cancer activities of celastrol and celastrol-contg. medicinal plant, which would be a valuable candidate for the intervention of NF-κB-dependent pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV26_Hc5ZXYrVg90H21EOLACvtfcHk0lguUSe9cadSNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSrtLrN&md5=b69a2fd4c384dbcf8c99f97ae1407353</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2006.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2006.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.-H.%26aulast%3DKoo%26aufirst%3DT.%2BH.%26aulast%3DYoon%26aufirst%3DH.%26aulast%3DJung%26aufirst%3DH.%2BS.%26aulast%3DJin%26aufirst%3DH.%2BZ.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DHong%26aufirst%3DY.-S.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26atitle%3DInhibition%2520of%2520NF-kappa%2520B%2520activation%2520through%2520targeting%2520I%2520kappa%2520B%2520kinase%2520by%2520celastrol%252C%2520a%2520quinone%2520methide%2520triterpenoid%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D72%26spage%3D1311%26epage%3D1321%26doi%3D10.1016%2Fj.bcp.2006.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chadli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botuyan, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauq, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez-Alvarado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mer, G.</span></span> <span> </span><span class="NLM_article-title">Celastrol inhibits Hsp90 chaperoning of steroid receptors by inducing fibrillization of the Co-chaperone p23</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">4224</span>– <span class="NLM_lpage">4231</span>, <span class="refDoi"> DOI: 10.1074/jbc.m109.081018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1074%2Fjbc.M109.081018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=19996313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Wlsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=4224-4231&author=A.+Chadliauthor=S.+J.+Feltsauthor=Q.+Wangauthor=W.+P.+Sullivanauthor=M.+V.+Botuyanauthor=A.+Fauqauthor=M.+Ramirez-Alvaradoauthor=G.+Mer&title=Celastrol+inhibits+Hsp90+chaperoning+of+steroid+receptors+by+inducing+fibrillization+of+the+Co-chaperone+p23&doi=10.1074%2Fjbc.m109.081018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Celastrol Inhibits Hsp90 Chaperoning of Steroid Receptors by Inducing Fibrillization of the Co-chaperone p23</span></div><div class="casAuthors">Chadli, Ahmed; Felts, Sara J.; Wang, Qin; Sullivan, William P.; Botuyan, Maria Victoria; Fauq, Abdul; Ramirez-Alvarado, Marina; Mer, Georges</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4224-4231</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Hsp90 is an ATP-dependent mol. chaperone.  The best-characterized inhibitors of Hsp90 target its ATP binding pocket, causing nonselective degrdn. of Hsp90 client proteins.  Here, we show that the small mol. celastrol inhibits the Hsp90 chaperoning machinery by inactivating the co-chaperone p23, resulting in a more selective destabilization of steroid receptors compared with kinase clients.  Our in vitro and in vivo results demonstrate that celastrol disrupts p23 function by altering its three-dimensional structure, leading to rapid formation of amyloid-like fibrils.  This study reveals a unique inhibition mechanism of p23 by a small mol. that could be exploited in the dissection of protein fibrillization processes as well as in the therapeutics of steroid receptor-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqHTE_VeHYP7Vg90H21EOLACvtfcHk0li-3EumO-7UMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Wlsr4%253D&md5=fd92f09e314736504429dc245cadd570</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.081018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.081018%26sid%3Dliteratum%253Aachs%26aulast%3DChadli%26aufirst%3DA.%26aulast%3DFelts%26aufirst%3DS.%2BJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DSullivan%26aufirst%3DW.%2BP.%26aulast%3DBotuyan%26aufirst%3DM.%2BV.%26aulast%3DFauq%26aufirst%3DA.%26aulast%3DRamirez-Alvarado%26aufirst%3DM.%26aulast%3DMer%26aufirst%3DG.%26atitle%3DCelastrol%2520inhibits%2520Hsp90%2520chaperoning%2520of%2520steroid%2520receptors%2520by%2520inducing%2520fibrillization%2520of%2520the%2520Co-chaperone%2520p23%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D4224%26epage%3D4231%26doi%3D10.1074%2Fjbc.m109.081018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, C.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-07-0484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1158%2F1535-7163.mct-07-0484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=18202019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVyhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=162-170&author=T.+Zhangauthor=A.+Hamzaauthor=X.+Caoauthor=B.+Wangauthor=S.+Yuauthor=C.-G.+Zhanauthor=D.+Sun&title=A+novel+Hsp90+inhibitor+to+disrupt+Hsp90%2FCdc37+complex+against+pancreatic+cancer+cells&doi=10.1158%2F1535-7163.mct-07-0484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells</span></div><div class="casAuthors">Zhang, Tao; Hamza, Adel; Cao, Xianhua; Wang, Bing; Yu, Shuwen; Zhan, Chang-Guo; Sun, Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">162-170</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Pancreatic cancer is an aggressive disease with multiple biochem. and genetic alterations.  Thus, a single agent to hit one mol. target may not be sufficient to treat this disease.  The purpose of this study is to identify a novel Hsp90 inhibitor to disrupt protein-protein interactions of Hsp90 and its cochaperones for down-regulating many oncogenes simultaneously against pancreatic cancer cells.  Here, we reported that celastrol disrupted Hsp90-Cdc37 interaction in the superchaperone complex to exhibit antitumor activity in vitro and in vivo.  Mol. docking and mol. dynamic simulations showed that celastrol blocked the crit. interaction of Glu33 (Hsp90) and Arg167 (Cdc37).  Immunopptn. confirmed that celastrol (10 μmol/L) disrupted the Hsp90-Cdc37 interaction in the pancreatic cancer cell line Panc-1.  In contrast to classic Hsp90 inhibitor (geldanamycin), celastrol (0.1-100 μmol/L) did not interfere with ATP binding to Hsp90.  However, celastrol (1-5 μmol/L) induced Hsp90 client protein degrdn. (Cdk4 and Akt) by 70% to 80% and increased Hsp70 expression by 12-fold.  Celastrol induced apoptosis in vitro and significantly inhibited tumor growth in Panc-1 xenografts.  Moreover, celastrol (3 mg/kg) effectively suppressed tumor metastasis by more than 80% in RIP1-Tag2 transgenic mouse model with pancreatic islet cell carcinogenesis.  The data suggest that celastrol is a novel Hsp90 inhibitor to disrupt Hsp90-Cdc37 interaction against pancreatic cancer cells. [Mol Cancer Ther 2008;7(1):162-70].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYaUNr9Bi1cbVg90H21EOLACvtfcHk0li-3EumO-7UMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVyhtQ%253D%253D&md5=2af27701d6ccd4397c7a7486d1335730</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.mct-07-0484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.mct-07-0484%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DHamza%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DZhan%26aufirst%3DC.-G.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DA%2520novel%2520Hsp90%2520inhibitor%2520to%2520disrupt%2520Hsp90%252FCdc37%2520complex%2520against%2520pancreatic%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D162%26epage%3D170%26doi%3D10.1158%2F1535-7163.mct-07-0484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of celastrol to inhibit hsp90 and cdc37 interaction</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">35381</span>– <span class="NLM_lpage">35389</span>, <span class="refDoi"> DOI: 10.1074/jbc.m109.051532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1074%2Fjbc.m109.051532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=19858214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCqurjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=35381-35389&author=T.+Zhangauthor=Y.+Liauthor=Y.+Yuauthor=P.+Zouauthor=Y.+Jiangauthor=D.+Sun&title=Characterization+of+celastrol+to+inhibit+hsp90+and+cdc37+interaction&doi=10.1074%2Fjbc.m109.051532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction</span></div><div class="casAuthors">Zhang, Tao; Li, Yanyan; Yu, Yanke; Zou, Peng; Jiang, Yiqun; Sun, Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">35381-35389</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mol. chaperone heat shock protein 90 (Hsp90) is required for the stabilization and conformational maturation of various oncogenic proteins in cancer.  The loading of protein kinases to Hsp90 is actively mediated by the co-chaperone Cdc37.  The crucial role of the Hsp90-Cdc37 complex has made it an exciting target for cancer treatment.  In this study, the authors characterize Hsp90 and Cdc37 interaction and drug disruption using a reconstituted protein system.  The GST pull-down assay and ELISA assay show that Cdc37 binds to ADP-bound/nucleotide-free Hsp90 but not ATP-bound Hsp90.  Celastrol disrupts Hsp90-Cdc37 complex formation, whereas the classical Hsp90 inhibitors (e.g., geldanamycin) have no effect.  Celastrol inhibits Hsp90 ATPase activity without blocking ATP binding.  Proteolytic fingerprinting indicates celastrol binds to Hsp90 C-terminal domain to protect it from trypsin digestion.  These data suggest that celastrol may represent a new class of Hsp90 inhibitor by modifying Hsp90 C terminus to allosterically regulate its chaperone activity and disrupt Hsp90-Cdc37 complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPbfNGpAapIrVg90H21EOLACvtfcHk0li-3EumO-7UMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCqurjN&md5=f8d15de4ecac58de8bb5274d9cf9cdcd</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m109.051532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m109.051532%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520celastrol%2520to%2520inhibit%2520hsp90%2520and%2520cdc37%2520interaction%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D35381%26epage%3D35389%26doi%3D10.1074%2Fjbc.m109.051532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">104</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.00104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.3389%2Ffphar.2018.00104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=29491837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Skt7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=104&author=S.+R.+Chenauthor=Y.+Daiauthor=J.+Zhaoauthor=L.+Linauthor=Y.+Wangauthor=Y.+Wang&title=A+Mechanistic+Overview+of+Triptolide+and+Celastrol%2C+Natural+Products+from+Tripterygium+wilfordii+Hook+F&doi=10.3389%2Ffphar.2018.00104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A mechanistic overview of triptolide and celastrol, natural products from Tripterygium wilfordii Hook F</span></div><div class="casAuthors">Chen, Shao-Ru; Dai, Yan; Zhao, Jing; Lin, Ligen; Wang, Yitao; Wang, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104/1-104/13</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Triptolide and celastrol are predominantly active natural products isolated from the medicinal plant Tripterygium wilfordii Hook F.  These compds. exhibit similar pharmacol. activities, including anti-cancer, anti-inflammation, anti-obesity, and anti-diabetic activities.  Triptolide and celastrol also provide neuroprotection and prevent cardiovascular and metabolic diseases.  However, toxicity restricts the further development of triptolide and celastrol.  In this review, we comprehensively review therapeutic targets and mechanisms of action, and translational study of triptolide and celastrol.  We systemically discuss the structure-activity-relationship of triptolide, celastrol, and their derivs.  Furthermore, we propose the use of structural derivs., targeted therapy, and combination treatment as possible solns. to reduce toxicity and increase therapeutic window of these potent natural products from T. wilfordii Hook F.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF6S3u2q0YLLVg90H21EOLACvtfcHk0lheMhL-GU9pqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Skt7rE&md5=826675620f132aa76d9b07f466fb9631</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00104%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%2BR.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DA%2520Mechanistic%2520Overview%2520of%2520Triptolide%2520and%2520Celastrol%252C%2520Natural%2520Products%2520from%2520Tripterygium%2520wilfordii%2520Hook%2520F%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26spage%3D104%26doi%3D10.3389%2Ffphar.2018.00104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span> <span> </span><span class="NLM_article-title">Isoalantolactone induces apoptosis through ROS-mediated ER stress and inhibition of STAT3 in prostate cancer cells</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">309</span>, <span class="refDoi"> DOI: 10.1186/s13046-018-0987-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1186%2Fs13046-018-0987-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30541589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFaisL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=309&author=W.+Chenauthor=P.+Liauthor=Y.+Liuauthor=Y.+Yangauthor=X.+Yeauthor=F.+Zhangauthor=H.+Huang&title=Isoalantolactone+induces+apoptosis+through+ROS-mediated+ER+stress+and+inhibition+of+STAT3+in+prostate+cancer+cells&doi=10.1186%2Fs13046-018-0987-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Isoalantolactone induces apoptosis through ROS-mediated ER stress and inhibition of STAT3 in prostate cancer cells</span></div><div class="casAuthors">Chen, Wei; Li, Ping; Liu, Yi; Yang, Yu; Ye, Xueting; Zhang, Fangyi; Huang, Hang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">309</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Prostate cancer is one of the most commonly diagnosed cancers in men worldwide.  Currently available therapies for metastatic prostate cancer are only marginally effective.  Therefore, new therapeutic agents are urgently needed to improve patient outcome.  Isoalantolactone (IATL), an active sesquiterpene naturally present in many vegetables and medicinal plants, is known to induce cell death and apoptosis in various cancer cell lines.  Nevertheless, antitumor mechanisms initiated by IATL in cancer cells have not been fully defined.  Cell apoptosis and cellular ROS levels were analyzed by flow cytometry.  Western blot and qRT-PCR were used to analyze the protein and mRNA levels of indicated mols., resp.  Nude mice xenograft model was used to test the effects of IATL on prostate cancer cell growth in vivo.  In this study, we found that IATL dose-dependently inhibited cancer cell growth and induced apoptosis in PC-3 and DU145 cells.  Mechanistically, our data found that IATL induced reactive oxygen species (ROS) prodn., resulting in the activation of endoplasmic reticulum stress pathway and eventually cell apoptosis in prostate cancer cells.  IATL also decreased the protein expression levels of p-STAT3 and STAT3, and the effects of IATL were reversed by pretreatment with N-acetyl-L-cysteine (NAC).  In vivo, we found that IATL inhibited the growth of prostate cancer xenografts without exhibiting toxicity.  Treatment of mice bearing human prostate cancer xenografts with IATL was also assocd. with induction of ER stress and inhibtion of STAT3.  In summary, our results unveil a previously unrecognized mechanism underlying the biol. activity of IATL, and provide a novel anti-cancer candidate for the treatment of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8v5bRq7s8Y7Vg90H21EOLACvtfcHk0lheMhL-GU9pqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFaisL7N&md5=44235d11eeac774f52ea531a3b3fbc86</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1186%2Fs13046-018-0987-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-018-0987-9%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DH.%26atitle%3DIsoalantolactone%2520induces%2520apoptosis%2520through%2520ROS-mediated%2520ER%2520stress%2520and%2520inhibition%2520of%2520STAT3%2520in%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2018%26volume%3D37%26spage%3D309%26doi%3D10.1186%2Fs13046-018-0987-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">Isoalantolactone inhibits IKKbeta kinase activity to interrupt the NF-kappaB/COX-2-mediated signaling cascade and induces apoptosis regulated by the mitochondrial translocation of cofilin in glioblastoma</span>. <i>Cancer Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1655</span>– <span class="NLM_lpage">1670</span>, <span class="refDoi"> DOI: 10.1002/cam4.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1002%2Fcam4.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30740911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1MXoslSlsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=1655-1670&author=J.+S.+Xingauthor=X.+Wangauthor=Y.+L.+Lanauthor=J.+C.+Louauthor=B.+Maauthor=T.+Zhuauthor=H.+Zhangauthor=D.+Wangauthor=Z.+Yuauthor=Z.+Yuanauthor=X.+Y.+Liauthor=B.+Zhang&title=Isoalantolactone+inhibits+IKKbeta+kinase+activity+to+interrupt+the+NF-kappaB%2FCOX-2-mediated+signaling+cascade+and+induces+apoptosis+regulated+by+the+mitochondrial+translocation+of+cofilin+in+glioblastoma&doi=10.1002%2Fcam4.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Isoalantolactone inhibits IKKβ kinase activity to interrupt the NF-κB/COX-2-mediated signaling cascade and induces apoptosis regulated by the mitochondrial translocation of cofilin in glioblastoma</span></div><div class="casAuthors">Xing, Jin-Shan; Wang, Xun; Lan, Yu-Long; Lou, Jia-Cheng; Ma, Binbin; Zhu, Tingzhun; Zhang, Hongqiang; Wang, Dongsheng; Yu, Zhikuan; Yuan, Zhongbo; Li, Xin-Yu; Zhang, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1655-1670</span>CODEN:
                <span class="NLM_cas:coden">CMAEDL</span>;
        ISSN:<span class="NLM_cas:issn">2045-7634</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Isoalantolactone (IATL), a sesquiterpene lactone compd., possesses many pharmacol. and biol. activities, but its role in glioblastoma (GBM) treatment is still unknown.  The aim of the current study was to investigate the antiglioma effects of IATL and to explore the underlying mol. mechanisms.  In the current study, the biol. functions of IATL were examd. by MTT, cell migration, colony formation, and cell apoptosis assays.  Confocal immunofluorescence techniques, chromatin immunopptn., and pull-down assays were used to explore the precise underlying mol. mechanisms.  To examine IATL activity and the mol. mechanisms by which it inhibits glioma growth in vivo, we used a xenograft tumor mouse model.  Furthermore, Western blotting was used to confirm the changes in protein expression after IATL treatment.  According to the results, IATL inhibited IKKβ phosphorylation, thus inhibiting both the binding of NF-κB to the cyclooxygenase 2 (COX-2) promoter and the recruitment of p300 and eventually inhibiting COX-2 expression.  In addn., IATL induced glioma cell apoptosis by promoting the conversion of F-actin to G-actin, which in turn activates the cytochrome c (Cyt c) and caspase-dependent apoptotic pathways.  In the animal expts., IATL reduced the size and wt. of glioma tumors in xenograft mice and inhibited the expression of COX-2 and phosphorylated NF-κB p65 in the transplanted tumors.  In conclusion, the current study indicated that IATL inhibited the expression of COX-2 through the NF-κB signaling pathway and induced the apoptosis of glioma cells by increasing actin transformation.  These results suggested that IATL could be greatly effective in GBM treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAiYzJ7DY2ubVg90H21EOLACvtfcHk0lheMhL-GU9pqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXoslSlsLk%253D&md5=73fa8ebb6c40236a834b937057c9b4af</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fcam4.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcam4.2013%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DJ.%2BS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLan%26aufirst%3DY.%2BL.%26aulast%3DLou%26aufirst%3DJ.%2BC.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DYuan%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DIsoalantolactone%2520inhibits%2520IKKbeta%2520kinase%2520activity%2520to%2520interrupt%2520the%2520NF-kappaB%252FCOX-2-mediated%2520signaling%2520cascade%2520and%2520induces%2520apoptosis%2520regulated%2520by%2520the%2520mitochondrial%2520translocation%2520of%2520cofilin%2520in%2520glioblastoma%26jtitle%3DCancer%2520Med.%26date%3D2019%26volume%3D8%26spage%3D1655%26epage%3D1670%26doi%3D10.1002%2Fcam4.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, X.</span></span> <span> </span><span class="NLM_article-title">Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2350</span>– <span class="NLM_lpage">2394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=29312794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSqsLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=2350-2394&author=F.+Liauthor=T.+Jiangauthor=Q.+Liauthor=X.+Ling&title=Camptothecin+%28CPT%29+and+its+derivatives+are+known+to+target+topoisomerase+I+%28Top1%29+as+their+mechanism+of+action%3A+did+we+miss+something+in+CPT+analogue+molecular+targets+for+treating+human+disease+such+as+cancer%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?</span></div><div class="casAuthors">Li, Fengzhi; Jiang, Tao; Li, Qingyong; Ling, Xiang</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2350-2394</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Camptothecin (CPT) was discovered from plant exts. more than 60 years ago.  Since then, only two CPT analogs (irinotecan and topotecan) have been approved for cancer treatment, although several thousand CPT derivs. have been synthesized and many of them were actively studied in our research community over the past 6+ decades.  In this review article, we briefly summarize: (1) the discovery and early development of CPTs, (2) the recognized CPT mechanism of action (MOA), (3) the synthesis of CPT and CPT analogs, and (4) the structureactivity relationship (SAR) of CPT and its analogs.  Next, we provide evidence that certain CPT analogs can exert improved efficacy with low toxicity independently of topoisomerase I (Top1) inhibition; instead, these CPT analogs use novel MOAs by targeting important cancer survival-assocd. oncogenic proteins and/or by bypassing various treatment-resistant mechanisms.  We then present a comprehensive review of the most advanced CPT analogs in clin. development, with the goal of resolving why no new CPTs have been FDA approved for cancer treatment, beyond irinotecan and topotecan.  We argue that new CPT Top1 inhibitor drugs are unlikely being found to be significantly better than irinotecan and/or topotecan in terms of the overall antitumor activity and toxicity.  The significance of CPT analogs that possess novel MOAs has not been sufficiently recognized so far.  In our opinion, this is a research area with great potential to make a breakthrough for development of the next generation of CPT analogs that possess high efficacy (due to novel targets) and low toxicity (due to low inhibition of Top1 activity/function) for effective treatment of human disease, including cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVoqOo5tdSCLVg90H21EOLACvtfcHk0ljnDDWNlT1p5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSqsLvE&md5=a5bf7cd36b32b3aa71155909205bfeae</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLing%26aufirst%3DX.%26atitle%3DCamptothecin%2520%2528CPT%2529%2520and%2520its%2520derivatives%2520are%2520known%2520to%2520target%2520topoisomerase%2520I%2520%2528Top1%2529%2520as%2520their%2520mechanism%2520of%2520action%253A%2520did%2520we%2520miss%2520something%2520in%2520CPT%2520analogue%2520molecular%2520targets%2520for%2520treating%2520human%2520disease%2520such%2520as%2520cancer%253F%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2017%26volume%3D7%26spage%3D2350%26epage%3D2394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, K. L.</span>; <span class="NLM_string-name">Wells, C. I.</span>; <span class="NLM_string-name">Moore, J. T.</span></span> <span> </span><span class="NLM_article-title">Identification of Kinase Inhibitors that Regulate Nuclear Receptor Nurr1 (NR4A2) Cellular Activity</span>. <span class="NLM_year">2019</span>, bioRxiv:420976. biorxiv.org e-Print archive. <a href="https://doi.org/420910.421101/420976" class="extLink">https://doi.org/420910.421101/420976</a> (accessed Nov 4, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=K.+L.+Williams&author=C.+I.+Wells&author=J.+T.+Moore&title=Identification+of+Kinase+Inhibitors+that+Regulate+Nuclear+Receptor+Nurr1+%28NR4A2%29+Cellular+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DK.%2BL.%26atitle%3DIdentification%2520of%2520Kinase%2520Inhibitors%2520that%2520Regulate%2520Nuclear%2520Receptor%2520Nurr1%2520%2528NR4A2%2529%2520Cellular%2520Activity%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariga, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisowath, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wernsdorfer, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkman, A.</span></span> <span> </span><span class="NLM_article-title">Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">4089</span>– <span class="NLM_lpage">4096</span>, <span class="refDoi"> DOI: 10.1128/aac.48.11.4089-4096.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1128%2FAAC.48.11.4089-4096.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=15504826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvVyksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=4089-4096&author=S.+T.+Marigaauthor=J.+P.+Gilauthor=C.+Sisowathauthor=W.+H.+Wernsdorferauthor=A.+Bj%C3%B6rkman&title=Synergism+between+amodiaquine+and+its+major+metabolite%2C+desethylamodiaquine%2C+against+Plasmodium+falciparum+in+vitro&doi=10.1128%2Faac.48.11.4089-4096.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro</span></div><div class="casAuthors">Mariga, S. T.; Gil, J. P.; Sisowath, C.; Wernsdorfer, W. H.; Bjoerkman, A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4089-4096</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The in vitro activity of the prodrug amodiaquine and its metabolite monodesethyl-amodiaquine was studied for 3 strains of P. falciparum: LS-2, LS-3, and LS-1.  Both compds. showed significant activity against all 3 strains; the activity of amodiaquine was slightly higher than that of the metabolite.  By use of a checkerboard design, interaction studies with both compds. yielded evidence of significant synergism; means of the sums of the fractional inhibitory concns. were 0.0392-0.0746 for strain LS-2, 0.1567-0.3102 for strain LS-3, and 0.025-0.3369 for strain LS-1.  In further investigations, the interaction of amodiaquine with monodesethyl-amodiaquine was tested at clin. relevant concns. of both compds.  In these studies, involving amodiaquine at picomolar and femtomolar concns., the compd. was found to exert high potentiating activity on monodesethyl-amodiaquine.  This interaction produced mean ratios of obsd. to expected activity of 0.0505-0.0642 for strain LS-2, 0.0882-0.3820 for strain LS-3, and 0.0752-0.2924 for strain LS-1.  The synergistic activity was most marked at monodesethyl-amodiaquine/amodiaquine ratios up to 100,000:1 but was still evident at higher ratios.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdbsJY5gLhxrVg90H21EOLACvtfcHk0ljnDDWNlT1p5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvVyksr0%253D&md5=73b82cbfc2375528e6641ad60452a2e1</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.11.4089-4096.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.11.4089-4096.2004%26sid%3Dliteratum%253Aachs%26aulast%3DMariga%26aufirst%3DS.%2BT.%26aulast%3DGil%26aufirst%3DJ.%2BP.%26aulast%3DSisowath%26aufirst%3DC.%26aulast%3DWernsdorfer%26aufirst%3DW.%2BH.%26aulast%3DBj%25C3%25B6rkman%26aufirst%3DA.%26atitle%3DSynergism%2520between%2520amodiaquine%2520and%2520its%2520major%2520metabolite%252C%2520desethylamodiaquine%252C%2520against%2520Plasmodium%2520falciparum%2520in%2520vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D4089%26epage%3D4096%26doi%3D10.1128%2Faac.48.11.4089-4096.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wake, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishibori, M.</span></span> <span> </span><span class="NLM_article-title">Effect of amodiaquine, a histamine N-methyltransferase inhibitor, on, Propionibacterium acnes and lipopolysaccharide-induced hepatitis in mice</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>558</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2006.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.ejphar.2006.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=17222819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVGgurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=558&publication_year=2007&pages=179-184&author=A.+Yokoyamaauthor=S.+Moriauthor=H.+K.+Takahashiauthor=T.+Kankeauthor=H.+Wakeauthor=M.+Nishibori&title=Effect+of+amodiaquine%2C+a+histamine+N-methyltransferase+inhibitor%2C+on%2C+Propionibacterium+acnes+and+lipopolysaccharide-induced+hepatitis+in+mice&doi=10.1016%2Fj.ejphar.2006.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of amodiaquine, a histamine N-methyltransferase inhibitor, on, Propionibacterium acnes and lipopolysaccharide-induced hepatitis in mice</span></div><div class="casAuthors">Yokoyama, Akira; Mori, Shuji; Takahashi, Hideo K.; Kanke, Toru; Wake, Hidenori; Nishibori, Masahiro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">558</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">179-184</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We examd. whether treatment with amodiaquine, a potent inhibitor of histamine N-methyltransferase protects mice from Propionibacterium acnes (P. acnes)-primed and lipopolysaccharide (LPS)-induced hepatitis.  The s.c. injection of amodiaquine (2 and 5 mg/kg) significantly increased the histamine levels in the liver in comparison to saline treated mice.  Pretreatment with amodiaquine also improved the survival rate of the hepatitis mice, and this improvement was partially assocd. with the decrease in serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT).  Amodiaquine partially suppressed increases of tumor necrosis factor (TNF)-α in the serum and TNF-α mRNA expression in the liver, whereas the expression of interleukin (IL)-18, interferon (IFN)-γ and IL-12 in the liver was not changed by amodiaquine treatment.  In conclusion, the present findings suggested that the elevation of endogenous histamine by amodiaquine may thus play a protective role through the regulation of TNF-α prodn. in endotoxin-induced hepatic injury mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiB6-8szeQNbVg90H21EOLACvtfcHk0ljPSUwB5-Wa9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVGgurg%253D&md5=deb6892ff2c28deecc7466aec71273f3</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DA.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DH.%2BK.%26aulast%3DKanke%26aufirst%3DT.%26aulast%3DWake%26aufirst%3DH.%26aulast%3DNishibori%26aufirst%3DM.%26atitle%3DEffect%2520of%2520amodiaquine%252C%2520a%2520histamine%2520N-methyltransferase%2520inhibitor%252C%2520on%252C%2520Propionibacterium%2520acnes%2520and%2520lipopolysaccharide-induced%2520hepatitis%2520in%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D558%26spage%3D179%26epage%3D184%26doi%3D10.1016%2Fj.ejphar.2006.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wennerholm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordmark, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PihlsgÅrd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahindi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertilsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, L. L.</span></span> <span> </span><span class="NLM_article-title">Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D6) and losartan (CYP2C9) in vivo</span>. <i>Eur. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">546</span>, <span class="refDoi"> DOI: 10.1007/s00228-006-0121-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1007%2Fs00228-006-0121-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=16783563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFOntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=539-546&author=A.+Wennerholmauthor=A.+Nordmarkauthor=M.+Pihlsg%C3%85rdauthor=M.+Mahindiauthor=L.+Bertilssonauthor=L.+L.+Gustafsson&title=Amodiaquine%2C+its+desethylated+metabolite%2C+or+both%2C+inhibit+the+metabolism+of+debrisoquine+%28CYP2D6%29+and+losartan+%28CYP2C9%29+in+vivo&doi=10.1007%2Fs00228-006-0121-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D6) and losartan (CYP2C9) in vivo</span></div><div class="casAuthors">Wennerholm, Agneta; Nordmark, Anna; Pihlsgard, Maria; Mahindi, Margarita; Bertilsson, Leif; Gustafsson, Lars L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">539-546</span>CODEN:
                <span class="NLM_cas:coden">EJCPAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-6970</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Objective: To study the extent of in vivo inhibition by the antimalarial drug amodiaquine, its active metabolite N-desethylamodiaquine, or both, of the metab. of four probe drugs of the enzymes CYP2D6, CYP2C19, CYP2C9 and CYP1A2.  Methods: Twelve healthy Swedish volunteers received a cocktail of four probe drugs (debrisoquine, omeprazole, losartan and caffeine) to det. their baseline metabolic capacities.  After a washout period, they received a 600 mg oral dose of amodiaquine hydrochloride; and 2-3 h later the cocktail was administered again.  One week after the intake of amodiaquine, the subjects received the cocktail a third time.  The levels of probe drugs and their metabolites as well as amodiaquine and its metabolite were detd. by HPLC.  Results: Plasma levels of amodiaquine and N-desethylamodiaquine could be followed in all subjects for 6 h and 28 days, resp.  Among the 12 subjects, a 3-fold variation in amodiaquine AUC and a 2-fold variation in N-desethylamodiaquine AUC, were obsd.  The CYP2D6 and CYP2C9 activities of the subjects were measured by debrisoquine and losartan phenotyping tests, resp.  There were significant mean increases in debrisoquine metabolic ratio (MR) between baseline and the second cocktail [MR2 h-MRbaseline 1.426 (95% confidence interval 1.159, 1.755), P=0.002; ANOVA, Fisher LSD test] and in mean losartan MR between baseline and the second cocktail [MR2 h-MRbaseline 1.724 (95% confidence interval 1.076, 2.762), P=0.026; ANOVA, Fisher LSD test].  The effects on CYP2D6 and CYP2C9 activities subsided within a week after intake of amodiaquine as tested by the phenotyping cocktail.  The changes in omeprazole MRs and caffeine MRs were not statistically significant between any of the study phases.  Conclusion: A single dose of amodiaquine decreased CYP2D6 and CYP2C9 activities significantly compared to baseline values.  Amodiaquine has the potential to cause drug-drug interactions and should be further investigated in malarial patients treated with drug combinations contg. amodiaquine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFobVb5Wd1w7Vg90H21EOLACvtfcHk0ljPSUwB5-Wa9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFOntbo%253D&md5=5c78316061af34c1e5774baf59bbfc49</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1007%2Fs00228-006-0121-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00228-006-0121-3%26sid%3Dliteratum%253Aachs%26aulast%3DWennerholm%26aufirst%3DA.%26aulast%3DNordmark%26aufirst%3DA.%26aulast%3DPihlsg%25C3%2585rd%26aufirst%3DM.%26aulast%3DMahindi%26aufirst%3DM.%26aulast%3DBertilsson%26aufirst%3DL.%26aulast%3DGustafsson%26aufirst%3DL.%2BL.%26atitle%3DAmodiaquine%252C%2520its%2520desethylated%2520metabolite%252C%2520or%2520both%252C%2520inhibit%2520the%2520metabolism%2520of%2520debrisoquine%2520%2528CYP2D6%2529%2520and%2520losartan%2520%2528CYP2C9%2529%2520in%2520vivo%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D62%26spage%3D539%26epage%3D546%26doi%3D10.1007%2Fs00228-006-0121-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, M. L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsin, L.-Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labarge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidehi, N.</span></span> <span> </span><span class="NLM_article-title">Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e31004</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0031004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1371%2Fjournal.pone.0031004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=22319600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis12hu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=J.+Kimauthor=M.+L.+R.+Yipauthor=X.+Shenauthor=H.+Liauthor=L.-Y.+C.+Hsinauthor=S.+Labargeauthor=E.+L.+Heinrichauthor=W.+Leeauthor=J.+Luauthor=N.+Vaidehi&title=Identification+of+anti-malarial+compounds+as+novel+antagonists+to+chemokine+receptor+CXCR4+in+pancreatic+cancer+cells&doi=10.1371%2Fjournal.pone.0031004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic Cancer cells</span></div><div class="casAuthors">Kim, Joseph; Yip, M. L. Richard; Shen, Xiaoming; Li, Hubert; Hsin, Li-Yu Charlie; Labarge, Samuel; Heinrich, Eileen L.; Lee, Wendy; Lu, Jianming; Vaidehi, Nagarajan</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e31004</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Despite recent advances in targeted therapies, patients with pancreatic adenocarcinoma continue to have poor survival highlighting the urgency to identify novel therapeutic targets.  Our previous investigations have implicated chemokine receptor CXCR4 and its selective ligand CXCL12 in the pathogenesis and progression of pancreatic intraepithelial neoplasia and invasive pancreatic cancer; hence, CXCR4 is a promising target for suppression of pancreatic cancer growth.  Here, we combined in silico structural modeling of CXCR4 to screen for candidate anti-CXCR4 compds. with in vitro cell line assays and identified NSC56612 from the National Cancer Institute's (NCI) Open Chem. Repository Collection as an inhibitor of activated CXCR4.  Next, we identified that NSC56612 is structurally similar to the established anti-malarial drugs chloroquine and hydroxychloroquine.  We evaluated these compds. in pancreatic cancer cells in vitro and obsd. specific antagonism of CXCR4-mediated signaling and cell proliferation.  Recent in vivo therapeutic applications of chloroquine in pancreatic cancer mouse models have demonstrated decreased tumor growth and improved survival.  Our results thus provide a mol. target and basis for further evaluation of chloroquine and hydroxychloroquine in pancreatic cancer.  Historically safe in humans, chloroquine and hydroxychloroquine appear to be promising agents to safely and effectively target CXCR4 in patients with pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgw2ZeidIq57Vg90H21EOLACvtfcHk0ljjPPqp-UBTyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis12hu7c%253D&md5=08e47b35a2dc954f422894ab25d7ebd2</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0031004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0031004%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DYip%26aufirst%3DM.%2BL.%2BR.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DHsin%26aufirst%3DL.-Y.%2BC.%26aulast%3DLabarge%26aufirst%3DS.%26aulast%3DHeinrich%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DVaidehi%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520anti-malarial%2520compounds%2520as%2520novel%2520antagonists%2520to%2520chemokine%2520receptor%2520CXCR4%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0031004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, B.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo antitumor effects of chloroquine on oral squamous cell carcinoma</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5779</span>– <span class="NLM_lpage">5786</span>, <span class="refDoi"> DOI: 10.3892/mmr.2017.7342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.3892%2Fmmr.2017.7342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=28849182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsFWhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=5779-5786&author=L.+Jiaauthor=J.+Wangauthor=T.+Wuauthor=J.+Wuauthor=J.+Lingauthor=B.+Cheng&title=In+vitro+and+in+vivo+antitumor+effects+of+chloroquine+on+oral+squamous+cell+carcinoma&doi=10.3892%2Fmmr.2017.7342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo antitumor effects of chloroquine on oral squamous cell carcinoma</span></div><div class="casAuthors">Jia, Lihua; Wang, Juan; Wu, Tong; Wu, Jinan; Ling, Junqi; Cheng, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">5779-5786</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-3004</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Chloroquine, which is a widely used antimalarial drug, has been reported to exert anticancer activity in some tumor types; however, its potential effects on oral squamous cell carcinoma (OSCC) remain unclear.  The present study aimed to explore the effects and possible underlying mechanisms of chloroquine against OSCC.  MTT and clonogenic assays were conducted to evaluate the effects of chloroquine on the human OSCC cell lines SCC25 and CAL27.  Cell cycle progression and apoptosis were detected using flow cytometry.  Autophagy was monitored using microtubule-assocd. protein 1A/1B-light chain 3 as an autophagosomal marker.  In order to det. the in vivo antitumor effects of chloroquine on OSCC, a CAL27 xenograft model was used.  The results demonstrated that chloroquine markedly inhibited the proliferation and the colony-forming ability of both OSCC cell lines in a dose- and time-dependent manner in vitro.  Chloroquine also disrupted the cell cycle, resulting in the cell cycle arrest of CAL27 and SCC25 cells at G0/G1 phase, via downregulation of cyclin D1.  In addn., chloroquine inhibited autophagy, and induced autophagosome and autolysosome accumulation in the cytoplasm, thus interfering with degrdn.; however, OSCC apoptosis was barely affected by chloroquine.  The results of the in vivo study demonstrated that chloroquine effectively inhibited OSCC tumor growth in the CAL27 xenograft model.  In conclusion, the present study reported the in vitro and in vivo antitumor effects of chloroquine on OSCC, and the results indicated that chloroquine may be considered a potent therapeutic agent against human OSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoerV3Ctk4tBrVg90H21EOLACvtfcHk0ljjPPqp-UBTyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsFWhsL0%253D&md5=7eda8b6db5124f7e44b4b662b0b84cd5</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2017.7342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2017.7342%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DB.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antitumor%2520effects%2520of%2520chloroquine%2520on%2520oral%2520squamous%2520cell%2520carcinoma%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2017%26volume%3D16%26spage%3D5779%26epage%3D5786%26doi%3D10.3892%2Fmmr.2017.7342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mauthe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orhon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luhr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hijlkema, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppes, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engedal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiori, F.</span></span> <span> </span><span class="NLM_article-title">Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1435</span>– <span class="NLM_lpage">1455</span>, <span class="refDoi"> DOI: 10.1080/15548627.2018.1474314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1080%2F15548627.2018.1474314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=29940786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVSnu73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=1435-1455&author=M.+Mautheauthor=I.+Orhonauthor=C.+Rocchiauthor=X.+Zhouauthor=M.+Luhrauthor=K.-J.+Hijlkemaauthor=R.+P.+Coppesauthor=N.+Engedalauthor=M.+Mariauthor=F.+Reggiori&title=Chloroquine+inhibits+autophagic+flux+by+decreasing+autophagosome-lysosome+fusion&doi=10.1080%2F15548627.2018.1474314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion</span></div><div class="casAuthors">Mauthe, Mario; Orhon, Idil; Rocchi, Cecilia; Zhou, Xingdong; Luhr, Morten; Hijlkema, Kerst-Jan; Coppes, Robert P.; Engedal, Nikolai; Mari, Muriel; Reggiori, Fulvio</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1435-1455</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8635</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Macroautophagy/autophagy is a conserved transport pathway where targeted structures are sequestered by phagophores, which mature into autophagosomes, and then delivered into lysosomes for degrdn.  Autophagy is involved in the pathophysiol. of numerous diseases and its modulation is beneficial for the outcome of numerous specific diseases.  Several lysosomal inhibitors such as bafilomycin A1 (BafA1), protease inhibitors and chloroquine (CQ), have been used interchangeably to block autophagy in in vitro expts. assuming that they all primarily block lysosomal degrdn.  Among them, only CQ and its derivate hydroxychloroquine (HCQ) are FDA-approved drugs and are thus currently the principal compds. used in clin. trials aimed to treat tumors through autophagy inhibition.  However, the precise mechanism of how CQ blocks autophagy remains to be firmly demonstrated.  In this study, we focus on how CQ inhibits autophagy and directly compare its effects to those of BafA1.  We show that CQ mainly inhibits autophagy by impairing autophagosome fusion with lysosomes rather than by affecting the acidity and/or degradative activity of this organelle.  Furthermore, CQ induces an autophagy-independent severe disorganization of the Golgi and endo-lysosomal systems, which might contribute to the fusion impairment.  Strikingly, HCQ-treated mice also show a Golgi disorganization in kidney and intestinal tissues.  Altogether, our data reveal that CQ and HCQ are not bona fide surrogates for other types of late stage lysosomal inhibitors for in vivo expts.  Moreover, the multiple cellular alterations caused by CQ and HCQ call for caution when interpreting results obtained by blocking autophagy with this drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo02-sVNfO1D7Vg90H21EOLACvtfcHk0lgDcIJUCBJASA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVSnu73F&md5=d43f1329f9cf0f15bb9aaea593a4d408</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1080%2F15548627.2018.1474314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15548627.2018.1474314%26sid%3Dliteratum%253Aachs%26aulast%3DMauthe%26aufirst%3DM.%26aulast%3DOrhon%26aufirst%3DI.%26aulast%3DRocchi%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DLuhr%26aufirst%3DM.%26aulast%3DHijlkema%26aufirst%3DK.-J.%26aulast%3DCoppes%26aufirst%3DR.%2BP.%26aulast%3DEngedal%26aufirst%3DN.%26aulast%3DMari%26aufirst%3DM.%26aulast%3DReggiori%26aufirst%3DF.%26atitle%3DChloroquine%2520inhibits%2520autophagic%2520flux%2520by%2520decreasing%2520autophagosome-lysosome%2520fusion%26jtitle%3DAutophagy%26date%3D2018%26volume%3D14%26spage%3D1435%26epage%3D1455%26doi%3D10.1080%2F15548627.2018.1474314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-S.</span></span> <span> </span><span class="NLM_article-title">4-amino-7-chloroquinoline derivatives for treating Parkinson’s disease: implications for drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1517/17460441.2016.1154529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1517%2F17460441.2016.1154529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=26924734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlGqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=337-341&author=C.-H.+Kimauthor=P.+Leblancauthor=K.-S.+Kim&title=4-amino-7-chloroquinoline+derivatives+for+treating+Parkinson%E2%80%99s+disease%3A+implications+for+drug+discovery&doi=10.1517%2F17460441.2016.1154529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">4-amino-7-chloroquinoline derivatives for treating Parkinson's disease: implications for drug discovery</span></div><div class="casAuthors">Kim, Chun-Hyung; Leblanc, Pierre; Kim, Kwang-Soo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-341</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">It is possible to identify small mols. that can activate NR4A2 function by direct interaction with its LBD and that the structure of 4-amino-7-chloroquinoline is a crit. SAR for the activation of Nurr1 and provides the framework for further optimization of NR4A2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3FsQ0xFKekbVg90H21EOLACvtfcHk0lgDcIJUCBJASA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlGqsLc%253D&md5=c915dff60d7f747ab61deca7c3eac0b4</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1517%2F17460441.2016.1154529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2016.1154529%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DC.-H.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DK.-S.%26atitle%3D4-amino-7-chloroquinoline%2520derivatives%2520for%2520treating%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2016%26volume%3D11%26spage%3D337%26epage%3D341%26doi%3D10.1517%2F17460441.2016.1154529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willems, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">The orphan nuclear receptor Nurr1 is responsive to non-steroidal anti-inflammatory drugs</span>. <i>Commun. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">85</span>, <span class="refDoi"> DOI: 10.1038/s42004-020-0331-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fs42004-020-0331-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVKksrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&pages=85&author=S.+Willemsauthor=K.+Whitneyauthor=X.+Niauthor=A.+Chaikuadauthor=S.+Knappauthor=J.+Heeringauthor=D.+Merk&title=The+orphan+nuclear+receptor+Nurr1+is+responsive+to+non-steroidal+anti-inflammatory+drugs&doi=10.1038%2Fs42004-020-0331-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan nuclear receptor Nurr1 is responsive to non-steroidal anti-inflammatory drugs</span></div><div class="casAuthors">Willems, Sabine; Kilu, Whitney; Ni, Xiaomin; Chaikuad, Apirat; Knapp, Stefan; Heering, Jan; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Communications Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85</span>CODEN:
                <span class="NLM_cas:coden">CCOHCT</span>;
        ISSN:<span class="NLM_cas:issn">2399-3669</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Nuclear receptor related 1 (Nurr1) is an orphan ligand-activated transcription factor and considered as neuroprotective transcriptional regulator with great potential as therapeutic target for neurodegenerative diseases.  However, the collection of available Nurr1 modulators and mechanistic understanding of Nurr1 are limited.  Here, we report the discovery of several structurally diverse non-steroidal anti-inflammatory drugs as inverse Nurr1 agonists demonstrating that Nurr1 activity can be regulated bidirectionally.  As chem. tools, these ligands enable unraveling the co-regulatory network of Nurr1 and the mode of action distinguishing agonists from inverse agonists.  In addn. to its ability to dimerize, we observe an ability of Nurr1 to recruit several canonical nuclear receptor co-regulators in a ligand-dependent fashion.  Distinct dimerization states and co-regulator interaction patterns arise as discriminating factors of Nurr1 agonists and inverse agonists.  Our results contribute a valuable collection of Nurr1 modulators and relevant mechanistic insights for future Nurr1 target validation and drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4xAONvjGyx7Vg90H21EOLACvtfcHk0lgDcIJUCBJASA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVKksrvE&md5=780001615544ae3f93a28007f8f492be</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fs42004-020-0331-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs42004-020-0331-0%26sid%3Dliteratum%253Aachs%26aulast%3DWillems%26aufirst%3DS.%26aulast%3DWhitney%26aufirst%3DK.%26aulast%3DNi%26aufirst%3DX.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DHeering%26aufirst%3DJ.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DThe%2520orphan%2520nuclear%2520receptor%2520Nurr1%2520is%2520responsive%2520to%2520non-steroidal%2520anti-inflammatory%2520drugs%26jtitle%3DCommun.%2520Chem.%26date%3D2020%26volume%3D3%26spage%3D85%26doi%3D10.1038%2Fs42004-020-0331-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shifera, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardin, J. A.</span></span> <span> </span><span class="NLM_article-title">Factors modulating expression of Renilla luciferase from control plasmids used in luciferase reporter gene assays</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>396</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2009.09.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.ab.2009.09.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=19788887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFShtbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2010&pages=167-172&author=A.+S.+Shiferaauthor=J.+A.+Hardin&title=Factors+modulating+expression+of+Renilla+luciferase+from+control+plasmids+used+in+luciferase+reporter+gene+assays&doi=10.1016%2Fj.ab.2009.09.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Factors modulating expression of Renilla luciferase from control plasmids used in luciferase reporter gene assays</span></div><div class="casAuthors">Shifera, Amde Selassie; Hardin, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-172</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Topics include: Renilla luciferase-expressing plasmids; promoter structure of Renilla luciferase in pRL-TK plasmid; factors that suppress the expression of transfected Renilla luciferase; factors that induce the expression of transfected Renilla luciferase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9MjTFtSAdZ7Vg90H21EOLACvtfcHk0linBPefSNA8Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFShtbzL&md5=09343dba2ad525eef6f93556b478e061</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2009.09.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2009.09.043%26sid%3Dliteratum%253Aachs%26aulast%3DShifera%26aufirst%3DA.%2BS.%26aulast%3DHardin%26aufirst%3DJ.%2BA.%26atitle%3DFactors%2520modulating%2520expression%2520of%2520Renilla%2520luciferase%2520from%2520control%2520plasmids%2520used%2520in%2520luciferase%2520reporter%2520gene%2520assays%26jtitle%3DAnal.%2520Biochem.%26date%3D2010%26volume%3D396%26spage%3D167%26epage%3D172%26doi%3D10.1016%2Fj.ab.2009.09.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atlasi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heaney, A. P.</span></span> <span> </span><span class="NLM_article-title">False responses of Renilla luciferase reporter control to nuclear receptor TR4</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>430</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1007/s11010-017-2961-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1007%2Fs11010-017-2961-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=28210900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFWitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2017&pages=139-147&author=D.+Zhangauthor=S.+S.+Atlasiauthor=K.+K.+Patelauthor=Z.+Zhuangauthor=A.+P.+Heaney&title=False+responses+of+Renilla+luciferase+reporter+control+to+nuclear+receptor+TR4&doi=10.1007%2Fs11010-017-2961-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">False responses of Renilla luciferase reporter control to nuclear receptor TR4</span></div><div class="casAuthors">Zhang, Dongyun; Atlasi, Sam S.; Patel, Krishna K.; Zhuang, Zihao; Heaney, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Renilla luciferase reporter is a widely used internal control in dual luciferase reporter assay system, where its transcription is driven by a constitutively active promoter.  However, the authenticity of the Renilla luciferase response in some exptl. settings has recently been questioned.  Testicular receptor 4 (TR4, also known as NR2C2) belongs to the subfamily 2 of nuclear receptors.  TR4 binds to a direct repeat regulatory element in the promoter of a variety of target genes and plays a key role in tumorigenesis, lipoprotein regulation, and central nervous system development.  In our exptl. system using murine pituitary corticotroph tumor AtT20 cells to investigate TR4 actions on POMC transcription, we found that overexpression of TR4 resulted in reduced Renilla luciferase expression whereas knockdown TR4 increased Renilla luciferase expression.  The TR4 inhibitory effect was mediated by the TR4 DNA-binding domain and behaved similarly to the GR and its agonist, Dexamethasone.  We further demonstrated that the chimeric intron, commonly present in various Renilla plasmid backbones such as pRL-Null, pRL-SV40, and pRL-TK, was responsible for TR4's inhibitory effect.  The results suggest that an intron-free Renilla luciferase reporter may provide a satisfactory internal control for TR4 at certain dose range.  Our findings advocate caution on the use of Renilla luciferase as an internal control in TR4-directed studies to avoid misleading data interpretation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSXvGIqbF5K7Vg90H21EOLACvtfcHk0linBPefSNA8Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFWitro%253D&md5=c3b156ec769c9e1c8e30357dfe0c0921</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1007%2Fs11010-017-2961-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-017-2961-9%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DAtlasi%26aufirst%3DS.%2BS.%26aulast%3DPatel%26aufirst%3DK.%2BK.%26aulast%3DZhuang%26aufirst%3DZ.%26aulast%3DHeaney%26aufirst%3DA.%2BP.%26atitle%3DFalse%2520responses%2520of%2520Renilla%2520luciferase%2520reporter%2520control%2520to%2520nuclear%2520receptor%2520TR4%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2017%26volume%3D430%26spage%3D139%26epage%3D147%26doi%3D10.1007%2Fs11010-017-2961-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinovic, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fröhlich, O.</span></span> <span> </span><span class="NLM_article-title">Pitfall of an internal control plasmid: response of Renilla luciferase (pRL-TK) plasmid to dihydrotestosterone and dexamethasone</span>. <i>Biotechniques</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">782</span>– <span class="NLM_lpage">784</span>, <span class="refDoi"> DOI: 10.2144/00294st04</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.2144%2F00294st04" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=11056808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVymtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=782-784&author=N.+M.+Ibrahimauthor=A.+C.+Marinovicauthor=S.+R.+Priceauthor=L.+G.+Youngauthor=O.+Fr%C3%B6hlich&title=Pitfall+of+an+internal+control+plasmid%3A+response+of+Renilla+luciferase+%28pRL-TK%29+plasmid+to+dihydrotestosterone+and+dexamethasone&doi=10.2144%2F00294st04"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Pitfall of an internal control plasmid: response of Renilla luciferase (pRL-TK) plasmid to dihydrotestosterone and dexamethasone</span></div><div class="casAuthors">Ibrahim, N. M.; Marinovic, A. C.; Price, S. R.; Young, L. G.; Frohlich, O.</div><div class="citationInfo"><span class="NLM_cas:title">BioTechniques</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">782-784</span>CODEN:
                <span class="NLM_cas:coden">BTNQDO</span>;
        ISSN:<span class="NLM_cas:issn">0736-6205</span>.
    
            (<span class="NLM_cas:orgname">Eaton Publishing Co.</span>)
        </div><div class="casAbstract">The thymidine kinase promoter-Renilla luciferase reporter plasmid (pRL-TK) is commonly used as a control for transfection efficiency in the Dual-Luciferase Reporter Assay System.  While investigating hormone response elements in the promoters of the androgen-dependent, epididymis-specific EP2 gene, the authors found that hormone treatment affected the luciferase activity of pRL-TK-transfected cells.  In African Green Monkey Kidney (CV-1) cells, cotransfected transiently with a hormone-responsive promoter-firefly luciferase reporter plasmid and with pRL-TK, Renilla luciferase activity increased in response to dihydrotestosterone (DHT) and decreased in response to dexamethasone (DEX).  When a thromboxane synthase promoter Renilla luciferase plasmid (pRL-TS) was used in place of pRL-TK, Renilla luciferase activity remained const. in CV-1 cells treated with DHT but decreased in CV-1 cells treated with DEX.  In transfection studies, internal control plasmid expression in response to treatment must be carefully monitored to ensure proper interpretation of normalized results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYXvxbIMVfe7Vg90H21EOLACvtfcHk0linBPefSNA8Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVymtr8%253D&md5=2d300340bd5983e00ceb5a1944ec4eda</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.2144%2F00294st04&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2144%252F00294st04%26sid%3Dliteratum%253Aachs%26aulast%3DIbrahim%26aufirst%3DN.%2BM.%26aulast%3DMarinovic%26aufirst%3DA.%2BC.%26aulast%3DPrice%26aufirst%3DS.%2BR.%26aulast%3DYoung%26aufirst%3DL.%2BG.%26aulast%3DFr%25C3%25B6hlich%26aufirst%3DO.%26atitle%3DPitfall%2520of%2520an%2520internal%2520control%2520plasmid%253A%2520response%2520of%2520Renilla%2520luciferase%2520%2528pRL-TK%2529%2520plasmid%2520to%2520dihydrotestosterone%2520and%2520dexamethasone%26jtitle%3DBiotechniques%26date%3D2000%26volume%3D29%26spage%3D782%26epage%3D784%26doi%3D10.2144%2F00294st04" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovin, B. H.</span></span> <span> </span><span class="NLM_article-title">Unexpected sensitivity of synthetic Renilla luciferase control vectors to treatment with a cyclopentenone prostaglandin</span>. <i>Biotechniques</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1144</span>– <span class="NLM_lpage">1148</span>, <span class="refDoi"> DOI: 10.2144/03356bm04</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.2144%2F03356bm04" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=14682047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVart74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=1144-1148&author=X.+Zhangauthor=H.-Z.+Chenauthor=B.+H.+Rovin&title=Unexpected+sensitivity+of+synthetic+Renilla+luciferase+control+vectors+to+treatment+with+a+cyclopentenone+prostaglandin&doi=10.2144%2F03356bm04"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Unexpected sensitivity of synthetic Renilla luciferase control vectors to treatment with a cyclopentenone prostaglandin</span></div><div class="casAuthors">Zhang, Xiaolan; Chen, Hui-zi; Rovin, Brad H.</div><div class="citationInfo"><span class="NLM_cas:title">BioTechniques</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1144,1146,1148</span>CODEN:
                <span class="NLM_cas:coden">BTNQDO</span>;
        ISSN:<span class="NLM_cas:issn">0736-6205</span>.
    
            (<span class="NLM_cas:orgname">Eaton Publishing Co.</span>)
        </div><div class="casAbstract">The sensitivity of Renilla luciferase reporter vectors, phRG-TK and phRG-B, to the cyclopentenone prostaglandin 15-deoxy-Δ 12,14-prostaglandin J2 (15d-PGJ2) and the cytokines interleukin-1β (IL-1β) and tumor necrosis factor-α was studied.  15D-PGJ2 displayed dose-dependent inhibition of phRG-TK and phRG-B expression, while its solvent, Me acetate, had little effect.  The max. inhibition of Renilla expression for both vectors was achieved with concns. of 15d-PGJ2 between 7.5 and 10 μM.  These 15d-PGJ2 concns. were non-toxic, but cellular toxicity as characterized by cell shrinkage, development of cytoplasmic vesicles, and detachment from the culture flasks was apparent at concns. of 15 μM or greater.  The inhibition of Renilla expression was stimulus-specific because IL-1β and TNF-α had no significant effect on phRG-TK or phRG-B activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNIuz401O9nrVg90H21EOLACvtfcHk0ljh1dqhUwantw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVart74%253D&md5=7dfb3eb87c50721f8b21fb7a733d5b2f</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.2144%2F03356bm04&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2144%252F03356bm04%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.-Z.%26aulast%3DRovin%26aufirst%3DB.%2BH.%26atitle%3DUnexpected%2520sensitivity%2520of%2520synthetic%2520Renilla%2520luciferase%2520control%2520vectors%2520to%2520treatment%2520with%2520a%2520cyclopentenone%2520prostaglandin%26jtitle%3DBiotechniques%26date%3D2003%26volume%3D35%26spage%3D1144%26epage%3D1148%26doi%3D10.2144%2F03356bm04" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. M.</span></span> <span> </span><span class="NLM_article-title">Comparison of the responsiveness of the pGL3 and pGL4 luciferase reporter vectors to steroid hormones</span>. <i>Biotechniques</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.2144/05392st02</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.2144%2F05392ST02" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=16116793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2MXot1Cls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2005&pages=203-207&author=D.+C.+Doughertyauthor=M.+M.+Sanders&title=Comparison+of+the+responsiveness+of+the+pGL3+and+pGL4+luciferase+reporter+vectors+to+steroid+hormones&doi=10.2144%2F05392st02"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the responsiveness of the pGL3 and pGL4 luciferase reporter vectors to steroid hormones</span></div><div class="casAuthors">Dougherty, Dawne C.; Sanders, Michel M.</div><div class="citationInfo"><span class="NLM_cas:title">BioTechniques</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-207</span>CODEN:
                <span class="NLM_cas:coden">BTNQDO</span>;
        ISSN:<span class="NLM_cas:issn">0736-6205</span>.
    
            (<span class="NLM_cas:orgname">Informa Life Sciences Publishing</span>)
        </div><div class="casAbstract">The ovalbumin gene (Ov) gene is responsive to estrogen, glucocorticoid, androgen, and progesterone.  In our efforts to characterize the regulation of the Ov gene by steroid hormones, we have repeatedly obsd. that many vector backbones and promoters are responsive to steroids.  In order to det. which vectors are most suitable for these types of analyses, vectors from Promega's pGL3 and newly engineered pGL4 Dual-Luciferase Reporter Assay System were tested with both estrogen and/or corticosterone.  The results confirmed that both series are induced by glucocorticoids in transient transfections of primary oviduct tubular gland cells, which contain glucocorticoid receptors, but not in MCF-7 cells, which do not.  Modest effects that were dependent upon backbone and promoter context were obsd. with both series of vectors with estrogen.  Thus, use of these vectors for expts. analyzing the effects of steroid hormones, esp. glucocorticoids, should be done with caution.  However, the new pGL4 series does have some advantages over the older series, and a comparison of transcription factor binding sites is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9cCVC4zLDUrVg90H21EOLACvtfcHk0ljh1dqhUwantw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXot1Cls7w%253D&md5=bfe5a8538cadc4dff549aab6b5677e64</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.2144%2F05392ST02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2144%252F05392ST02%26sid%3Dliteratum%253Aachs%26aulast%3DDougherty%26aufirst%3DD.%2BC.%26aulast%3DSanders%26aufirst%3DM.%2BM.%26atitle%3DComparison%2520of%2520the%2520responsiveness%2520of%2520the%2520pGL3%2520and%2520pGL4%2520luciferase%2520reporter%2520vectors%2520to%2520steroid%2520hormones%26jtitle%3DBiotechniques%26date%3D2005%26volume%3D39%26spage%3D203%26epage%3D207%26doi%3D10.2144%2F05392st02" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norris, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fetler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. A.</span></span> <span> </span><span class="NLM_article-title">NMRFx Processor: a cross-platform NMR data processing program</span>. <i>J. Biomol. NMR</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1007/s10858-016-0049-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1007%2Fs10858-016-0049-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=27457481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1eisb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=205-216&author=M.+Norrisauthor=B.+Fetlerauthor=J.+Marchantauthor=B.+A.+Johnson&title=NMRFx+Processor%3A+a+cross-platform+NMR+data+processing+program&doi=10.1007%2Fs10858-016-0049-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">NMRFx Processor: a cross-platform NMR data processing program</span></div><div class="casAuthors">Norris, Michael; Fetler, Bayard; Marchant, Jan; Johnson, Bruce A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">205-216</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review NMRFx Processor is a new program for the processing of NMR data.  Written in the Java programming language, NMRFx Processor is a cross-platform application and runs on Linux, Mac OS X and Windows operating systems.  The application can be run in both a graphical user interface (GUI) mode and from the command line.  Processing scripts are written in the Python programming language and executed so that the low-level Java commands are automatically run in parallel on computers with multiple cores or CPUs.  Processing scripts can be generated automatically from the parameters of NMR expts. or interactively constructed in the GUI.  A wide variety of processing operations are provided, including methods for processing of non-uniformly sampled datasets using iterative soft thresholding.  The interactive GUI also enables the use of the program as an educational tool for teaching basic and advanced techniques in NMR data anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6T1V_iPMP4rVg90H21EOLACvtfcHk0ljh1dqhUwantw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1eisb3I&md5=7589f77c3e33a1db07e1ce15dc04cefc</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs10858-016-0049-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10858-016-0049-6%26sid%3Dliteratum%253Aachs%26aulast%3DNorris%26aufirst%3DM.%26aulast%3DFetler%26aufirst%3DB.%26aulast%3DMarchant%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DB.%2BA.%26atitle%3DNMRFx%2520Processor%253A%2520a%2520cross-platform%2520NMR%2520data%2520processing%2520program%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D2016%26volume%3D65%26spage%3D205%26epage%3D216%26doi%3D10.1007%2Fs10858-016-0049-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. A.</span></span> <span> </span><span class="NLM_article-title">Using NMRView to visualize and analyze the NMR spectra of macromolecules</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1385/1-59259-809-9:313</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1385%2F1-59259-809-9%3A313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=15318002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVWiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2004&pages=313-352&author=B.+A.+Johnson&title=Using+NMRView+to+visualize+and+analyze+the+NMR+spectra+of+macromolecules&doi=10.1385%2F1-59259-809-9%3A313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Using NMRView to visualize and analyze the NMR spectra of macromolecules</span></div><div class="casAuthors">Johnson, Bruce A.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">Protein NMR Techniques</span>),
    <span class="NLM_cas:pages">313-352</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">NMR expts. on macromols. can generate a tremendous amt. of data that must be analyzed and correlated to generate conclusions about the structure and dynamics of the mol. system.  NMRView is a computer program that is designed to be useful in visualizing and analyzing these data.  NMRView works with various types of NMR datasets and can have multiple datasets and display windows opened simultaneously.  Virtually all actions of the program can be controlled through the Tcl scripting language, and new graphical user interface components can be added with the Tk toolkit.  NMR spectral peaks can be analyzed and assigned.  A suite of tools exists within NMRView for assigning the data from triple-resonance expts.  The std. method for obtaining the most up-to-date version of NMRView is by downloading it from the website www.onemoonscientific.com.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKmaQ9ZKQqsbVg90H21EOLACvtfcHk0ljh1dqhUwantw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVWiu7s%253D&md5=640e0e779a459334090ea4536627d179</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1385%2F1-59259-809-9%3A313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1-59259-809-9%253A313%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DB.%2BA.%26atitle%3DUsing%2520NMRView%2520to%2520visualize%2520and%2520analyze%2520the%2520NMR%2520spectra%2520of%2520macromolecules%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2004%26volume%3D278%26spage%3D313%26epage%3D352%26doi%3D10.1385%2F1-59259-809-9%3A313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michiels, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dongen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Günther, U.</span></span> <span> </span><span class="NLM_article-title">Assignment of the orphan nuclear receptor Nurr1 by NMR</span>. <i>Biomol. NMR Assignments</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1007/s12104-010-9210-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1007%2Fs12104-010-9210-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=20300892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVGrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=101-105&author=P.+Michielsauthor=K.+Atkinsauthor=C.+Ludwigauthor=S.+Whittakerauthor=M.+van+Dongenauthor=U.+G%C3%BCnther&title=Assignment+of+the+orphan+nuclear+receptor+Nurr1+by+NMR&doi=10.1007%2Fs12104-010-9210-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Assignment of the orphan nuclear receptor Nurr1 by NMR</span></div><div class="casAuthors">Michiels, Paul; Atkins, Karen; Ludwig, Christian; Whittaker, Sara; Dongen, Maria; Gunther, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecular NMR Assignments</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-105</span>CODEN:
                <span class="NLM_cas:coden">BNAIBR</span>;
        ISSN:<span class="NLM_cas:issn">1874-2718</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The orphan nuclear receptor Nurr1 has been implicated in a no. of conditions including Parkinson's disease and Schizophrenia.  As such, it is of interest to study its interactions with other proteins, possibly mediated by small mols., considering possible use as a drug target.  The authors produced 2H, 15N, 13C labeled-Nurr1 to generate the backbone amide NH, carbonyl C', Calpha and Cbeta assignments.  About 84.0% of residues could be assigned.  Most of the 37 missing assignments fall in 3 regions of the protein.  Two of these surround a putative ligand-binding region of Nurr1, suggesting that this region of the protein is flexible, despite the ligand-binding pocket being filled with hydrophobic side-chains from residues surrounding the ligand binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouuGc7Wh9IvbVg90H21EOLACvtfcHk0ljXGRdgiVxv5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVGrs7w%253D&md5=7c084366b4c6410fa1397928b9516892</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs12104-010-9210-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12104-010-9210-4%26sid%3Dliteratum%253Aachs%26aulast%3DMichiels%26aufirst%3DP.%26aulast%3DAtkins%26aufirst%3DK.%26aulast%3DLudwig%26aufirst%3DC.%26aulast%3DWhittaker%26aufirst%3DS.%26aulast%3Dvan%2BDongen%26aufirst%3DM.%26aulast%3DG%25C3%25BCnther%26aufirst%3DU.%26atitle%3DAssignment%2520of%2520the%2520orphan%2520nuclear%2520receptor%2520Nurr1%2520by%2520NMR%26jtitle%3DBiomol.%2520NMR%2520Assignments%26date%3D2010%26volume%3D4%26spage%3D101%26epage%3D105%26doi%3D10.1007%2Fs12104-010-9210-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, M. P.</span></span> <span> </span><span class="NLM_article-title">Using chemical shift perturbation to characterise ligand binding</span>. <i>Prog. Nucl. Magn. Reson. Spectrosc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1016/j.pnmrs.2013.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.pnmrs.2013.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=23962882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1yrsbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=1-16&author=M.+P.+Williamson&title=Using+chemical+shift+perturbation+to+characterise+ligand+binding&doi=10.1016%2Fj.pnmrs.2013.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Using chemical shift perturbation to characterise ligand binding</span></div><div class="casAuthors">Williamson, Mike P.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Nuclear Magnetic Resonance Spectroscopy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">PNMRAT</span>;
        ISSN:<span class="NLM_cas:issn">0079-6565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chem. shift perturbation (CSP, chem. shift mapping or complexation-induced changes in chem. shift, CIS) follows changes in the chem. shifts of a protein when a ligand is added, and uses these to det. the location of the binding site, the affinity of the ligand, and/or possibly the structure of the complex.  A key factor in detg. the appearance of spectra during a titrn. is the exchange rate between free and bound, or more specifically the off-rate koff.  When koff is greater than the chem. shift difference between free and bound, which typically equates to an affinity Kd weaker than about 3 μM, then exchange is fast on the chem. shift timescale.  Under these circumstances, the obsd. shift is the population-weighted av. of free and bound, which allows Kd to be detd. from measurement of peak positions, provided the measurements are made appropriately. 1H shifts are influenced to a large extent by through-space interactions, whereas 13Cα and 13Cβ shifts are influenced more by through-bond effects. 15N and 13C' shifts are influenced both by through-bond and by through-space (hydrogen bonding) interactions.  For detg. the location of a bound ligand on the basis of shift change, the most appropriate method is therefore usually to measure 15N HSQC spectra, calc. the geometrical distance moved by the peak, weighting 15N shifts by a factor of about 0.14 compared to 1H shifts, and select those residues for which the weighted shift change is larger than the std. deviation of the shift for all residues.  Other methods are discussed, in particular the measurement of 13CH3 signals.  Slow to intermediate exchange rates lead to line broadening, and make Kd values very difficult to obtain.  There is no good way to distinguish changes in chem. shift due to direct binding of the ligand from changes in chem. shift due to allosteric change.  Ligand binding at multiple sites can often be characterized, by simultaneous fitting of many measured shift changes, or more simply by adding substoichiometric amts. of ligand.  The chem. shift changes can be used as restraints for docking ligand onto protein.  By use of quant. calcns. of ligand-induced chem. shift changes, it is becoming possible to det. not just the position but also the orientation of ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq34OdvCgPGqbVg90H21EOLACvtfcHk0ljXGRdgiVxv5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1yrsbzE&md5=74fc06bb4f4b3df369619bbf730016ce</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.pnmrs.2013.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnmrs.2013.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DM.%2BP.%26atitle%3DUsing%2520chemical%2520shift%2520perturbation%2520to%2520characterise%2520ligand%2520binding%26jtitle%3DProg.%2520Nucl.%2520Magn.%2520Reson.%2520Spectrosc.%26date%3D2013%26volume%3D73%26spage%3D1%26epage%3D16%26doi%3D10.1016%2Fj.pnmrs.2013.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Svetlana A. Kholodar, Geoffrey Lang, Wilian A. Cortopassi, Yoshie Iizuka, Harman S. Brah, Matthew P. Jacobson, <span class="NLM_string-name hlFld-ContribAuthor">Pamela M. England</span>. </span><span class="cited-content_cbyCitation_article-title">Analogs of the Dopamine Metabolite 5,6-Dihydroxyindole Bind Directly to and Activate the Nuclear Receptor Nurr1. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.1c00326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.1c00326%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DAnalogs%252Bof%252Bthe%252BDopamine%252BMetabolite%252B5%25252C6-Dihydroxyindole%252BBind%252BDirectly%252Bto%252Band%252BActivate%252Bthe%252BNuclear%252BReceptor%252BNurr1%26aulast%3DKholodar%26aufirst%3DSvetlana%2BA.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D04052021%26date%3D11062021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sabine Willems, Julia Ohrndorf, Whitney Kilu, Jan Heering, <span class="NLM_string-name hlFld-ContribAuthor">Daniel Merk</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-like Chloroquinolineamines Activate the Orphan Nuclear Receptor Nurr1 and Elucidate Activation Mechanisms. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2659-2668. <a href="https://doi.org/10.1021/acs.jmedchem.0c01779" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01779</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01779%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-like%252BChloroquinolineamines%252BActivate%252Bthe%252BOrphan%252BNuclear%252BReceptor%252BNurr1%252Band%252BElucidate%252BActivation%252BMechanisms%26aulast%3DWillems%26aufirst%3DSabine%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D19102020%26date%3D25022021%26volume%3D64%26issue%3D5%26spage%3D2659%26epage%3D2668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David E.  Phelan</span>, <span class="hlFld-ContribAuthor ">Masahiko  Shigemura</span>, <span class="hlFld-ContribAuthor ">Sarah  Aldhafiri</span>, <span class="hlFld-ContribAuthor ">Catarina  Mota</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Hall</span>, <span class="hlFld-ContribAuthor ">Jacob I.  Sznajder</span>, <span class="hlFld-ContribAuthor ">Evelyn P.  Murphy</span>, <span class="hlFld-ContribAuthor ">Daniel  Crean</span>, <span class="hlFld-ContribAuthor ">Eoin P.  Cummins</span>. </span><span class="cited-content_cbyCitation_article-title">Transcriptional Profiling of Monocytes Deficient in Nuclear Orphan Receptors NR4A2 and NR4A3 Reveals Distinct Signalling Roles Related to Antigen Presentation and Viral Response. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fimmu.2021.676644" title="DOI URL">https://doi.org/10.3389/fimmu.2021.676644</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2021.676644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2021.676644%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DTranscriptional%252BProfiling%252Bof%252BMonocytes%252BDeficient%252Bin%252BNuclear%252BOrphan%252BReceptors%252BNR4A2%252Band%252BNR4A3%252BReveals%252BDistinct%252BSignalling%252BRoles%252BRelated%252Bto%252BAntigen%252BPresentation%252Band%252BViral%252BResponse%26aulast%3DPhelan%26aufirst%3DDavid%2BE.%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen  Safe</span>, <span class="hlFld-ContribAuthor ">Rupesh  Shrestha</span>, <span class="hlFld-ContribAuthor ">Kumaravel  Mohankumar</span>. </span><span class="cited-content_cbyCitation_article-title">Orphan nuclear receptor 4A1 (NR4A1) and novel ligands. </span><span class="cited-content_cbyCitation_journal-name">Essays in Biochemistry</span><span> <strong>2021,</strong> <em>582 </em><a href="https://doi.org/10.1042/EBC20200164" title="DOI URL">https://doi.org/10.1042/EBC20200164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/EBC20200164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FEBC20200164%26sid%3Dliteratum%253Aachs%26jtitle%3DEssays%2520in%2520Biochemistry%26atitle%3DOrphan%252Bnuclear%252Breceptor%252B4A1%252B%252528NR4A1%252529%252Band%252Bnovel%252Bligands%26aulast%3DSafe%26aufirst%3DStephen%26date%3D2021%26date%3D2021%26volume%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Crean</span>, <span class="hlFld-ContribAuthor ">Evelyn P.  Murphy</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting NR4A Nuclear Receptors to Control Stromal Cell Inflammation, Metabolism, Angiogenesis, and Tumorigenesis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cell and Developmental Biology</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fcell.2021.589770" title="DOI URL">https://doi.org/10.3389/fcell.2021.589770</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcell.2021.589770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcell.2021.589770%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DTargeting%252BNR4A%252BNuclear%252BReceptors%252Bto%252BControl%252BStromal%252BCell%252BInflammation%25252C%252BMetabolism%25252C%252BAngiogenesis%25252C%252Band%252BTumorigenesis%26aulast%3DCrean%26aufirst%3DDaniel%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of the 12 NR4A ligands characterized in this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of the 4-amino-7-chloroquinoline derivatives on transcription of (A) full-length Nurr1 or (B) Nurr1-RXRα using NBRE3-luc or NurRE3-luc reporters in HEK293T, PC12, and SK-<i>N</i>-BE(2)-C cells. (C) Control assays including a constitutively active Gal4-VP16/UAS-luc assay and a CellTiter–Glo toxicity assay. Data represent mean ± standard error of the mean (s.e.m.) (<i>n</i> = 4); *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, ****<i>P</i> ≤ 0.0001, one-way ANOVA with multiple comparisons to vehicle control in each condition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of the Nurr1 HTS-derived ligands on transcription of (A) full-length Nurr1 or (B) Nurr1-RXRα using NBRE3-luc or NurRE3-luc reporters in HEK293T, PC12, and SK-<i>N</i>-BE(2)-C cells. (C) Control assays including a constitutively active Gal4-VP16/UAS-luc assay and a CellTiter–Glo toxicity assay. Data represent mean ± s.e.m. (<i>n</i> = 4); *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, ****<i>P</i> ≤ 0.0001, one-way ANOVA with multiple comparisons to vehicle control in each condition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of the other Nurr1 modulators on transcription of (A) full-length Nurr1 or (B) Nurr1-RXRα using NBRE3-luc or NurRE3-luc reporters in HEK293T, PC12, and SK-<i>N</i>-BE(2)-C cells. (C) Control assays including a constitutively active Gal4-VP16/UAS-luc assay and a CellTiter–Glo toxicity assay. Data represent mean ± s.e.m. (<i>n</i> = 4); *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, ****<i>P</i> ≤ 0.0001, one-way ANOVA with multiple comparisons to vehicle control in each condition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of the Nur77 modulators on transcription of (A) full-length Nurr1 or (B) Nurr1-RXRα using NBRE3-luc or NurRE3-luc reporters in HEK293T, PC12, and SK-<i>N</i>-BE(2)-C cells. (C) Control assays including a constitutively active Gal4-VP16/UAS-luc assay and a CellTiter–Glo toxicity assay. Data represent mean ± s.e.m. (<i>n</i> = 4); *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, ****<i>P</i> ≤ 0.0001, one-way ANOVA with multiple comparisons to vehicle control in each condition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Protein NMR spectroscopy ligand footprinting data. 2D [<sup>1</sup>H,<sup>15</sup>N]-TROSY-HSQC data (700 MHz, 298 K) of <sup>15</sup>N-labeled Nurr1 LBD in the presence of vehicle control (black spectra) or 2× ligand reveal ligands that do not bind to the Nurr1 LBD (blue spectra) and ligands that bind to the Nurr1 LBD (orange spectra).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Grouped quantitative analysis of the 2D NMR ligand footprinting data. (A) NMR CSPs and (B) peak intensities were used to determine the group mean and s.d. cutoffs to highlight significant changes in the per-ligand quantitative analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Per-ligand quantitative analysis of the 2D NMR ligand footprinting data, including (A) differential NMR CSP analysis and (B) NMR peak intensity analysis. Blue circles indicate residues with no significant effect; residues with a CSP or peak intensity change ≥ mean ± 4 s.d. or 8 s.d. are colored orange or black, respectively; residues with peak intensities that decrease or disappear into the noise are colored orange or black, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/medium/jm0c00894_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Comparison of NMR structural footprinting data to ligand-bound NR4A LBD crystal structures. (A) NMR mapped onto the Nurr1 LBD crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OVL">1OVL</a>, chain B). The inset legend shows the coloring scheme for residues with significant NMR CSP or peak intensity values. (B) Crystal structures of TMPA-bound Nur77 LBD (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3V3Q">3V3Q</a>) with other modeled and crystallized Nur77 ligand binding sites reported in the literature highlighted as well as Nurr1 LBD crystal structures bound to 5,6-dihydroxyindole (DHI; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DDA">6DDA</a>, chain A) and prostaglandin A1 (PGA1; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5Y41">5Y41</a>, chain A).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00894/20201218/images/large/jm0c00894_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00894&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i28">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02410" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02410" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 87 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herring, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elison, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tessem, J. S.</span></span> <span> </span><span class="NLM_article-title">Function of Nr4a Orphan Nuclear Receptors in Proliferation, Apoptosis and Fuel Utilization Across Tissues</span>. <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1373</span>, <span class="refDoi"> DOI: 10.3390/cells8111373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.3390%2Fcells8111373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BB3cXns1GgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=1373&author=J.+A.+Herringauthor=W.+S.+Elisonauthor=J.+S.+Tessem&title=Function+of+Nr4a+Orphan+Nuclear+Receptors+in+Proliferation%2C+Apoptosis+and+Fuel+Utilization+Across+Tissues&doi=10.3390%2Fcells8111373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Function of Nr4a orphan nuclear receptors in proliferation, apoptosis and fuel utilization across tissues</span></div><div class="casAuthors">Herring, Jacob A.; Elison, Weston S.; Tesse, Jeffery S.</div><div class="citationInfo"><span class="NLM_cas:title">Cells</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1373</span>CODEN:
                <span class="NLM_cas:coden">CELLC6</span>;
        ISSN:<span class="NLM_cas:issn">2073-4409</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The Nr4a family of nuclear hormone receptors is composed of three members-Nr4a1/Nur77, Nr4a2/Nurr1 and Nr4a3/Nor1.  While currently defined as ligandless, these transcription factors have been shown to regulate varied processes across a host of tissues.  Of particular interest, the Nr4a family impinge, in a tissue dependent fashion, on cellular proliferation, apoptosis and fuel utilization.  The regulation of these processes occurs through both nuclear and non-genomic pathways.  The purpose of this review is to provide a balanced perspective of the tissue specific and Nr4a family member specific, effects on cellular proliferation, apoptosis and fuel utilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq86S-YVAgdLVg90H21EOLACvtfcHk0lhzTlLb9x6aSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXns1GgsLg%253D&md5=c7e16caaa658578580053471374e2c94</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3390%2Fcells8111373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells8111373%26sid%3Dliteratum%253Aachs%26aulast%3DHerring%26aufirst%3DJ.%2BA.%26aulast%3DElison%26aufirst%3DW.%2BS.%26aulast%3DTessem%26aufirst%3DJ.%2BS.%26atitle%3DFunction%2520of%2520Nr4a%2520Orphan%2520Nuclear%2520Receptors%2520in%2520Proliferation%252C%2520Apoptosis%2520and%2520Fuel%2520Utilization%2520Across%2520Tissues%26jtitle%3DCells%26date%3D2019%26volume%3D8%26spage%3D1373%26doi%3D10.3390%2Fcells8111373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aarnisalo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlmann, T.</span></span> <span> </span><span class="NLM_article-title">Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>423</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1038/nature01645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fnature01645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=12774125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktVygtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=423&publication_year=2003&pages=555-560&author=Z.+Wangauthor=G.+Benoitauthor=J.+Liuauthor=S.+Prasadauthor=P.+Aarnisaloauthor=X.+Liuauthor=H.+Xuauthor=N.+P.+C.+Walkerauthor=T.+Perlmann&title=Structure+and+function+of+Nurr1+identifies+a+class+of+ligand-independent+nuclear+receptors&doi=10.1038%2Fnature01645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors</span></div><div class="casAuthors">Wang, Zhulun; Benoit, Gerard; Liu, Jinsong; Prasad, Srividya; Aarnisalo, Piia; Liu, Xiaohong; Xu, Haoda; Walker, Nigel P. C.; Perlmann, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">423</span>
        (<span class="NLM_cas:issue">6939</span>),
    <span class="NLM_cas:pages">555-560</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Members of the nuclear receptor (NR) superfamily of transcription factors modulate gene transcription in response to small lipophilic mols.  Transcriptional activity is regulated by ligands binding to the carboxy-terminal ligand-binding domains (LBDs) of cognate NRs.  A subgroup of NRs referred to as 'orphan receptors' lack identified ligands, however, raising issues about the function of their LBDs.  Here we report the crystal structure of the LBD of the orphan receptor Nurr1 at 2.2 Å resoln.  The Nurr1 LBD adopts a canonical protein fold resembling that of agonist-bound, transcriptionally active LBDs in NRs, but the structure has two distinctive features.  First, the Nurr1 LBD contains no cavity as a result of the tight packing of side chains from several bulky hydrophobic residues in the region normally occupied by ligands.  Second, Nurr1 lacks a 'classical' binding site for coactivators.  Despite these differences, the Nurr1 LBD can be regulated in mammalian cells.  Notably, transcriptional activity is correlated with the Nurr1 LBD adopting a more stable conformation.  Our findings highlight a unique structural class of NRs and define a model for ligand-independent NR function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf_Dsl30OicrVg90H21EOLACvtfcHk0lhzTlLb9x6aSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktVygtb4%253D&md5=d19448447ffb618404ae84e4aa37c505</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature01645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01645%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBenoit%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DAarnisalo%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DWalker%26aufirst%3DN.%2BP.%2BC.%26aulast%3DPerlmann%26aufirst%3DT.%26atitle%3DStructure%2520and%2520function%2520of%2520Nurr1%2520identifies%2520a%2520class%2520of%2520ligand-independent%2520nuclear%2520receptors%26jtitle%3DNature%26date%3D2003%26volume%3D423%26spage%3D555%26epage%3D560%26doi%3D10.1038%2Fnature01645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flaig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greschik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peluso-Iltis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moras, D.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the cell-specific activities of the NGFI-B and the Nurr1 ligand-binding domain</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">19250</span>– <span class="NLM_lpage">19258</span>, <span class="refDoi"> DOI: 10.1074/jbc.m413175200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1074%2Fjbc.M413175200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=15716272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFersLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=19250-19258&author=R.+Flaigauthor=H.+Greschikauthor=C.+Peluso-Iltisauthor=D.+Moras&title=Structural+basis+for+the+cell-specific+activities+of+the+NGFI-B+and+the+Nurr1+ligand-binding+domain&doi=10.1074%2Fjbc.m413175200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Cell-specific Activities of the NGFI-B and the Nurr1 Ligand-binding Domain</span></div><div class="casAuthors">Flaig, Ralf; Greschik, Holger; Peluso-Iltis, Carole; Moras, Dino</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">19250-19258</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">NGFI-B is a ligand-independent orphan nuclear receptor of the NR4A subfamily that displays important functional differences with its homolog Nurr1.  In particular, the NGFI-B ligand-binding domain (LBD) exhibits only modest activity in cell lines in which the Nurr1 LBD strongly activates transcription.  To gain insight into the structural basis for the distinct activation potentials, we detd. the crystal structure of the NGFI-B LBD at 2.4-Å resoln.  Superimposition with the Nurr1 LBD revealed a significant shift of the position of helix 12, potentially caused by conservative amino acids exchanges in helix 3 or helix 12.  Replacement of the helix 11-12 region of Nurr1 with that of NGFI-B dramatically reduces the transcriptional activity of the Nurr1 LBD.  Similarly, mutation of Met414 in helix 3 to leucine or of Leu591 in helix 12 to isoleucine (the corresponding residues found in NGFI-B) significantly affects Nurr1 transactivation.  In comparison, swapping the helix 11-12 region of Nurr1 into NGFI-B results in a modest increase of activity.  These observations reveal a high sensitivity of LBD activity to changes that influence helix 12 positioning.  Furthermore, mutation of hydrophobic surface residues in the helix 11-12 region (outside the canonical co-activator surface constituted by helixes 3, 4, and 12) severely affects Nurr1 transactivation.  Together, our data suggest that a novel co-regulator surface that includes helix 11 and a specifically positioned helix 12 det. the cell type-dependent activities of the NGFI-B and the Nurr1 LBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF1CyOIWd03LVg90H21EOLACvtfcHk0lihhMjwsoMfig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFersLs%253D&md5=901b8ef3584d1e95bc78d6da1090adcb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413175200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413175200%26sid%3Dliteratum%253Aachs%26aulast%3DFlaig%26aufirst%3DR.%26aulast%3DGreschik%26aufirst%3DH.%26aulast%3DPeluso-Iltis%26aufirst%3DC.%26aulast%3DMoras%26aufirst%3DD.%26atitle%3DStructural%2520basis%2520for%2520the%2520cell-specific%2520activities%2520of%2520the%2520NGFI-B%2520and%2520the%2520Nurr1%2520ligand-binding%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D19250%26epage%3D19258%26doi%3D10.1074%2Fjbc.m413175200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Vera, I. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Tello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharmarajan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marciano, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matta-Camacho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giri, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rance, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojetin, D. J.</span></span> <span> </span><span class="NLM_article-title">Defining a Canonical Ligand-Binding Pocket in the Orphan Nuclear Receptor Nurr1</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.str.2018.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.str.2018.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30416039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFCgsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=66-77&author=I.+M.+S.+de%0AVeraauthor=P.+Munoz-Telloauthor=J.+Zhengauthor=V.+Dharmarajanauthor=D.+P.+Marcianoauthor=E.+Matta-Camachoauthor=P.+K.+Giriauthor=J.+Shangauthor=T.+S.+Hughesauthor=M.+Ranceauthor=P.+R.+Griffinauthor=D.+J.+Kojetin&title=Defining+a+Canonical+Ligand-Binding+Pocket+in+the+Orphan+Nuclear+Receptor+Nurr1&doi=10.1016%2Fj.str.2018.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Defining a Canonical Ligand-Binding Pocket in the Orphan Nuclear Receptor Nurr1</span></div><div class="casAuthors">de Vera, Ian Mitchelle S.; Munoz-Tello, Paola; Zheng, Jie; Dharmarajan, Venkatasubramanian; Marciano, David P.; Matta-Camacho, Edna; Giri, Pankaj Kumar; Shang, Jinsai; Hughes, Travis S.; Rance, Mark; Griffin, Patrick R.; Kojetin, Douglas J.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-77.e5</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Nuclear receptor-related 1 protein (Nurr1/NR4A2) is an orphan nuclear receptor (NR) that is considered to function without a canonical ligand-binding pocket (LBP).  A crystal structure of the Nurr1 ligand-binding domain (LBD) revealed no phys. space in the conserved region where other NRs with solvent accessible apo-protein LBPs bind synthetic and natural ligands.  Using soln. NMR spectroscopy, hydrogen/deuterium exchange mass spectrometry, and mol. dynamics simulations, we show that the putative canonical Nurr1 LBP is dynamic with high solvent accessibility, exchanges between two or more conformations on the microsecond-to-millisecond timescale, and can expand from the collapsed crystd. conformation to allow binding of unsatd. fatty acids.  These findings should stimulate future studies to probe the ligandability and druggability of Nurr1 for both endogenous and synthetic ligands, which could lead to new therapeutics for Nurr1-related diseases, including Parkinson's disease and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZuBncq_Z9MbVg90H21EOLACvtfcHk0lihhMjwsoMfig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFCgsb3N&md5=f7b412a0b24e32cfae48ad55661f7707</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2018.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2018.10.002%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVera%26aufirst%3DI.%2BM.%2BS.%26aulast%3DMunoz-Tello%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DDharmarajan%26aufirst%3DV.%26aulast%3DMarciano%26aufirst%3DD.%2BP.%26aulast%3DMatta-Camacho%26aufirst%3DE.%26aulast%3DGiri%26aufirst%3DP.%2BK.%26aulast%3DShang%26aufirst%3DJ.%26aulast%3DHughes%26aufirst%3DT.%2BS.%26aulast%3DRance%26aufirst%3DM.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DKojetin%26aufirst%3DD.%2BJ.%26atitle%3DDefining%2520a%2520Canonical%2520Ligand-Binding%2520Pocket%2520in%2520the%2520Orphan%2520Nuclear%2520Receptor%2520Nurr1%26jtitle%3DStructure%26date%3D2019%26volume%3D27%26spage%3D66%26epage%3D77%26doi%3D10.1016%2Fj.str.2018.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Vera, I. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giri, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Tello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhrmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matta-Camacho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granados, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, W. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creamer, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojetin, D. J.</span></span> <span> </span><span class="NLM_article-title">Identification of a Binding Site for Unsaturated Fatty Acids in the Orphan Nuclear Receptor Nurr1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1795</span>– <span class="NLM_lpage">1799</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvVyhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1795-1799&author=I.+M.+S.+de%0AVeraauthor=P.+K.+Giriauthor=P.+Munoz-Telloauthor=R.+Brustauthor=J.+Fuhrmannauthor=E.+Matta-Camachoauthor=J.+Shangauthor=S.+Campbellauthor=H.+D.+Wilsonauthor=J.+Granadosauthor=W.+J.+Gardnerauthor=T.+P.+Creamerauthor=L.+A.+Soltauthor=D.+J.+Kojetin&title=Identification+of+a+Binding+Site+for+Unsaturated+Fatty+Acids+in+the+Orphan+Nuclear+Receptor+Nurr1&doi=10.1021%2Facschembio.6b00037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Binding Site for Unsaturated Fatty Acids in the Orphan Nuclear Receptor Nurr1</span></div><div class="casAuthors">de Vera, Ian Mitchelle S.; Giri, Pankaj K.; Munoz-Tello, Paola; Brust, Richard; Fuhrmann, Jakob; Matta-Camacho, Edna; Shang, Jinsai; Campbell, Sean; Wilson, Henry D.; Granados, Juan; Gardner, William J.; Creamer, Trevor P.; Solt, Laura. A.; Kojetin, Douglas J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1795-1799</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nurr1/NR4A2 is an orphan nuclear receptor, and currently there are no known natural ligands that bind Nurr1.  A recent metabolomics study identified unsatd. fatty acids, including arachidonic acid and docosahexaenoic acid (DHA), that interact with the ligand-binding domain (LBD) of a related orphan receptor, Nur77/NR4A1.  However, the binding location and whether these ligands bind other NR4A receptors were not defined.  Here, we show that unsatd. fatty acids also interact with the Nurr1 LBD, and soln. NMR spectroscopy reveals the binding epitope of DHA at its putative ligand-binding pocket.  Biochem. assays reveal that DHA-bound Nurr1 interacts with high affinity with a peptide derived from PIASγ, a protein that interacts with Nurr1 in cellular exts., and DHA also affects cellular Nurr1 transactivation.  This work is the first structural report of a natural ligand binding to a canonical NR4A ligand-binding pocket and indicates a natural ligand can bind and affect Nurr1 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnqenMorJ3jLVg90H21EOLACvtfcHk0lihhMjwsoMfig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvVyhsLs%253D&md5=598f95ccc2051710ed6c2662c843d8f8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00037%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVera%26aufirst%3DI.%2BM.%2BS.%26aulast%3DGiri%26aufirst%3DP.%2BK.%26aulast%3DMunoz-Tello%26aufirst%3DP.%26aulast%3DBrust%26aufirst%3DR.%26aulast%3DFuhrmann%26aufirst%3DJ.%26aulast%3DMatta-Camacho%26aufirst%3DE.%26aulast%3DShang%26aufirst%3DJ.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DH.%2BD.%26aulast%3DGranados%26aufirst%3DJ.%26aulast%3DGardner%26aufirst%3DW.%2BJ.%26aulast%3DCreamer%26aufirst%3DT.%2BP.%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DKojetin%26aufirst%3DD.%2BJ.%26atitle%3DIdentification%2520of%2520a%2520Binding%2520Site%2520for%2520Unsaturated%2520Fatty%2520Acids%2520in%2520the%2520Orphan%2520Nuclear%2520Receptor%2520Nurr1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D1795%26epage%3D1799%26doi%3D10.1021%2Facschembio.6b00037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vinayavekhin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghatelian, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of a protein-metabolite interaction between unsaturated fatty acids and the nuclear receptor Nur77 using a metabolomics approach</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">17168</span>– <span class="NLM_lpage">17171</span>, <span class="refDoi"> DOI: 10.1021/ja208199h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja208199h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1OnsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=17168-17171&author=N.+Vinayavekhinauthor=A.+Saghatelian&title=Discovery+of+a+protein-metabolite+interaction+between+unsaturated+fatty+acids+and+the+nuclear+receptor+Nur77+using+a+metabolomics+approach&doi=10.1021%2Fja208199h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Protein-Metabolite Interaction between Unsaturated Fatty Acids and the Nuclear Receptor Nur77 Using a Metabolomics Approach</span></div><div class="casAuthors">Vinayavekhin, Nawaporn; Saghatelian, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">17168-17171</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neuron-derived clone 77 (Nur77) is an orphan nuclear receptor with currently no known natural ligands.  Here we applied a metabolomics platform for detecting protein-metabolite interactions (PMIs) to identify lipids that bind to Nur77.  Using this approach, we discovered that the Nur77 ligand-binding domain (Nur77LBD) enriches unsatd. fatty acids (UFAs) in tissue lipid mixts.  The interaction of Nur77 with arachidonic acid and docosahexaenoic acid was subsequently characterized using a no. of biophys. and biochem. assays.  Together these data indicate that UFAs bind to Nur77LBD to cause changes in the conformation and oligomerization of the receptor.  UFAs are the only endogenous lipids reported to bind to Nur77, which highlights the use of metabolomics in the discovery of novel PMIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqziCNKNrJSIrVg90H21EOLACvtfcHk0liPPrk4LplKTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1OnsbrJ&md5=4b50bc3a70cedccb6c188aa7959c0769</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fja208199h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja208199h%26sid%3Dliteratum%253Aachs%26aulast%3DVinayavekhin%26aufirst%3DN.%26aulast%3DSaghatelian%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520protein-metabolite%2520interaction%2520between%2520unsaturated%2520fatty%2520acids%2520and%2520the%2520nuclear%2520receptor%2520Nur77%2520using%2520a%2520metabolomics%2520approach%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D17168%26epage%3D17171%26doi%3D10.1021%2Fja208199h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toh, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beldar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feitosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petsko, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-S.</span></span> <span> </span><span class="NLM_article-title">PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">886</span>, <span class="refDoi"> DOI: 10.1038/s41589-020-0553-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fs41589-020-0553-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=32451509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVSgsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2020&pages=876-886&author=S.+Rajanauthor=Y.+Jangauthor=C.-H.+Kimauthor=W.+Kimauthor=H.+T.+Tohauthor=J.+Jeonauthor=B.+Songauthor=A.+Serraauthor=J.+Lescarauthor=J.+Y.+Yooauthor=S.+Beldarauthor=H.+Yeauthor=C.+Kangauthor=X.-W.+Liuauthor=M.+Feitosaauthor=Y.+Kimauthor=D.+Hwangauthor=G.+Gohauthor=K.-L.+Limauthor=H.+M.+Parkauthor=C.+H.+Leeauthor=S.+F.+Ohauthor=G.+A.+Petskoauthor=H.+S.+Yoonauthor=K.-S.+Kim&title=PGE1+and+PGA1+bind+to+Nurr1+and+activate+its+transcriptional+function&doi=10.1038%2Fs41589-020-0553-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function</span></div><div class="casAuthors">Rajan, Sreekanth; Jang, Yongwoo; Kim, Chun-Hyung; Kim, Woori; Toh, Hui Ting; Jeon, Jeha; Song, Bin; Serra, Aida; Lescar, Julien; Yoo, Jun Yeob; Beldar, Serap; Ye, Hong; Kang, Congbao; Liu, Xue-Wei; Feitosa, Melissa; Kim, Yeahan; Hwang, Dabin; Goh, Geraldine; Lim, Kah-Leong; Park, Hye Min; Lee, Choong Hwan; Oh, Sungwhan F.; Petsko, Gregory A.; Yoon, Ho Sup; Kim, Kwang-Soo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">876-886</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The orphan nuclear receptor Nurr1 is crit. for the development, maintenance and protection of midbrain dopaminergic (mDA) neurons.  Here we show that prostaglandin E1 (PGE1) and its dehydrated metabolite, PGA1, directly interact with the ligand-binding domain (LBD) of Nurr1 and stimulate its transcriptional function.  We also report the crystallog. structure of Nurr1-LBD bound to PGA1 at 2.05 Å resoln.  PGA1 couples covalently to Nurr1-LBD by forming a Michael adduct with Cys566, and induces notable conformational changes, including a 21° shift of the activation function-2 helix (H12) away from the protein core.  Furthermore, PGE1/PGA1 exhibit neuroprotective effects in a Nurr1-dependent manner, prominently enhance expression of Nurr1 target genes in mDA neurons and improve motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse models of Parkinson's disease.  Based on these results, we propose that PGE1/PGA1 represent native ligands of Nurr1 and can exert neuroprotective effects on mDA neurons, via activation of Nurr1's transcriptional function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMia6BJvwVdLVg90H21EOLACvtfcHk0liPPrk4LplKTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVSgsLzI&md5=5e726ca7eff0e5ed8216d4d4bc99b4e9</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fs41589-020-0553-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41589-020-0553-6%26sid%3Dliteratum%253Aachs%26aulast%3DRajan%26aufirst%3DS.%26aulast%3DJang%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DC.-H.%26aulast%3DKim%26aufirst%3DW.%26aulast%3DToh%26aufirst%3DH.%2BT.%26aulast%3DJeon%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DB.%26aulast%3DSerra%26aufirst%3DA.%26aulast%3DLescar%26aufirst%3DJ.%26aulast%3DYoo%26aufirst%3DJ.%2BY.%26aulast%3DBeldar%26aufirst%3DS.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DX.-W.%26aulast%3DFeitosa%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DHwang%26aufirst%3DD.%26aulast%3DGoh%26aufirst%3DG.%26aulast%3DLim%26aufirst%3DK.-L.%26aulast%3DPark%26aufirst%3DH.%2BM.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DOh%26aufirst%3DS.%2BF.%26aulast%3DPetsko%26aufirst%3DG.%2BA.%26aulast%3DYoon%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DK.-S.%26atitle%3DPGE1%2520and%2520PGA1%2520bind%2520to%2520Nurr1%2520and%2520activate%2520its%2520transcriptional%2520function%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2020%26volume%3D16%26spage%3D876%26epage%3D886%26doi%3D10.1038%2Fs41589-020-0553-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruning, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oltrabella, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kholodar, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletterick, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">England, P. M.</span></span> <span> </span><span class="NLM_article-title">Covalent Modification and Regulation of the Nuclear Receptor Nurr1 by a Dopamine Metabolite</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2019.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.chembiol.2019.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30853418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1MXks1SitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=674-685&author=J.+M.+Bruningauthor=Y.+Wangauthor=F.+Oltrabellaauthor=B.+Tianauthor=S.+A.+Kholodarauthor=H.+Liuauthor=P.+Bhattacharyaauthor=S.+Guoauthor=J.+M.+Holtonauthor=R.+J.+Fletterickauthor=M.+P.+Jacobsonauthor=P.+M.+England&title=Covalent+Modification+and+Regulation+of+the+Nuclear+Receptor+Nurr1+by+a+Dopamine+Metabolite&doi=10.1016%2Fj.chembiol.2019.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Modification and Regulation of the Nuclear Receptor Nurr1 by a Dopamine Metabolite</span></div><div class="casAuthors">Bruning, John M.; Wang, Yan; Oltrabella, Francesca; Tian, Boxue; Kholodar, Svetlana A.; Liu, Harrison; Bhattacharya, Paulomi; Guo, Su; Holton, James M.; Fletterick, Robert J.; Jacobson, Matthew P.; England, Pamela M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">674-685.e6</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nurr1, a nuclear receptor essential for the development, maintenance, and survival of midbrain dopaminergic neurons, is a potential therapeutic target for Parkinson's disease, a neurol. disorder characterized by the degeneration of these same neurons.  Efforts to identify Nurr1 agonists have been hampered by the recognition that it lacks several classic regulatory elements of nuclear receptor function, including the canonical ligand-binding pocket.  Here we report that the dopamine metabolite 5,6-dihydroxyindole (DHI) binds directly to and modulates the activity of Nurr1.  Using biophys. assays and X-ray crystallog., we show that DHI binds to the ligand-binding domain within a non-canonical pocket, forming a covalent adduct with Cys566.  In cultured cells and zebrafish, DHI stimulates Nurr1 activity, including the transcription of target genes underlying dopamine homeostasis.  These findings suggest avenues for developing synthetic Nurr1 ligands to ameliorate the symptoms and progression of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbfTNdzAqeRLVg90H21EOLACvtfcHk0lhHUX3YgWEQwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXks1SitLw%253D&md5=9d083c1ceca8cfb134b566ac191ef810</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2019.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2019.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DBruning%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DOltrabella%26aufirst%3DF.%26aulast%3DTian%26aufirst%3DB.%26aulast%3DKholodar%26aufirst%3DS.%2BA.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DBhattacharya%26aufirst%3DP.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DHolton%26aufirst%3DJ.%2BM.%26aulast%3DFletterick%26aufirst%3DR.%2BJ.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DEngland%26aufirst%3DP.%2BM.%26atitle%3DCovalent%2520Modification%2520and%2520Regulation%2520of%2520the%2520Nuclear%2520Receptor%2520Nurr1%2520by%2520a%2520Dopamine%2520Metabolite%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D674%26epage%3D685%26doi%3D10.1016%2Fj.chembiol.2019.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, U.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morpurgo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abudayyeh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjalkens, R. B.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptor 4A (NR4A) family - orphans no more</span>. <i>J. Steroid Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.jsbmb.2015.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.jsbmb.2015.04.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=25917081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnt1Wjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2016&pages=48-60&author=S.+Safeauthor=U.-H.+Jinauthor=B.+Morpurgoauthor=A.+Abudayyehauthor=M.+Singhauthor=R.+B.+Tjalkens&title=Nuclear+receptor+4A+%28NR4A%29+family+-+orphans+no+more&doi=10.1016%2Fj.jsbmb.2015.04.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptor 4A (NR4A) family - orphans no more</span></div><div class="casAuthors">Safe, Stephen; Jin, Un-Ho; Morpurgo, Benjamin; Abudayyeh, Ala; Singh, Mandip; Tjalkens, Ronald B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48-60</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The orphan nuclear receptors NR4A1, NR4A2 and NR4A3 are immediate early genes induced by multiple stressors, and the NR4A receptors play an important role in maintaining cellular homeostasis and disease.  There is increasing evidence for the role of these receptors in metabolic, cardiovascular and neurol. functions and also in inflammation and inflammatory diseases and in immune functions and cancer.  Despite the similarities of NR4A1, NR4A2 and NR4A3 and their interactions with common cis-genomic elements, they exhibit unique activities and cell-/tissue-specific functions.  Although endogenous ligands for NR4A receptors have not been identified, there is increasing evidence that structurally-diverse synthetic mols. can directly interact with the ligand binding domain of NR4A1 and act as agonists or antagonists, and ligands for NR4A2 and NR4A3 have also been identified.  Since NR4A receptors are key factors in multiple diseases, there are opportunities for the future development of NR4A ligands for clin. applications in treating multiple health problems including metabolic, neurol. and cardiovascular diseases, other inflammatory conditions, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWR4RU0ikZNrVg90H21EOLACvtfcHk0lhHUX3YgWEQwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnt1Wjs7k%253D&md5=1dbc9721e70c9f19ea72032a60d351fe</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2015.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2015.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DSafe%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DU.-H.%26aulast%3DMorpurgo%26aufirst%3DB.%26aulast%3DAbudayyeh%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DTjalkens%26aufirst%3DR.%2BB.%26atitle%3DNuclear%2520receptor%25204A%2520%2528NR4A%2529%2520family%2520-%2520orphans%2520no%2520more%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2016%26volume%3D157%26spage%3D48%26epage%3D60%26doi%3D10.1016%2Fj.jsbmb.2015.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sekiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashiwagi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudensky, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichinose, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, A.</span></span> <span> </span><span class="NLM_article-title">The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">269</span>, <span class="refDoi"> DOI: 10.1038/ncomms1272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fncomms1272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=21468021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A280%3ADC%252BC3Mvht1Wqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=269&author=T.+Sekiyaauthor=I.+Kashiwagiauthor=N.+Inoueauthor=R.+Moritaauthor=S.+Horiauthor=H.+Waldmannauthor=A.+Y.+Rudenskyauthor=H.+Ichinoseauthor=D.+Metzgerauthor=P.+Chambonauthor=A.+Yoshimura&title=The+nuclear+orphan+receptor+Nr4a2+induces+Foxp3+and+regulates+differentiation+of+CD4%2B+T+cells&doi=10.1038%2Fncomms1272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells</span></div><div class="casAuthors">Sekiya Takashi; Kashiwagi Ikkou; Inoue Naoko; Morita Rimpei; Hori Shohei; Waldmann Herman; Rudensky Alexander Y; Ichinose Hiroshi; Metzger Daniel; Chambon Pierre; Yoshimura Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">269</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Regulatory T cells (Tregs) have a central role in maintaining immune homoeostasis through various mechanisms.  Although the Forkhead transcription factor Foxp3 defines the Treg cell lineage and functions, the molecular mechanisms of Foxp3 induction and maintenance remain elusive.  Here we show that Foxp3 is one of the direct targets of Nr4a2.  Nr4a2 binds to regulatory regions of Foxp3, where it mediates permissive histone modifications.  Ectopic expression of Nr4a2 imparts Treg-like suppressive activity to naive CD4(+) T cells by inducing Foxp3 and by repressing cytokine production, including interferon-γ and interleukin-2.  Deletion of Nr4a2 in T cells attenuates induction of Tregs and causes aberrant induction of Th1, leading to the exacerbation of colitis.  Nr4a2-deficeint Tregs are prone to lose Foxp3 expression and have attenuated suppressive ability both in vitro and in vivo.  Thus, Nr4a2 has the ability to maintain T-cell homoeostasis by regulating induction, maintenance and suppressor functions of Tregs, and by repression of aberrant Th1 induction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNsvtqioWPE1MGsG_HTXYFfW6udTcc2ea-6oEFsUbUwLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mvht1Wqug%253D%253D&md5=52076bb0140c05bfbdce9a5f0f6e2f2e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fncomms1272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1272%26sid%3Dliteratum%253Aachs%26aulast%3DSekiya%26aufirst%3DT.%26aulast%3DKashiwagi%26aufirst%3DI.%26aulast%3DInoue%26aufirst%3DN.%26aulast%3DMorita%26aufirst%3DR.%26aulast%3DHori%26aufirst%3DS.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DRudensky%26aufirst%3DA.%2BY.%26aulast%3DIchinose%26aufirst%3DH.%26aulast%3DMetzger%26aufirst%3DD.%26aulast%3DChambon%26aufirst%3DP.%26aulast%3DYoshimura%26aufirst%3DA.%26atitle%3DThe%2520nuclear%2520orphan%2520receptor%2520Nr4a2%2520induces%2520Foxp3%2520and%2520regulates%2520differentiation%2520of%2520CD4%252B%2520T%2520cells%26jtitle%3DNat.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D269%26doi%3D10.1038%2Fncomms1272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sekiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashiwagi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichinose, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, A.</span></span> <span> </span><span class="NLM_article-title">Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1038/ni.2520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fni.2520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=23334790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=230-237&author=T.+Sekiyaauthor=I.+Kashiwagiauthor=R.+Yoshidaauthor=T.+Fukayaauthor=R.+Moritaauthor=A.+Kimuraauthor=H.+Ichinoseauthor=D.+Metzgerauthor=P.+Chambonauthor=A.+Yoshimura&title=Nr4a+receptors+are+essential+for+thymic+regulatory+T+cell+development+and+immune+homeostasis&doi=10.1038%2Fni.2520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis</span></div><div class="casAuthors">Sekiya, Takashi; Kashiwagi, Ikkou; Yoshida, Rei; Fukaya, Tomohiro; Morita, Rimpei; Kimura, Akihiro; Ichinose, Hiroshi; Metzger, Daniel; Chambon, Pierre; Yoshimura, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">230-237</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Regulatory T cells (Treg cells) develop from progenitor thymocytes after the engagement of T cell antigen receptors (TCRs) with high-affinity ligands, but the underlying mol. mechanisms are still unclear.  Here we show that the Nr4a nuclear receptors, which are encoded by immediate-early genes upregulated by TCR stimulation in thymocytes, have essential roles in Treg cell development.  Mice that lacked all Nr4a factors could not produce Treg cells and died early owing to systemic autoimmunity.  Nr4a receptors directly activated the promoter of the gene encoding the transcription factor Foxp3, and forced activation of Nr4a receptors bypassed low-strength TCR signaling to drive the Treg cell developmental program.  Our results suggest that Nr4a receptors have key roles in detg. CD4+ T cell fates in the thymus and thus contribute to immune homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVYG89540YGbVg90H21EOLACvtfcHk0lh4qVnJcwUpDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSjtL0%253D&md5=dcd81ab80944a238b75ef81985d22d35</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fni.2520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2520%26sid%3Dliteratum%253Aachs%26aulast%3DSekiya%26aufirst%3DT.%26aulast%3DKashiwagi%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DR.%26aulast%3DFukaya%26aufirst%3DT.%26aulast%3DMorita%26aufirst%3DR.%26aulast%3DKimura%26aufirst%3DA.%26aulast%3DIchinose%26aufirst%3DH.%26aulast%3DMetzger%26aufirst%3DD.%26aulast%3DChambon%26aufirst%3DP.%26aulast%3DYoshimura%26aufirst%3DA.%26atitle%3DNr4a%2520receptors%2520are%2520essential%2520for%2520thymic%2520regulatory%2520T%2520cell%2520development%2520and%2520immune%2520homeostasis%26jtitle%3DNat.%2520Immunol.%26date%3D2013%26volume%3D14%26spage%3D230%26epage%3D237%26doi%3D10.1038%2Fni.2520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naffin-Olivos, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petsko, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-S.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson’s disease</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">8756</span>– <span class="NLM_lpage">8761</span>, <span class="refDoi"> DOI: 10.1073/pnas.1509742112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1073%2Fpnas.1509742112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=26124091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOrs7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=8756-8761&author=C.-H.+Kimauthor=B.-S.+Hanauthor=J.+Moonauthor=D.-J.+Kimauthor=J.+Shinauthor=S.+Rajanauthor=Q.+T.+Nguyenauthor=M.+Sohnauthor=W.-G.+Kimauthor=M.+Hanauthor=I.+Jeongauthor=K.-S.+Kimauthor=E.-H.+Leeauthor=Y.+Tuauthor=J.+L.+Naffin-Olivosauthor=C.-H.+Parkauthor=D.+Ringeauthor=H.+S.+Yoonauthor=G.+A.+Petskoauthor=K.-S.+Kim&title=Nuclear+receptor+Nurr1+agonists+enhance+its+dual+functions+and+improve+behavioral+deficits+in+an+animal+model+of+Parkinson%E2%80%99s+disease&doi=10.1073%2Fpnas.1509742112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson's disease</span></div><div class="casAuthors">Kim, Chun-Hyung; Han, Baek-Soo; Moon, Jisook; Kim, Deog-Joong; Shin, Joon; Rajan, Sreekanth; Nguyen, Quoc Toan; Sohn, Mijin; Kim, Won-Gon; Han, Minjoon; Jeong, Inhye; Kim, Kyoung-Shim; Lee, Eun-Hye; Tu, Yupeng; Naffin-Olivos, Jacqueline L.; Park, Chang-Hwan; Ringe, Dagmar; Yoon, Ho Sup; Petsko, Gregory A.; Kim, Kwang-Soo</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">8756-8761</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Parkinson's disease (PD), primarily caused by selective degeneration of midbrain dopamine (mDA) neurons, is the most prevalent movement disorder, affecting 1-2% of the global population over the age of 65.  Currently available pharmacol. treatments are largely symptomatic and lose their efficacy over time with accompanying severe side effects such as dyskinesia.  Thus, there is an unmet clin. need to develop mechanism-based and/or disease-modifying treatments.  Based on the unique dual role of the nuclear orphan receptor Nurr1 for development and maintenance of mDA neurons and their protection from inflammation-induced death, we hypothesize that Nurr1 can be a mol. target for neuroprotective therapeutic development for PD.  Here we show successful identification of Nurr1 agonists sharing an identical chem. scaffold, 4-amino-7-chloroquinoline, suggesting a crit. structure-activity relationship.  In particular, we found that two antimalarial drugs, amodiaquine and chloroquine stimulate the transcriptional function of Nurr1 through phys. interaction with its ligand binding domain (LBD).  Remarkably, these compds. were able to enhance the contrasting dual functions of Nurr1 by further increasing transcriptional activation of mDA-specific genes and further enhancing transrepression of neurotoxic proinflammatory gene expression in microglia.  Importantly, these compds. significantly improved behavioral deficits in 6-hydroxydopamine lesioned rat model of PD without any detectable signs of dyskinesia-like behavior.  These findings offer proof of principle that small mols. targeting the Nurr1 LBD can be used as a mechanism-based and neuroprotective strategy for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaWD4RLxZ8nbVg90H21EOLACvtfcHk0lh4qVnJcwUpDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOrs7%252FL&md5=715bbb21e39675989c84aa2ab51447dc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1509742112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1509742112%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DC.-H.%26aulast%3DHan%26aufirst%3DB.-S.%26aulast%3DMoon%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DD.-J.%26aulast%3DShin%26aufirst%3DJ.%26aulast%3DRajan%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DQ.%2BT.%26aulast%3DSohn%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DW.-G.%26aulast%3DHan%26aufirst%3DM.%26aulast%3DJeong%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DK.-S.%26aulast%3DLee%26aufirst%3DE.-H.%26aulast%3DTu%26aufirst%3DY.%26aulast%3DNaffin-Olivos%26aufirst%3DJ.%2BL.%26aulast%3DPark%26aufirst%3DC.-H.%26aulast%3DRinge%26aufirst%3DD.%26aulast%3DYoon%26aufirst%3DH.%2BS.%26aulast%3DPetsko%26aufirst%3DG.%2BA.%26aulast%3DKim%26aufirst%3DK.-S.%26atitle%3DNuclear%2520receptor%2520Nurr1%2520agonists%2520enhance%2520its%2520dual%2520functions%2520and%2520improve%2520behavioral%2520deficits%2520in%2520an%2520animal%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3D8756%26epage%3D8761%26doi%3D10.1073%2Fpnas.1509742112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-S.</span></span> <span> </span><span class="NLM_article-title">Nurr1 (NR4A2) regulates Alzheimer’s disease-related pathogenesis and cognitive function in the 5XFAD mouse model</span>. <i>Aging Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>, <span class="NLM_elocation-id">e12866</span> <span class="refDoi"> DOI: 10.1111/acel.12866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1111%2Facel.12866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30515963" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&author=M.+Moonauthor=E.+S.+Jungauthor=S.+G.+Jeonauthor=M.-Y.+Chaauthor=Y.+Jangauthor=W.+Kimauthor=C.+Lopesauthor=I.+Mook-Jungauthor=K.-S.+Kim&title=Nurr1+%28NR4A2%29+regulates+Alzheimer%E2%80%99s+disease-related+pathogenesis+and+cognitive+function+in+the+5XFAD+mouse+model&doi=10.1111%2Facel.12866"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Facel.12866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Facel.12866%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DM.%26aulast%3DJung%26aufirst%3DE.%2BS.%26aulast%3DJeon%26aufirst%3DS.%2BG.%26aulast%3DCha%26aufirst%3DM.-Y.%26aulast%3DJang%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DW.%26aulast%3DLopes%26aufirst%3DC.%26aulast%3DMook-Jung%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DK.-S.%26atitle%3DNurr1%2520%2528NR4A2%2529%2520regulates%2520Alzheimer%25E2%2580%2599s%2520disease-related%2520pathogenesis%2520and%2520cognitive%2520function%2520in%2520the%25205XFAD%2520mouse%2520model%26jtitle%3DAging%2520Cell%26date%3D2019%26volume%3D18%26doi%3D10.1111%2Facel.12866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McAnally, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiquee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomaa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divlianska, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peddibhotla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morfa, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hershberger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terry, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farjo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quigley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulton, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. H.</span></span> <span> </span><span class="NLM_article-title">Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">e0202436</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0202436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1371%2Fjournal.pone.0202436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30208056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlagsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&author=D.+McAnallyauthor=K.+Siddiqueeauthor=A.+Gomaaauthor=A.+Szaboauthor=S.+Vasileauthor=P.+R.+Maloneyauthor=D.+B.+Divlianskaauthor=S.+Peddibhotlaauthor=C.+J.+Morfaauthor=P.+Hershbergerauthor=R.+Falterauthor=R.+Williamsonauthor=D.+B.+Terryauthor=R.+Farjoauthor=A.+B.+Pinkertonauthor=X.+Qiauthor=J.+Quigleyauthor=M.+E.+Boultonauthor=M.+B.+Grantauthor=L.+H.+Smith&title=Repurposing+antimalarial+aminoquinolines+and+related+compounds+for+treatment+of+retinal+neovascularization&doi=10.1371%2Fjournal.pone.0202436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization</span></div><div class="casAuthors">McAnally, Danielle; Siddiquee, Khandaker; Gomaa, Ahmed; Szabo, Andras; Vasile, Stefan; Maloney, Patrick R.; Divlianska, Daniela B.; Peddibhotla, Satyamaheshwar; Morfa, Camilo J.; Hershberger, Paul; Falter, Rebecca; Williamson, Robert; Terry, David B.; Farjo, Rafal; Pinkerton, Anthony B.; Qi, Xiaping; Quigley, Judith; Boulton, Michael E.; Grant, Maria B.; Smith, Layton H.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e0202436/1-e0202436/23</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Neovascularization is the pathol. driver of blinding eye diseases such as retinopathy of prematurity, proliferative diabetic retinopathy, and wet age-related macular degeneration.  The loss of vision resulting from these diseases significantly impacts the productivity and quality of life of patients, and represents a substantial burden on the health care system.  Current std. of care includes biologics that target vascular endothelial growth factor (VEGF), a key mediator of neovascularization.  While anti-VGEF therapies have been successful, up to 30% of patients are non-responsive.  Therefore, there is a need for new therapeutic targets, and small mol. inhibitors of angiogenesis to complement existing treatments.  Apelin and its receptor have recently been shown to play a key role in both developmental and pathol. angiogenesis in the eye.  Through a cell-based highthroughput screen, we identified 4-aminoquinoline antimalarial drugs as potent selective antagonists of APJ.  The prototypical 4-aminoquinoline, amodiaquine was found to be a selective, non-competitive APJ antagonist that inhibited apelin signaling in a concentrationdependent manner.  Addnl., amodiaquine suppressed both apelin-and VEGF-induced endothelial tube formation.  Intravitreal amodaiquine significantly reduced choroidal neovascularization (CNV) lesion vol. in the laser-induced CNV mouse model, and showed no signs of ocular toxicity at the highest doses tested.  This work firmly establishes APJ as a novel, chem. tractable therapeutic target for the treatment of ocular neovascularization, and that amodiaquine is a potential candidate for repurposing and further toxicol., and pharmacokinetic evaluation in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIAOMW3MbqSrVg90H21EOLACvtfcHk0lh4qVnJcwUpDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlagsbrJ&md5=d3ed9a88af05b43d9c4ed842bf481de6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0202436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0202436%26sid%3Dliteratum%253Aachs%26aulast%3DMcAnally%26aufirst%3DD.%26aulast%3DSiddiquee%26aufirst%3DK.%26aulast%3DGomaa%26aufirst%3DA.%26aulast%3DSzabo%26aufirst%3DA.%26aulast%3DVasile%26aufirst%3DS.%26aulast%3DMaloney%26aufirst%3DP.%2BR.%26aulast%3DDivlianska%26aufirst%3DD.%2BB.%26aulast%3DPeddibhotla%26aufirst%3DS.%26aulast%3DMorfa%26aufirst%3DC.%2BJ.%26aulast%3DHershberger%26aufirst%3DP.%26aulast%3DFalter%26aufirst%3DR.%26aulast%3DWilliamson%26aufirst%3DR.%26aulast%3DTerry%26aufirst%3DD.%2BB.%26aulast%3DFarjo%26aufirst%3DR.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DQuigley%26aufirst%3DJ.%26aulast%3DBoulton%26aufirst%3DM.%2BE.%26aulast%3DGrant%26aufirst%3DM.%2BB.%26aulast%3DSmith%26aufirst%3DL.%2BH.%26atitle%3DRepurposing%2520antimalarial%2520aminoquinolines%2520and%2520related%2520compounds%2520for%2520treatment%2520of%2520retinal%2520neovascularization%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26doi%3D10.1371%2Fjournal.pone.0202436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesplède, T.</span></span> <span> </span><span class="NLM_article-title">Antimalarial drugs and their metabolites are potent Zika virus inhibitors</span>. <i>J. Med. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">1182</span>– <span class="NLM_lpage">1190</span>, <span class="refDoi"> DOI: 10.1002/jmv.25440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1002%2Fjmv.25440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30801742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvVOqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2019&pages=1182-1190&author=Y.+Hanauthor=H.+T.+Phamauthor=H.+Xuauthor=Y.+Quanauthor=T.+Mespl%C3%A8de&title=Antimalarial+drugs+and+their+metabolites+are+potent+Zika+virus+inhibitors&doi=10.1002%2Fjmv.25440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drugs and their metabolites are potent Zika virus inhibitors</span></div><div class="casAuthors">Han, Yingshan; Pham, Hanh T.; Xu, Hongtao; Quan, Yudong; Mesplede, Thibault</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Virology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1182-1190</span>CODEN:
                <span class="NLM_cas:coden">JMVIDB</span>;
        ISSN:<span class="NLM_cas:issn">0146-6615</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Studies aimed at repurposing existing drugs revealed that some antimalarial compds. possess anti-Zika virus (anti-ZIKV) activity.  Here, we further tested 14 addnl. antimalarial drugs and their metabolites or analogs for anti-ZIKV activity using a phenotypic screening approach.  We identified four compds. with varying anti-ZIKV activity, including a metabolite of amodiaquine termed desethylamodiaquine (DAQ) and N-desethylchloroquine (DECQ), a metabolite of chloroquine, which both exhibited low micromolar effective concns. against three different ZIKV strains.  Two other compds. termed dihydroartemisinin (DHA) and quinidine (QD) exhibited only partial inhibition of ZIKV replication.  Characterization of the inhibitory mechanisms of DAQ and DECQ showed that both drugs target the entry step as well as postentry events of the viral replication cycle.  These hits represent attractive starting points for future optimization of new anti-ZIKV drug candidates derived from antimalarial drugs and their analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolD7tHr00uD7Vg90H21EOLACvtfcHk0ljpEa_d5HjYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvVOqsLc%253D&md5=111c2c9601b956ac74b275827c3e9fa7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fjmv.25440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmv.25440%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DY.%26aulast%3DPham%26aufirst%3DH.%2BT.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DQuan%26aufirst%3DY.%26aulast%3DMespl%25C3%25A8de%26aufirst%3DT.%26atitle%3DAntimalarial%2520drugs%2520and%2520their%2520metabolites%2520are%2520potent%2520Zika%2520virus%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Virol.%26date%3D2019%26volume%3D91%26spage%3D1182%26epage%3D1190%26doi%3D10.1002%2Fjmv.25440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakakibara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, R. A.</span></span> <span> </span><span class="NLM_article-title">Novel amodiaquine derivatives potently inhibit Ebola virus infection</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2018.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.antiviral.2018.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30395872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyqsb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2018&pages=175-182&author=Y.+Sakuraiauthor=N.+Sakakibaraauthor=M.+Toyamaauthor=M.+Babaauthor=R.+A.+Davey&title=Novel+amodiaquine+derivatives+potently+inhibit+Ebola+virus+infection&doi=10.1016%2Fj.antiviral.2018.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Novel amodiaquine derivatives potently inhibit Ebola virus infection</span></div><div class="casAuthors">Sakurai, Yasuteru; Sakakibara, Norikazu; Toyama, Masaaki; Baba, Masanori; Davey, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">175-182</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ebola virus disease is a severe disease caused by highly pathogenic Ebolaviruses.  Although it shows a high mortality rate in humans, currently there is no licensed therapeutic.  During the recent epidemic in West Africa, it was demonstrated that administration of antimalarial medication contg. amodiaquine significantly lowered mortality rate of patients infected with the virus.  Here, in order to improve its antiviral activity, a series of amodiaquine derivs. were synthesized and tested for Ebola virus infection.  We found that multiple compds. were more potent than amodiaquine.  The structure-activity relationship anal. revealed that the two independent parts, which are the alkyl chains extending from the aminomethyl group and a halogen bonded to the quinoline ring, were keys for enhancing antiviral potency without increasing toxicity.  When these modifications were combined, the antiviral efficacy could be further improved with the selectivity indexes being over 10-times higher than amodiaquine.  Mechanistic evaluation demonstrated that the potent derivs. blocked host cell entry of Ebola virus, like the parental amodiaquine.  Taken together, our work identified novel potent amodiaquine derivs., which will aid in further development of effective antiviral therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg7fQHI66_hbVg90H21EOLACvtfcHk0ljpEa_d5HjYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyqsb7F&md5=eabfccce2ea4a88acdc00c1f6c2e745c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2018.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2018.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DSakurai%26aufirst%3DY.%26aulast%3DSakakibara%26aufirst%3DN.%26aulast%3DToyama%26aufirst%3DM.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DDavey%26aufirst%3DR.%2BA.%26atitle%3DNovel%2520amodiaquine%2520derivatives%2520potently%2520inhibit%2520Ebola%2520virus%2520infection%26jtitle%3DAntiviral%2520Res.%26date%3D2018%26volume%3D160%26spage%3D175%26epage%3D182%26doi%3D10.1016%2Fj.antiviral.2018.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, D. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluzman, I. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, D. E.</span></span> <span> </span><span class="NLM_article-title">On the molecular mechanism of chloroquine’s antimalarial action</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">11865</span>– <span class="NLM_lpage">11870</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.21.11865</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1073%2Fpnas.93.21.11865" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=8876229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADyaK28Xmtlamt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=11865-11870&author=D.+J.+Sullivanauthor=I.+Y.+Gluzmanauthor=D.+G.+Russellauthor=D.+E.+Goldberg&title=On+the+molecular+mechanism+of+chloroquine%E2%80%99s+antimalarial+action&doi=10.1073%2Fpnas.93.21.11865"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">On the molecular mechanism of chloroquine's antimalarial action</span></div><div class="casAuthors">Sullivan, David J., Jr.; Gluzman, Ilya Y.; Russell, David G.; Goldberg, Daniel E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">11865-11870</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Chloroquine is thought to exert its antimalarial effect by preventing the polymn. of toxic heme released during proteolysis of Hb in the Plasmodium digestive vacuole.  The mechanism of this blockade has not been established.  The authors incubated cultured parasites with subinhibitory doses of [3H]chloroquine and [3H]quinidine.  These [3H]quinoline compds. became assocd. with hemozoin as assessed by electron microscope autoradiog. and subcellular fractionation.  In vitro, binding of [3H]quinoline inhibitors to the hemozoin chain depended on the addn. of heme substrate.  These data counter previous conclusions regarding the lack of quinoline assocn. with hemozoin, explain the exaggerated accumulation of quinolines in the Plasmodium digestive vacuole, and suggest that a quinoline-heme complex incorporates into the growing polymer to terminate chain extension, blocking further sequestration of toxic heme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEX6AGc8Unx7Vg90H21EOLACvtfcHk0ljpEa_d5HjYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xmtlamt7k%253D&md5=075515c130f356354f42e5641693a356</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.21.11865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.21.11865%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DD.%2BJ.%26aulast%3DGluzman%26aufirst%3DI.%2BY.%26aulast%3DRussell%26aufirst%3DD.%2BG.%26aulast%3DGoldberg%26aufirst%3DD.%2BE.%26atitle%3DOn%2520the%2520molecular%2520mechanism%2520of%2520chloroquine%25E2%2580%2599s%2520antimalarial%2520action%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D11865%26epage%3D11870%26doi%3D10.1073%2Fpnas.93.21.11865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengerer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattes, H.</span></span> <span> </span><span class="NLM_article-title">Identification of a potent agonist of the orphan nuclear receptor Nurr1</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">955</span>– <span class="NLM_lpage">958</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200600078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1002%2Fcmdc.200600078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=16952138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVCmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=955-958&author=C.+Duboisauthor=B.+Hengererauthor=H.+Mattes&title=Identification+of+a+potent+agonist+of+the+orphan+nuclear+receptor+Nurr1&doi=10.1002%2Fcmdc.200600078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a potent agonist of the orphan nuclear receptor Nurr1</span></div><div class="casAuthors">Dubois, Celine; Hengerer, Bastian; Mattes, Henri</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">955-958</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Mimotope's SynPhase double lanterns were used for the development of a six-step synthesis of benzimidazoles.  A library of 3840 benzimidazoles was prepd. on Mimotope's double lanterns using the sort-and-combine strategy.  A no. of micromolar agonists of Nurr1, which increased the luciferase reporter-gene activity by a factor of 2, could be identified by screening the first generation library of 3256 compds.  To improve the potency of the first-generation hits, we designed and synthesized a second-generation library biased toward Nurr1.  Very potent Nurrl agonists (e.g. I ) were thus rapidly identified by designing, synthesizing, and screening a first-generation library oriented toward nuclear receptors, followed by a small, biased second-generation library.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqAkTyjtOyTbVg90H21EOLACvtfcHk0lgl5Ow34L-o0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVCmu7o%253D&md5=cf81e4fdb1410b826f77479f61f0c30c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200600078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200600078%26sid%3Dliteratum%253Aachs%26aulast%3DDubois%26aufirst%3DC.%26aulast%3DHengerer%26aufirst%3DB.%26aulast%3DMattes%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520a%2520potent%2520agonist%2520of%2520the%2520orphan%2520nuclear%2520receptor%2520Nurr1%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D955%26epage%3D958%26doi%3D10.1002%2Fcmdc.200600078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Krosigk, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathé, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengerer, B.</span></span> <span> </span><span class="NLM_article-title">Identification of a series of highly potent activators of the Nurr1 signaling pathway</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.09.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.bmcl.2006.09.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=17035009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2sXislSg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=193-196&author=S.+Hintermannauthor=M.+Chiesiauthor=U.+von+Krosigkauthor=D.+Math%C3%A9author=R.+Felberauthor=B.+Hengerer&title=Identification+of+a+series+of+highly+potent+activators+of+the+Nurr1+signaling+pathway&doi=10.1016%2Fj.bmcl.2006.09.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a series of highly potent activators of the Nurr1 signaling pathway</span></div><div class="casAuthors">Hintermann, Samuel; Chiesi, Michele; von Krosigk, Ulrike; Mathe, Daniele; Felber, Richard; Hengerer, Bastian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-196</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The nuclear receptor Nurr1 (NR4A2) is critically involved in the development and maintenance of midbrain dopaminergic neurons and is believed to function independently of endogenous activation.  The hit identification and SAR studies leading to isoxazolo-pyridinone 7e (I), a highly potent, brain penetrable activator of the Nurr1 signaling pathway, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcDV-XImUf67Vg90H21EOLACvtfcHk0lgl5Ow34L-o0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXislSg&md5=8cb547a0ff17183aaef9a87dd1db29ef</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.09.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.09.062%26sid%3Dliteratum%253Aachs%26aulast%3DHintermann%26aufirst%3DS.%26aulast%3DChiesi%26aufirst%3DM.%26aulast%3Dvon%2BKrosigk%26aufirst%3DU.%26aulast%3DMath%25C3%25A9%26aufirst%3DD.%26aulast%3DFelber%26aufirst%3DR.%26aulast%3DHengerer%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520a%2520series%2520of%2520highly%2520potent%2520activators%2520of%2520the%2520Nurr1%2520signaling%2520pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D193%26epage%3D196%26doi%3D10.1016%2Fj.bmcl.2006.09.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montarolo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffaele, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furlan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertolotto, A.</span></span> <span> </span><span class="NLM_article-title">Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e108791</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0108791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1371%2Fjournal.pone.0108791" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=25265488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslegtbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=F.+Montaroloauthor=C.+Raffaeleauthor=S.+Pergaauthor=S.+Martireauthor=A.+Finardiauthor=R.+Furlanauthor=S.+Hintermannauthor=A.+Bertolotto&title=Effects+of+isoxazolo-pyridinone+7e%2C+a+potent+activator+of+the+Nurr1+signaling+pathway%2C+on+experimental+autoimmune+encephalomyelitis+in+mice&doi=10.1371%2Fjournal.pone.0108791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice</span></div><div class="casAuthors">Montarolo, Francesca; Raffaele, Chiara; Perga, Simona; Martire, Serena; Finardi, Annamaria; Furlan, Roberto; Hintermann, Samuel; Bertolotto, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e108791/1-e108791/9, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Multiple sclerosis (MS) is an autoimmune chronic disease of the central nervous system (CNS) characterized by immune-mediated inflammation, demyelination and subsequent axonal damage.  Gene expression profiling showed that Nurr1, an orphan nuclear receptor, is down-regulated in peripheral blood mononuclear cells of MS patients.  Nurr1 exerts an anti-inflammatory role repressing the activity of the pro-inflammatory transcription factor NF-kB.  Here, we report that the preventive treatment with isoxazolo-pyridinone 7e, an activator of Nurr1 signaling pathway, reduces the incidence and the severity of a MS murine model, i.e. exptl. autoimmune encephalomyelitis (EAE).  The compd. is able to attenuate inflammation and neurodegeneration in spinal cords of EAE mice by an NF-kB pathway-dependent process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqNGVvjCYeK7Vg90H21EOLACvtfcHk0lgl5Ow34L-o0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslegtbvP&md5=bdf7ca10afd4a66a10360bb2ef394c69</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0108791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0108791%26sid%3Dliteratum%253Aachs%26aulast%3DMontarolo%26aufirst%3DF.%26aulast%3DRaffaele%26aufirst%3DC.%26aulast%3DPerga%26aufirst%3DS.%26aulast%3DMartire%26aufirst%3DS.%26aulast%3DFinardi%26aufirst%3DA.%26aulast%3DFurlan%26aufirst%3DR.%26aulast%3DHintermann%26aufirst%3DS.%26aulast%3DBertolotto%26aufirst%3DA.%26atitle%3DEffects%2520of%2520isoxazolo-pyridinone%25207e%252C%2520a%2520potent%2520activator%2520of%2520the%2520Nurr1%2520signaling%2520pathway%252C%2520on%2520experimental%2520autoimmune%2520encephalomyelitis%2520in%2520mice%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0108791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lesuisse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malanda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyronel, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evanno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lardenois, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De-Peretti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abécassis, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnéoud, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgevin, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cegarra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dommergue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Even, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luc, T. P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almario, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castel, M.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taupin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigé, X.</span></span> <span> </span><span class="NLM_article-title">Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson’s disease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.bmcl.2019.01.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30773432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjt1Sqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=929-932&author=D.+Lesuisseauthor=A.+Malandaauthor=J.-F.+Peyronelauthor=Y.+Evannoauthor=P.+Lardenoisauthor=D.+De-Perettiauthor=P.-Y.+Ab%C3%A9cassisauthor=P.+Barn%C3%A9oudauthor=P.+Brunelauthor=M.-C.+Burgevinauthor=C.+Cegarraauthor=F.+Augerauthor=A.+Dommergueauthor=C.+Lafonauthor=L.+Evenauthor=J.+Tsiauthor=T.+P.+H.+Lucauthor=A.+Almarioauthor=A.+Olivierauthor=M.-N.+Castelauthor=V.+Taupinauthor=T.+Rooneyauthor=X.+Vig%C3%A9&title=Development+of+a+novel+NURR1%2FNOT+agonist+from+hit+to+lead+and+candidate+for+the+potential+treatment+of+Parkinson%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2019.01.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease</span></div><div class="casAuthors">Lesuisse, Dominique; Malanda, Andre; Peyronel, Jean-Francois; Evanno, Yannick; Lardenois, Patrick; De-Peretti, Danielle; Abecassis, Pierre-Yves; Barneoud, Pascal; Brunel, Pascale; Burgevin, Marie-Claude; Cegarra, Celine; Auger, Florian; Dommergue, Amelie; Lafon, Corinne; Even, Luc; Tsi, Joanna; Luc, Thy Phuong Hieu; Almario, Antonio; Olivier, Anne; Castel, Marie-Noelle; Taupin, Veronique; Rooney, Thomas; Vige, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">929-932</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the course of a program aimed at identifying Nurr1/NOT agonists for potential treatment of Parkinson's disease, a few hits from high throughput screening were identified and characterized.  A combined optimization pointed to a very narrow and stringent structure activity relationship.  A comprehensive program of optimization led to a potent and safe candidate drug displaying neuroprotective and anti-inflammatory activity in several in vitro and in vivo models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcufBh3Md1wbVg90H21EOLACvtfcHk0lhw1rDkqD8w5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjt1Sqtbg%253D&md5=20b882a19d4c0db9abf47f45dfbc8b61</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DLesuisse%26aufirst%3DD.%26aulast%3DMalanda%26aufirst%3DA.%26aulast%3DPeyronel%26aufirst%3DJ.-F.%26aulast%3DEvanno%26aufirst%3DY.%26aulast%3DLardenois%26aufirst%3DP.%26aulast%3DDe-Peretti%26aufirst%3DD.%26aulast%3DAb%25C3%25A9cassis%26aufirst%3DP.-Y.%26aulast%3DBarn%25C3%25A9oud%26aufirst%3DP.%26aulast%3DBrunel%26aufirst%3DP.%26aulast%3DBurgevin%26aufirst%3DM.-C.%26aulast%3DCegarra%26aufirst%3DC.%26aulast%3DAuger%26aufirst%3DF.%26aulast%3DDommergue%26aufirst%3DA.%26aulast%3DLafon%26aufirst%3DC.%26aulast%3DEven%26aufirst%3DL.%26aulast%3DTsi%26aufirst%3DJ.%26aulast%3DLuc%26aufirst%3DT.%2BP.%2BH.%26aulast%3DAlmario%26aufirst%3DA.%26aulast%3DOlivier%26aufirst%3DA.%26aulast%3DCastel%26aufirst%3DM.-N.%26aulast%3DTaupin%26aufirst%3DV.%26aulast%3DRooney%26aufirst%3DT.%26aulast%3DVig%25C3%25A9%26aufirst%3DX.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520NURR1%252FNOT%2520agonist%2520from%2520hit%2520to%2520lead%2520and%2520candidate%2520for%2520the%2520potential%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D929%26epage%3D932%26doi%3D10.1016%2Fj.bmcl.2019.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3’-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">1445</span>– <span class="NLM_lpage">1455</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2012.02.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.bcp.2012.02.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=22405837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFGitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=1445-1455&author=X.+Liauthor=S.-O.+Leeauthor=S.+Safe&title=Structure-dependent+activation+of+NR4A2+%28Nurr1%29+by+1%2C1-bis%283%E2%80%99-indolyl%29-1-%28aromatic%29methane+analogs+in+pancreatic+cancer+cells&doi=10.1016%2Fj.bcp.2012.02.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3'-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cells</span></div><div class="casAuthors">Li, Xi; Lee, Syng-Ook; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1445-1455</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NR4A2 (Nurr1) is an orphan nuclear receptor with no known endogenous ligands and is highly expressed in many cancer cell lines including Panc1 and Panc28 pancreatic cancer cells.  Structure-dependent activation of NR4A2 by a series of 1,1-bis(3'-indolyl)-1-(arom.)methane (C-DIM) analogs was detd. in pancreatic cancer cells transfected with yeast GAL4-Nurr1 chimeras and a UASx5-luc reporter gene or constructs contg. response elements that bind NR4A2.  Among 23 different structural analogs, Ph groups contg. p-substituted trifluoromethyl, t-Bu, cyano, bromo, iodo and trifluoromethoxy groups were the most active compds. in transactivation assay.  The p-bromophenyl analog (DIM-C-pPhBr) was used as a model for structure-activity studies among a series of ortho-, meta- and para-bromophenyl isomers and the corresponding indole 2- and N-Me analogs.  Results show that NR4A2 activation was maximal with the p-bromophenyl analog and methylation of the indole NH group abrogated activity.  Moreover, using GAL4-Nurr1 (full length) or GAL-Nurr1-A/B and GAL4-Nurr1-(C-F) chimeras expressing N- and C-terminal domains of Nurr1, resp., DIM-C-pPhBr activated all three constructs and these responses were differentially affected by kinase inhibitors.  DIM-C-pPhBr also modulated expression of several Nurr1-regulated genes in pancreatic cancer cells including vasoactive intestinal peptide (VIP), and the immunohistochem. and western blot analyses indicated that DIM-C-pPhBr activates nuclear NR4A2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS0O1bRvqj0LVg90H21EOLACvtfcHk0lhw1rDkqD8w5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFGitbY%253D&md5=c2a6e2dfb65f41fe9aa193af7335d25e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.02.021%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DS.-O.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DStructure-dependent%2520activation%2520of%2520NR4A2%2520%2528Nurr1%2529%2520by%25201%252C1-bis%25283%25E2%2580%2599-indolyl%2529-1-%2528aromatic%2529methane%2520analogs%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D1445%26epage%3D1455%26doi%3D10.1016%2Fj.bcp.2012.02.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjalkens, R. B.</span></span> <span> </span><span class="NLM_article-title">A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>607</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2015.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.neulet.2015.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=26383113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1SlurnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=607&publication_year=2015&pages=83-89&author=S.+L.+Hammondauthor=S.+Safeauthor=R.+B.+Tjalkens&title=A+novel+synthetic+activator+of+Nurr1+induces+dopaminergic+gene+expression+and+protects+against+6-hydroxydopamine+neurotoxicity+in+vitro&doi=10.1016%2Fj.neulet.2015.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro</span></div><div class="casAuthors">Hammond, Sean L.; Safe, Stephen; Tjalkens, Ronald B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">607</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83-89</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Degeneration of dopaminergic neurons in Parkinson's disease (PD) is assocd. with decreased expression of the orphan nuclear receptor Nurr1 (NR4A2), which is crit. for both homeostasis and development of dopamine (DA) neurons.  The synthetic, phytochem.-based compd., 1,1-bis (3'-indolyl)-1-(p-chlorophenyl) methane (C-DIM12) activates Nurr1 in cancer cells and prevents loss of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD in mice.  In the present study, we examd. the capacity of C-DIM12 to induce expression of Nurr1-regulated genes in two dopaminergic neuronal cell lines (N2A, N27) and to protect against 6-hydroxydopamine (6-OHDA) neurotoxicity.  C-DIM12 induced expression of Nurr1-regulated genes that was abolished by Nurr1 knockdown.  C-DIM12 increased expression of transfected human Nurr1, induced Nurr1 protein expression in primary dopaminergic neurons and enhanced neuronal survival from exposure to 6-OHDA.  These data indicate that C-DIM12 stimulates neuroprotective expression Nurr1-regulated genes in DA neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlLJOnSUsgArVg90H21EOLACvtfcHk0lhw1rDkqD8w5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1SlurnJ&md5=0d9a83edeeec515918023b330ab72f50</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2015.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2015.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DHammond%26aufirst%3DS.%2BL.%26aulast%3DSafe%26aufirst%3DS.%26aulast%3DTjalkens%26aufirst%3DR.%2BB.%26atitle%3DA%2520novel%2520synthetic%2520activator%2520of%2520Nurr1%2520induces%2520dopaminergic%2520gene%2520expression%2520and%2520protects%2520against%25206-hydroxydopamine%2520neurotoxicity%2520in%2520vitro%26jtitle%3DNeurosci.%2520Lett.%26date%3D2015%26volume%3D607%26spage%3D83%26epage%3D89%26doi%3D10.1016%2Fj.neulet.2015.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popichak, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richman, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damale, P. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, E. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backos, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjalkens, R. B.</span></span> <span> </span><span class="NLM_article-title">The Nurr1 Ligand,1,1-bis(3’-Indolyl)-1-(p-Chlorophenyl)Methane, Modulates Glial Reactivity and Is Neuroprotective in MPTP-Induced Parkinsonism</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">636</span>– <span class="NLM_lpage">651</span>, <span class="refDoi"> DOI: 10.1124/jpet.117.246389</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1124%2Fjpet.117.246389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=29626009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVCntb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2018&pages=636-651&author=S.+L.+Hammondauthor=K.+A.+Popichakauthor=X.+Liauthor=L.+G.+Huntauthor=E.+H.+Richmanauthor=P.+U.+Damaleauthor=E.+K.+P.+Chongauthor=D.+S.+Backosauthor=S.+Safeauthor=R.+B.+Tjalkens&title=The+Nurr1+Ligand%2C1%2C1-bis%283%E2%80%99-Indolyl%29-1-%28p-Chlorophenyl%29Methane%2C+Modulates+Glial+Reactivity+and+Is+Neuroprotective+in+MPTP-Induced+Parkinsonism&doi=10.1124%2Fjpet.117.246389"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The Nurr1 ligand,1,1-bis(3'-indolyl)-1-(p-chlorophenyl)methane, modulates glial reactivity and is neuroprotective in MPTP-induced parkinsonisms</span></div><div class="casAuthors">Hammond, Sean L.; Popichak, Katriana A.; Li, Xi; Hunt, Lindsay G.; Richman, Evan H.; Damale, Pranav U.; Chong, Edwin K. P.; Backos, Donald S.; Safe, Stephen; Tjalkens, Ronald B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">636-651</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We postulated that the activation of Nurr1 would suppress the activation of glia and thereby protect against loss of DA neurons after subacute lesioning with MPTP.  Our previous studies have shown that a synthetic Nurr1 ligand, C-DIM12, suppresses inflammatory gene expression in primary astrocytes and induces a dopaminergic phenotype in neurons.  Pharmacokinetic anal. of C-DIM12 in mice by liq. chromatog.-mass spectrometry demonstrated that approx. three times more compd. concd. in the brain than in plasma.  Mice treated with four doses of MPTP + probenecid over 14 days were monitored for neurobehavioral function, loss of dopaminergic neurons, and glial activation.  C-DIM12 protected against the loss of DA neurons in the substantia nigra pars compacta and DA terminals in the striatum, maintained a ramified phenotype in microglia, and suppressed activation of astrocytes.  In vitro reporter assays demonstrated that C-DIM12 was an effective activator of Nurr1 transcription in neuronal cell lines.  Computational modeling of C-DIM12 binding to the three-dimensional structure of human Nurr1 identified a high-affinity binding interaction with Nurr1 at the coactivator domain.  Taken together, these data suggest that C-DIM12 is an activator of Nurr1 that suppresses glial activation and neuronal loss in vivo after treatment with MPTP, and that this receptor could be an efficacious target for disease modification in individuals with Parkinson's disease and related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopgugLhnM2J7Vg90H21EOLACvtfcHk0ljMJR3Qo5e8nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVCntb3O&md5=77dd95db62e674cd310b56a041be2b89</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.117.246389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.117.246389%26sid%3Dliteratum%253Aachs%26aulast%3DHammond%26aufirst%3DS.%2BL.%26aulast%3DPopichak%26aufirst%3DK.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHunt%26aufirst%3DL.%2BG.%26aulast%3DRichman%26aufirst%3DE.%2BH.%26aulast%3DDamale%26aufirst%3DP.%2BU.%26aulast%3DChong%26aufirst%3DE.%2BK.%2BP.%26aulast%3DBackos%26aufirst%3DD.%2BS.%26aulast%3DSafe%26aufirst%3DS.%26aulast%3DTjalkens%26aufirst%3DR.%2BB.%26atitle%3DThe%2520Nurr1%2520Ligand%252C1%252C1-bis%25283%25E2%2580%2599-Indolyl%2529-1-%2528p-Chlorophenyl%2529Methane%252C%2520Modulates%2520Glial%2520Reactivity%2520and%2520Is%2520Neuroprotective%2520in%2520MPTP-Induced%2520Parkinsonism%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2018%26volume%3D365%26spage%3D636%26epage%3D651%26doi%3D10.1124%2Fjpet.117.246389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papineni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chintharlapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamat, A. M.</span></span> <span> </span><span class="NLM_article-title">1,1-Bis(3’-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3825</span>– <span class="NLM_lpage">3833</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-08-0730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1158%2F1535-7163.MCT-08-0730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=19074857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2iurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=3825-3833&author=T.+Inamotoauthor=S.+Papineniauthor=S.+Chintharlapalliauthor=S.-D.+Choauthor=S.+Safeauthor=A.+M.+Kamat&title=1%2C1-Bis%283%E2%80%99-indolyl%29-1-%28p-chlorophenyl%29methane+activates+the+orphan+nuclear+receptor+Nurr1+and+inhibits+bladder+cancer+growth&doi=10.1158%2F1535-7163.mct-08-0730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">1,1-Bis(3'-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth</span></div><div class="casAuthors">Inamoto, Teruo; Papineni, Sabitha; Chintharlapalli, Sudhakar; Cho, Sung-Dae; Safe, Stephen; Kamat, Ashish M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3825-3833</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Nurr1 is an orphan nuclear receptor and a member of the nerve growth factor I-B subfamily of transcription factors with no known endogenous ligand or stimulator.  We show, for the first time, evidence that Nurr1 is expressed in a panel of 11 human bladder cancer cell lines.  A new class of methylene-substituted diindolylmethanes (C-DIM) were screened and 1,1-bis(3'-indolyl)-1-(p-chlorophenyl)methane (DIM-C-pPhCl) activated the ligand-binding domain of Nurr1.  Treatment of bladder cancer cells with Nurr1-active C-DIM resulted in decreased cell survival (MTT assay) and induction of cell death pathways, resulting in poly(ADP-ribose) polymerase cleavage and DNA fragmentation.  The specificity of the Nurr1-active compd. was shown using RNA interference in 253J B-V cells, whereby small interfering RNA against Nurr1 attenuated ligand-dependent activation of Nurr1 and poly(ADP-ribose) polymerase cleavage.  Furthermore, activation of Nurr1 resulted in stimulation of tumor necrosis factor-related apoptosis-inducing ligand and small interfering RNA expts. attenuated tumor necrosis factor-related apoptosis-inducing ligand prodn.  In an orthotopic model of human bladder tumors established in nude mice, administration of a Nurr1-active C-DIM suppressed bladder cancer growth.  These results identify Nurr1 as a potential target for bladder cancer therapy and also identify a novel agent for activating Nurr1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouz8JILbKS57Vg90H21EOLACvtfcHk0ljMJR3Qo5e8nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2iurbK&md5=1cfbb9b8327fcd644d5eb996b79e2e69</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0730%26sid%3Dliteratum%253Aachs%26aulast%3DInamoto%26aufirst%3DT.%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DS.-D.%26aulast%3DSafe%26aufirst%3DS.%26aulast%3DKamat%26aufirst%3DA.%2BM.%26atitle%3D1%252C1-Bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-chlorophenyl%2529methane%2520activates%2520the%2520orphan%2520nuclear%2520receptor%2520Nurr1%2520and%2520inhibits%2520bladder%2520cancer%2520growth%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D3825%26epage%3D3833%26doi%3D10.1158%2F1535-7163.mct-08-0730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hibino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikuma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsukasa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omata-Mise, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Nr4a Receptors Enhances Antitumor Immunity by Breaking Treg-Mediated Immune Tolerance</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">3027</span>– <span class="NLM_lpage">3040</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-17-3102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1158%2F0008-5472.CAN-17-3102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=29559474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKjsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=3027-3040&author=S.+Hibinoauthor=S.+Chikumaauthor=T.+Kondoauthor=M.+Itoauthor=H.+Nakatsukasaauthor=S.+Omata-Miseauthor=A.+Yoshimura&title=Inhibition+of+Nr4a+Receptors+Enhances+Antitumor+Immunity+by+Breaking+Treg-Mediated+Immune+Tolerance&doi=10.1158%2F0008-5472.can-17-3102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Nr4a receptors enhances antitumor immunity by breaking Treg-mediated immune tolerance</span></div><div class="casAuthors">Hibino, Sana; Chikuma, Shunsuke; Kondo, Taisuke; Ito, Minako; Nakatsukasa, Hiroko; Omata-Mise, Setsuko; Yoshimura, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3027-3040</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Enhanced infiltration of regulatory T cells (Treg) into tumor tissue is detrimental to patients with cancer and is closely assocd. with poor prognosis as they create an immunosuppressive state that suppresses antitumor immune responses.  Therefore, breaking Treg-mediated immune tolerance is important when considering cancer immunotherapy.  Here, we show that the Nr4a nuclear receptors, key transcription factors maintaining Treg genetic programs, contribute to Treg-mediated suppression of antitumor immunity in the tumor microenvironment.  Mice lacking Nr4a1 and Nr4a2 genes specifically in Tregs showed resistance to tumor growth in transplantation models without exhibiting any severe systemic autoimmunity.  The chemotherapeutic agent camptothecin and a common cyclooxygenase-2 inhibitor were found to inhibit transcriptional activity and induction of Nr4a factors, and they synergistically exerted antitumor effects.  Genetic inactivation or pharmacol. inhibition of Nr4a factors unleashed effector activities of CD8+ cytotoxic T cells and evoked potent antitumor immune responses.  These findings demonstrate that inactivation of Nr4a in Tregs breaks immune tolerance toward cancer, and pharmacol. modulation of Nr4a activity may be a novel cancer treatment strategy targeting the immunosuppressive tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSj-KLLzLI-7Vg90H21EOLACvtfcHk0ljMJR3Qo5e8nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKjsb%252FK&md5=8121148b58f88e18a3eead1fe7c50522</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-17-3102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-17-3102%26sid%3Dliteratum%253Aachs%26aulast%3DHibino%26aufirst%3DS.%26aulast%3DChikuma%26aufirst%3DS.%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DNakatsukasa%26aufirst%3DH.%26aulast%3DOmata-Mise%26aufirst%3DS.%26aulast%3DYoshimura%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520Nr4a%2520Receptors%2520Enhances%2520Antitumor%2520Immunity%2520by%2520Breaking%2520Treg-Mediated%2520Immune%2520Tolerance%26jtitle%3DCancer%2520Res.%26date%3D2018%26volume%3D78%26spage%3D3027%26epage%3D3040%26doi%3D10.1158%2F0008-5472.can-17-3102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alitongbieke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-k.</span></span> <span> </span><span class="NLM_article-title">Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2017.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.molcel.2017.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=28388439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvFWgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2017&pages=141-153&author=M.+Huauthor=Q.+Luoauthor=G.+Alitongbiekeauthor=S.+Chongauthor=C.+Xuauthor=L.+Xieauthor=X.+Chenauthor=D.+Zhangauthor=Y.+Zhouauthor=Z.+Wangauthor=X.+Yeauthor=L.+Caiauthor=F.+Zhangauthor=H.+Chenauthor=F.+Jiangauthor=H.+Fangauthor=S.+Yangauthor=J.+Liuauthor=M.+T.+Diaz-Mecoauthor=Y.+Suauthor=H.+Zhouauthor=J.+Moscatauthor=X.+Linauthor=X.-k.+Zhang&title=Celastrol-Induced+Nur77+Interaction+with+TRAF2+Alleviates+Inflammation+by+Promoting+Mitochondrial+Ubiquitination+and+Autophagy&doi=10.1016%2Fj.molcel.2017.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy</span></div><div class="casAuthors">Hu, Mengjie; Luo, Qiang; Alitongbieke, Gulimiran; Chong, Shuyi; Xu, Chenting; Xie, Lei; Chen, Xiaohui; Zhang, Duo; Zhou, Yuqi; Wang, Zhaokai; Ye, Xiaohong; Cai, Lijun; Zhang, Fang; Chen, Huibin; Jiang, Fuquan; Fang, Hui; Yang, Shanjun; Liu, Jie; Diaz-Meco, Maria T.; Su, Ying; Zhou, Hu; Moscat, Jorge; Lin, Xiangzhi; Zhang, Xiao-kun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-153.e6</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mitochondria play an integral role in cell death, autophagy, immunity, and inflammation.  We previously showed that Nur77, an orphan nuclear receptor, induces apoptosis by targeting mitochondria.  Here, we report that celastrol, a potent anti-inflammatory pentacyclic triterpene, binds Nur77 to inhibit inflammation and induce autophagy in a Nur77-dependent manner.  Celastrol promotes Nur77 translocation from the nucleus to mitochondria, where it interacts with tumor necrosis factor receptor-assocd. factor 2 (TRAF2), a scaffold protein and E3 ubiquitin ligase important for inflammatory signaling.  The interaction is mediated by an LxxLL motif in TRAF2 and results not only in the inhibition of TRAF2 ubiquitination but also in Lys63-linked Nur77 ubiquitination.  Under inflammatory conditions, ubiquitinated Nur77 resides at mitochondria, rendering them sensitive to autophagy, an event involving Nur77 interaction with p62/SQSTM1.  Together, our results identify Nur77 as a crit. intracellular target for celastrol and unravel a mechanism of Nur77-dependent clearance of inflamed mitochondria to alleviate inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrONhphh-QPwrVg90H21EOLACvtfcHk0lh6DXANby3tWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvFWgs7s%253D&md5=a8efd7d1312b3252511ad4d8cd8db045</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2017.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2017.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DAlitongbieke%26aufirst%3DG.%26aulast%3DChong%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.-k.%26atitle%3DCelastrol-Induced%2520Nur77%2520Interaction%2520with%2520TRAF2%2520Alleviates%2520Inflammation%2520by%2520Promoting%2520Mitochondrial%2520Ubiquitination%2520and%2520Autophagy%26jtitle%3DMol.%2520Cell%26date%3D2017%26volume%3D66%26spage%3D141%26epage%3D153%26doi%3D10.1016%2Fj.molcel.2017.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-O.</span></span> <span> </span><span class="NLM_article-title">Dual targeting of Nur77 and AMPKalpha by isoalantolactone inhibits adipogenesis in vitro and decreases body fat mass in vivo</span>. <i>Int. J. Obes.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">952</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1038/s41366-018-0276-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fs41366-018-0276-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFSms7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2019&pages=952-962&author=Y.-S.+Jungauthor=H.-S.+Leeauthor=H.-R.+Choauthor=K.-J.+Kimauthor=J.-H.+Kimauthor=S.+Safeauthor=S.-O.+Lee&title=Dual+targeting+of+Nur77+and+AMPKalpha+by+isoalantolactone+inhibits+adipogenesis+in+vitro+and+decreases+body+fat+mass+in+vivo&doi=10.1038%2Fs41366-018-0276-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Dual targeting of Nur77 and AMPKα by isoalantolactone inhibits adipogenesis in vitro and decreases body fat mass in vivo</span></div><div class="casAuthors">Jung, Yeon-Seop; Lee, Hyo-Seon; Cho, Hye-Rin; Kim, Keuk-Jun; Kim, Joung-Hee; Safe, Stephen; Lee, Syng-Ook</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Obesity</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">952-962</span>CODEN:
                <span class="NLM_cas:coden">IJOBDP</span>;
        ISSN:<span class="NLM_cas:issn">0307-0565</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Background: Suppression of adipogenesis has been considered as a potential target for the prevention and treatment of obesity and assocd. metabolic disorders, and the nuclear receptor 4A1 (NR4A1/Nur77) and AMPKα are known to play important roles during early and intermediate stages of adipogenesis.  Therefore, we hypothesized that dual targeting Nur77 and AMPKα would show strong inhibitory effect on adipogenesis.  Methods: We screened a herbal medicine-based small mol. library to identify novel natural compds. dual targeting Nur77 and AMPKα, and the antiadipogenic effects and mechanisms of action of a "hit" compd. were studied in 3T3-L1 cells.  In vivo antiobesity effects of the compd. were also investigated in high-fat diet (HFD)-induced obese mice.  Results: We identified isoalantolactone (ISO) as a new NR4A1 inactivator that also activates AMPKα in 3T3-L1 cells.  ISO, as expected, inhibited adipogenic differentiation of 3T3-L1 preadipocytes, accompanied by reduced mitotic clonal expansion (MCE) which occurs in the early stage of adipogenesis and decreased expression of genes required for MCE and cell cycle markers including cyclin A, cyclin D1.  Furthermore, ISO reduced body wt. gain and fat mass (epididymal, s.c., perirenal, and inguinal white adipose tissues) in the high-fat diet-fed C57BL/6 N mice.  Serum levels of triglycerides, aspartate transaminase, and alanine transaminase and hepatic steatosis were also significantly improved in the ISO-treated group compared to the high-fat diet control group.  Conclusions: These results suggest that ISO dual targeting Nur77 and AMPKα during adipogenesis represents a novel class of mechanism-based antiadipogenic agents for treatment of obesity and assocd. metabolic disorders, including hyperlipidemia and fatty liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0v5SFb4ElYbVg90H21EOLACvtfcHk0lh6DXANby3tWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFSms7fP&md5=7e9eab7cc05227ff49cf98e8cf957bc7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fs41366-018-0276-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41366-018-0276-x%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DY.-S.%26aulast%3DLee%26aufirst%3DH.-S.%26aulast%3DCho%26aufirst%3DH.-R.%26aulast%3DKim%26aufirst%3DK.-J.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DSafe%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.-O.%26atitle%3DDual%2520targeting%2520of%2520Nur77%2520and%2520AMPKalpha%2520by%2520isoalantolactone%2520inhibits%2520adipogenesis%2520in%2520vitro%2520and%2520decreases%2520body%2520fat%2520mass%2520in%2520vivo%26jtitle%3DInt.%2520J.%2520Obes.%26date%3D2019%26volume%3D43%26spage%3D952%26epage%3D962%26doi%3D10.1038%2Fs41366-018-0276-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weimer, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span> <span> </span><span class="NLM_article-title">Cytosporone B is an agonist for nuclear orphan receptor Nur77</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1038/nchembio.106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fnchembio.106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=18690216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvFGrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=548-556&author=Y.+Zhanauthor=X.+Duauthor=H.+Chenauthor=J.+Liuauthor=B.+Zhaoauthor=D.+Huangauthor=G.+Liauthor=Q.+Xuauthor=M.+Zhangauthor=B.+C.+Weimerauthor=D.+Chenauthor=Z.+Chengauthor=L.+Zhangauthor=Q.+Liauthor=S.+Liauthor=Z.+Zhengauthor=S.+Songauthor=Y.+Huangauthor=Z.+Yeauthor=W.+Suauthor=S.-C.+Linauthor=Y.+Shenauthor=Q.+Wu&title=Cytosporone+B+is+an+agonist+for+nuclear+orphan+receptor+Nur77&doi=10.1038%2Fnchembio.106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Cytosporone B is an agonist for nuclear orphan receptor Nur77</span></div><div class="casAuthors">Zhan, Yanyan; Du, Xiping; Chen, Hangzi; Liu, Jingjing; Zhao, Bixing; Huang, Danhong; Li, Guideng; Xu, Qingyan; Zhang, Mingqing; Weimer, Bart C.; Chen, Dong; Cheng, Zhe; Zhang, Lianru; Li, Qinxi; Li, Shaowei; Zheng, Zhonghui; Song, Siyang; Huang, Yaojian; Ye, Zhiyun; Su, Wenjin; Lin, Sheng-Cai; Shen, Yuemao; Wu, Qiao</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">548-556</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nuclear orphan receptor Nur77 has important roles in many biol. processes.  However, a physiol. ligand for Nur77 has not been identified.  Here, we report that the octaketide cytosporone B (Csn-B) is a naturally occurring agonist for Nur77.  Csn-B specifically binds to the ligand-binding domain of Nur77 and stimulates Nur77-dependent transactivational activity towards target genes including Nr4a1 (Nur77) itself, which contains multiple consensus response elements allowing pos. autoregulation in a Csn-B-dependent manner.  Csn-B also elevates blood glucose levels in fasting C57 mice, an effect that is accompanied by induction of multiple genes involved in gluconeogenesis.  These biol. effects were not obsd. in Nur77-null (Nr4a1-/-) mice, which indicates that Csn-B regulates gluconeogenesis through Nur77.  Moreover, Csn-B induced apoptosis and retarded xenograft tumor growth by inducing Nur77 expression, translocating Nur77 to mitochondria to cause cytochrome c release.  Thus, Csn-B may represent a promising therapeutic drug for cancers and hypoglycemia, and it may also be useful as a reagent to increase understanding of Nur77 biol. function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAkSrX4z4xs7Vg90H21EOLACvtfcHk0lh6DXANby3tWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvFGrt7g%253D&md5=0514b5b3d32810b2de3b0218479e23f7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.106%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWeimer%26aufirst%3DB.%2BC.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DS.-C.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DQ.%26atitle%3DCytosporone%2520B%2520is%2520an%2520agonist%2520for%2520nuclear%2520orphan%2520receptor%2520Nur77%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D548%26epage%3D556%26doi%3D10.1038%2Fnchembio.106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Y.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, J.-j.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-r.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-k.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.-p.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.-j.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Y.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.-d.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.-q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span> <span> </span><span class="NLM_article-title">The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">904</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fnchembio.1069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=22983157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCqu7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=897-904&author=Y.-y.+Zhanauthor=Y.+Chenauthor=Q.+Zhangauthor=J.-j.+Zhuangauthor=M.+Tianauthor=H.-z.+Chenauthor=L.-r.+Zhangauthor=H.-k.+Zhangauthor=J.-p.+Heauthor=W.-j.+Wangauthor=R.+Wuauthor=Y.+Wangauthor=C.+Shiauthor=K.+Yangauthor=A.-z.+Liauthor=Y.-z.+Xinauthor=T.+Y.+Liauthor=J.+Y.+Yangauthor=Z.-h.+Zhengauthor=C.-d.+Yuauthor=S.-C.+Linauthor=C.+Changauthor=P.-q.+Huangauthor=T.+Linauthor=Q.+Wu&title=The+orphan+nuclear+receptor+Nur77+regulates+LKB1+localization+and+activates+AMPK&doi=10.1038%2Fnchembio.1069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK</span></div><div class="casAuthors">Zhan, Yan-yan; Chen, Yan; Zhang, Qian; Zhuang, Jia-jia; Tian, Min; Chen, Hang-zi; Zhang, Lian-ru; Zhang, Hong-kui; He, Jian-ping; Wang, Wei-jia; Wu, Rong; Wang, Yuan; Shi, Chunfang; Yang, Kai; Li, An-zhong; Xin, Yong-zhen; Li, Terytty Yang; Yang, James Y.; Zheng, Zhong-hui; Yu, Chun-dong; Lin, Sheng-Cai; Chang, Chawn-shang; Huang, Pei-qiang; Lin, Tianwei; Wu, Qiao</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">897-904</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Liver kinase B1 (LKB1) has important roles in governing energy homeostasis by regulating the activity of the energy sensor kinase AMP-activated protein kinase (AMPK).  The regulation of LKB1 function, however, is still poorly understood.  Here we demonstrate that the orphan nuclear receptor Nur77 binds and sequesters LKB1 in the nucleus, thereby attenuating AMPK activation.  This Nur77 function is antagonized by the chem. compd. Et 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl]acetate (TMPA), which interacts with Nur77 with high affinity and at specific sites.  TMPA binding of Nur77 results in the release and shuttling of LKB1 to the cytoplasm to phosphorylate AMPKα.  Moreover, TMPA effectively reduces blood glucose and alleviates insulin resistance in type II db/db and high-fat diet- and streptozotocin-induced diabetic mice but not in diabetic littermates with the Nur77 gene knocked out.  This study attains a mechanistic understanding of the regulation of LKB1-AMPK axis and implicates Nur77 as a new and amenable target for the design and development of therapeutics to treat metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodWFZn_EPN37Vg90H21EOLACvtfcHk0lgzaKufPRDd_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCqu7jF&md5=f00c49daf55792014107d6857e8b729b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1069%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DY.-y.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhuang%26aufirst%3DJ.-j.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.-z.%26aulast%3DZhang%26aufirst%3DL.-r.%26aulast%3DZhang%26aufirst%3DH.-k.%26aulast%3DHe%26aufirst%3DJ.-p.%26aulast%3DWang%26aufirst%3DW.-j.%26aulast%3DWu%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DA.-z.%26aulast%3DXin%26aufirst%3DY.-z.%26aulast%3DLi%26aufirst%3DT.%2BY.%26aulast%3DYang%26aufirst%3DJ.%2BY.%26aulast%3DZheng%26aufirst%3DZ.-h.%26aulast%3DYu%26aufirst%3DC.-d.%26aulast%3DLin%26aufirst%3DS.-C.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DP.-q.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DQ.%26atitle%3DThe%2520orphan%2520nuclear%2520receptor%2520Nur77%2520regulates%2520LKB1%2520localization%2520and%2520activates%2520AMPK%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D897%26epage%3D904%26doi%3D10.1038%2Fnchembio.1069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.-w.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.-f.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-k.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.-p.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, Y.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.-j.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.-q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span> <span> </span><span class="NLM_article-title">Impeding the interaction between Nur77 and p38 reduces LPS-induced inflammation</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fnchembio.1788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=25822914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVOns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=339-346&author=L.+Liauthor=Y.+Liuauthor=H.-z.+Chenauthor=F.-w.+Liauthor=J.-f.+Wuauthor=H.-k.+Zhangauthor=J.-p.+Heauthor=Y.-z.+Xingauthor=Y.+Chenauthor=W.-j.+Wangauthor=X.-y.+Tianauthor=A.-z.+Liauthor=Q.+Zhangauthor=P.-q.+Huangauthor=J.+Hanauthor=T.+Linauthor=Q.+Wu&title=Impeding+the+interaction+between+Nur77+and+p38+reduces+LPS-induced+inflammation&doi=10.1038%2Fnchembio.1788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Impeding the interaction between Nur77 and p38 reduces LPS-induced inflammation</span></div><div class="casAuthors">Li, Li; Liu, Yuan; Chen, Hang-zi; Li, Feng-wei; Wu, Jian-feng; Zhang, Hong-kui; He, Jian-ping; Xing, Yong-zhen; Chen, Yan; Wang, Wei-jia; Tian, Xu-yang; Li, An-zhong; Zhang, Qian; Huang, Pei-qiang; Han, Jiahuai; Lin, Tianwei; Wu, Qiao</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">339-346</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sepsis, a hyperinflammatory response that can result in multiple organ dysfunctions, is a leading cause of mortality from infection.  Here, we show that orphan nuclear receptor Nur77 (also known as TR3) can enhance resistance to lipopolysaccharide (LPS)-induced sepsis in mice by inhibiting NF-κB activity and suppressing aberrant cytokine prodn.  Nur77 directly assocs. with p65 to block its binding to the κB element.  However, this function of Nur77 is countered by the LPS-activated p38α phosphorylation of Nur77.  Dampening the interaction between Nur77 and p38α would favor Nur77 suppression of the hyperinflammatory response.  A compd., n-pentyl 2-[3,5-dihydroxy-2-(1-nonanoyl) phenyl]acetate (PDNPA), screened from a Nur77-biased library, blocked the Nur77-p38α interaction by targeting the ligand-binding domain of Nur77 and restored the suppression of the hyperinflammatory response through Nur77 inhibition of NF-κB.  This study assocs. the nuclear receptor with immune homeostasis and implicates a new therapeutic strategy to treat hyperinflammatory responses by targeting a p38α substrate to modulate p38α-regulated functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlFjaOVE8eLrVg90H21EOLACvtfcHk0lgzaKufPRDd_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVOns74%253D&md5=648de4a3c58bba85279ae13a37a6c0a2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1788%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.-z.%26aulast%3DLi%26aufirst%3DF.-w.%26aulast%3DWu%26aufirst%3DJ.-f.%26aulast%3DZhang%26aufirst%3DH.-k.%26aulast%3DHe%26aufirst%3DJ.-p.%26aulast%3DXing%26aufirst%3DY.-z.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DW.-j.%26aulast%3DTian%26aufirst%3DX.-y.%26aulast%3DLi%26aufirst%3DA.-z.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DP.-q.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DQ.%26atitle%3DImpeding%2520the%2520interaction%2520between%2520Nur77%2520and%2520p38%2520reduces%2520LPS-induced%2520inflammation%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D339%26epage%3D346%26doi%3D10.1038%2Fnchembio.1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Law, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conneely, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMayo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, B. W.</span></span> <span> </span><span class="NLM_article-title">Identification of a new brain-specific transcription factor, NURR1</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2129</span>– <span class="NLM_lpage">2135</span>, <span class="refDoi"> DOI: 10.1210/mend.6.12.1491694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1210%2Fmend.6.12.1491694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1491694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADyaK3sXltFSnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1992&pages=2129-2135&author=S.+W.+Lawauthor=O.+M.+Conneelyauthor=F.+J.+DeMayoauthor=B.+W.+O%E2%80%99Malley&title=Identification+of+a+new+brain-specific+transcription+factor%2C+NURR1&doi=10.1210%2Fmend.6.12.1491694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a new brain-specific transcription factor, NURR1</span></div><div class="casAuthors">Law, Simon W.; Conneely, Orla M.; DeMayo, Franco J.; O'Malley, Bert W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2129-35</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    </div><div class="casAbstract">A novel member of the nuclear receptor superfamily was identified and cloned.  The cDNA was isolated from a mouse brain cDNA library and encodes a protein 598 amino acids in length with a predicted mol wt of 66 kDa.  The amino acid sequence of the protein is closely related to an addnl. family member and immediate early gene product, Nur77, and the novel factor is referred to as Nurr1 (Nur-related factor 1).  The relationship between Nurr1 and Nurr77 suggests that these proteins constitute an addnl. subfamily within the nuclear receptor superfamily.  Like Nur77, the expression of Nurr1 is induced by membrane depolarization of PC12 cells.  However, while Nur77 shows an early transcriptional response to nerve growth factor stimulation, the failure of Nurr1 to respond to this agent suggests a differential selectivity of the two proteins in terms of their transcriptional responses to specific stimuli.  Finally, both proteins are differentially expressed during development and in tissues of the adult mouse.  Unlike Nur77, Nurr1 is predominantly located in brain tissue, suggesting a primary role for this putative transcription factor in regulation of gene expression in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoRxB8SfdoCrVg90H21EOLACvtfcHk0li16q9aw7S8_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltFSnsLY%253D&md5=9f919c247e1dca3d27f5ae7ad76edafc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1210%2Fmend.6.12.1491694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend.6.12.1491694%26sid%3Dliteratum%253Aachs%26aulast%3DLaw%26aufirst%3DS.%2BW.%26aulast%3DConneely%26aufirst%3DO.%2BM.%26aulast%3DDeMayo%26aufirst%3DF.%2BJ.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DB.%2BW.%26atitle%3DIdentification%2520of%2520a%2520new%2520brain-specific%2520transcription%2520factor%252C%2520NURR1%26jtitle%3DMol.%2520Endocrinol.%26date%3D1992%26volume%3D6%26spage%3D2129%26epage%3D2135%26doi%3D10.1210%2Fmend.6.12.1491694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakurada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohshima-Sakurada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gage, F. H.</span></span> <span> </span><span class="NLM_article-title">Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain</span>. <i>Development</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">4017</span>– <span class="NLM_lpage">4026</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10457011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADyaK1MXmsleqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=1999&pages=4017-4026&author=K.+Sakuradaauthor=M.+Ohshima-Sakuradaauthor=T.+D.+Palmerauthor=F.+H.+Gage&title=Nurr1%2C+an+orphan+nuclear+receptor%2C+is+a+transcriptional+activator+of+endogenous+tyrosine+hydroxylase+in+neural+progenitor+cells+derived+from+the+adult+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain</span></div><div class="casAuthors">Sakurada, Kazuhiro; Ohshima-Sakurada, Mikiko; Palmer, Theo D.; Gage, Fred H.</div><div class="citationInfo"><span class="NLM_cas:title">Development (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4017-4026</span>CODEN:
                <span class="NLM_cas:coden">DEVPED</span>;
        ISSN:<span class="NLM_cas:issn">0950-1991</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Adult rat-derived hippocampal progenitor cells express many of the mols. implicated in midbrain dopaminergic detn., including FGF receptors 1, 2 and 3, the sonic hedgehog receptor components Smo and Ptc, and the region-specific transcription factors Ptx3 and Nurr1.  Here we use undifferentiated progenitors to probe the events leading to the dopaminergic phenotype and find that the influences of Nurr1 can be temporally and mechanistically uncoupled from the patterning influences of sonic hedgehog and FGF-8 or the more generic process of neuronal differentiation itself.  In gain-of-function expts., Nurr1 is able to activate transcription of the tyrosine hydroxylase gene by binding a response element within a region of the tyrosine hydroxylase promoter necessary for midbrain-specific expression.  This activation is mediated through a retinoid X receptor independent mechanism and occurs in all precursors, regardless of differentiation status.  Overexpression of Nurr1 does not affect proliferation or stimulate neuronal differentiation and has no influence on the expression of other dopaminergic markers.  This uncoupling of tyrosine hydroxylase expression from other dopaminergic markers suggests that the midbrain dopaminergic identity is dictated by a combination of pan-dopaminergic (e.g., Shh/FGF-8) and region-specific (Nurr1) mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6NAMlC-Lq8rVg90H21EOLACvtfcHk0li16q9aw7S8_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsleqsLc%253D&md5=3b9a7d90aab591a525fea0ef83ddc15f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakurada%26aufirst%3DK.%26aulast%3DOhshima-Sakurada%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DT.%2BD.%26aulast%3DGage%26aufirst%3DF.%2BH.%26atitle%3DNurr1%252C%2520an%2520orphan%2520nuclear%2520receptor%252C%2520is%2520a%2520transcriptional%2520activator%2520of%2520endogenous%2520tyrosine%2520hydroxylase%2520in%2520neural%2520progenitor%2520cells%2520derived%2520from%2520the%2520adult%2520brain%26jtitle%3DDevelopment%26date%3D1999%26volume%3D126%26spage%3D4017%26epage%3D4026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacson, O.</span></span> <span> </span><span class="NLM_article-title">Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">622</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2003.01671.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1046%2Fj.1471-4159.2003.01671.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=12694388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslyrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2003&pages=622-634&author=K.-S.+Kimauthor=C.-H.+Kimauthor=D.-Y.+Hwangauthor=H.+Seoauthor=S.+Chungauthor=S.+J.+Hongauthor=J.-K.+Limauthor=T.+Andersonauthor=O.+Isacson&title=Orphan+nuclear+receptor+Nurr1+directly+transactivates+the+promoter+activity+of+the+tyrosine+hydroxylase+gene+in+a+cell-specific+manner&doi=10.1046%2Fj.1471-4159.2003.01671.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner</span></div><div class="casAuthors">Kim, Kwang-Soo; Kim, Chun-Hyung; Hwang, Dong-Youn; Seo, Hyemyung; Chung, Sangmi; Hong, Seok Jong; Lim, Jin-Kyu; Anderson, Therese; Isacson, Ole</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">622-634</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Tyrosine hydroxylase (TH) catalyzes the first and rate-limiting step of catecholamine synthesis and its expression is necessary for neurotransmitter specification of all catecholaminergic neurons, while dopamine β-hydroxylase (DBH) is essential for the noradrenergic phenotype.  In the present study, we show that Nurr1, an orphan nuclear receptor crit. for dopaminergic (DA) neuron development, directly transactivates the promoter activity of the TH gene in a cell type-dependent manner, while it does not regulate the DBH promoter.  Consistent with these results, only the TH promoter contains multiple sequence motifs homologous to the known Nurr1-binding motif, NBRE.  TH promoter deletional anal. indicates that < 1.0 kb upstream sequences, encompassing three NBRE-like motifs (i.e. NL1, NL2 and NL3) are mostly responsible for the effects of Nurr1.  Among these potential motifs, site-directed mutational anal. showed that NL1, residing from -35 to -28 bp, was most crit. for mediating the transactivation by Nurr1.  Strikingly, however, both DNase I footprinting and electrophoretic mobility shift assays showed that NL3, but not NL1 or NL2, has high binding affinity to Nurr1.  To det. whether the proximity of these motifs may be important for transactivation by Nurr1 in the transient transfection assay, we generated reporter gene constructs in which NL3 is immediately proximal to the TATA box.  Indeed, NL3 was more efficient in this position than NL1 or NL2 for mediating the transactivation by Nurr1.  Our results suggest that Nurr1 may play a direct role for specification of DA neurotransmitter identity by activating TH gene transcription in a cell context-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4cyf0ggk2erVg90H21EOLACvtfcHk0li16q9aw7S8_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslyrsL0%253D&md5=b2cfce68df99f27a0f0fa4404d4f98c2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2003.01671.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2003.01671.x%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.-S.%26aulast%3DKim%26aufirst%3DC.-H.%26aulast%3DHwang%26aufirst%3DD.-Y.%26aulast%3DSeo%26aufirst%3DH.%26aulast%3DChung%26aufirst%3DS.%26aulast%3DHong%26aufirst%3DS.%2BJ.%26aulast%3DLim%26aufirst%3DJ.-K.%26aulast%3DAnderson%26aufirst%3DT.%26aulast%3DIsacson%26aufirst%3DO.%26atitle%3DOrphan%2520nuclear%2520receptor%2520Nurr1%2520directly%2520transactivates%2520the%2520promoter%2520activity%2520of%2520the%2520tyrosine%2520hydroxylase%2520gene%2520in%2520a%2520cell-specific%2520manner%26jtitle%3DJ.%2520Neurochem.%26date%3D2003%26volume%3D85%26spage%3D622%26epage%3D634%26doi%3D10.1046%2Fj.1471-4159.2003.01671.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, W.</span></span> <span> </span><span class="NLM_article-title">Nurr1 regulates Top IIbeta and functions in axon genesis of mesencephalic dopaminergic neurons</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">4</span>, <span class="refDoi"> DOI: 10.1186/1750-1326-7-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1186%2F1750-1326-7-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=22296971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC38XotFKqtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=4&author=X.+Hengauthor=G.+Jinauthor=X.+Zhangauthor=D.+Yangauthor=M.+Zhuauthor=S.+Fuauthor=X.+Liauthor=W.+Le&title=Nurr1+regulates+Top+IIbeta+and+functions+in+axon+genesis+of+mesencephalic+dopaminergic+neurons&doi=10.1186%2F1750-1326-7-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Nurr1 regulates Top IIβ and functions in axon genesis of mesencephalic dopaminergic neurons</span></div><div class="casAuthors">Heng, Xin; Jin, Gang; Zhang, Xin; Yang, Dehuang; Zhu, Mingzhe; Fu, Shijun; Li, Xuping; Le, Weidong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: NURR1 (also named as NR4A2) is a member of the steroid/thyroid hormone receptor family, which can bind to DNA and modulate expression of target genes.  Previous studies have shown that NURR1 is essential for the nigral dopaminergic neuron phenotype and function maintenance and the defects of the gene are possibly assocd. with Parkinson's disease (PD).  Results: In this study, we used new born Nurr1 knock-out mice combined with Affymetrix genechip technol. and real time polymerase chain reaction (PCR) to identify Nurr1 regulated genes, which led to the discovery of several transcripts differentially expressed in the nigro-striatal pathway of Nurr1 knock-out mice.  We found that an axon genesis gene called Topoisomerase IIβ (Top IIβ) was down-regulated in Nurr1 knock-out mice and we identified two functional NURR1 binding sites in the proximal Top IIβ promoter.  While in Top IIβ null mice, we saw a significant loss of dopaminergic neurons in the substantial nigra and lack of neurites along the nigro-striatal pathway.  Using specific TOP II antagonist ICRF-193 or Top IIβ siRNA in the primary cultures of ventral mesencephalic (VM) neurons, we documented that suppression of TOP IIβ expression resulted in VM neurites shortening and growth cones collapsing.  Furthermore, microinjection of ICRF-193 into the mouse medial forebrain bundle (MFB) led to the loss of nigro-striatal projection.  Conclusion: Taken together, our findings suggest that Top IIβ might be a down-stream target of Nurr1, which might influence the processes of axon genesis in dopaminergic neurons via the regulation of TOP IIβ expression.  The Nurr1-Top IIβ interaction may shed light on the pathol. role of Nurr1 defect in the nigro-striatal pathway deficiency assocd. with PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb-6IDM-rUnLVg90H21EOLACvtfcHk0litCUWGtAcJwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotFKqtLc%253D&md5=04ed715adc18a156f0b28a887f8ab862</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-7-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-7-4%26sid%3Dliteratum%253Aachs%26aulast%3DHeng%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLe%26aufirst%3DW.%26atitle%3DNurr1%2520regulates%2520Top%2520IIbeta%2520and%2520functions%2520in%2520axon%2520genesis%2520of%2520mesencephalic%2520dopaminergic%2520neurons%26jtitle%3DMol.%2520Neurodegener.%26date%3D2012%26volume%3D7%26spage%3D4%26doi%3D10.1186%2F1750-1326-7-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Philips, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesage, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingras, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maira, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hugo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drouin, J.</span></span> <span> </span><span class="NLM_article-title">Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">5946</span>– <span class="NLM_lpage">5951</span>, <span class="refDoi"> DOI: 10.1128/mcb.17.10.5946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1128%2FMCB.17.10.5946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=9315652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADyaK2sXmtlOisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=5946-5951&author=A.+Philipsauthor=S.+Lesageauthor=R.+Gingrasauthor=M.+H.+Mairaauthor=Y.+Gauthierauthor=P.+Hugoauthor=J.+Drouin&title=Novel+dimeric+Nur77+signaling+mechanism+in+endocrine+and+lymphoid+cells&doi=10.1128%2Fmcb.17.10.5946"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells</span></div><div class="casAuthors">Philips, Alexandre; Lesage, Sylvie; Gingras, Rock; Maira, Mario-Hernan; Gauthier, Yves; Hugo, Patrice; Drouin, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5946-5951</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Within the nuclear receptor family, Nur77 (also known as NGFI-B) distinguishes itself by its ability to bind a target sequence (the NBRE) as a monomer and by its role in T-cell receptor (TCR)-induced apoptosis in T cells.  We now report on a novel mechanism of Nur77 action that is mediated by homodimers.  These dimers bind a Nur77 response element (NurRE), which has been identified as a target of CRH-induced Nur77 in the pro-opiomelanocortin (POMC) gene promoter.  Both halves of the palindromic NurRE are required for responsiveness to physiol. signals, like CRH in pituitary-derived AtT-20 cells.  Similarly, in T-cell hybridomas, TCR activation induced NurRE but not NBRE reporters.  The in vivo signaling function of Nur77 thus appears to be mediated by dimers acting on a palindromic response element of unusual spacing between its half-sites.  This mechanism may represent the biol. relevant paradigm of action for this subfamily of orphan nuclear receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4vdXJoZYrCrVg90H21EOLACvtfcHk0litCUWGtAcJwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtlOisr0%253D&md5=23aa8c40283a821e743b3ebafaaebb32</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1128%2FMCB.17.10.5946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.17.10.5946%26sid%3Dliteratum%253Aachs%26aulast%3DPhilips%26aufirst%3DA.%26aulast%3DLesage%26aufirst%3DS.%26aulast%3DGingras%26aufirst%3DR.%26aulast%3DMaira%26aufirst%3DM.%2BH.%26aulast%3DGauthier%26aufirst%3DY.%26aulast%3DHugo%26aufirst%3DP.%26aulast%3DDrouin%26aufirst%3DJ.%26atitle%3DNovel%2520dimeric%2520Nur77%2520signaling%2520mechanism%2520in%2520endocrine%2520and%2520lymphoid%2520cells%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1997%26volume%3D17%26spage%3D5946%26epage%3D5951%26doi%3D10.1128%2Fmcb.17.10.5946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philips, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drouin, J.</span></span> <span> </span><span class="NLM_article-title">Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">7549</span>– <span class="NLM_lpage">7557</span>, <span class="refDoi"> DOI: 10.1128/mcb.19.11.7549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1128%2FMCB.19.11.7549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10523643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFekt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=7549-7557&author=M.+Mairaauthor=C.+Martensauthor=A.+Philipsauthor=J.+Drouin&title=Heterodimerization+between+members+of+the+Nur+subfamily+of+orphan+nuclear+receptors+as+a+novel+mechanism+for+gene+activation&doi=10.1128%2Fmcb.19.11.7549"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation</span></div><div class="casAuthors">Maira, Mario; Martens, Christine; Philips, Alexandre; Drouin, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7549-7557</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The authors have recently shown that the orphan nuclear receptor Nur77 (NGFI-B) is most active in transcription when it is interacting with a cognate DNA sequence as a homodimer.  Further, the authors have shown that the target for Nur77 dimers, the Nur response element (NurRE), is responsive to physiol. stimuli in both endocrine and lymphoid cells, whereas other DNA targets of Nur77 action are not.  The Nur77 subfamily also includes two related receptors, Nur-related factor 1 (Nurr1) and neuron-derived orphan receptor 1 (NOR-1).  Often, more than one member of this subfamily is induced in response to extracellular signals.  The authors now show that Nur77 and Nurr1 form heterodimers in vitro in the presence or absence of NurRE, and the authors have documented interactions between these proteins in vivo by using a two-hybrid system in mammalian cells.  These heterodimers synergistically enhance transcription from NurRE reporters in comparison to that seen with homodimers.  The naturally occurring NurRE from the pro-opiomelanocortin gene preferentially binds and activates transcription in the presence of Nur77 homo- or heterodimers, while a consensus NurRE sequence does not show this preference.  Taken together, the data indicate that members of the Nur77 subfamily are most potent as heterodimers and that different dimers exhibit target sequence preference.  Thus, the authors propose that a combinatorial code relying on specific NurRE sequences might be responsible for the activation of subsets of target genes by one of the members of the Nur77 subfamily of transcription factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN_PcLpX1MWbVg90H21EOLACvtfcHk0litCUWGtAcJwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFekt7k%253D&md5=6216924bd742d76309b033c091d273fd</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1128%2FMCB.19.11.7549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.19.11.7549%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DM.%26aulast%3DMartens%26aufirst%3DC.%26aulast%3DPhilips%26aufirst%3DA.%26aulast%3DDrouin%26aufirst%3DJ.%26atitle%3DHeterodimerization%2520between%2520members%2520of%2520the%2520Nur%2520subfamily%2520of%2520orphan%2520nuclear%2520receptors%2520as%2520a%2520novel%2520mechanism%2520for%2520gene%2520activation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1999%26volume%3D19%26spage%3D7549%26epage%3D7557%26doi%3D10.1128%2Fmcb.19.11.7549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis of binding of homodimers of the nuclear receptor NR4A2 to selective Nur-responsive DNA elements</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">19795</span>– <span class="NLM_lpage">19803</span>, <span class="refDoi"> DOI: 10.1074/jbc.ra119.010730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1074%2Fjbc.RA119.010730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=31723028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjt1agu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=19795-19803&author=L.+Jiangauthor=S.+Daiauthor=J.+Liauthor=X.+Liangauthor=L.+Quauthor=X.+Chenauthor=M.+Guoauthor=Z.+Chenauthor=L.+Chenauthor=H.+Weiauthor=Y.+Chen&title=Structural+basis+of+binding+of+homodimers+of+the+nuclear+receptor+NR4A2+to+selective+Nur-responsive+DNA+elements&doi=10.1074%2Fjbc.ra119.010730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of binding of homodimers of the nuclear receptor NR4A2 to selective Nur-responsive DNA elements</span></div><div class="casAuthors">Jiang, Longying; Dai, Shuyan; Li, Jun; Liang, Xujun; Qu, Lingzhi; Chen, Xiaojuan; Guo, Ming; Chen, Zhuchu; Chen, Lin; Wei, Hudie; Chen, Yongheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">19795-19803</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Proteins of nuclear receptor subfamily 4 group A (NR4A), including NR4A1/NGFI-B, NR4A2/Nurr1, and NR4A3/NOR-1, are nuclear transcription factors that play important roles in metab., apoptosis, and proliferation.  NR4A proteins recognize DNA response elements as monomers or dimers to regulate the transcription of a variety of genes involved in multiple biol. processes.  In this study, we detd. two crystal structures of the NR4A2 DNA-binding domain (NR4A2-DBD) bound to two Nur-responsive elements: an inverted repeat and an everted repeat at 2.6-2.8 Å resoln.  The structures revealed that two NR4A2-DBD mols. bind independently to the everted repeat, whereas two other NR4A2-DBD mols. form a novel dimer interface on the inverted repeat.  Moreover, substitution of the interfacial residue valine 298 to lysine as well as mutation of DNA bases involved in the interactions abolished the dimerization.  Overall, our structural, biochem., and bioinformatics analyses provide a mol. basis for the binding of the NR4A2 protein dimers to NurREs and advance our understanding of the dimerization specificity of nuclear receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgx9U7c_pOxrVg90H21EOLACvtfcHk0litCUWGtAcJwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjt1agu7Y%253D&md5=3e3b4cb518d4011cd43b21feca17ebd6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA119.010730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA119.010730%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DDai%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520binding%2520of%2520homodimers%2520of%2520the%2520nuclear%2520receptor%2520NR4A2%2520to%2520selective%2520Nur-responsive%2520DNA%2520elements%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D19795%26epage%3D19803%26doi%3D10.1074%2Fjbc.ra119.010730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perlmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, L.</span></span> <span> </span><span class="NLM_article-title">A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">769</span>– <span class="NLM_lpage">782</span>, <span class="refDoi"> DOI: 10.1101/gad.9.7.769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1101%2Fgad.9.7.769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=7705655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADyaK2MXltVaht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=769-782&author=T.+Perlmannauthor=L.+Jansson&title=A+novel+pathway+for+vitamin+A+signaling+mediated+by+RXR+heterodimerization+with+NGFI-B+and+NURR1&doi=10.1101%2Fgad.9.7.769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1</span></div><div class="casAuthors">Perlmann, Thomas; Jansson, Lottie</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">769-82</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">In addn. to its role as a 9-cis retinoic acid receptor, RXR has an important role in the regulation of multiple hormonal pathways through heterodimerization with nuclear receptors.  Here, we show that two orphan receptors, NGFI-B and NURR1, which have been shown previously to interact with DNA as monomers, also can heterodimerize with RXR.  These heterodimers bind selectively to a class of retinoic acid response elements composed of direct repeats spaced by 5 nucleotides.  In this respect they are similar to heterodimers formed between RXR and the receptor for all-trans retinoic acid, RAR.  However, whereas RXR is inhibited in the RXR-RAR heterodimer, NGFI-B/NURR1 promote efficient activation in response to RXR ligands and therefore shift RXR from a silent to an active heterodimerization partner.  These data show that NGFI-B and NURR1 can increase the potential of RXR to modulate gene expression in a ligand-dependent manner by allowing a distinct class of direct repeats to serve as specific RXR response elements.  Because expression of both NGFI-B and NURR1 is rapidly induced by various growth factors, these findings also suggest a novel mechanism for convergence between vitamin A or retinoid and growth factor signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj7IW_x7cjxbVg90H21EOLACvtfcHk0lipV8EWAS1q_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXltVaht7c%253D&md5=c9ea7577edf4a5b92721144a5ef1382f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1101%2Fgad.9.7.769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.9.7.769%26sid%3Dliteratum%253Aachs%26aulast%3DPerlmann%26aufirst%3DT.%26aulast%3DJansson%26aufirst%3DL.%26atitle%3DA%2520novel%2520pathway%2520for%2520vitamin%2520A%2520signaling%2520mediated%2520by%2520RXR%2520heterodimerization%2520with%2520NGFI-B%2520and%2520NURR1%26jtitle%3DGenes%2520Dev.%26date%3D1995%26volume%3D9%26spage%3D769%26epage%3D782%26doi%3D10.1101%2Fgad.9.7.769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forman, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umesono, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">Unique response pathways are established by allosteric interactions among nuclear hormone receptors</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(95)90075-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2F0092-8674%2895%2990075-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=7758108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADyaK2MXlvVGgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1995&pages=541-550&author=B.+M.+Formanauthor=K.+Umesonoauthor=J.+Chenauthor=R.+M.+Evans&title=Unique+response+pathways+are+established+by+allosteric+interactions+among+nuclear+hormone+receptors&doi=10.1016%2F0092-8674%2895%2990075-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Unique response pathways are established by allosteric interactions among nuclear hormone receptors</span></div><div class="casAuthors">Forman, Barry Marc; Umesono, Kazuhiko; Chen, Jasmine; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-50</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Heterodimerization is a common paradigm among eukaryotic transcription factors.  The 9-cis retinoic acid receptor (RXR) serves as a common heterodimerization partner for several nuclear receptors, including the thyroid hormone receptor (T3R) and retinoic acid receptor (RAR).  This raises the question as to whether these complexes possess dual hormonal responsiveness.  The authors devised a strategy to examine the transcriptional properties of each receptor individually or when tethered to a heterodimeric partner.  The authors find that the intrinsic binding properties of RXR are masked in T3R-RXR and RAR-RXR heterodimers.  In contrast, RXR is active as a non-DNA-binding cofactor with the NGFI-B/Nurr1 orphan receptors.  Heterodimerization of RXR with constitutively active NGFI-B/Nurr1 creates a novel hormone-dependent complex.  These findings suggest that allosteric interactions among heterodimers create complexes with unique properties.  The authors suggest that allostery is a crit. feature underlying the generation of diversity in hormone response networks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXnSAjdD71E7Vg90H21EOLACvtfcHk0lipV8EWAS1q_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlvVGgurw%253D&md5=7a07058aae8f6557c939c1febcaacc92</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2895%2990075-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252895%252990075-6%26sid%3Dliteratum%253Aachs%26aulast%3DForman%26aufirst%3DB.%2BM.%26aulast%3DUmesono%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DUnique%2520response%2520pathways%2520are%2520established%2520by%2520allosteric%2520interactions%2520among%2520nuclear%2520hormone%2520receptors%26jtitle%3DCell%26date%3D1995%26volume%3D81%26spage%3D541%26epage%3D550%26doi%3D10.1016%2F0092-8674%2895%2990075-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvidsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolin, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlmann, T.</span></span> <span> </span><span class="NLM_article-title">Activity of the Nurr1 carboxyl-terminal domain depends on cell type and integrity of the activation function 2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">37483</span>– <span class="NLM_lpage">37490</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.52.37483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1074%2Fjbc.274.52.37483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10601324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD3cXpsFGn" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=37483-37490&author=D.+S.+Castroauthor=M.+Arvidssonauthor=M.+B.+Bolinauthor=T.+Perlmann&title=Activity+of+the+Nurr1+carboxyl-terminal+domain+depends+on+cell+type+and+integrity+of+the+activation+function+2&doi=10.1074%2Fjbc.274.52.37483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of the Nurr1 carboxyl-terminal domain depends on cell type and integrity of the activation function 2</span></div><div class="casAuthors">Castro, Diogo S.; Arvidsson, Mariette; Bolin, Maria Bondesson; Perlmann, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">37483-37490</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nurr1, a member of the nuclear hormone receptor superfamily, was recently demonstrated to be of crit. importance in the developing central nervous system, where it is required for the generation of midbrain dopamine cells.  Nuclear receptors encompass a transcriptional activation function (activation function 2; AF2) within their carboxyl-terminal domains important for ligand-induced transcriptional activation.  Since a Nurr1 ligand remains to be identified, the role of the Nurr1 AF2 region in transcriptional activation is unclear.  However, here we show that the Nurr1 AF2 contributes to constitutive activation independent of exogenously added ligands in human embryo kidney 293 cells and in neural cell lines.  Extensive mutagenesis indicated a crucial role of the AF2 core region for transactivation but also identified unique features differing from previously characterized receptors.  In addn., Nurr1 did not appear to interact with, and was not stimulated by, several previously identified coactivators such as the steroid receptor coactivator 1.  In contrast, adenovirus protein E1A, stably expressed in 293 cells, was shown to contribute to AF2-dependent activation.  Finally, while the AF2 core of RXR is required for ligand-induced transcriptional activation by Nurr1-RXR heterodimers, the functional integrity of Nurr1 AF2 core is not crit.  These results establish that the ligand binding domain of Nurr1 has intrinsic capacity for transcriptional activation depending on cell type and mode of DNA binding.  Furthermore, these results are consistent with the possibility that gene expression in the central nervous system can be modulated by an as yet unidentified ligand interacting with the ligand binding domain of Nurr1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMSA-jr5BbzrVg90H21EOLACvtfcHk0lipV8EWAS1q_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXpsFGn&md5=1edf1eaaffedb1ba2e1de924939b5308</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.52.37483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.52.37483%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DD.%2BS.%26aulast%3DArvidsson%26aufirst%3DM.%26aulast%3DBolin%26aufirst%3DM.%2BB.%26aulast%3DPerlmann%26aufirst%3DT.%26atitle%3DActivity%2520of%2520the%2520Nurr1%2520carboxyl-terminal%2520domain%2520depends%2520on%2520cell%2520type%2520and%2520integrity%2520of%2520the%2520activation%2520function%25202%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D37483%26epage%3D37490%26doi%3D10.1074%2Fjbc.274.52.37483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer</span>. <i>Clin. Transl. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">788</span>– <span class="NLM_lpage">794</span>, <span class="refDoi"> DOI: 10.1007/s12094-015-1305-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1007%2Fs12094-015-1305-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=26022133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2MXps1ejsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=788-794&author=J.+Guoauthor=G.+Zuauthor=T.+Zhouauthor=J.+Xingauthor=Z.+Wang&title=Clinicopathological+significance+of+orphan+nuclear+receptor+Nurr1+expression+in+gastric+cancer&doi=10.1007%2Fs12094-015-1305-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer</span></div><div class="casAuthors">Guo, J.; Zu, G.; Zhou, T.; Xing, J.; Wang, Z.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Translational Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">788-794</span>CODEN:
                <span class="NLM_cas:coden">CTOLAM</span>;
        ISSN:<span class="NLM_cas:issn">1699-048X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag Italia S.r.l.</span>)
        </div><div class="casAbstract">Background: Gastric cancer is the fourth most common cancer and the second leading cause of cancer-related deaths worldwide.  Gastric cancer is characterized by high levels of invasion and metastasis.  Increasing attention is being focused on discovering mol. markers for the diagnosis of gastric cancer and for predicting its prognosis.  The objective of the present study was to evaluate Nurr1 expression in gastric cancer and to assess its correlation with clinicopathol. parameters and prognosis in gastric cancer patients.  Methods: Tissue samples were obtained from 120 gastric cancer patients.  We investigated Nurr1 expression in human normal and gastric cancer tissues using real-time reverse transcription polymerase chain reaction (qRT-PCR), western blotting, and immunohistochem.  We detd. the assocn. between Nurr1 and recurrence, prognosis and patient clinicopathol. parameters.  Univariate and multivariate survival analyses with a Cox's proportional hazards regression model were used to identify independent factors related to recurrence and prognosis.  Results: The immunohistochem., qRT-PCR and western blot analyses revealed that Nurr1 expression was increased in gastric cancer tissues compared with normal gastric tissue (P < 0.05).  Nurr1 expression was significantly correlated with the tumor size, depth of tumor invasion, lymph node metastasis, recurrence, and distant metastasis of gastric cancer (P < 0.05).  Moreover, Nurr1-high patients also exhibited poorer overall survival (OS) and disease-free survival compared with Nurr1-low patients (P < 0.01).  The univariate and multivariate survival analyses suggested that Nurr1 expression (P = 0.011), histol. (P = 0.018), depth of tumor invasion (P = 0.037), and presence of lymph node metastasis (P = 0.031) were independent prognostic factors for recurrence.  In addn., Nurr1 expression (P = 0.007), depth of tumor invasion (P = 0.014), lymph node metastasis (P = 0.044), distant metastasis (P = 0.023), and recurrence (P = 0.011) were independent prognostic factors of OS in gastric cancer patients.  Conclusions: The Nurr1 protein may be useful as a marker of recurrence, metastasis, and poor prognosis following curative resection in patients with gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyB_9kJBZ_QLVg90H21EOLACvtfcHk0lh0_wfzLKiotw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXps1ejsbs%253D&md5=8281bfca5d977599a8bf6211fec874bd</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs12094-015-1305-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12094-015-1305-z%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DZu%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DXing%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DClinicopathological%2520significance%2520of%2520orphan%2520nuclear%2520receptor%2520Nurr1%2520expression%2520in%2520gastric%2520cancer%26jtitle%3DClin.%2520Transl.%2520Oncol.%26date%3D2015%26volume%3D17%26spage%3D788%26epage%3D794%26doi%3D10.1007%2Fs12094-015-1305-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.-W.</span></span> <span> </span><span class="NLM_article-title">High cytoplasmic expression of the orphan nuclear receptor NR4A2 predicts poor survival in nasopharyngeal carcinoma</span>. <i>Asian Pac. J. Cancer Prev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2805</span>– <span class="NLM_lpage">2809</span>, <span class="refDoi"> DOI: 10.7314/apjcp.2013.14.5.2805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.7314%2FAPJCP.2013.14.5.2805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=23803035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A280%3ADC%252BC3sjmtVSjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=2805-2809&author=J.+Wangauthor=J.+Yangauthor=B.-B.+Liauthor=Z.-W.+He&title=High+cytoplasmic+expression+of+the+orphan+nuclear+receptor+NR4A2+predicts+poor+survival+in+nasopharyngeal+carcinoma&doi=10.7314%2Fapjcp.2013.14.5.2805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">High cytoplasmic expression of the orphan nuclear receptor NR4A2 predicts poor survival in nasopharyngeal carcinoma</span></div><div class="casAuthors">Wang Jian; Yang Jing; Li Bin-Bin; He Zhi-Wei</div><div class="citationInfo"><span class="NLM_cas:title">Asian Pacific journal of cancer prevention : APJCP</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2805-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  This study aimed at investigating whether the orphan nuclear receptor NR4A2 is significantly associated with clinicopathologic features and overall survival of patients with nasopharyngeal carcinoma (NPC).  METHODS:  Immunohistochemistry was performed to determine NR4A2 protein expression in 84 NPC tissues and 20 non-cancerous nasopharyngeal (NP) tissues.  The prognostic significance of NR4A2 protein expression was evaluated using Cox proportional hazards regression models and Kaplan-Meier survival analysis.  RESULTS:  We did not find a significant association between total NR4A2 expression and clinicopathological variables in 84 patients with NPC.  However, we observed that high cytoplasmic expression of NR4A2 was significantly associated with tumor size (T classification) (P = 0.006), lymph node metastasis (N classification) (P = 0.002) and clinical stage (P = 0.017).  Patients with higher cytoplasmic NR4A2 expression had a significantly lower survival rate than those with lower cytoplasmic NR4A2 expression (P = 0.004).  Multivariate Cox regression analysis analysis suggested that the level of cytoplasmic NR4A2 expression was an independent prognostic indicator for overall survival of patients with NPC (P = 0.033).  CONCLUSIONS:  High cytoplasmic expression of NR4A2 is a potential unfavorable prognostic factor for patients with NPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZwlxTnrwJ8_IW7hznt0zpfW6udTcc2eZmW56WjlpEtrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjmtVSjtQ%253D%253D&md5=b1e88320effe8f2e9d1c97b25974a9fd</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.7314%2FAPJCP.2013.14.5.2805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7314%252FAPJCP.2013.14.5.2805%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DB.-B.%26aulast%3DHe%26aufirst%3DZ.-W.%26atitle%3DHigh%2520cytoplasmic%2520expression%2520of%2520the%2520orphan%2520nuclear%2520receptor%2520NR4A2%2520predicts%2520poor%2520survival%2520in%2520nasopharyngeal%2520carcinoma%26jtitle%3DAsian%2520Pac.%2520J.%2520Cancer%2520Prev.%26date%3D2013%26volume%3D14%26spage%3D2805%26epage%3D2809%26doi%3D10.7314%2Fapjcp.2013.14.5.2805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, U.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohankumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelhaugh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjalkens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas</span>. <i>J. Neuro Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1007/s11060-019-03349-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1007%2Fs11060-019-03349-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=31754919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCitb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2020&pages=25-39&author=K.+Karkiauthor=X.+Liauthor=U.-H.+Jinauthor=K.+Mohankumarauthor=M.+Zareiauthor=S.+K.+Michelhaughauthor=S.+Mittalauthor=R.+Tjalkensauthor=S.+Safe&title=Nuclear+receptor+4A2+%28NR4A2%29+is+a+druggable+target+for+glioblastomas&doi=10.1007%2Fs11060-019-03349-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas</span></div><div class="casAuthors">Karki, Keshav; Li, Xi; Jin, Un-Ho; Mohankumar, Kumaravel; Zarei, Mahsa; Michelhaugh, Sharon K.; Mittal, Sandeep; Tjalkens, Ronald; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-39</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Introduction: The orphan nuclear receptor 4A2 (NR4A2) has been extensively characterized in subcellular regions of the brain and is necessary for the function of dopaminergic neurons.  The NR4A2 ligand, 1,1-bis (31-indoly1)-1-(p-chlorophenyl)methane (DIM-C-pPhCl) inhibits markers of neuroinflammation and degeneration in mouse models and in this study we investigated expression and function of NR4A2 in glioblastoma (GBM).  Methods: Established and patient-derived cell lines were used as models and the expression and functions of NR4A2 were detd. by western blots and NR4A2 gene silencing by antisense oligonucleotides resp.  Effects of NR4A2 knockdown and DIM-C-pPhCl on cell growth, induction of apoptosis (Annexin V Staining) and migration/invasion (Boyden chamber and spheroid invasion assay) and transactivation of NR4A2-regulated reporter genes were detd.  Tumor growth was investigated in athymic nude mice bearing U87-MG cells as xenografts.  Results: NR4A2 knockdown and DIM-C-pPhCl inhibited GBM cell and tumor growth, induced apoptosis and inhibited migration and invasion of GBM cells.  DIM-C-pPhCl and related analogs also inhibited NR4A2-regulated transactivation (luciferase activity) confirming that DIM-C-pPhCl acts as an NR4A2 antagonist and blocks NR4A2-dependent pro-oncogenic responses in GBM.  Conclusion: We demonstrate for the first time that NR4A2 is pro-oncogenic in GBM and thus a potential druggable target for patients with tumors expressing this receptor.  Moreover, our bis-indole-derived NR4A2 antagonists represent a novel class of anti-cancer agents with potential future clin. applications for treating GBM.  Graphic abstr.: [Figure not available: see fulltext.].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEdcmrnjM9ULVg90H21EOLACvtfcHk0lh0_wfzLKiotw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCitb7P&md5=c59faaf59f390c4f657c058a44ff8791</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1007%2Fs11060-019-03349-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-019-03349-y%26sid%3Dliteratum%253Aachs%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DU.-H.%26aulast%3DMohankumar%26aufirst%3DK.%26aulast%3DZarei%26aufirst%3DM.%26aulast%3DMichelhaugh%26aufirst%3DS.%2BK.%26aulast%3DMittal%26aufirst%3DS.%26aulast%3DTjalkens%26aufirst%3DR.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DNuclear%2520receptor%25204A2%2520%2528NR4A2%2529%2520is%2520a%2520druggable%2520target%2520for%2520glioblastomas%26jtitle%3DJ.%2520Neuro%2520Oncol.%26date%3D2020%26volume%3D146%26spage%3D25%26epage%3D39%26doi%3D10.1007%2Fs11060-019-03349-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chintharlapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burghardt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papineni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">Activation of Nur77 by selected 1,1-Bis(3’-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">24903</span>– <span class="NLM_lpage">24914</span>, <span class="refDoi"> DOI: 10.1074/jbc.m500107200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1074%2Fjbc.M500107200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=15871945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFyqsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=24903-24914&author=S.+Chintharlapalliauthor=R.+Burghardtauthor=S.+Papineniauthor=S.+Ramaiahauthor=K.+Yoonauthor=S.+Safe&title=Activation+of+Nur77+by+selected+1%2C1-Bis%283%E2%80%99-indolyl%29-1-%28p-substituted+phenyl%29methanes+induces+apoptosis+through+nuclear+pathways&doi=10.1074%2Fjbc.m500107200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Nur77 by Selected 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes Induces Apoptosis through Nuclear Pathways</span></div><div class="casAuthors">Chintharlapalli, Sudhakar; Burghardt, Robert; Papineni, Sabitha; Ramaiah, Shashi; Yoon, Kyungsil; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">24903-24914</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nur77 is an orphan receptor and a member of the nerve growth factor-I-B subfamily of the nuclear receptor family of transcription factors.  Based on the results of transactivation assays in pancreatic and other cancer cell lines, we have now identified for the first time Nur77 agonists typified by 1,1-bis(3-indolyl)-1-(p-anisyl)methane that activate GAL4-Nur77 chimeras expressing wild-type and the ligand binding domain (E/F) of Nur77.  In Panc-28 pancreatic cancer cells, Nur77 agonists activate the nuclear receptor, and downstream responses include decreased cell survival and induction of cell death pathways, including tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and poly(ADP-ribose) polymerase (PARP) cleavage.  Moreover, the transactivation and apoptotic responses are also induced in other pancreatic, prostate, and breast cancer cells that express Nur77.  In Panc-28 cells, small inhibitory RNA for Nur77 reverses ligand-dependent transactivation and induction of TRAIL and PARP cleavage.  Nur77 agonists also inhibit tumor growth in vivo in athymic mice bearing Panc-28 cell xenografts.  These results identify compds. that activate Nur77 through the ligand binding domain and show that ligand-dependent activation of Nur77 through nuclear pathways in cancer cells induces cell death and these compds. are a novel class of anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_VexMGI2027Vg90H21EOLACvtfcHk0lg1RpuWX9nfVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFyqsb8%253D&md5=d82803ea6f94a2fb25317d2cd9f7a57d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M500107200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M500107200%26sid%3Dliteratum%253Aachs%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DBurghardt%26aufirst%3DR.%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DRamaiah%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DK.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DActivation%2520of%2520Nur77%2520by%2520selected%25201%252C1-Bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-substituted%2520phenyl%2529methanes%2520induces%2520apoptosis%2520through%2520nuclear%2520pathways%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D24903%26epage%3D24914%26doi%3D10.1074%2Fjbc.m500107200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chintharlapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">683</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-06-2907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1158%2F0008-5472.CAN-06-2907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=17234778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVKrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=674-683&author=S.+D.+Choauthor=K.+Yoonauthor=S.+Chintharlapalliauthor=M.+Abdelrahimauthor=P.+Leiauthor=S.+Hamiltonauthor=S.+Khanauthor=S.+K.+Ramaiahauthor=S.+Safe&title=Nur77+agonists+induce+proapoptotic+genes+and+responses+in+colon+cancer+cells+through+nuclear+receptor-dependent+and+nuclear+receptor-independent+pathways&doi=10.1158%2F0008-5472.can-06-2907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Nur77 Agonists Induce Proapoptotic Genes and Responses in Colon Cancer Cells through Nuclear Receptor-Dependent and Nuclear Receptor-Independent Pathways</span></div><div class="casAuthors">Cho, Sung Dae; Yoon, Kyungsil; Chintharlapalli, Sudhakar; Abdelrahim, Maen; Lei, Ping; Hamilton, Stanley; Khan, Shaheen; Ramaiah, Shashi K.; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">674-683</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Nerve growth factor-induced Bα (NGFI-Bα, Nur77) is an orphan nuclear receptor with no known endogenous ligands; however, recent studies on a series of methylene-substituted diindolylmethanes (C-DIM) have identified 1,1-bis(3'-indolyl)-1-(phenyl)methane (DIM-C-Ph) and 1,1-bis(3'-indolyl)-1-(p-anisyl)methane (DIM-C-pPhOCH3) as Nur77 agonists.  Nur77 is expressed in several colon cancer cell lines (RKO, SW480, HCT-116, HT-29, and HCT-15), and we also obsd. by immunostaining that Nur77 was overexpressed in colon tumors compared with normal colon tissue.  DIM-C-Ph and DIM-C-pPhOCH3 decreased survival and induced apoptosis in RKO colon cancer cells, and this was accompanied by induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein.  The induction of apoptosis and TRAIL by DIM-C-pPhOCH3 was significantly inhibited by a small inhibitory RNA for Nur77 (iNur77); however, it was evident from RNA interference studies that DIM-C-pPhOCH3 also induced Nur77-independent apoptosis.  Anal. of DIM-C-pPhOCH3-induced gene expression using microarrays identified several proapoptotic genes, and anal. by reverse transcription-PCR in the presence or absence of iNur77 showed that induction of programmed cell death gene 1 was Nur77 dependent, whereas induction of cystathionase and activating transcription factor 3 was Nur77 independent.  DIM-C-pPhOCH3 (25 mg/kg/d) also inhibited tumor growth in athymic nude mice bearing RKO cell xenografts.  These results show that Nur77-active C-DIM compds. represent a new class of anti-colon cancer drugs that act through receptor-dependent and receptor-independent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUKcKfJxo5RLVg90H21EOLACvtfcHk0lg1RpuWX9nfVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVKrtg%253D%253D&md5=a2f00bc08b0ee78096e8e27f6ea25c77</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-2907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-2907%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BD.%26aulast%3DYoon%26aufirst%3DK.%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DAbdelrahim%26aufirst%3DM.%26aulast%3DLei%26aufirst%3DP.%26aulast%3DHamilton%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DRamaiah%26aufirst%3DS.%2BK.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DNur77%2520agonists%2520induce%2520proapoptotic%2520genes%2520and%2520responses%2520in%2520colon%2520cancer%2520cells%2520through%2520nuclear%2520receptor-dependent%2520and%2520nuclear%2520receptor-independent%2520pathways%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D674%26epage%3D683%26doi%3D10.1158%2F0008-5472.can-06-2907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K.</span>; <span class="NLM_string-name">Chen, C. C.</span>; <span class="NLM_string-name">Orr, A. A.</span>; <span class="NLM_string-name">Barreto, P. N.</span>; <span class="NLM_string-name">Tamamis, P.</span>; <span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">Activation of COUP-TFI by a Novel Diindolylmethane Derivative</span>.  <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2019</span><b>,</b>  <span class="NLM_volume">8</span>.<span class="refDoi"> DOI: 10.3390/cells8030220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.3390%2Fcells8030220" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&author=K.+Yoon&author=C.+C.+Chen&author=A.+A.+Orr&author=P.+N.+Barreto&author=P.+Tamamis&author=S.+Safe&title=Activation+of+COUP-TFI+by+a+Novel+Diindolylmethane+Derivative&doi=10.3390%2Fcells8030220"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3390%2Fcells8030220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells8030220%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DK.%26atitle%3DActivation%2520of%2520COUP-TFI%2520by%2520a%2520Novel%2520Diindolylmethane%2520Derivative%26jtitle%3DCells%26date%3D2019%26volume%3D8%26doi%3D10.3390%2Fcells8030220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chintharlapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samudio, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">1,1-Bis(3’-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">5994</span>– <span class="NLM_lpage">6001</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-04-0399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1158%2F0008-5472.CAN-04-0399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=15342379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFCls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=5994-6001&author=S.+Chintharlapalliauthor=R.+Smithauthor=I.+Samudioauthor=W.+Zhangauthor=S.+Safe&title=1%2C1-Bis%283%E2%80%99-indolyl%29-1-%28p-substitutedphenyl%29methanes+induce+peroxisome+proliferator-activated+receptor+gamma-mediated+growth+inhibition%2C+transactivation%2C+and+differentiation+markers+in+colon+cancer+cells&doi=10.1158%2F0008-5472.can-04-0399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induce proxisome proliferator-activated receptor γ-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells</span></div><div class="casAuthors">Chintharlapalli, Sudhakar; Smith, Roger, III; Samudio, Ismael; Zhang, Wei; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5994-6001</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">1,1-bis(3'indolyl)-1-(p-substituted Ph methanes contg. p-trifluoromethyl (DIM-C-pPhCF3), p-t-Bu (DIM-C-pPhtBu), and p-Ph (DIM-C-pPhC6H5) groups induce peroxisome proliferator-activated receptor γ (PPARγ)-mediated transactivation in HT-29, HCT-15, RKO, and SW480 colon cancer cell lines.  Rosiglitazone also induces transactivation in these cell lines and inhibited growth of HT-29 cells, which express wild-type PPARγ but not HCT-15 cells, which express mutant (K422Q) PPARγ.  In contrast, DIM-C-pPhCF3, DIM-C-pPhtBu, and DIM-C-pPhC6H5 inhibited growth of both HT-29 and HCT-15 cells with IC50 values ranging from 1 to 10 μmol/L.  Rosiglitazone and diindolylmethane (DIM) analogs did not affect expression of cyclin D1, p21, or p27 protein levels or apoptosis in HCT-15 or HT-29 cells but induced keratin 18 in both cell lines.  However, rosiglitazone induced caveolins 1 and 2 in HT-29 but not HCT-15 cells, whereas these differentiation markers were induced by DIM-C-pPhCF3 and DIM-C-pPhC6H5 in both cell lines.  Because overexpression of caveolin 1 is known to suppress colon cancer cell and tumor growth, the growth inhibitory effects of rosiglitazone and the DIM compds. are assocd. with PPARγ-dependent induction of caveolins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpinNdV8qZTUrVg90H21EOLACvtfcHk0lg1RpuWX9nfVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFCls70%253D&md5=1c770d15a7242e04d55353153676a97b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-0399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-0399%26sid%3Dliteratum%253Aachs%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DSamudio%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3D1%252C1-Bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-substitutedphenyl%2529methanes%2520induce%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma-mediated%2520growth%2520inhibition%252C%2520transactivation%252C%2520and%2520differentiation%2520markers%2520in%2520colon%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D5994%26epage%3D6001%26doi%3D10.1158%2F0008-5472.can-04-0399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrow, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samudio, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3’-indolyl)-1-(p-substituted phenyl)methanes</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=15026545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFCnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=247-260&author=C.+Qinauthor=D.+Morrowauthor=J.+Stewartauthor=K.+Spencerauthor=W.+Porterauthor=R.+Smithauthor=T.+Phillipsauthor=M.+Abdelrahimauthor=I.+Samudioauthor=S.+Safe&title=A+new+class+of+peroxisome+proliferator-activated+receptor+gamma+%28PPARgamma%29+agonists+that+inhibit+growth+of+breast+cancer+cells%3A+1%2C1-Bis%283%E2%80%99-indolyl%29-1-%28p-substituted+phenyl%29methanes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A new class of peroxisome proliferator-activated receptor γ (PPARγ) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes</span></div><div class="casAuthors">Qin, Chunhua; Morrow, Derek; Stewart, Jessica; Spencer, Kyle; Porter, Weston; Smith, Roger, III; Phillips, Timothy; Abdelrahim, Maen; Samudio, Ismael; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-260</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">1,1-Bis(3'-indolyl)-1-(p-trifluoromethylphenyl)methane (DIM-C-pPhCF3) and several p-substituted Ph analogs have been investigated as a new class of peroxisome proliferator-activated receptor γ (PPARγ) agonists.  Structure-activity studies in PPARγ-dependent transactivation assays in MCF-7 breast cancer cells show that 5-20 μM concns. of compds. contg. p-trifluoromethyl, t-Bu, cyano, dimethylamino, and Ph groups were active, whereas p-Me, hydrogen, methoxy, hydroxyl, or halogen groups were inactive as PPARγ agonists.  Induction of PPARγ-dependent transactivation by 15-deoxy-Δ12,14-prostaglandin J2 (PGJ2) and DIM-C-pPhCF3 was inhibited in MCF-7 cells cotreated with the PPARγ-specific antagonist N-(4'-aminopyridyl)-2-chloro-5-nitrobenzamide.  In mammalian two-hybrid assays, DIM-C-pPhCF3 and PGJ2 (5-20 μM) induced interactions of PPARγ with steroid receptor coactivator (SRC) 1, SRC2 (TIFII), and thyroid hormone receptor-assocd. protein 220 but not with SRC3 (AIB1).  In contrast, DIM-C-pPhCF3, but not PGJ2, induced interactions of PPARγ with PPARγ coactivator-1.  C-substituted diindolylmethanes inhibit carcinogen-induced rat mammary tumor growth, induce differentiation in 3T3-L1 preadipocytes, inhibit MCF-7 cell growth and G0/G1-S phase progression, induce apoptosis, and down-regulate cyclin D1 protein and estrogen receptor α in breast cancer cells.  These compds. are a novel class of synthetic PPARγ agonists that induce responses in MCF-7 cells similar to those obsd. for PGJ2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMkCAR_DeYarVg90H21EOLACvtfcHk0likXz6knh12sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFCnsrc%253D&md5=e1c5b7fd6be48bb4a3f4956138344681</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DC.%26aulast%3DMorrow%26aufirst%3DD.%26aulast%3DStewart%26aufirst%3DJ.%26aulast%3DSpencer%26aufirst%3DK.%26aulast%3DPorter%26aufirst%3DW.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DPhillips%26aufirst%3DT.%26aulast%3DAbdelrahim%26aufirst%3DM.%26aulast%3DSamudio%26aufirst%3DI.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DA%2520new%2520class%2520of%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma%2520%2528PPARgamma%2529%2520agonists%2520that%2520inhibit%2520growth%2520of%2520breast%2520cancer%2520cells%253A%25201%252C1-Bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-substituted%2520phenyl%2529methanes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D247%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tjalkens, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbone, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">The peroxisome proliferator-activated receptor-gamma agonist 1,1-bis(3’-indolyl)-1-(p-trifluoromethylphenyl)methane suppresses manganese-induced production of nitric oxide in astrocytes and inhibits apoptosis in cocultured PC12 cells</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">618</span>– <span class="NLM_lpage">629</span>, <span class="refDoi"> DOI: 10.1002/jnr.21524</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1002%2Fjnr.21524" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=18041089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvF2qt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2008&pages=618-629&author=R.+B.+Tjalkensauthor=X.+Liuauthor=B.+Mohlauthor=T.+Wrightauthor=J.+A.+Morenoauthor=D.+L.+Carboneauthor=S.+Safe&title=The+peroxisome+proliferator-activated+receptor-gamma+agonist+1%2C1-bis%283%E2%80%99-indolyl%29-1-%28p-trifluoromethylphenyl%29methane+suppresses+manganese-induced+production+of+nitric+oxide+in+astrocytes+and+inhibits+apoptosis+in+cocultured+PC12+cells&doi=10.1002%2Fjnr.21524"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The peroxisome proliferator-activated receptor-γ agonist 1,1-bis(3'-indolyl)-1-(P-trifluoromethylphenyl)methane suppresses manganese-induced production of nitric oxide in astrocytes and inhibits apoptosis in cocultured PC12 cells</span></div><div class="casAuthors">Tjalkens, Ronald B.; Liu, Xuhong; Mohl, Brianne; Wright, Tyler; Moreno, Julie A.; Carbone, David L.; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">618-629</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Reactive astrogliosis is a prominent neuropathol. feature of manganism, a neurodegenerative disorder caused by excessive accumulation of manganese (Mn) in the basal ganglia.  Activation of astrocytes has been linked to neuronal injury in manganism resulting from overprodn. of inflammatory mediators, including tumor necrosis factor-α (TNFα), interferon-γ (IFNγ), interleukin-1β (IL-1β), and nitric oxide (NO), but the signaling mechanisms by which Mn regulates these factors remain poorly understood.  We previously reported that Mn enhances prodn. of NO in activated astrocytes that promotes apoptosis in cocultured neuronal cells by a mechanism involving the transcription factor nuclear factor-κB (NF-κB).  Because NF-κB-dependent expression of inducible nitric oxide synthase (NOS2) can be antagonized by the nuclear orphan receptor peroxisome proliferator-activated receptor-γ (PPARγ), we postulated that a novel agonist of this receptor, 1,1-bis(3'-indolyl)-1-(p-trifluoromethylphenyl)methane (cDIM1), would suppress expression of NOS2 in astrocytes and protect cocultured neuronal cells from apoptosis.  Submicromolar concns. of cDIM1 potently suppressed prodn. of NO and expression of NOS2 in cultured astrocytes exposed to Mn and IFNγ/TNFα and prevented apoptosis in cocultures of differentiated PC12 cells, but this neuroprotective effect was lost in the absence of astrocytes.  By using fluorescence reporter and chromatin immunopptn. (ChIP) assays, we found that cDIM1 prevented activation of NF-κB in astrocytes by a mechanism involving stabilization of the nuclear corepressor 2 (NCoR2) on the proximal NF-κB binding site of the NOS2 promoter.  These data suggest that PPARγ may be an effective target for limiting inflammatory activation of astrocytes during neurol. injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqiAX_z5uhR7Vg90H21EOLACvtfcHk0likXz6knh12sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvF2qt7o%253D&md5=e548a174ef0e5d8c3de6c0aefb001c42</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fjnr.21524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.21524%26sid%3Dliteratum%253Aachs%26aulast%3DTjalkens%26aufirst%3DR.%2BB.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMohl%26aufirst%3DB.%26aulast%3DWright%26aufirst%3DT.%26aulast%3DMoreno%26aufirst%3DJ.%2BA.%26aulast%3DCarbone%26aufirst%3DD.%2BL.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DThe%2520peroxisome%2520proliferator-activated%2520receptor-gamma%2520agonist%25201%252C1-bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-trifluoromethylphenyl%2529methane%2520suppresses%2520manganese-induced%2520production%2520of%2520nitric%2520oxide%2520in%2520astrocytes%2520and%2520inhibits%2520apoptosis%2520in%2520cocultured%2520PC12%2520cells%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2008%26volume%3D86%26spage%3D618%26epage%3D629%26doi%3D10.1002%2Fjnr.21524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3’-indoly)-1-(p-substituted phenyl)methanes</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3363</span>– <span class="NLM_lpage">3372</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-08-0439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1158%2F1535-7163.MCT-08-0439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=18852139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ensbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=3363-3372&author=P.+Leiauthor=M.+Abdelrahimauthor=S.+D.+Choauthor=X.+Liuauthor=S.+Safe&title=Structure-dependent+activation+of+endoplasmic+reticulum+stress-mediated+apoptosis+in+pancreatic+cancer+by+1%2C1-bis%283%E2%80%99-indoly%29-1-%28p-substituted+phenyl%29methanes&doi=10.1158%2F1535-7163.mct-08-0439"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3'-indoly)-1-(p-substituted phenyl)methanes</span></div><div class="casAuthors">Lei, Ping; Abdelrahim, Maen; Cho, Sung Dae; Liu, Xingi; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3363-3372</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">1,1-Bis(3'-indoly)-1-(p-substituted phenyl)methanes (C-DIM) exhibit structure-dependent activation of peroxisome proliferator-activated receptor γ and nerve growth factor-induced Bα (Nur77) and induce receptor-dependent and receptor-independent apoptosis in cancer cells and tumors.  In this study, we investigated the activation of apoptosis in pancreatic cancer cells by p-bromo (DIM-C-pPhBr) and p-fluoro (DIM-C-pPhF) and structurally related analogs that do not activate either peroxisome proliferator-activated receptor γ or Nur77.  The ortho, meta, and para-bromo and -fluoro isomers all activated endoplasmic reticulum (ER) stress-dependent apoptosis in pancreatic cancer cells; however, methylation of the indole N group significantly decreased activity, suggesting that a free N was important for activation of ER stress.  Both DIM-C-pPhBr and DIM-C-pPhF resembled the classic ER stress inducer thapsigargin in pancreatic cancer cells and activated ER stress markers, such as glucose-related protein 78 and the c-Jun NH2 kinase pathway, resulting in the induction of CCAAT/enhancer-binding protein homologous protein, death receptor 5, and the extrinsic apoptotic pathway.  Moreover, DIM-C-pPhBr also inhibited tumor growth in an orthotopic model for pancreatic cancer, demonstrating the clin. potential for this C-DIM compd. in pancreatic cancer chemotherapy. [Mol Cancer Ther 2008;7(10):3363-72].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw6lLOXOR9trVg90H21EOLACvtfcHk0likXz6knh12sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ensbzN&md5=72c77dbedcc137b04ca11b4efab1e734</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0439%26sid%3Dliteratum%253Aachs%26aulast%3DLei%26aufirst%3DP.%26aulast%3DAbdelrahim%26aufirst%3DM.%26aulast%3DCho%26aufirst%3DS.%2BD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DStructure-dependent%2520activation%2520of%2520endoplasmic%2520reticulum%2520stress-mediated%2520apoptosis%2520in%2520pancreatic%2520cancer%2520by%25201%252C1-bis%25283%25E2%2580%2599-indoly%2529-1-%2528p-substituted%2520phenyl%2529methanes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D3363%26epage%3D3372%26doi%3D10.1158%2F1535-7163.mct-08-0439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chintharlapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">1,1-Bis(3’-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1139</span>– <span class="NLM_lpage">1147</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgn103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1093%2Fcarcin%2Fbgn103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=18460448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1Wjtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=1139-1147&author=P.+Leiauthor=M.+Abdelrahimauthor=S.+D.+Choauthor=S.+Liuauthor=S.+Chintharlapalliauthor=S.+Safe&title=1%2C1-Bis%283%E2%80%99-indolyl%29-1-%28p-substituted+phenyl%29methanes+inhibit+colon+cancer+cell+and+tumor+growth+through+activation+of+c-jun+N-terminal+kinase&doi=10.1093%2Fcarcin%2Fbgn103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase</span></div><div class="casAuthors">Lei, Ping; Abdelrahim, Maen; Cho, Sung Dae; Liu, Shengxi; Chintharlapalli, Sudhakar; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1139-1147</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes (C-DIMs) activate the orphan receptors peroxisome proliferator-activated receptor γ (PPARγ) and Nur77 and induce receptor-dependent and -independent apoptotic pathways in colon and other cancer cells.  Structure-activity studies show that the p-bromo (DIM-C-pPhBr) and p-fluoro (DIM-C-pPhF) analogs, which exhibit minimal activation of Nur77 and PPARγ, induce expression of CCAAT/enhancer-binding protein homologous protein (CHOP/GADD153) in colon cancer cells.  Moreover, among a series of bromo and fluoro C-DIM analogs, their induction of CHOP was dependent on the position of the Ph substituents (para ≥ meta ≥ ortho) and required a free indole group.  DIM-C-pPhBr and DIM-C-pPhF not only induced CHOP but also activated death receptor 5 (CHOP dependent), cleavage of caspase 8 and poly (ADP ribose) polymerase (PARP) that is consistent with activation of the extrinsic pathway of apoptosis.  These responses were assocd. with the activation of c-jun N-terminal kinase (JNK) pathway since inhibition of JNK inhibited induction of the extrinsic apoptotic pathway by these C-DIMs.  However, in contrast to classical inducers of endoplasmic reticulum (ER) stress such as tunicamycin and thapsigargin, the C-DIM compds. did not induce glucose-related protein 78 that is a marker of ER stress.  Proapoptotic and anticarcinogenic effects were also obsd. in athymic nude mice bearing RKO cell xenografts and treated with 30 mg/kg/day DIM-C-pPhBr and this was accompanied by increased JNK phosphorylation in the tumors.  Thus, the anticarcinogenic activity of DIM-C-pPhBr in colon cancer cells and tumors is related to a novel ER stress-independent activation of JNK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAQ0-WoIHm_LVg90H21EOLACvtfcHk0ljErtjQLAZFjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1Wjtrg%253D&md5=21550476c08f698ed832bb5c241bc5f9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgn103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgn103%26sid%3Dliteratum%253Aachs%26aulast%3DLei%26aufirst%3DP.%26aulast%3DAbdelrahim%26aufirst%3DM.%26aulast%3DCho%26aufirst%3DS.%2BD.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3D1%252C1-Bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-substituted%2520phenyl%2529methanes%2520inhibit%2520colon%2520cancer%2520cell%2520and%2520tumor%2520growth%2520through%2520activation%2520of%2520c-jun%2520N-terminal%2520kinase%26jtitle%3DCarcinogenesis%26date%3D2008%26volume%3D29%26spage%3D1139%26epage%3D1147%26doi%3D10.1093%2Fcarcin%2Fbgn103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montes-Grajales, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivero-Verbél, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, J. T.</span></span> <span> </span><span class="NLM_article-title">3,3’-Diindolylmethane (DIM) and its ring-substituted halogenated analogs (ring-DIMs) induce differential mechanisms of survival and death in androgen-dependent and -independent prostate cancer cells</span>. <i>Genes Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.18632/genesandcancer.60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.18632%2Fgenesandcancer.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=26124925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCmtbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=265-280&author=A.+A.+Goldbergauthor=H.+Drazauthor=D.+Montes-Grajalesauthor=J.+Olivero-Verb%C3%A9lauthor=S.+H.+Safeauthor=J.+T.+Sanderson&title=3%2C3%E2%80%99-Diindolylmethane+%28DIM%29+and+its+ring-substituted+halogenated+analogs+%28ring-DIMs%29+induce+differential+mechanisms+of+survival+and+death+in+androgen-dependent+and+-independent+prostate+cancer+cells&doi=10.18632%2Fgenesandcancer.60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">3,3'-Diindolylmethane (DIM) and its ring-substituted halogenated analogs (ring-DIMs) induce differential mechanisms of survival and death in androgen-dependent and -independent prostate cancer cells</span></div><div class="casAuthors">Goldberg, Alexander A.; Draz, Hossam; Montes-Grajales, Diana; Olivero-Verbel, Jesus; Safe, Stephen H.; Sanderson, J. Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">265-280</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Impact Journals LLC</span>)
        </div><div class="casAbstract">We recently reported that novel ring-substituted analogs of 3,3'-diindolylmethane (ring-DIMs) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cells.  In this paper, we have focused on the mechanism(s) assocd. with ring-DIM-mediated cell death, and on identifying the specific intracellular target(s) of these compds.  The 4,4'- and 7,7'-dichloroDIMs and 4,4'- and 7,7'-dibromoDIMs induced the death of LNCaP, C42B and DU145 prostate cancer cells, but not that of immortalized normal human prostate epithelial (RWPE-1) cells.  Ring-DIMs caused the early loss of mitochondrial membrane potential (MMP) and decreased mitochondrial ATP generation in prostate cancer cells.  Cyclosporin A, an inhibitor of the mitochondrial permeability transition pore, inhibited ring-DIM-mediated cell death, and salubrinal, an inhibitor of ER stress, inhibited cell death mediated only by 4,4'-dihaloDIMs.  We found that although salubrinal did not inhibit the onset of ER stress, it prevented 4,4'-dibromoDIM mediated loss of MMP.  Salubrinal potentiated cell death in response to 7,7'-dihaloDIMs and DIM, and this effect concurred with increased loss of MMP.  Using in silico 3-D docking affinity anal., we identified Ca2+/calmodulin-dependent kinase II (CaMKII) as a potential direct target for the most toxic ring-DIM, 4,4'-dibromoDIM.  An inhibitor of CaMKII, KN93, but not its inactive analog KN92, abrogated cell death mediated by 4,4'-dibromoDIM.  The ring-DIMs induced ER stress and autophagy, but these processes were not necessary for ring-DIM-mediated cell death.  Inhibition of autophagy with bafilomycin A1, 3-methyladenine or by LC3B gene silencing sensitized LNCaP and C42B, but not ATG5-deficient DU145 cells to ring-DIM- and DIM-mediated cell death.  We propose that autophagy induced by the ring-DIMs and DIM has a cytoprotective function in prostate cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB4daZF7T7PbVg90H21EOLACvtfcHk0ljErtjQLAZFjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCmtbnP&md5=477fbec4d80e44c678d3b3f74fc73e11</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.18632%2Fgenesandcancer.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Fgenesandcancer.60%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DA.%2BA.%26aulast%3DDraz%26aufirst%3DH.%26aulast%3DMontes-Grajales%26aufirst%3DD.%26aulast%3DOlivero-Verb%25C3%25A9l%26aufirst%3DJ.%26aulast%3DSafe%26aufirst%3DS.%2BH.%26aulast%3DSanderson%26aufirst%3DJ.%2BT.%26atitle%3D3%252C3%25E2%2580%2599-Diindolylmethane%2520%2528DIM%2529%2520and%2520its%2520ring-substituted%2520halogenated%2520analogs%2520%2528ring-DIMs%2529%2520induce%2520differential%2520mechanisms%2520of%2520survival%2520and%2520death%2520in%2520androgen-dependent%2520and%2520-independent%2520prostate%2520cancer%2520cells%26jtitle%3DGenes%2520Cancer%26date%3D2015%26volume%3D6%26spage%3D265%26epage%3D280%26doi%3D10.18632%2Fgenesandcancer.60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papineni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chintharlapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">1,1-bis(3’-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1002/mc.20378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1002%2Fmc.20378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=17957723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1egt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=252-263&author=S.+D.+Choauthor=P.+Leiauthor=M.+Abdelrahimauthor=K.+Yoonauthor=S.+Liuauthor=J.+Guoauthor=S.+Papineniauthor=S.+Chintharlapalliauthor=S.+Safe&title=1%2C1-bis%283%E2%80%99-indolyl%29-1-%28p-methoxyphenyl%29methane+activates+Nur77-independent+proapoptotic+responses+in+colon+cancer+cells&doi=10.1002%2Fmc.20378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells</span></div><div class="casAuthors">Cho, Sung Dae; Lei, Ping; Abdelrahim, Maen; Yoon, Kyungsil; Liu, Shengxi; Guo, Jingjing; Papineni, Sabitha; Chintharlapalli, Sudhakar; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">252-263</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">1,1-Bis(3'-indolyl)-1-(p-methoxyphenyl)methane (DIM-C-pPhOCH3) is a methylene-substituted diindolylmethane (C-DIM) analog that activates the orphan receptor nerve growth factor-induced-Bα (NGFI-Bα, Nur77).  RNA interference studies with small inhibitory RNA for Nur77 demonstrate that DIM-C-pPhOCH3 induces Nur77-dependent and -independent apoptosis, and this study has focused on delineating the Nur77-independent proapoptotic pathways induced by the C-DIM analog.  DIM-C-pPhOCH3 induced caspase-dependent apoptosis in RKO colon cancer cells through decreased mitochondrial membrane potential which is accompanied by increased mitochondrial bax/bcl-2 ratios and release of cytochrome c into the cytosol.  DIM-C-pPhOCH3 also induced phosphatidylinositol-3-kinase-dependent activation of early growth response gene-1 which, in turn, induced expression of the proapoptotic nonsteroidal anti-inflammatory drug-activated gene-1 (NAG1) in RKO and SW480 colon cancer cells.  Moreover, DIM-C-pPhOCH3 also induced NAG-1 expression in colon tumors in athymic nude mice bearing RKO cells as xenografts.  DIM-C-pPhOCH3 also activated the extrinsic apoptosis pathway through increased phosphorylation of c-jun N-terminal kinase which, in turn, activated C/EBP homologous transcription factor (CHOP) and death receptor 5 (DR5).  Thus, the effectiveness of DIM-C-pPhOCH3 as a tumor growth inhibitor is through activation of Nur77-dependent and -independent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqqncrgkKkjLVg90H21EOLACvtfcHk0ljErtjQLAZFjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1egt74%253D&md5=d6696f104bc24c55291c2afe90992e89</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fmc.20378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.20378%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BD.%26aulast%3DLei%26aufirst%3DP.%26aulast%3DAbdelrahim%26aufirst%3DM.%26aulast%3DYoon%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3D1%252C1-bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-methoxyphenyl%2529methane%2520activates%2520Nur77-independent%2520proapoptotic%2520responses%2520in%2520colon%2520cancer%2520cells%26jtitle%3DMol.%2520Carcinog.%26date%3D2008%26volume%3D47%26spage%3D252%26epage%3D263%26doi%3D10.1002%2Fmc.20378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chintharlapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papineni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">1,1-bis(3’-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">558</span>– <span class="NLM_lpage">569</span>, <span class="refDoi"> DOI: 10.1124/mol.106.028696</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1124%2Fmol.106.028696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=17093136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=558-569&author=S.+Chintharlapalliauthor=S.+Papineniauthor=S.+Safe&title=1%2C1-bis%283%E2%80%99-indolyl%29-1-%28p-substitutedphenyl%29methanes+inhibit+growth%2C+induce+apoptosis%2C+and+decrease+the+androgen+receptor+in+LNCaP+prostate+cancer+cells+through+peroxisome+proliferator-activated+receptor+gamma-independent+pathways&doi=10.1124%2Fmol.106.028696"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">1,1-Bis(3'-indolyl)-1-(p-substituted-phenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor γ-independent pathways</span></div><div class="casAuthors">Chintharlapalli, Sudhakar; Papineni, Sabitha; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">558-569</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">1,1-Bis(3'-indolyl)-1-(p-substituted-phenyl)methanes (C-DIMs) contg. para-trifluoromethyl, t-Bu, and Ph groups are a novel class of peroxisome proliferator-activated receptor (PPAR)γ agonists.  In LNCaP prostate cancer cells, these compds. induce PPARγ-dependent transactivation, inhibit cell proliferation, and induce apoptosis.  In addn., these PPARγ agonists modulate a no. of antiproliferative and proapoptotic responses, including induction of p27, activating transcription factor 3, and nonsteroidal anti-inflammatory drug-activated gene-1 and down-regulation of cyclin D1 and caveolin-1.  Moreover, the PPARγ antagonist 2-chloro-5-nitrobenzanilide (GW9662) does not inhibit these effects.  The C-DIM compds. also abrogate androgen receptor (AR)-mediated signaling and decrease prostate-specific antigen (PSA) and AR protein expression, and these responses were PPARγ-independent.  The effects of C-DIMs on AR and PSA were due to decreased AR and PSA mRNA expression in LNCaP cells.  Thus, this series of methylene-substituted diindolylmethane derivs. simultaneously activate multiple pathways in LNCaP cells, including ablation of androgen-responsiveness and down-regulation of caveolin-1.  Both of these responses are assocd. with activation of proapoptotic pathways in this cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMOfRk7P3197Vg90H21EOLACvtfcHk0ljNKpNbLuxO3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWrsL0%253D&md5=e866e2d7ef19b3d67a945fda976c4edf</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.028696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.028696%26sid%3Dliteratum%253Aachs%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3D1%252C1-bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-substitutedphenyl%2529methanes%2520inhibit%2520growth%252C%2520induce%2520apoptosis%252C%2520and%2520decrease%2520the%2520androgen%2520receptor%2520in%2520LNCaP%2520prostate%2520cancer%2520cells%2520through%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma-independent%2520pathways%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D71%26spage%3D558%26epage%3D569%26doi%3D10.1124%2Fmol.106.028696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S.</span></span> <span> </span><span class="NLM_article-title">1,1-Bis(3’-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2324</span>– <span class="NLM_lpage">2336</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-06-0184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1158%2F1535-7163.MCT-06-0184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=16985067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1ynsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2324-2336&author=P.+Leiauthor=M.+Abdelrahimauthor=S.+Safe&title=1%2C1-Bis%283%E2%80%99-indolyl%29-1-%28p-substituted+phenyl%29methanes+inhibit+ovarian+cancer+cell+growth+through+peroxisome+proliferator-activated+receptor-dependent+and+independent+pathways&doi=10.1158%2F1535-7163.mct-06-0184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways</span></div><div class="casAuthors">Lei, Ping; Abdelrahim, Maen; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2324-2336</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">1,1-Bis(3'-indolyl)-1-(p-t-butylphenyl)methane (DIM-C-pPhtBu) is a peroxisome proliferator-activated receptor γ (PPARγ) agonist, and treatment of SKOV3 ovarian cancer cells with this compd. (5 μmol/L) inhibits cell proliferation, whereas up to 15 μmol/L rosiglitazone had no effect on cell growth.  DIM-C-pPhtBu also inhibits G0-G1 to S phase cell cycle progression and this is linked, in part, to PPARγ-dependent induction of the cyclin-dependent kinase inhibitor p21.  DIM-C-pPhtBu induces PPARγ-independent down-regulation of cyclin D1 and we therefore further investigated activation of receptor-independent pathways.  DIM-C-pPhtBu also induced apoptosis in SKOV3 cells and this was related to induction of glucose-related protein 78, which is typically up-regulated as part of the unfolded protein response during endoplasmic reticulum (ER) stress.  Activation of ER stress was also obsd. in other ovarian cancer cell lines treated with DIM-C-pPhtBu.  In addn., DIM-C-pPhtBu induced CCAAT/enhancer binding protein homologous protein through both ER stress and c-jun NH2-terminal kinase-dependent pathways, and CCAAT/enhancer binding protein homologous protein activated death receptor 5 and the extrinsic pathway of apoptosis.  These results show that DIM-C-pPhtBu inhibits growth and induces apoptosis in ovarian cancer cells through both PPARγ-dependent and PPARγ-independent pathways, and this complex mechanism of action will be advantageous for future clin. development of these compds. for treatment of ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMKBTSTWgdm7Vg90H21EOLACvtfcHk0ljNKpNbLuxO3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1ynsLc%253D&md5=4d1d58ed4b13a2a0b2e30870b33a6bd2</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0184%26sid%3Dliteratum%253Aachs%26aulast%3DLei%26aufirst%3DP.%26aulast%3DAbdelrahim%26aufirst%3DM.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3D1%252C1-Bis%25283%25E2%2580%2599-indolyl%2529-1-%2528p-substituted%2520phenyl%2529methanes%2520inhibit%2520ovarian%2520cancer%2520cell%2520growth%2520through%2520peroxisome%2520proliferator-activated%2520receptor-dependent%2520and%2520independent%2520pathways%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D2324%26epage%3D2336%26doi%3D10.1158%2F1535-7163.mct-06-0184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salminen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtonen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paimela, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaarniranta, K.</span></span> <span> </span><span class="NLM_article-title">Celastrol: Molecular targets of Thunder God Vine</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>394</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">442</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2010.03.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.bbrc.2010.03.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=20226165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC3cXks1Kjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=2010&pages=439-442&author=A.+Salminenauthor=M.+Lehtonenauthor=T.+Paimelaauthor=K.+Kaarniranta&title=Celastrol%3A+Molecular+targets+of+Thunder+God+Vine&doi=10.1016%2Fj.bbrc.2010.03.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Celastrol: Molecular targets of Thunder God Vine</span></div><div class="casAuthors">Salminen, Antero; Lehtonen, Marko; Paimela, Tuomas; Kaarniranta, Kai</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">439-442</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Celastrol, a quinone methide triterpene, is a pharmacol. active compd. present in Thunder God Vine root exts. used as a remedy of inflammatory and autoimmune diseases, e.g. rheumatoid arthritis.  Celastrol is one of the most promising medicinal mols. isolated from the plant exts. of traditional medicines.  Mol. studies have identified several mol. targets which are mostly centered on the inhibition of IKK-NF-κB signaling.  Celastrol (i) inhibits directly the IKKα and β kinases, (ii) inactivates the Cdc37 and p23 proteins which are co-chaperones of HSP90, (iii) inhibits the function of proteasomes, and (iv) activates the HSF1 and subsequently triggers the heat shock response.  It seems that the quinone methide structure present in celastrol can react with the thiol groups of cysteine residues, forming covalent protein adducts.  In lab. expts., celastrol has proved to be a potent inhibitor of inflammatory responses and cancer formation as well as alleviating diseases of proteostasis deficiency.  Celastrol needs still to pass several hurdles, e.g. ADMET assays, before it can enter the armory of western drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAqujhaYI_2bVg90H21EOLACvtfcHk0lh2nhKaBdatJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXks1Kjurs%253D&md5=4fff51afc9fc9b391ed0195ab70618bd</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2010.03.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2010.03.050%26sid%3Dliteratum%253Aachs%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DLehtonen%26aufirst%3DM.%26aulast%3DPaimela%26aufirst%3DT.%26aulast%3DKaarniranta%26aufirst%3DK.%26atitle%3DCelastrol%253A%2520Molecular%2520targets%2520of%2520Thunder%2520God%2520Vine%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2010%26volume%3D394%26spage%3D439%26epage%3D442%26doi%3D10.1016%2Fj.bbrc.2010.03.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teriete, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raveendra-Panickar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendelton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazo, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiseman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holien, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misund, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliynyk, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsenian-Henriksson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosford, N. D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prochownik, E. V.</span></span> <span> </span><span class="NLM_article-title">Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">32380</span>– <span class="NLM_lpage">32395</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.6116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.18632%2Foncotarget.6116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=26474287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A280%3ADC%252BC28zitlGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=32380-32395&author=H.+Wangauthor=P.+Terieteauthor=A.+Huauthor=D.+Raveendra-Panickarauthor=K.+Pendeltonauthor=J.+S.+Lazoauthor=J.+Eisemanauthor=T.+Holienauthor=K.+Misundauthor=G.+Oliynykauthor=M.+Arsenian-Henrikssonauthor=N.+D.+P.+Cosfordauthor=A.+Sundanauthor=E.+V.+Prochownik&title=Direct+inhibition+of+c-Myc-Max+heterodimers+by+celastrol+and+celastrol-inspired+triterpenoids&doi=10.18632%2Foncotarget.6116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids</span></div><div class="casAuthors">Wang Huabo; Hu Angela; Pendelton Kelsey; Prochownik Edward V; Teriete Peter; Raveendra-Panickar Dhanya; Cosford Nicholas D P; Lazo John S; Eiseman Julie; Eiseman Julie; Prochownik Edward V; Holien Toril; Misund Kristine; Sundan Anders; Oliynyk Ganna; Arsenian-Henriksson Marie; Prochownik Edward V</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">32380-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Many oncogenic signals originate from abnormal protein-protein interactions that are potential targets for small molecule inhibitors.  However, the therapeutic disruption of these interactions has proved elusive.  We report here that the naturally-occurring triterpenoid celastrol is an inhibitor of the c-Myc (Myc) oncoprotein, which is over-expressed in many human cancers.  Most Myc inhibitors prevent the association between Myc and its obligate heterodimerization partner Max via their respective bHLH-ZIP domains.  In contrast, we show that celastrol binds to and alters the quaternary structure of the pre-formed dimer and abrogates its DNA binding.  Celastrol contains a reactive quinone methide group that promiscuously forms Michael adducts with numerous target proteins and other free sulfhydryl-containing molecules.  Interestingly, triterpenoid derivatives lacking the quinone methide showed enhanced specificity and potency against Myc.  As with other Myc inhibitors, these analogs rapidly reduced the abundance of Myc protein and provoked a global energy crisis marked by ATP depletion, neutral lipid accumulation, AMP-activated protein kinase activation, cell cycle arrest and apoptosis.  They also inhibited the proliferation of numerous established human cancer cell lines as well as primary myeloma explants that were otherwise resistant to JQ1, a potent indirect Myc inhibitor.  N-Myc amplified neuroblastoma cells showed similar responses and, in additional, underwent neuronal differentiation.  These studies indicate that certain pharmacologically undesirable properties of celastrol such as Michael adduct formation can be eliminated while increasing selectivity and potency toward Myc and N-Myc.  This, together with their low in vivo toxicity, provides a strong rationale for pursuing the development of additional Myc-specific triterpenoid derivatives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLYuH_K-VTYFMGsG_HTXYFfW6udTcc2eYyb4NTOuExKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zitlGmug%253D%253D&md5=c11fcf599276f90b82c813af934f12b1</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.6116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.6116%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DTeriete%26aufirst%3DP.%26aulast%3DHu%26aufirst%3DA.%26aulast%3DRaveendra-Panickar%26aufirst%3DD.%26aulast%3DPendelton%26aufirst%3DK.%26aulast%3DLazo%26aufirst%3DJ.%2BS.%26aulast%3DEiseman%26aufirst%3DJ.%26aulast%3DHolien%26aufirst%3DT.%26aulast%3DMisund%26aufirst%3DK.%26aulast%3DOliynyk%26aufirst%3DG.%26aulast%3DArsenian-Henriksson%26aufirst%3DM.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26aulast%3DSundan%26aufirst%3DA.%26aulast%3DProchownik%26aufirst%3DE.%2BV.%26atitle%3DDirect%2520inhibition%2520of%2520c-Myc-Max%2520heterodimers%2520by%2520celastrol%2520and%2520celastrol-inspired%2520triterpenoids%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D32380%26epage%3D32395%26doi%3D10.18632%2Foncotarget.6116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Z.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.-B.</span></span> <span> </span><span class="NLM_article-title">Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">914</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgt395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1093%2Fcarcin%2Fbgt395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=24293411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtVOhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=905-914&author=Z.+Liuauthor=L.+Maauthor=Z.-S.+Wenauthor=Z.+Huauthor=F.-Q.+Wuauthor=W.+Liauthor=J.+Liuauthor=G.-B.+Zhou&title=Cancerous+inhibitor+of+PP2A+is+targeted+by+natural+compound+celastrol+for+degradation+in+non-small-cell+lung+cancer&doi=10.1093%2Fcarcin%2Fbgt395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer</span></div><div class="casAuthors">Liu, Zi; Ma, Liang; Wen, Zhe-Sheng; Hu, Zheng; Wu, Fu-Qun; Li, Wei; Liu, Jinsong; Zhou, Guang-Biao</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">905-914</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Summary Celastrol binds CIP2A and enhances CIP2A-CHIP interaction, leading to ubiquitination/degrdn. of CIP2A and inhibition of lung cancer cells in vitro and in vivo.  Celastrol potentiates cisplatin's efficacy by suppressing the CIP2A-Akt pathway, and therefore CIP2A inhibitors may represent novel therapeutics for cancer.  Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an oncoprotein overexpressed and inversely assocd. with prognosis in lung and many other human cancers.  It modulates phospho-Akt and stabilizes c-Myc, and is required for cell proliferation and malignant transformation, indicating that CIP2A may play an important role in carcinogenesis.  We reported here that a small compd. celastrol could induce a rapid degrdn. of CIP2A, through the ubiquitin-proteasome pathway with the carboxyl terminus of Hsp70-interacting protein (CHIP) as the E3 ligase.  Celastrol directly bound CIP2A protein and promoted CIP2A-CHIP interaction, leading to subsequent degrdn. of CIP2A in non-small-cell lung cancer cells.  Furthermore, celastrol effectively inhibited cell proliferation and induced apoptosis in non-small-cell lung cancer cells, whereas CIP2A silencing enhanced these effects.  Celastrol also suppressed tumor growth in xenograft murine models.  In addn., celastrol potentiated the inhibitory effect of cytotoxic agent cisplatin on lung cancer cells in vitro and in vivo via inhibition of CIP2A-Akt pathway.  These data indicate that celastrol is a CIP2A-targeting agent that may have therapeutic potentials in lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXNNdcS85iUrVg90H21EOLACvtfcHk0lh2nhKaBdatJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtVOhsro%253D&md5=4bbe0e98b42f03543ce12a6a3d835434</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgt395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgt395%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWen%26aufirst%3DZ.-S.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DF.-Q.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.-B.%26atitle%3DCancerous%2520inhibitor%2520of%2520PP2A%2520is%2520targeted%2520by%2520natural%2520compound%2520celastrol%2520for%2520degradation%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DCarcinogenesis%26date%3D2014%26volume%3D35%26spage%3D905%26epage%3D914%26doi%3D10.1093%2Fcarcin%2Fbgt395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span> <span> </span><span class="NLM_article-title">Celastrol Attenuates Angiotensin II-Induced Cardiac Remodeling by Targeting STAT3</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1007</span>– <span class="NLM_lpage">1023</span>, <span class="refDoi"> DOI: 10.1161/circresaha.119.315861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1161%2FCIRCRESAHA.119.315861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=32098592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmvFShu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2020&pages=1007-1023&author=S.+Yeauthor=W.+Luoauthor=Z.+A.+Khanauthor=G.+Wuauthor=L.+Xuanauthor=P.+Shanauthor=K.+Linauthor=T.+Chenauthor=J.+Wangauthor=X.+Huauthor=S.+Wangauthor=W.+Huangauthor=G.+Liang&title=Celastrol+Attenuates+Angiotensin+II-Induced+Cardiac+Remodeling+by+Targeting+STAT3&doi=10.1161%2Fcircresaha.119.315861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Celastrol Attenuates Angiotensin II-Induced Cardiac Remodeling by Targeting STAT3</span></div><div class="casAuthors">Ye, Shiju; Luo, Wu; Khan, Zia A.; Wu, Gaojun; Xuan, Lina; Shan, Peiren; Lin, Ke; Chen, Taiwei; Wang, Jingying; Hu, Xiang; Wang, Shengjie; Huang, Weijian; Liang, Guang</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1007-1023</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Rationale: Excessive Ang II (angiotensin II) levels lead to a profibrotic and hypertrophic milieu that produces deleterious remodeling and dysfunction in hypertension-assocd. heart failure.  Agents that disrupt Ang II-induced cardiac dysfunction may have clin. utility in the treatment of hypertension-assocd. heart failure.  Objective: We have examd. the potential effect of celastrol-a bioactive compd. derived from the Celastraceae family-on Ang II-induced cardiac dysfunction.  Methods and results: In rat primary cardiomyocytes and H9C2 (rat cardiomyocyte-like H9C2) cells, celastrol attenuates Ang II-induced cellular hypertrophy and fibrotic responses.  Proteome microarrays, surface plasmon resonance, competitive binding assays, and mol. simulation were used to identify the mol. target of celastrol.  Our data showed that celastrol directly binds to and inhibits STAT (signal transducer and activator of transcription)-3 phosphorylation and nuclear translocation.  Functional tests demonstrated that the protection of celastrol is afforded through targeting STAT3.  Overexpression of STAT3 dampens the effect of celastrol by partially rescuing STAT3 activity.  Finally, we investigated the in vivo effect of celastrol treatment in mice challenged with Ang II and in the transverse aortic constriction model.  We show that celastrol administration protected heart function in Ang II-challenged and transverse aortic constriction-challenged mice by inhibiting cardiac fibrosis and hypertrophy.  Conclusions: Our studies show that celastrol inhibits Ang II-induced cardiac dysfunction by inhibiting STAT3 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrbLcHejN-jrVg90H21EOLACvtfcHk0lh2ydloy0nwug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmvFShu7o%253D&md5=77fc07db5196b5c92f7d925cbe104a19</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.119.315861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.119.315861%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DKhan%26aufirst%3DZ.%2BA.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DXuan%26aufirst%3DL.%26aulast%3DShan%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DG.%26atitle%3DCelastrol%2520Attenuates%2520Angiotensin%2520II-Induced%2520Cardiac%2520Remodeling%2520by%2520Targeting%2520STAT3%26jtitle%3DCirc.%2520Res.%26date%3D2020%26volume%3D126%26spage%3D1007%26epage%3D1023%26doi%3D10.1161%2Fcircresaha.119.315861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao-Pei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji-Kuai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao-Fang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ya-Min, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen-Jun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang-Bo, Z.</span></span> <span> </span><span class="NLM_article-title">Systematic identification of Celastrol-binding proteins reveals that Shoc2 is inhibited by Celastrol</span>. <i>Biosci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">BSR20181233</span>, <span class="refDoi"> DOI: 10.1042/bsr20181233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1042%2FBSR20181233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30333251" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=BSR20181233&author=H.+Xiao-Peiauthor=C.+Ji-Kuaiauthor=W.+Xueauthor=Y.+F.+Dongauthor=L.+Yanauthor=Z.+Xiao-Fangauthor=P.+Ya-Minauthor=C.+Wen-Junauthor=Z.+Jiang-Bo&title=Systematic+identification+of+Celastrol-binding+proteins+reveals+that+Shoc2+is+inhibited+by+Celastrol&doi=10.1042%2Fbsr20181233"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1042%2FBSR20181233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBSR20181233%26sid%3Dliteratum%253Aachs%26aulast%3DXiao-Pei%26aufirst%3DH.%26aulast%3DJi-Kuai%26aufirst%3DC.%26aulast%3DXue%26aufirst%3DW.%26aulast%3DDong%26aufirst%3DY.%2BF.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DXiao-Fang%26aufirst%3DZ.%26aulast%3DYa-Min%26aufirst%3DP.%26aulast%3DWen-Jun%26aufirst%3DC.%26aulast%3DJiang-Bo%26aufirst%3DZ.%26atitle%3DSystematic%2520identification%2520of%2520Celastrol-binding%2520proteins%2520reveals%2520that%2520Shoc2%2520is%2520inhibited%2520by%2520Celastrol%26jtitle%3DBiosci.%2520Rep.%26date%3D2018%26volume%3D38%26spage%3DBSR20181233%26doi%3D10.1042%2Fbsr20181233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1321</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2006.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.bcp.2006.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=16984800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSrtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=1311-1321&author=J.-H.+Leeauthor=T.+H.+Kooauthor=H.+Yoonauthor=H.+S.+Jungauthor=H.+Z.+Jinauthor=K.+Leeauthor=Y.-S.+Hongauthor=J.+J.+Lee&title=Inhibition+of+NF-kappa+B+activation+through+targeting+I+kappa+B+kinase+by+celastrol%2C+a+quinone+methide+triterpenoid&doi=10.1016%2Fj.bcp.2006.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of NF-κB activation through targeting IκB kinase by celastrol, a quinone methide triterpenoid</span></div><div class="casAuthors">Lee, Jeong-Hyung; Koo, Tae Hyeon; Yoon, Hyunkyung; Jung, Haeng Sun; Jin, Hui Zi; Lee, Kyeong; Hong, Young-Soo; Lee, Jung Joon</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1311-1321</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Celastrol, a quinone methide triterpenoid, was isolated as an inhibitor of NF-κB from Celastrus orbiculatus.  This compd. dose-dependently inhibited a variety of stimuli-induced NF-κB-regulated gene expression and the DNA-binding of NF-κB in different cell lines without affecting DNA-binding activity of AP-1.  Preincubation of celastrol completely blocked the LPS-, TNF-α-, or PMA-induced degrdn. and phosphorylation of IκBα.  Importantly, celastrol inhibited IKK activity and the constitutively active IKKβ activity in a dose-dependent manner without either affecting the NF-κB activation induced by RelA over-expression or directly suppressing the DNA-binding of activated NF-κB.  However, mutation of cysteine 179 in the activation loop of IKKβ abolished sensitivity towards to celastrol, suggesting that celastrol suppressed the NF-κB activation by targeting cysteine 179 in the IKK.  To verify that celastrol is a NF-κB inhibitor, we investigated its effect on some NF-κB target genes expressions.  Celastrol prevented not only LPS-induced mRNA expression of iNOS and TNF-α, but also TNF-α-induced Bfl-1/A1 expression, a prosurvival Bcl-2 homolog.  Consistent with these results, celastrol significantly suppressed the prodn. of NO and TNF-α in LPS-stimulated RAW264.7 cells, and increased the cytotoxicity of TNF-α in HT-1080 cells.  We also demonstrated that celastrol showed anti-inflammatory and anti-tumor activities in animal models.  Taken together, this study extends our understanding on the mol. mechanisms underlying the anti-inflammatory and anti-cancer activities of celastrol and celastrol-contg. medicinal plant, which would be a valuable candidate for the intervention of NF-κB-dependent pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV26_Hc5ZXYrVg90H21EOLACvtfcHk0lh2ydloy0nwug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSrtLrN&md5=b69a2fd4c384dbcf8c99f97ae1407353</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2006.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2006.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.-H.%26aulast%3DKoo%26aufirst%3DT.%2BH.%26aulast%3DYoon%26aufirst%3DH.%26aulast%3DJung%26aufirst%3DH.%2BS.%26aulast%3DJin%26aufirst%3DH.%2BZ.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DHong%26aufirst%3DY.-S.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26atitle%3DInhibition%2520of%2520NF-kappa%2520B%2520activation%2520through%2520targeting%2520I%2520kappa%2520B%2520kinase%2520by%2520celastrol%252C%2520a%2520quinone%2520methide%2520triterpenoid%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D72%26spage%3D1311%26epage%3D1321%26doi%3D10.1016%2Fj.bcp.2006.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chadli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botuyan, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauq, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez-Alvarado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mer, G.</span></span> <span> </span><span class="NLM_article-title">Celastrol inhibits Hsp90 chaperoning of steroid receptors by inducing fibrillization of the Co-chaperone p23</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">4224</span>– <span class="NLM_lpage">4231</span>, <span class="refDoi"> DOI: 10.1074/jbc.m109.081018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1074%2Fjbc.M109.081018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=19996313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Wlsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=4224-4231&author=A.+Chadliauthor=S.+J.+Feltsauthor=Q.+Wangauthor=W.+P.+Sullivanauthor=M.+V.+Botuyanauthor=A.+Fauqauthor=M.+Ramirez-Alvaradoauthor=G.+Mer&title=Celastrol+inhibits+Hsp90+chaperoning+of+steroid+receptors+by+inducing+fibrillization+of+the+Co-chaperone+p23&doi=10.1074%2Fjbc.m109.081018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Celastrol Inhibits Hsp90 Chaperoning of Steroid Receptors by Inducing Fibrillization of the Co-chaperone p23</span></div><div class="casAuthors">Chadli, Ahmed; Felts, Sara J.; Wang, Qin; Sullivan, William P.; Botuyan, Maria Victoria; Fauq, Abdul; Ramirez-Alvarado, Marina; Mer, Georges</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4224-4231</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Hsp90 is an ATP-dependent mol. chaperone.  The best-characterized inhibitors of Hsp90 target its ATP binding pocket, causing nonselective degrdn. of Hsp90 client proteins.  Here, we show that the small mol. celastrol inhibits the Hsp90 chaperoning machinery by inactivating the co-chaperone p23, resulting in a more selective destabilization of steroid receptors compared with kinase clients.  Our in vitro and in vivo results demonstrate that celastrol disrupts p23 function by altering its three-dimensional structure, leading to rapid formation of amyloid-like fibrils.  This study reveals a unique inhibition mechanism of p23 by a small mol. that could be exploited in the dissection of protein fibrillization processes as well as in the therapeutics of steroid receptor-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqHTE_VeHYP7Vg90H21EOLACvtfcHk0lh2ydloy0nwug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Wlsr4%253D&md5=fd92f09e314736504429dc245cadd570</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.081018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.081018%26sid%3Dliteratum%253Aachs%26aulast%3DChadli%26aufirst%3DA.%26aulast%3DFelts%26aufirst%3DS.%2BJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DSullivan%26aufirst%3DW.%2BP.%26aulast%3DBotuyan%26aufirst%3DM.%2BV.%26aulast%3DFauq%26aufirst%3DA.%26aulast%3DRamirez-Alvarado%26aufirst%3DM.%26aulast%3DMer%26aufirst%3DG.%26atitle%3DCelastrol%2520inhibits%2520Hsp90%2520chaperoning%2520of%2520steroid%2520receptors%2520by%2520inducing%2520fibrillization%2520of%2520the%2520Co-chaperone%2520p23%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D4224%26epage%3D4231%26doi%3D10.1074%2Fjbc.m109.081018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, C.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-07-0484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1158%2F1535-7163.mct-07-0484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=18202019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVyhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=162-170&author=T.+Zhangauthor=A.+Hamzaauthor=X.+Caoauthor=B.+Wangauthor=S.+Yuauthor=C.-G.+Zhanauthor=D.+Sun&title=A+novel+Hsp90+inhibitor+to+disrupt+Hsp90%2FCdc37+complex+against+pancreatic+cancer+cells&doi=10.1158%2F1535-7163.mct-07-0484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells</span></div><div class="casAuthors">Zhang, Tao; Hamza, Adel; Cao, Xianhua; Wang, Bing; Yu, Shuwen; Zhan, Chang-Guo; Sun, Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">162-170</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Pancreatic cancer is an aggressive disease with multiple biochem. and genetic alterations.  Thus, a single agent to hit one mol. target may not be sufficient to treat this disease.  The purpose of this study is to identify a novel Hsp90 inhibitor to disrupt protein-protein interactions of Hsp90 and its cochaperones for down-regulating many oncogenes simultaneously against pancreatic cancer cells.  Here, we reported that celastrol disrupted Hsp90-Cdc37 interaction in the superchaperone complex to exhibit antitumor activity in vitro and in vivo.  Mol. docking and mol. dynamic simulations showed that celastrol blocked the crit. interaction of Glu33 (Hsp90) and Arg167 (Cdc37).  Immunopptn. confirmed that celastrol (10 μmol/L) disrupted the Hsp90-Cdc37 interaction in the pancreatic cancer cell line Panc-1.  In contrast to classic Hsp90 inhibitor (geldanamycin), celastrol (0.1-100 μmol/L) did not interfere with ATP binding to Hsp90.  However, celastrol (1-5 μmol/L) induced Hsp90 client protein degrdn. (Cdk4 and Akt) by 70% to 80% and increased Hsp70 expression by 12-fold.  Celastrol induced apoptosis in vitro and significantly inhibited tumor growth in Panc-1 xenografts.  Moreover, celastrol (3 mg/kg) effectively suppressed tumor metastasis by more than 80% in RIP1-Tag2 transgenic mouse model with pancreatic islet cell carcinogenesis.  The data suggest that celastrol is a novel Hsp90 inhibitor to disrupt Hsp90-Cdc37 interaction against pancreatic cancer cells. [Mol Cancer Ther 2008;7(1):162-70].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYaUNr9Bi1cbVg90H21EOLACvtfcHk0liYl0Y-9eC4yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVyhtQ%253D%253D&md5=2af27701d6ccd4397c7a7486d1335730</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.mct-07-0484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.mct-07-0484%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DHamza%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DZhan%26aufirst%3DC.-G.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DA%2520novel%2520Hsp90%2520inhibitor%2520to%2520disrupt%2520Hsp90%252FCdc37%2520complex%2520against%2520pancreatic%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D162%26epage%3D170%26doi%3D10.1158%2F1535-7163.mct-07-0484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of celastrol to inhibit hsp90 and cdc37 interaction</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">35381</span>– <span class="NLM_lpage">35389</span>, <span class="refDoi"> DOI: 10.1074/jbc.m109.051532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1074%2Fjbc.m109.051532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=19858214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCqurjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=35381-35389&author=T.+Zhangauthor=Y.+Liauthor=Y.+Yuauthor=P.+Zouauthor=Y.+Jiangauthor=D.+Sun&title=Characterization+of+celastrol+to+inhibit+hsp90+and+cdc37+interaction&doi=10.1074%2Fjbc.m109.051532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction</span></div><div class="casAuthors">Zhang, Tao; Li, Yanyan; Yu, Yanke; Zou, Peng; Jiang, Yiqun; Sun, Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">35381-35389</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mol. chaperone heat shock protein 90 (Hsp90) is required for the stabilization and conformational maturation of various oncogenic proteins in cancer.  The loading of protein kinases to Hsp90 is actively mediated by the co-chaperone Cdc37.  The crucial role of the Hsp90-Cdc37 complex has made it an exciting target for cancer treatment.  In this study, the authors characterize Hsp90 and Cdc37 interaction and drug disruption using a reconstituted protein system.  The GST pull-down assay and ELISA assay show that Cdc37 binds to ADP-bound/nucleotide-free Hsp90 but not ATP-bound Hsp90.  Celastrol disrupts Hsp90-Cdc37 complex formation, whereas the classical Hsp90 inhibitors (e.g., geldanamycin) have no effect.  Celastrol inhibits Hsp90 ATPase activity without blocking ATP binding.  Proteolytic fingerprinting indicates celastrol binds to Hsp90 C-terminal domain to protect it from trypsin digestion.  These data suggest that celastrol may represent a new class of Hsp90 inhibitor by modifying Hsp90 C terminus to allosterically regulate its chaperone activity and disrupt Hsp90-Cdc37 complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPbfNGpAapIrVg90H21EOLACvtfcHk0liYl0Y-9eC4yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCqurjN&md5=f8d15de4ecac58de8bb5274d9cf9cdcd</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m109.051532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m109.051532%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520celastrol%2520to%2520inhibit%2520hsp90%2520and%2520cdc37%2520interaction%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D35381%26epage%3D35389%26doi%3D10.1074%2Fjbc.m109.051532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">104</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.00104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.3389%2Ffphar.2018.00104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=29491837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Skt7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=104&author=S.+R.+Chenauthor=Y.+Daiauthor=J.+Zhaoauthor=L.+Linauthor=Y.+Wangauthor=Y.+Wang&title=A+Mechanistic+Overview+of+Triptolide+and+Celastrol%2C+Natural+Products+from+Tripterygium+wilfordii+Hook+F&doi=10.3389%2Ffphar.2018.00104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A mechanistic overview of triptolide and celastrol, natural products from Tripterygium wilfordii Hook F</span></div><div class="casAuthors">Chen, Shao-Ru; Dai, Yan; Zhao, Jing; Lin, Ligen; Wang, Yitao; Wang, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104/1-104/13</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Triptolide and celastrol are predominantly active natural products isolated from the medicinal plant Tripterygium wilfordii Hook F.  These compds. exhibit similar pharmacol. activities, including anti-cancer, anti-inflammation, anti-obesity, and anti-diabetic activities.  Triptolide and celastrol also provide neuroprotection and prevent cardiovascular and metabolic diseases.  However, toxicity restricts the further development of triptolide and celastrol.  In this review, we comprehensively review therapeutic targets and mechanisms of action, and translational study of triptolide and celastrol.  We systemically discuss the structure-activity-relationship of triptolide, celastrol, and their derivs.  Furthermore, we propose the use of structural derivs., targeted therapy, and combination treatment as possible solns. to reduce toxicity and increase therapeutic window of these potent natural products from T. wilfordii Hook F.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF6S3u2q0YLLVg90H21EOLACvtfcHk0liYl0Y-9eC4yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Skt7rE&md5=826675620f132aa76d9b07f466fb9631</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00104%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%2BR.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DA%2520Mechanistic%2520Overview%2520of%2520Triptolide%2520and%2520Celastrol%252C%2520Natural%2520Products%2520from%2520Tripterygium%2520wilfordii%2520Hook%2520F%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26spage%3D104%26doi%3D10.3389%2Ffphar.2018.00104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span> <span> </span><span class="NLM_article-title">Isoalantolactone induces apoptosis through ROS-mediated ER stress and inhibition of STAT3 in prostate cancer cells</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">309</span>, <span class="refDoi"> DOI: 10.1186/s13046-018-0987-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1186%2Fs13046-018-0987-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30541589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFaisL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=309&author=W.+Chenauthor=P.+Liauthor=Y.+Liuauthor=Y.+Yangauthor=X.+Yeauthor=F.+Zhangauthor=H.+Huang&title=Isoalantolactone+induces+apoptosis+through+ROS-mediated+ER+stress+and+inhibition+of+STAT3+in+prostate+cancer+cells&doi=10.1186%2Fs13046-018-0987-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Isoalantolactone induces apoptosis through ROS-mediated ER stress and inhibition of STAT3 in prostate cancer cells</span></div><div class="casAuthors">Chen, Wei; Li, Ping; Liu, Yi; Yang, Yu; Ye, Xueting; Zhang, Fangyi; Huang, Hang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">309</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Prostate cancer is one of the most commonly diagnosed cancers in men worldwide.  Currently available therapies for metastatic prostate cancer are only marginally effective.  Therefore, new therapeutic agents are urgently needed to improve patient outcome.  Isoalantolactone (IATL), an active sesquiterpene naturally present in many vegetables and medicinal plants, is known to induce cell death and apoptosis in various cancer cell lines.  Nevertheless, antitumor mechanisms initiated by IATL in cancer cells have not been fully defined.  Cell apoptosis and cellular ROS levels were analyzed by flow cytometry.  Western blot and qRT-PCR were used to analyze the protein and mRNA levels of indicated mols., resp.  Nude mice xenograft model was used to test the effects of IATL on prostate cancer cell growth in vivo.  In this study, we found that IATL dose-dependently inhibited cancer cell growth and induced apoptosis in PC-3 and DU145 cells.  Mechanistically, our data found that IATL induced reactive oxygen species (ROS) prodn., resulting in the activation of endoplasmic reticulum stress pathway and eventually cell apoptosis in prostate cancer cells.  IATL also decreased the protein expression levels of p-STAT3 and STAT3, and the effects of IATL were reversed by pretreatment with N-acetyl-L-cysteine (NAC).  In vivo, we found that IATL inhibited the growth of prostate cancer xenografts without exhibiting toxicity.  Treatment of mice bearing human prostate cancer xenografts with IATL was also assocd. with induction of ER stress and inhibtion of STAT3.  In summary, our results unveil a previously unrecognized mechanism underlying the biol. activity of IATL, and provide a novel anti-cancer candidate for the treatment of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8v5bRq7s8Y7Vg90H21EOLACvtfcHk0lhdCjfM2WRD5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFaisL7N&md5=44235d11eeac774f52ea531a3b3fbc86</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1186%2Fs13046-018-0987-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-018-0987-9%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DH.%26atitle%3DIsoalantolactone%2520induces%2520apoptosis%2520through%2520ROS-mediated%2520ER%2520stress%2520and%2520inhibition%2520of%2520STAT3%2520in%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2018%26volume%3D37%26spage%3D309%26doi%3D10.1186%2Fs13046-018-0987-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">Isoalantolactone inhibits IKKbeta kinase activity to interrupt the NF-kappaB/COX-2-mediated signaling cascade and induces apoptosis regulated by the mitochondrial translocation of cofilin in glioblastoma</span>. <i>Cancer Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1655</span>– <span class="NLM_lpage">1670</span>, <span class="refDoi"> DOI: 10.1002/cam4.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1002%2Fcam4.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=30740911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1MXoslSlsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=1655-1670&author=J.+S.+Xingauthor=X.+Wangauthor=Y.+L.+Lanauthor=J.+C.+Louauthor=B.+Maauthor=T.+Zhuauthor=H.+Zhangauthor=D.+Wangauthor=Z.+Yuauthor=Z.+Yuanauthor=X.+Y.+Liauthor=B.+Zhang&title=Isoalantolactone+inhibits+IKKbeta+kinase+activity+to+interrupt+the+NF-kappaB%2FCOX-2-mediated+signaling+cascade+and+induces+apoptosis+regulated+by+the+mitochondrial+translocation+of+cofilin+in+glioblastoma&doi=10.1002%2Fcam4.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Isoalantolactone inhibits IKKβ kinase activity to interrupt the NF-κB/COX-2-mediated signaling cascade and induces apoptosis regulated by the mitochondrial translocation of cofilin in glioblastoma</span></div><div class="casAuthors">Xing, Jin-Shan; Wang, Xun; Lan, Yu-Long; Lou, Jia-Cheng; Ma, Binbin; Zhu, Tingzhun; Zhang, Hongqiang; Wang, Dongsheng; Yu, Zhikuan; Yuan, Zhongbo; Li, Xin-Yu; Zhang, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1655-1670</span>CODEN:
                <span class="NLM_cas:coden">CMAEDL</span>;
        ISSN:<span class="NLM_cas:issn">2045-7634</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Isoalantolactone (IATL), a sesquiterpene lactone compd., possesses many pharmacol. and biol. activities, but its role in glioblastoma (GBM) treatment is still unknown.  The aim of the current study was to investigate the antiglioma effects of IATL and to explore the underlying mol. mechanisms.  In the current study, the biol. functions of IATL were examd. by MTT, cell migration, colony formation, and cell apoptosis assays.  Confocal immunofluorescence techniques, chromatin immunopptn., and pull-down assays were used to explore the precise underlying mol. mechanisms.  To examine IATL activity and the mol. mechanisms by which it inhibits glioma growth in vivo, we used a xenograft tumor mouse model.  Furthermore, Western blotting was used to confirm the changes in protein expression after IATL treatment.  According to the results, IATL inhibited IKKβ phosphorylation, thus inhibiting both the binding of NF-κB to the cyclooxygenase 2 (COX-2) promoter and the recruitment of p300 and eventually inhibiting COX-2 expression.  In addn., IATL induced glioma cell apoptosis by promoting the conversion of F-actin to G-actin, which in turn activates the cytochrome c (Cyt c) and caspase-dependent apoptotic pathways.  In the animal expts., IATL reduced the size and wt. of glioma tumors in xenograft mice and inhibited the expression of COX-2 and phosphorylated NF-κB p65 in the transplanted tumors.  In conclusion, the current study indicated that IATL inhibited the expression of COX-2 through the NF-κB signaling pathway and induced the apoptosis of glioma cells by increasing actin transformation.  These results suggested that IATL could be greatly effective in GBM treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAiYzJ7DY2ubVg90H21EOLACvtfcHk0lhdCjfM2WRD5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXoslSlsLk%253D&md5=73fa8ebb6c40236a834b937057c9b4af</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fcam4.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcam4.2013%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DJ.%2BS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLan%26aufirst%3DY.%2BL.%26aulast%3DLou%26aufirst%3DJ.%2BC.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DYuan%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DIsoalantolactone%2520inhibits%2520IKKbeta%2520kinase%2520activity%2520to%2520interrupt%2520the%2520NF-kappaB%252FCOX-2-mediated%2520signaling%2520cascade%2520and%2520induces%2520apoptosis%2520regulated%2520by%2520the%2520mitochondrial%2520translocation%2520of%2520cofilin%2520in%2520glioblastoma%26jtitle%3DCancer%2520Med.%26date%3D2019%26volume%3D8%26spage%3D1655%26epage%3D1670%26doi%3D10.1002%2Fcam4.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, X.</span></span> <span> </span><span class="NLM_article-title">Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2350</span>– <span class="NLM_lpage">2394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=29312794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSqsLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=2350-2394&author=F.+Liauthor=T.+Jiangauthor=Q.+Liauthor=X.+Ling&title=Camptothecin+%28CPT%29+and+its+derivatives+are+known+to+target+topoisomerase+I+%28Top1%29+as+their+mechanism+of+action%3A+did+we+miss+something+in+CPT+analogue+molecular+targets+for+treating+human+disease+such+as+cancer%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?</span></div><div class="casAuthors">Li, Fengzhi; Jiang, Tao; Li, Qingyong; Ling, Xiang</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2350-2394</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Camptothecin (CPT) was discovered from plant exts. more than 60 years ago.  Since then, only two CPT analogs (irinotecan and topotecan) have been approved for cancer treatment, although several thousand CPT derivs. have been synthesized and many of them were actively studied in our research community over the past 6+ decades.  In this review article, we briefly summarize: (1) the discovery and early development of CPTs, (2) the recognized CPT mechanism of action (MOA), (3) the synthesis of CPT and CPT analogs, and (4) the structureactivity relationship (SAR) of CPT and its analogs.  Next, we provide evidence that certain CPT analogs can exert improved efficacy with low toxicity independently of topoisomerase I (Top1) inhibition; instead, these CPT analogs use novel MOAs by targeting important cancer survival-assocd. oncogenic proteins and/or by bypassing various treatment-resistant mechanisms.  We then present a comprehensive review of the most advanced CPT analogs in clin. development, with the goal of resolving why no new CPTs have been FDA approved for cancer treatment, beyond irinotecan and topotecan.  We argue that new CPT Top1 inhibitor drugs are unlikely being found to be significantly better than irinotecan and/or topotecan in terms of the overall antitumor activity and toxicity.  The significance of CPT analogs that possess novel MOAs has not been sufficiently recognized so far.  In our opinion, this is a research area with great potential to make a breakthrough for development of the next generation of CPT analogs that possess high efficacy (due to novel targets) and low toxicity (due to low inhibition of Top1 activity/function) for effective treatment of human disease, including cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVoqOo5tdSCLVg90H21EOLACvtfcHk0lhdCjfM2WRD5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSqsLvE&md5=a5bf7cd36b32b3aa71155909205bfeae</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLing%26aufirst%3DX.%26atitle%3DCamptothecin%2520%2528CPT%2529%2520and%2520its%2520derivatives%2520are%2520known%2520to%2520target%2520topoisomerase%2520I%2520%2528Top1%2529%2520as%2520their%2520mechanism%2520of%2520action%253A%2520did%2520we%2520miss%2520something%2520in%2520CPT%2520analogue%2520molecular%2520targets%2520for%2520treating%2520human%2520disease%2520such%2520as%2520cancer%253F%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2017%26volume%3D7%26spage%3D2350%26epage%3D2394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, K. L.</span>; <span class="NLM_string-name">Wells, C. I.</span>; <span class="NLM_string-name">Moore, J. T.</span></span> <span> </span><span class="NLM_article-title">Identification of Kinase Inhibitors that Regulate Nuclear Receptor Nurr1 (NR4A2) Cellular Activity</span>. <span class="NLM_year">2019</span>, bioRxiv:420976. biorxiv.org e-Print archive. <a href="https://doi.org/420910.421101/420976" class="extLink">https://doi.org/420910.421101/420976</a> (accessed Nov 4, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=K.+L.+Williams&author=C.+I.+Wells&author=J.+T.+Moore&title=Identification+of+Kinase+Inhibitors+that+Regulate+Nuclear+Receptor+Nurr1+%28NR4A2%29+Cellular+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DK.%2BL.%26atitle%3DIdentification%2520of%2520Kinase%2520Inhibitors%2520that%2520Regulate%2520Nuclear%2520Receptor%2520Nurr1%2520%2528NR4A2%2529%2520Cellular%2520Activity%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariga, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisowath, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wernsdorfer, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkman, A.</span></span> <span> </span><span class="NLM_article-title">Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">4089</span>– <span class="NLM_lpage">4096</span>, <span class="refDoi"> DOI: 10.1128/aac.48.11.4089-4096.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1128%2FAAC.48.11.4089-4096.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=15504826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvVyksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=4089-4096&author=S.+T.+Marigaauthor=J.+P.+Gilauthor=C.+Sisowathauthor=W.+H.+Wernsdorferauthor=A.+Bj%C3%B6rkman&title=Synergism+between+amodiaquine+and+its+major+metabolite%2C+desethylamodiaquine%2C+against+Plasmodium+falciparum+in+vitro&doi=10.1128%2Faac.48.11.4089-4096.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro</span></div><div class="casAuthors">Mariga, S. T.; Gil, J. P.; Sisowath, C.; Wernsdorfer, W. H.; Bjoerkman, A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4089-4096</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The in vitro activity of the prodrug amodiaquine and its metabolite monodesethyl-amodiaquine was studied for 3 strains of P. falciparum: LS-2, LS-3, and LS-1.  Both compds. showed significant activity against all 3 strains; the activity of amodiaquine was slightly higher than that of the metabolite.  By use of a checkerboard design, interaction studies with both compds. yielded evidence of significant synergism; means of the sums of the fractional inhibitory concns. were 0.0392-0.0746 for strain LS-2, 0.1567-0.3102 for strain LS-3, and 0.025-0.3369 for strain LS-1.  In further investigations, the interaction of amodiaquine with monodesethyl-amodiaquine was tested at clin. relevant concns. of both compds.  In these studies, involving amodiaquine at picomolar and femtomolar concns., the compd. was found to exert high potentiating activity on monodesethyl-amodiaquine.  This interaction produced mean ratios of obsd. to expected activity of 0.0505-0.0642 for strain LS-2, 0.0882-0.3820 for strain LS-3, and 0.0752-0.2924 for strain LS-1.  The synergistic activity was most marked at monodesethyl-amodiaquine/amodiaquine ratios up to 100,000:1 but was still evident at higher ratios.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdbsJY5gLhxrVg90H21EOLACvtfcHk0lj7SpttoY4rtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvVyksr0%253D&md5=73b82cbfc2375528e6641ad60452a2e1</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.11.4089-4096.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.11.4089-4096.2004%26sid%3Dliteratum%253Aachs%26aulast%3DMariga%26aufirst%3DS.%2BT.%26aulast%3DGil%26aufirst%3DJ.%2BP.%26aulast%3DSisowath%26aufirst%3DC.%26aulast%3DWernsdorfer%26aufirst%3DW.%2BH.%26aulast%3DBj%25C3%25B6rkman%26aufirst%3DA.%26atitle%3DSynergism%2520between%2520amodiaquine%2520and%2520its%2520major%2520metabolite%252C%2520desethylamodiaquine%252C%2520against%2520Plasmodium%2520falciparum%2520in%2520vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D4089%26epage%3D4096%26doi%3D10.1128%2Faac.48.11.4089-4096.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wake, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishibori, M.</span></span> <span> </span><span class="NLM_article-title">Effect of amodiaquine, a histamine N-methyltransferase inhibitor, on, Propionibacterium acnes and lipopolysaccharide-induced hepatitis in mice</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>558</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2006.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.ejphar.2006.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=17222819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVGgurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=558&publication_year=2007&pages=179-184&author=A.+Yokoyamaauthor=S.+Moriauthor=H.+K.+Takahashiauthor=T.+Kankeauthor=H.+Wakeauthor=M.+Nishibori&title=Effect+of+amodiaquine%2C+a+histamine+N-methyltransferase+inhibitor%2C+on%2C+Propionibacterium+acnes+and+lipopolysaccharide-induced+hepatitis+in+mice&doi=10.1016%2Fj.ejphar.2006.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of amodiaquine, a histamine N-methyltransferase inhibitor, on, Propionibacterium acnes and lipopolysaccharide-induced hepatitis in mice</span></div><div class="casAuthors">Yokoyama, Akira; Mori, Shuji; Takahashi, Hideo K.; Kanke, Toru; Wake, Hidenori; Nishibori, Masahiro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">558</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">179-184</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We examd. whether treatment with amodiaquine, a potent inhibitor of histamine N-methyltransferase protects mice from Propionibacterium acnes (P. acnes)-primed and lipopolysaccharide (LPS)-induced hepatitis.  The s.c. injection of amodiaquine (2 and 5 mg/kg) significantly increased the histamine levels in the liver in comparison to saline treated mice.  Pretreatment with amodiaquine also improved the survival rate of the hepatitis mice, and this improvement was partially assocd. with the decrease in serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT).  Amodiaquine partially suppressed increases of tumor necrosis factor (TNF)-α in the serum and TNF-α mRNA expression in the liver, whereas the expression of interleukin (IL)-18, interferon (IFN)-γ and IL-12 in the liver was not changed by amodiaquine treatment.  In conclusion, the present findings suggested that the elevation of endogenous histamine by amodiaquine may thus play a protective role through the regulation of TNF-α prodn. in endotoxin-induced hepatic injury mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiB6-8szeQNbVg90H21EOLACvtfcHk0lj7SpttoY4rtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVGgurg%253D&md5=deb6892ff2c28deecc7466aec71273f3</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DA.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DH.%2BK.%26aulast%3DKanke%26aufirst%3DT.%26aulast%3DWake%26aufirst%3DH.%26aulast%3DNishibori%26aufirst%3DM.%26atitle%3DEffect%2520of%2520amodiaquine%252C%2520a%2520histamine%2520N-methyltransferase%2520inhibitor%252C%2520on%252C%2520Propionibacterium%2520acnes%2520and%2520lipopolysaccharide-induced%2520hepatitis%2520in%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D558%26spage%3D179%26epage%3D184%26doi%3D10.1016%2Fj.ejphar.2006.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wennerholm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordmark, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PihlsgÅrd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahindi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertilsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, L. L.</span></span> <span> </span><span class="NLM_article-title">Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D6) and losartan (CYP2C9) in vivo</span>. <i>Eur. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">546</span>, <span class="refDoi"> DOI: 10.1007/s00228-006-0121-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1007%2Fs00228-006-0121-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=16783563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFOntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=539-546&author=A.+Wennerholmauthor=A.+Nordmarkauthor=M.+Pihlsg%C3%85rdauthor=M.+Mahindiauthor=L.+Bertilssonauthor=L.+L.+Gustafsson&title=Amodiaquine%2C+its+desethylated+metabolite%2C+or+both%2C+inhibit+the+metabolism+of+debrisoquine+%28CYP2D6%29+and+losartan+%28CYP2C9%29+in+vivo&doi=10.1007%2Fs00228-006-0121-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D6) and losartan (CYP2C9) in vivo</span></div><div class="casAuthors">Wennerholm, Agneta; Nordmark, Anna; Pihlsgard, Maria; Mahindi, Margarita; Bertilsson, Leif; Gustafsson, Lars L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">539-546</span>CODEN:
                <span class="NLM_cas:coden">EJCPAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-6970</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Objective: To study the extent of in vivo inhibition by the antimalarial drug amodiaquine, its active metabolite N-desethylamodiaquine, or both, of the metab. of four probe drugs of the enzymes CYP2D6, CYP2C19, CYP2C9 and CYP1A2.  Methods: Twelve healthy Swedish volunteers received a cocktail of four probe drugs (debrisoquine, omeprazole, losartan and caffeine) to det. their baseline metabolic capacities.  After a washout period, they received a 600 mg oral dose of amodiaquine hydrochloride; and 2-3 h later the cocktail was administered again.  One week after the intake of amodiaquine, the subjects received the cocktail a third time.  The levels of probe drugs and their metabolites as well as amodiaquine and its metabolite were detd. by HPLC.  Results: Plasma levels of amodiaquine and N-desethylamodiaquine could be followed in all subjects for 6 h and 28 days, resp.  Among the 12 subjects, a 3-fold variation in amodiaquine AUC and a 2-fold variation in N-desethylamodiaquine AUC, were obsd.  The CYP2D6 and CYP2C9 activities of the subjects were measured by debrisoquine and losartan phenotyping tests, resp.  There were significant mean increases in debrisoquine metabolic ratio (MR) between baseline and the second cocktail [MR2 h-MRbaseline 1.426 (95% confidence interval 1.159, 1.755), P=0.002; ANOVA, Fisher LSD test] and in mean losartan MR between baseline and the second cocktail [MR2 h-MRbaseline 1.724 (95% confidence interval 1.076, 2.762), P=0.026; ANOVA, Fisher LSD test].  The effects on CYP2D6 and CYP2C9 activities subsided within a week after intake of amodiaquine as tested by the phenotyping cocktail.  The changes in omeprazole MRs and caffeine MRs were not statistically significant between any of the study phases.  Conclusion: A single dose of amodiaquine decreased CYP2D6 and CYP2C9 activities significantly compared to baseline values.  Amodiaquine has the potential to cause drug-drug interactions and should be further investigated in malarial patients treated with drug combinations contg. amodiaquine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFobVb5Wd1w7Vg90H21EOLACvtfcHk0lj7SpttoY4rtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFOntbo%253D&md5=5c78316061af34c1e5774baf59bbfc49</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1007%2Fs00228-006-0121-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00228-006-0121-3%26sid%3Dliteratum%253Aachs%26aulast%3DWennerholm%26aufirst%3DA.%26aulast%3DNordmark%26aufirst%3DA.%26aulast%3DPihlsg%25C3%2585rd%26aufirst%3DM.%26aulast%3DMahindi%26aufirst%3DM.%26aulast%3DBertilsson%26aufirst%3DL.%26aulast%3DGustafsson%26aufirst%3DL.%2BL.%26atitle%3DAmodiaquine%252C%2520its%2520desethylated%2520metabolite%252C%2520or%2520both%252C%2520inhibit%2520the%2520metabolism%2520of%2520debrisoquine%2520%2528CYP2D6%2529%2520and%2520losartan%2520%2528CYP2C9%2529%2520in%2520vivo%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D62%26spage%3D539%26epage%3D546%26doi%3D10.1007%2Fs00228-006-0121-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, M. L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsin, L.-Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labarge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidehi, N.</span></span> <span> </span><span class="NLM_article-title">Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e31004</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0031004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1371%2Fjournal.pone.0031004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=22319600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis12hu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=J.+Kimauthor=M.+L.+R.+Yipauthor=X.+Shenauthor=H.+Liauthor=L.-Y.+C.+Hsinauthor=S.+Labargeauthor=E.+L.+Heinrichauthor=W.+Leeauthor=J.+Luauthor=N.+Vaidehi&title=Identification+of+anti-malarial+compounds+as+novel+antagonists+to+chemokine+receptor+CXCR4+in+pancreatic+cancer+cells&doi=10.1371%2Fjournal.pone.0031004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic Cancer cells</span></div><div class="casAuthors">Kim, Joseph; Yip, M. L. Richard; Shen, Xiaoming; Li, Hubert; Hsin, Li-Yu Charlie; Labarge, Samuel; Heinrich, Eileen L.; Lee, Wendy; Lu, Jianming; Vaidehi, Nagarajan</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e31004</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Despite recent advances in targeted therapies, patients with pancreatic adenocarcinoma continue to have poor survival highlighting the urgency to identify novel therapeutic targets.  Our previous investigations have implicated chemokine receptor CXCR4 and its selective ligand CXCL12 in the pathogenesis and progression of pancreatic intraepithelial neoplasia and invasive pancreatic cancer; hence, CXCR4 is a promising target for suppression of pancreatic cancer growth.  Here, we combined in silico structural modeling of CXCR4 to screen for candidate anti-CXCR4 compds. with in vitro cell line assays and identified NSC56612 from the National Cancer Institute's (NCI) Open Chem. Repository Collection as an inhibitor of activated CXCR4.  Next, we identified that NSC56612 is structurally similar to the established anti-malarial drugs chloroquine and hydroxychloroquine.  We evaluated these compds. in pancreatic cancer cells in vitro and obsd. specific antagonism of CXCR4-mediated signaling and cell proliferation.  Recent in vivo therapeutic applications of chloroquine in pancreatic cancer mouse models have demonstrated decreased tumor growth and improved survival.  Our results thus provide a mol. target and basis for further evaluation of chloroquine and hydroxychloroquine in pancreatic cancer.  Historically safe in humans, chloroquine and hydroxychloroquine appear to be promising agents to safely and effectively target CXCR4 in patients with pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgw2ZeidIq57Vg90H21EOLACvtfcHk0lgEuV0Fa0xx3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis12hu7c%253D&md5=08e47b35a2dc954f422894ab25d7ebd2</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0031004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0031004%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DYip%26aufirst%3DM.%2BL.%2BR.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DHsin%26aufirst%3DL.-Y.%2BC.%26aulast%3DLabarge%26aufirst%3DS.%26aulast%3DHeinrich%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DVaidehi%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520anti-malarial%2520compounds%2520as%2520novel%2520antagonists%2520to%2520chemokine%2520receptor%2520CXCR4%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0031004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, B.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo antitumor effects of chloroquine on oral squamous cell carcinoma</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5779</span>– <span class="NLM_lpage">5786</span>, <span class="refDoi"> DOI: 10.3892/mmr.2017.7342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.3892%2Fmmr.2017.7342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=28849182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsFWhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=5779-5786&author=L.+Jiaauthor=J.+Wangauthor=T.+Wuauthor=J.+Wuauthor=J.+Lingauthor=B.+Cheng&title=In+vitro+and+in+vivo+antitumor+effects+of+chloroquine+on+oral+squamous+cell+carcinoma&doi=10.3892%2Fmmr.2017.7342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo antitumor effects of chloroquine on oral squamous cell carcinoma</span></div><div class="casAuthors">Jia, Lihua; Wang, Juan; Wu, Tong; Wu, Jinan; Ling, Junqi; Cheng, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">5779-5786</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-3004</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Chloroquine, which is a widely used antimalarial drug, has been reported to exert anticancer activity in some tumor types; however, its potential effects on oral squamous cell carcinoma (OSCC) remain unclear.  The present study aimed to explore the effects and possible underlying mechanisms of chloroquine against OSCC.  MTT and clonogenic assays were conducted to evaluate the effects of chloroquine on the human OSCC cell lines SCC25 and CAL27.  Cell cycle progression and apoptosis were detected using flow cytometry.  Autophagy was monitored using microtubule-assocd. protein 1A/1B-light chain 3 as an autophagosomal marker.  In order to det. the in vivo antitumor effects of chloroquine on OSCC, a CAL27 xenograft model was used.  The results demonstrated that chloroquine markedly inhibited the proliferation and the colony-forming ability of both OSCC cell lines in a dose- and time-dependent manner in vitro.  Chloroquine also disrupted the cell cycle, resulting in the cell cycle arrest of CAL27 and SCC25 cells at G0/G1 phase, via downregulation of cyclin D1.  In addn., chloroquine inhibited autophagy, and induced autophagosome and autolysosome accumulation in the cytoplasm, thus interfering with degrdn.; however, OSCC apoptosis was barely affected by chloroquine.  The results of the in vivo study demonstrated that chloroquine effectively inhibited OSCC tumor growth in the CAL27 xenograft model.  In conclusion, the present study reported the in vitro and in vivo antitumor effects of chloroquine on OSCC, and the results indicated that chloroquine may be considered a potent therapeutic agent against human OSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoerV3Ctk4tBrVg90H21EOLACvtfcHk0lgEuV0Fa0xx3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsFWhsL0%253D&md5=7eda8b6db5124f7e44b4b662b0b84cd5</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2017.7342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2017.7342%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DB.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antitumor%2520effects%2520of%2520chloroquine%2520on%2520oral%2520squamous%2520cell%2520carcinoma%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2017%26volume%3D16%26spage%3D5779%26epage%3D5786%26doi%3D10.3892%2Fmmr.2017.7342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mauthe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orhon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luhr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hijlkema, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppes, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engedal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiori, F.</span></span> <span> </span><span class="NLM_article-title">Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1435</span>– <span class="NLM_lpage">1455</span>, <span class="refDoi"> DOI: 10.1080/15548627.2018.1474314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1080%2F15548627.2018.1474314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=29940786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVSnu73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=1435-1455&author=M.+Mautheauthor=I.+Orhonauthor=C.+Rocchiauthor=X.+Zhouauthor=M.+Luhrauthor=K.-J.+Hijlkemaauthor=R.+P.+Coppesauthor=N.+Engedalauthor=M.+Mariauthor=F.+Reggiori&title=Chloroquine+inhibits+autophagic+flux+by+decreasing+autophagosome-lysosome+fusion&doi=10.1080%2F15548627.2018.1474314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion</span></div><div class="casAuthors">Mauthe, Mario; Orhon, Idil; Rocchi, Cecilia; Zhou, Xingdong; Luhr, Morten; Hijlkema, Kerst-Jan; Coppes, Robert P.; Engedal, Nikolai; Mari, Muriel; Reggiori, Fulvio</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1435-1455</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8635</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Macroautophagy/autophagy is a conserved transport pathway where targeted structures are sequestered by phagophores, which mature into autophagosomes, and then delivered into lysosomes for degrdn.  Autophagy is involved in the pathophysiol. of numerous diseases and its modulation is beneficial for the outcome of numerous specific diseases.  Several lysosomal inhibitors such as bafilomycin A1 (BafA1), protease inhibitors and chloroquine (CQ), have been used interchangeably to block autophagy in in vitro expts. assuming that they all primarily block lysosomal degrdn.  Among them, only CQ and its derivate hydroxychloroquine (HCQ) are FDA-approved drugs and are thus currently the principal compds. used in clin. trials aimed to treat tumors through autophagy inhibition.  However, the precise mechanism of how CQ blocks autophagy remains to be firmly demonstrated.  In this study, we focus on how CQ inhibits autophagy and directly compare its effects to those of BafA1.  We show that CQ mainly inhibits autophagy by impairing autophagosome fusion with lysosomes rather than by affecting the acidity and/or degradative activity of this organelle.  Furthermore, CQ induces an autophagy-independent severe disorganization of the Golgi and endo-lysosomal systems, which might contribute to the fusion impairment.  Strikingly, HCQ-treated mice also show a Golgi disorganization in kidney and intestinal tissues.  Altogether, our data reveal that CQ and HCQ are not bona fide surrogates for other types of late stage lysosomal inhibitors for in vivo expts.  Moreover, the multiple cellular alterations caused by CQ and HCQ call for caution when interpreting results obtained by blocking autophagy with this drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo02-sVNfO1D7Vg90H21EOLACvtfcHk0lhwUqDirjZfMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVSnu73F&md5=d43f1329f9cf0f15bb9aaea593a4d408</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1080%2F15548627.2018.1474314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15548627.2018.1474314%26sid%3Dliteratum%253Aachs%26aulast%3DMauthe%26aufirst%3DM.%26aulast%3DOrhon%26aufirst%3DI.%26aulast%3DRocchi%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DLuhr%26aufirst%3DM.%26aulast%3DHijlkema%26aufirst%3DK.-J.%26aulast%3DCoppes%26aufirst%3DR.%2BP.%26aulast%3DEngedal%26aufirst%3DN.%26aulast%3DMari%26aufirst%3DM.%26aulast%3DReggiori%26aufirst%3DF.%26atitle%3DChloroquine%2520inhibits%2520autophagic%2520flux%2520by%2520decreasing%2520autophagosome-lysosome%2520fusion%26jtitle%3DAutophagy%26date%3D2018%26volume%3D14%26spage%3D1435%26epage%3D1455%26doi%3D10.1080%2F15548627.2018.1474314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-S.</span></span> <span> </span><span class="NLM_article-title">4-amino-7-chloroquinoline derivatives for treating Parkinson’s disease: implications for drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1517/17460441.2016.1154529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1517%2F17460441.2016.1154529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=26924734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlGqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=337-341&author=C.-H.+Kimauthor=P.+Leblancauthor=K.-S.+Kim&title=4-amino-7-chloroquinoline+derivatives+for+treating+Parkinson%E2%80%99s+disease%3A+implications+for+drug+discovery&doi=10.1517%2F17460441.2016.1154529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">4-amino-7-chloroquinoline derivatives for treating Parkinson's disease: implications for drug discovery</span></div><div class="casAuthors">Kim, Chun-Hyung; Leblanc, Pierre; Kim, Kwang-Soo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-341</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">It is possible to identify small mols. that can activate NR4A2 function by direct interaction with its LBD and that the structure of 4-amino-7-chloroquinoline is a crit. SAR for the activation of Nurr1 and provides the framework for further optimization of NR4A2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3FsQ0xFKekbVg90H21EOLACvtfcHk0lhwUqDirjZfMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlGqsLc%253D&md5=c915dff60d7f747ab61deca7c3eac0b4</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1517%2F17460441.2016.1154529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2016.1154529%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DC.-H.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DK.-S.%26atitle%3D4-amino-7-chloroquinoline%2520derivatives%2520for%2520treating%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2016%26volume%3D11%26spage%3D337%26epage%3D341%26doi%3D10.1517%2F17460441.2016.1154529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willems, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">The orphan nuclear receptor Nurr1 is responsive to non-steroidal anti-inflammatory drugs</span>. <i>Commun. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">85</span>, <span class="refDoi"> DOI: 10.1038/s42004-020-0331-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1038%2Fs42004-020-0331-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVKksrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&pages=85&author=S.+Willemsauthor=K.+Whitneyauthor=X.+Niauthor=A.+Chaikuadauthor=S.+Knappauthor=J.+Heeringauthor=D.+Merk&title=The+orphan+nuclear+receptor+Nurr1+is+responsive+to+non-steroidal+anti-inflammatory+drugs&doi=10.1038%2Fs42004-020-0331-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan nuclear receptor Nurr1 is responsive to non-steroidal anti-inflammatory drugs</span></div><div class="casAuthors">Willems, Sabine; Kilu, Whitney; Ni, Xiaomin; Chaikuad, Apirat; Knapp, Stefan; Heering, Jan; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Communications Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85</span>CODEN:
                <span class="NLM_cas:coden">CCOHCT</span>;
        ISSN:<span class="NLM_cas:issn">2399-3669</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Nuclear receptor related 1 (Nurr1) is an orphan ligand-activated transcription factor and considered as neuroprotective transcriptional regulator with great potential as therapeutic target for neurodegenerative diseases.  However, the collection of available Nurr1 modulators and mechanistic understanding of Nurr1 are limited.  Here, we report the discovery of several structurally diverse non-steroidal anti-inflammatory drugs as inverse Nurr1 agonists demonstrating that Nurr1 activity can be regulated bidirectionally.  As chem. tools, these ligands enable unraveling the co-regulatory network of Nurr1 and the mode of action distinguishing agonists from inverse agonists.  In addn. to its ability to dimerize, we observe an ability of Nurr1 to recruit several canonical nuclear receptor co-regulators in a ligand-dependent fashion.  Distinct dimerization states and co-regulator interaction patterns arise as discriminating factors of Nurr1 agonists and inverse agonists.  Our results contribute a valuable collection of Nurr1 modulators and relevant mechanistic insights for future Nurr1 target validation and drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4xAONvjGyx7Vg90H21EOLACvtfcHk0lhwUqDirjZfMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVKksrvE&md5=780001615544ae3f93a28007f8f492be</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fs42004-020-0331-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs42004-020-0331-0%26sid%3Dliteratum%253Aachs%26aulast%3DWillems%26aufirst%3DS.%26aulast%3DWhitney%26aufirst%3DK.%26aulast%3DNi%26aufirst%3DX.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DHeering%26aufirst%3DJ.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DThe%2520orphan%2520nuclear%2520receptor%2520Nurr1%2520is%2520responsive%2520to%2520non-steroidal%2520anti-inflammatory%2520drugs%26jtitle%3DCommun.%2520Chem.%26date%3D2020%26volume%3D3%26spage%3D85%26doi%3D10.1038%2Fs42004-020-0331-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shifera, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardin, J. A.</span></span> <span> </span><span class="NLM_article-title">Factors modulating expression of Renilla luciferase from control plasmids used in luciferase reporter gene assays</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>396</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2009.09.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.ab.2009.09.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=19788887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFShtbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2010&pages=167-172&author=A.+S.+Shiferaauthor=J.+A.+Hardin&title=Factors+modulating+expression+of+Renilla+luciferase+from+control+plasmids+used+in+luciferase+reporter+gene+assays&doi=10.1016%2Fj.ab.2009.09.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Factors modulating expression of Renilla luciferase from control plasmids used in luciferase reporter gene assays</span></div><div class="casAuthors">Shifera, Amde Selassie; Hardin, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-172</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Topics include: Renilla luciferase-expressing plasmids; promoter structure of Renilla luciferase in pRL-TK plasmid; factors that suppress the expression of transfected Renilla luciferase; factors that induce the expression of transfected Renilla luciferase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9MjTFtSAdZ7Vg90H21EOLACvtfcHk0lhwUqDirjZfMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFShtbzL&md5=09343dba2ad525eef6f93556b478e061</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2009.09.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2009.09.043%26sid%3Dliteratum%253Aachs%26aulast%3DShifera%26aufirst%3DA.%2BS.%26aulast%3DHardin%26aufirst%3DJ.%2BA.%26atitle%3DFactors%2520modulating%2520expression%2520of%2520Renilla%2520luciferase%2520from%2520control%2520plasmids%2520used%2520in%2520luciferase%2520reporter%2520gene%2520assays%26jtitle%3DAnal.%2520Biochem.%26date%3D2010%26volume%3D396%26spage%3D167%26epage%3D172%26doi%3D10.1016%2Fj.ab.2009.09.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atlasi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heaney, A. P.</span></span> <span> </span><span class="NLM_article-title">False responses of Renilla luciferase reporter control to nuclear receptor TR4</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>430</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1007/s11010-017-2961-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1007%2Fs11010-017-2961-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=28210900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFWitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2017&pages=139-147&author=D.+Zhangauthor=S.+S.+Atlasiauthor=K.+K.+Patelauthor=Z.+Zhuangauthor=A.+P.+Heaney&title=False+responses+of+Renilla+luciferase+reporter+control+to+nuclear+receptor+TR4&doi=10.1007%2Fs11010-017-2961-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">False responses of Renilla luciferase reporter control to nuclear receptor TR4</span></div><div class="casAuthors">Zhang, Dongyun; Atlasi, Sam S.; Patel, Krishna K.; Zhuang, Zihao; Heaney, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Renilla luciferase reporter is a widely used internal control in dual luciferase reporter assay system, where its transcription is driven by a constitutively active promoter.  However, the authenticity of the Renilla luciferase response in some exptl. settings has recently been questioned.  Testicular receptor 4 (TR4, also known as NR2C2) belongs to the subfamily 2 of nuclear receptors.  TR4 binds to a direct repeat regulatory element in the promoter of a variety of target genes and plays a key role in tumorigenesis, lipoprotein regulation, and central nervous system development.  In our exptl. system using murine pituitary corticotroph tumor AtT20 cells to investigate TR4 actions on POMC transcription, we found that overexpression of TR4 resulted in reduced Renilla luciferase expression whereas knockdown TR4 increased Renilla luciferase expression.  The TR4 inhibitory effect was mediated by the TR4 DNA-binding domain and behaved similarly to the GR and its agonist, Dexamethasone.  We further demonstrated that the chimeric intron, commonly present in various Renilla plasmid backbones such as pRL-Null, pRL-SV40, and pRL-TK, was responsible for TR4's inhibitory effect.  The results suggest that an intron-free Renilla luciferase reporter may provide a satisfactory internal control for TR4 at certain dose range.  Our findings advocate caution on the use of Renilla luciferase as an internal control in TR4-directed studies to avoid misleading data interpretation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSXvGIqbF5K7Vg90H21EOLACvtfcHk0lj8Jpjvjtl9Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFWitro%253D&md5=c3b156ec769c9e1c8e30357dfe0c0921</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1007%2Fs11010-017-2961-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-017-2961-9%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DAtlasi%26aufirst%3DS.%2BS.%26aulast%3DPatel%26aufirst%3DK.%2BK.%26aulast%3DZhuang%26aufirst%3DZ.%26aulast%3DHeaney%26aufirst%3DA.%2BP.%26atitle%3DFalse%2520responses%2520of%2520Renilla%2520luciferase%2520reporter%2520control%2520to%2520nuclear%2520receptor%2520TR4%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2017%26volume%3D430%26spage%3D139%26epage%3D147%26doi%3D10.1007%2Fs11010-017-2961-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinovic, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fröhlich, O.</span></span> <span> </span><span class="NLM_article-title">Pitfall of an internal control plasmid: response of Renilla luciferase (pRL-TK) plasmid to dihydrotestosterone and dexamethasone</span>. <i>Biotechniques</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">782</span>– <span class="NLM_lpage">784</span>, <span class="refDoi"> DOI: 10.2144/00294st04</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.2144%2F00294st04" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=11056808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVymtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=782-784&author=N.+M.+Ibrahimauthor=A.+C.+Marinovicauthor=S.+R.+Priceauthor=L.+G.+Youngauthor=O.+Fr%C3%B6hlich&title=Pitfall+of+an+internal+control+plasmid%3A+response+of+Renilla+luciferase+%28pRL-TK%29+plasmid+to+dihydrotestosterone+and+dexamethasone&doi=10.2144%2F00294st04"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Pitfall of an internal control plasmid: response of Renilla luciferase (pRL-TK) plasmid to dihydrotestosterone and dexamethasone</span></div><div class="casAuthors">Ibrahim, N. M.; Marinovic, A. C.; Price, S. R.; Young, L. G.; Frohlich, O.</div><div class="citationInfo"><span class="NLM_cas:title">BioTechniques</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">782-784</span>CODEN:
                <span class="NLM_cas:coden">BTNQDO</span>;
        ISSN:<span class="NLM_cas:issn">0736-6205</span>.
    
            (<span class="NLM_cas:orgname">Eaton Publishing Co.</span>)
        </div><div class="casAbstract">The thymidine kinase promoter-Renilla luciferase reporter plasmid (pRL-TK) is commonly used as a control for transfection efficiency in the Dual-Luciferase Reporter Assay System.  While investigating hormone response elements in the promoters of the androgen-dependent, epididymis-specific EP2 gene, the authors found that hormone treatment affected the luciferase activity of pRL-TK-transfected cells.  In African Green Monkey Kidney (CV-1) cells, cotransfected transiently with a hormone-responsive promoter-firefly luciferase reporter plasmid and with pRL-TK, Renilla luciferase activity increased in response to dihydrotestosterone (DHT) and decreased in response to dexamethasone (DEX).  When a thromboxane synthase promoter Renilla luciferase plasmid (pRL-TS) was used in place of pRL-TK, Renilla luciferase activity remained const. in CV-1 cells treated with DHT but decreased in CV-1 cells treated with DEX.  In transfection studies, internal control plasmid expression in response to treatment must be carefully monitored to ensure proper interpretation of normalized results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYXvxbIMVfe7Vg90H21EOLACvtfcHk0lj8Jpjvjtl9Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVymtr8%253D&md5=2d300340bd5983e00ceb5a1944ec4eda</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.2144%2F00294st04&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2144%252F00294st04%26sid%3Dliteratum%253Aachs%26aulast%3DIbrahim%26aufirst%3DN.%2BM.%26aulast%3DMarinovic%26aufirst%3DA.%2BC.%26aulast%3DPrice%26aufirst%3DS.%2BR.%26aulast%3DYoung%26aufirst%3DL.%2BG.%26aulast%3DFr%25C3%25B6hlich%26aufirst%3DO.%26atitle%3DPitfall%2520of%2520an%2520internal%2520control%2520plasmid%253A%2520response%2520of%2520Renilla%2520luciferase%2520%2528pRL-TK%2529%2520plasmid%2520to%2520dihydrotestosterone%2520and%2520dexamethasone%26jtitle%3DBiotechniques%26date%3D2000%26volume%3D29%26spage%3D782%26epage%3D784%26doi%3D10.2144%2F00294st04" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovin, B. H.</span></span> <span> </span><span class="NLM_article-title">Unexpected sensitivity of synthetic Renilla luciferase control vectors to treatment with a cyclopentenone prostaglandin</span>. <i>Biotechniques</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1144</span>– <span class="NLM_lpage">1148</span>, <span class="refDoi"> DOI: 10.2144/03356bm04</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.2144%2F03356bm04" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=14682047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVart74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=1144-1148&author=X.+Zhangauthor=H.-Z.+Chenauthor=B.+H.+Rovin&title=Unexpected+sensitivity+of+synthetic+Renilla+luciferase+control+vectors+to+treatment+with+a+cyclopentenone+prostaglandin&doi=10.2144%2F03356bm04"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Unexpected sensitivity of synthetic Renilla luciferase control vectors to treatment with a cyclopentenone prostaglandin</span></div><div class="casAuthors">Zhang, Xiaolan; Chen, Hui-zi; Rovin, Brad H.</div><div class="citationInfo"><span class="NLM_cas:title">BioTechniques</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1144,1146,1148</span>CODEN:
                <span class="NLM_cas:coden">BTNQDO</span>;
        ISSN:<span class="NLM_cas:issn">0736-6205</span>.
    
            (<span class="NLM_cas:orgname">Eaton Publishing Co.</span>)
        </div><div class="casAbstract">The sensitivity of Renilla luciferase reporter vectors, phRG-TK and phRG-B, to the cyclopentenone prostaglandin 15-deoxy-Δ 12,14-prostaglandin J2 (15d-PGJ2) and the cytokines interleukin-1β (IL-1β) and tumor necrosis factor-α was studied.  15D-PGJ2 displayed dose-dependent inhibition of phRG-TK and phRG-B expression, while its solvent, Me acetate, had little effect.  The max. inhibition of Renilla expression for both vectors was achieved with concns. of 15d-PGJ2 between 7.5 and 10 μM.  These 15d-PGJ2 concns. were non-toxic, but cellular toxicity as characterized by cell shrinkage, development of cytoplasmic vesicles, and detachment from the culture flasks was apparent at concns. of 15 μM or greater.  The inhibition of Renilla expression was stimulus-specific because IL-1β and TNF-α had no significant effect on phRG-TK or phRG-B activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNIuz401O9nrVg90H21EOLACvtfcHk0lj8Jpjvjtl9Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVart74%253D&md5=7dfb3eb87c50721f8b21fb7a733d5b2f</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.2144%2F03356bm04&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2144%252F03356bm04%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.-Z.%26aulast%3DRovin%26aufirst%3DB.%2BH.%26atitle%3DUnexpected%2520sensitivity%2520of%2520synthetic%2520Renilla%2520luciferase%2520control%2520vectors%2520to%2520treatment%2520with%2520a%2520cyclopentenone%2520prostaglandin%26jtitle%3DBiotechniques%26date%3D2003%26volume%3D35%26spage%3D1144%26epage%3D1148%26doi%3D10.2144%2F03356bm04" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. M.</span></span> <span> </span><span class="NLM_article-title">Comparison of the responsiveness of the pGL3 and pGL4 luciferase reporter vectors to steroid hormones</span>. <i>Biotechniques</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.2144/05392st02</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.2144%2F05392ST02" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=16116793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2MXot1Cls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2005&pages=203-207&author=D.+C.+Doughertyauthor=M.+M.+Sanders&title=Comparison+of+the+responsiveness+of+the+pGL3+and+pGL4+luciferase+reporter+vectors+to+steroid+hormones&doi=10.2144%2F05392st02"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the responsiveness of the pGL3 and pGL4 luciferase reporter vectors to steroid hormones</span></div><div class="casAuthors">Dougherty, Dawne C.; Sanders, Michel M.</div><div class="citationInfo"><span class="NLM_cas:title">BioTechniques</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-207</span>CODEN:
                <span class="NLM_cas:coden">BTNQDO</span>;
        ISSN:<span class="NLM_cas:issn">0736-6205</span>.
    
            (<span class="NLM_cas:orgname">Informa Life Sciences Publishing</span>)
        </div><div class="casAbstract">The ovalbumin gene (Ov) gene is responsive to estrogen, glucocorticoid, androgen, and progesterone.  In our efforts to characterize the regulation of the Ov gene by steroid hormones, we have repeatedly obsd. that many vector backbones and promoters are responsive to steroids.  In order to det. which vectors are most suitable for these types of analyses, vectors from Promega's pGL3 and newly engineered pGL4 Dual-Luciferase Reporter Assay System were tested with both estrogen and/or corticosterone.  The results confirmed that both series are induced by glucocorticoids in transient transfections of primary oviduct tubular gland cells, which contain glucocorticoid receptors, but not in MCF-7 cells, which do not.  Modest effects that were dependent upon backbone and promoter context were obsd. with both series of vectors with estrogen.  Thus, use of these vectors for expts. analyzing the effects of steroid hormones, esp. glucocorticoids, should be done with caution.  However, the new pGL4 series does have some advantages over the older series, and a comparison of transcription factor binding sites is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9cCVC4zLDUrVg90H21EOLACvtfcHk0livkxj7_b0g_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXot1Cls7w%253D&md5=bfe5a8538cadc4dff549aab6b5677e64</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.2144%2F05392ST02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2144%252F05392ST02%26sid%3Dliteratum%253Aachs%26aulast%3DDougherty%26aufirst%3DD.%2BC.%26aulast%3DSanders%26aufirst%3DM.%2BM.%26atitle%3DComparison%2520of%2520the%2520responsiveness%2520of%2520the%2520pGL3%2520and%2520pGL4%2520luciferase%2520reporter%2520vectors%2520to%2520steroid%2520hormones%26jtitle%3DBiotechniques%26date%3D2005%26volume%3D39%26spage%3D203%26epage%3D207%26doi%3D10.2144%2F05392st02" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norris, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fetler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. A.</span></span> <span> </span><span class="NLM_article-title">NMRFx Processor: a cross-platform NMR data processing program</span>. <i>J. Biomol. NMR</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1007/s10858-016-0049-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1007%2Fs10858-016-0049-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=27457481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1eisb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=205-216&author=M.+Norrisauthor=B.+Fetlerauthor=J.+Marchantauthor=B.+A.+Johnson&title=NMRFx+Processor%3A+a+cross-platform+NMR+data+processing+program&doi=10.1007%2Fs10858-016-0049-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">NMRFx Processor: a cross-platform NMR data processing program</span></div><div class="casAuthors">Norris, Michael; Fetler, Bayard; Marchant, Jan; Johnson, Bruce A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">205-216</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review NMRFx Processor is a new program for the processing of NMR data.  Written in the Java programming language, NMRFx Processor is a cross-platform application and runs on Linux, Mac OS X and Windows operating systems.  The application can be run in both a graphical user interface (GUI) mode and from the command line.  Processing scripts are written in the Python programming language and executed so that the low-level Java commands are automatically run in parallel on computers with multiple cores or CPUs.  Processing scripts can be generated automatically from the parameters of NMR expts. or interactively constructed in the GUI.  A wide variety of processing operations are provided, including methods for processing of non-uniformly sampled datasets using iterative soft thresholding.  The interactive GUI also enables the use of the program as an educational tool for teaching basic and advanced techniques in NMR data anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6T1V_iPMP4rVg90H21EOLACvtfcHk0livkxj7_b0g_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1eisb3I&md5=7589f77c3e33a1db07e1ce15dc04cefc</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs10858-016-0049-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10858-016-0049-6%26sid%3Dliteratum%253Aachs%26aulast%3DNorris%26aufirst%3DM.%26aulast%3DFetler%26aufirst%3DB.%26aulast%3DMarchant%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DB.%2BA.%26atitle%3DNMRFx%2520Processor%253A%2520a%2520cross-platform%2520NMR%2520data%2520processing%2520program%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D2016%26volume%3D65%26spage%3D205%26epage%3D216%26doi%3D10.1007%2Fs10858-016-0049-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. A.</span></span> <span> </span><span class="NLM_article-title">Using NMRView to visualize and analyze the NMR spectra of macromolecules</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1385/1-59259-809-9:313</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1385%2F1-59259-809-9%3A313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=15318002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVWiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2004&pages=313-352&author=B.+A.+Johnson&title=Using+NMRView+to+visualize+and+analyze+the+NMR+spectra+of+macromolecules&doi=10.1385%2F1-59259-809-9%3A313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Using NMRView to visualize and analyze the NMR spectra of macromolecules</span></div><div class="casAuthors">Johnson, Bruce A.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">Protein NMR Techniques</span>),
    <span class="NLM_cas:pages">313-352</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">NMR expts. on macromols. can generate a tremendous amt. of data that must be analyzed and correlated to generate conclusions about the structure and dynamics of the mol. system.  NMRView is a computer program that is designed to be useful in visualizing and analyzing these data.  NMRView works with various types of NMR datasets and can have multiple datasets and display windows opened simultaneously.  Virtually all actions of the program can be controlled through the Tcl scripting language, and new graphical user interface components can be added with the Tk toolkit.  NMR spectral peaks can be analyzed and assigned.  A suite of tools exists within NMRView for assigning the data from triple-resonance expts.  The std. method for obtaining the most up-to-date version of NMRView is by downloading it from the website www.onemoonscientific.com.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKmaQ9ZKQqsbVg90H21EOLACvtfcHk0livkxj7_b0g_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVWiu7s%253D&md5=640e0e779a459334090ea4536627d179</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1385%2F1-59259-809-9%3A313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1-59259-809-9%253A313%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DB.%2BA.%26atitle%3DUsing%2520NMRView%2520to%2520visualize%2520and%2520analyze%2520the%2520NMR%2520spectra%2520of%2520macromolecules%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2004%26volume%3D278%26spage%3D313%26epage%3D352%26doi%3D10.1385%2F1-59259-809-9%3A313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michiels, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dongen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Günther, U.</span></span> <span> </span><span class="NLM_article-title">Assignment of the orphan nuclear receptor Nurr1 by NMR</span>. <i>Biomol. NMR Assignments</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1007/s12104-010-9210-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1007%2Fs12104-010-9210-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=20300892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVGrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=101-105&author=P.+Michielsauthor=K.+Atkinsauthor=C.+Ludwigauthor=S.+Whittakerauthor=M.+van+Dongenauthor=U.+G%C3%BCnther&title=Assignment+of+the+orphan+nuclear+receptor+Nurr1+by+NMR&doi=10.1007%2Fs12104-010-9210-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Assignment of the orphan nuclear receptor Nurr1 by NMR</span></div><div class="casAuthors">Michiels, Paul; Atkins, Karen; Ludwig, Christian; Whittaker, Sara; Dongen, Maria; Gunther, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecular NMR Assignments</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-105</span>CODEN:
                <span class="NLM_cas:coden">BNAIBR</span>;
        ISSN:<span class="NLM_cas:issn">1874-2718</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The orphan nuclear receptor Nurr1 has been implicated in a no. of conditions including Parkinson's disease and Schizophrenia.  As such, it is of interest to study its interactions with other proteins, possibly mediated by small mols., considering possible use as a drug target.  The authors produced 2H, 15N, 13C labeled-Nurr1 to generate the backbone amide NH, carbonyl C', Calpha and Cbeta assignments.  About 84.0% of residues could be assigned.  Most of the 37 missing assignments fall in 3 regions of the protein.  Two of these surround a putative ligand-binding region of Nurr1, suggesting that this region of the protein is flexible, despite the ligand-binding pocket being filled with hydrophobic side-chains from residues surrounding the ligand binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouuGc7Wh9IvbVg90H21EOLACvtfcHk0livkxj7_b0g_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVGrs7w%253D&md5=7c084366b4c6410fa1397928b9516892</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs12104-010-9210-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12104-010-9210-4%26sid%3Dliteratum%253Aachs%26aulast%3DMichiels%26aufirst%3DP.%26aulast%3DAtkins%26aufirst%3DK.%26aulast%3DLudwig%26aufirst%3DC.%26aulast%3DWhittaker%26aufirst%3DS.%26aulast%3Dvan%2BDongen%26aufirst%3DM.%26aulast%3DG%25C3%25BCnther%26aufirst%3DU.%26atitle%3DAssignment%2520of%2520the%2520orphan%2520nuclear%2520receptor%2520Nurr1%2520by%2520NMR%26jtitle%3DBiomol.%2520NMR%2520Assignments%26date%3D2010%26volume%3D4%26spage%3D101%26epage%3D105%26doi%3D10.1007%2Fs12104-010-9210-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, M. P.</span></span> <span> </span><span class="NLM_article-title">Using chemical shift perturbation to characterise ligand binding</span>. <i>Prog. Nucl. Magn. Reson. Spectrosc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1016/j.pnmrs.2013.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=10.1016%2Fj.pnmrs.2013.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=23962882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1yrsbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=1-16&author=M.+P.+Williamson&title=Using+chemical+shift+perturbation+to+characterise+ligand+binding&doi=10.1016%2Fj.pnmrs.2013.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Using chemical shift perturbation to characterise ligand binding</span></div><div class="casAuthors">Williamson, Mike P.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Nuclear Magnetic Resonance Spectroscopy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">PNMRAT</span>;
        ISSN:<span class="NLM_cas:issn">0079-6565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chem. shift perturbation (CSP, chem. shift mapping or complexation-induced changes in chem. shift, CIS) follows changes in the chem. shifts of a protein when a ligand is added, and uses these to det. the location of the binding site, the affinity of the ligand, and/or possibly the structure of the complex.  A key factor in detg. the appearance of spectra during a titrn. is the exchange rate between free and bound, or more specifically the off-rate koff.  When koff is greater than the chem. shift difference between free and bound, which typically equates to an affinity Kd weaker than about 3 μM, then exchange is fast on the chem. shift timescale.  Under these circumstances, the obsd. shift is the population-weighted av. of free and bound, which allows Kd to be detd. from measurement of peak positions, provided the measurements are made appropriately. 1H shifts are influenced to a large extent by through-space interactions, whereas 13Cα and 13Cβ shifts are influenced more by through-bond effects. 15N and 13C' shifts are influenced both by through-bond and by through-space (hydrogen bonding) interactions.  For detg. the location of a bound ligand on the basis of shift change, the most appropriate method is therefore usually to measure 15N HSQC spectra, calc. the geometrical distance moved by the peak, weighting 15N shifts by a factor of about 0.14 compared to 1H shifts, and select those residues for which the weighted shift change is larger than the std. deviation of the shift for all residues.  Other methods are discussed, in particular the measurement of 13CH3 signals.  Slow to intermediate exchange rates lead to line broadening, and make Kd values very difficult to obtain.  There is no good way to distinguish changes in chem. shift due to direct binding of the ligand from changes in chem. shift due to allosteric change.  Ligand binding at multiple sites can often be characterized, by simultaneous fitting of many measured shift changes, or more simply by adding substoichiometric amts. of ligand.  The chem. shift changes can be used as restraints for docking ligand onto protein.  By use of quant. calcns. of ligand-induced chem. shift changes, it is becoming possible to det. not just the position but also the orientation of ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq34OdvCgPGqbVg90H21EOLACvtfcHk0li9ddy0XeMXgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1yrsbzE&md5=74fc06bb4f4b3df369619bbf730016ce</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.pnmrs.2013.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnmrs.2013.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DM.%2BP.%26atitle%3DUsing%2520chemical%2520shift%2520perturbation%2520to%2520characterise%2520ligand%2520binding%26jtitle%3DProg.%2520Nucl.%2520Magn.%2520Reson.%2520Spectrosc.%26date%3D2013%26volume%3D73%26spage%3D1%26epage%3D16%26doi%3D10.1016%2Fj.pnmrs.2013.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OVL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OVL','PDB','1OVL'); return false;">PDB: 1OVL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3V3Q" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3V3Q','PDB','3V3Q'); return false;">PDB: 3V3Q</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DDA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DDA','PDB','6DDA'); return false;">PDB: 6DDA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5Y41" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5Y41','PDB','5Y41'); return false;">PDB: 5Y41</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i23"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00894">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_26113"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00894?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00894</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">HPLC data for in-house synthesized compounds and CoA data for purchased compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00894/suppl_file/jm0c00894_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00894/suppl_file/jm0c00894_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00894/suppl_file/jm0c00894_si_001.pdf">jm0c00894_si_001.pdf (3.98 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00894/suppl_file/jm0c00894_si_002.csv">jm0c00894_si_002.csv (0.87 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00894&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-24%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00894%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00894" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                11MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0da3b2f552495","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
